sampleID	_EVENT	_INTEGRATION	OS.time	OS	OS.unit	_PATIENT	RFS.time	RFS	RFS.unit	_TIME_TO_EVENT	_TIME_TO_EVENT_UNIT	_cohort	_primary_disease	_primary_site	additional_pharmaceutical_therapy	additional_radiation_therapy	age_at_initial_pathologic_diagnosis	bcr_followup_barcode	bcr_patient_barcode	bcr_sample_barcode	biochemical_recurrence	bone_scan_results	clinical_M	clinical_T	days_to_birth	days_to_bone_scan_performed	days_to_collection	days_to_death	days_to_diagnostic_computed_tomography_performed	days_to_diagnostic_mri_performed	days_to_first_biochemical_recurrence	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_new_tumor_event_after_initial_treatment	days_to_psa	days_to_second_biochemical_recurrence	days_to_third_biochemical_recurrence	diagnostic_ct_abd_pelvis_performed	diagnostic_ct_abd_pelvis_result	diagnostic_mri_performed	diagnostic_mri_result	followup_case_report_form_submission_reason	followup_treatment_success	form_completion_date	gender	gleason_score	histological_type	history_of_neoadjuvant_treatment	icd_10	icd_o_3_histology	icd_o_3_site	informed_consent_verified	initial_pathologic_diagnosis_method	initial_weight	intermediate_dimension	is_ffpe	laterality	longest_dimension	lost_follow_up	lymphnodes_examined	new_neoplasm_event_occurrence_anatomic_site	new_neoplasm_event_type	new_neoplasm_occurrence_anatomic_site_text	new_tumor_event_after_initial_treatment	number_of_lymphnodes_examined	number_of_lymphnodes_positive_by_he	oct_embedded	other_dx	pathologic_N	pathologic_T	pathology_report_file_name	patient_death_reason	patient_id	person_neoplasm_cancer_status	primary_pattern	primary_therapy_outcome_success	psa_value	radiation_therapy	residual_tumor	sample_type	sample_type_id	secondary_pattern	shortest_dimension	source_of_patient_death_reason	targeted_molecular_therapy	tertiary_pattern	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	tumor_level	tumor_progression_post_ht	tumor_tissue_site	type_ofprogression_of_disease_ht	vial_number	vital_status	year_of_initial_pathologic_diagnosis	zone_of_origin	_GENOMIC_ID_TCGA_PRAD_exp_HiSeqV2_exon	_GENOMIC_ID_TCGA_PRAD_gistic2thd	_GENOMIC_ID_TCGA_PRAD_hMethyl450	_GENOMIC_ID_TCGA_PRAD_mutation	_GENOMIC_ID_TCGA_PRAD_mutation_broad_gene	_GENOMIC_ID_TCGA_PRAD_exp_HiSeqV2	_GENOMIC_ID_TCGA_PRAD_PDMRNAseq	_GENOMIC_ID_TCGA_PRAD_miRNA_HiSeq	_GENOMIC_ID_TCGA_PRAD_RPPA	_GENOMIC_ID_TCGA_PRAD_gistic2	_GENOMIC_ID_TCGA_PRAD_exp_HiSeqV2_percentile	_GENOMIC_ID_TCGA_PRAD_PDMRNAseqCNV	_GENOMIC_ID_data/public/TCGA/PRAD/miRNA_HiSeq_gene	_GENOMIC_ID_TCGA_PRAD_mutation_bcm_gene	_GENOMIC_ID_TCGA_PRAD_mutation_curated_broad_gene	_GENOMIC_ID_TCGA_PRAD_exp_HiSeqV2_PANCAN
TCGA-2A-A8VL-01	0	TCGA-2A-A8VL-01	621	0	days	TCGA-2A-A8VL	621	0	days	621	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			51	TCGA-2A-A8VL-F71759	TCGA-2A-A8VL	TCGA-2A-A8VL-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-18658	21	1273					0	621		585			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	140		NO	Left		NO	YES				NO	15	0	true	No	N0	T2b	TCGA-2A-A8VL.FC65B44D-EDAD-4A48-A564-8721C5CD3AA8.pdf		A8VL	TUMOR FREE	3		0.05	NO	R0	Primary Tumor	01	3			NO	4	NO	YES	2A	Middle|Base		Prostate		A	LIVING	2010	Peripheral Zone	e10fe58f-7ceb-4ad8-bce3-5ffbefc05cb5	TCGA-2A-A8VL-01A-21D-A376-01	TCGA-2A-A8VL-01A-21D-A378-05		TCGA-2A-A8VL-01A-21D-A377-08	e10fe58f-7ceb-4ad8-bce3-5ffbefc05cb5	TCGA-2A-A8VL-01	TCGA-2A-A8VL-01	1487FD23-ED22-4942-86D6-CF19837F63B9	TCGA-2A-A8VL-01A-21D-A376-01	e10fe58f-7ceb-4ad8-bce3-5ffbefc05cb5	TCGA-2A-A8VL-01	TCGA-2A-A8VL-01		TCGA-2A-A8VL-01A-21D-A377-08	e10fe58f-7ceb-4ad8-bce3-5ffbefc05cb5
TCGA-2A-A8VO-01	0	TCGA-2A-A8VO-01	1701	0	days	TCGA-2A-A8VO	1701	0	days	1701	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57	TCGA-2A-A8VO-F71780	TCGA-2A-A8VO	TCGA-2A-A8VO-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-20958	22	1290		11	84		0	1701		1332			YES	No Evidence of Extraprostatic Extension	YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	110		NO	Bilateral		NO	NO				NO			true	No		T3a	TCGA-2A-A8VO.B699D2D8-1EB6-4BFE-A468-D1FFA5F32D98.pdf		A8VO	TUMOR FREE	3		0.05	NO	R1	Primary Tumor	01	3			NO	4	NO	YES	2A	Apex|Middle|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones	20a779a3-04ab-4080-b11d-ed7b22fcd2da	TCGA-2A-A8VO-01A-11D-A376-01	TCGA-2A-A8VO-01A-11D-A378-05		TCGA-2A-A8VO-01A-11D-A377-08	20a779a3-04ab-4080-b11d-ed7b22fcd2da	TCGA-2A-A8VO-01	TCGA-2A-A8VO-01	FF23B458-D1F8-4001-A8E3-7F8785435C76	TCGA-2A-A8VO-01A-11D-A376-01	20a779a3-04ab-4080-b11d-ed7b22fcd2da	TCGA-2A-A8VO-01	TCGA-2A-A8VO-01		TCGA-2A-A8VO-01A-11D-A377-08	20a779a3-04ab-4080-b11d-ed7b22fcd2da
TCGA-2A-A8VT-01	0	TCGA-2A-A8VT-01	1373	0	days	TCGA-2A-A8VT	1373	0	days	1373	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			47	TCGA-2A-A8VT-F71798	TCGA-2A-A8VT	TCGA-2A-A8VT-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-17365	4	923		-2	4		0	1373		995			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Stable Disease	2015-3-31	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	140		NO	Bilateral		NO	YES				NO	16	2	true	No	N1	T4	TCGA-2A-A8VT.9A772AE3-EDB9-4AAB-8883-6BA9CBCA71CD.pdf		A8VT	TUMOR FREE	4	Complete Remission/Response	0.05	YES	R1	Primary Tumor	01	5			YES		NO	YES	2A	Apex|Middle|Base		Prostate		A	LIVING	2011	Overlapping / Multiple Zones	2e80aebe-77b5-496c-bde9-494b9b94ee3f	TCGA-2A-A8VT-01A-11D-A376-01	TCGA-2A-A8VT-01A-11D-A378-05		TCGA-2A-A8VT-01A-11D-A377-08	2e80aebe-77b5-496c-bde9-494b9b94ee3f	TCGA-2A-A8VT-01	TCGA-2A-A8VT-01	931CEBFB-011C-4797-8E05-8012D3ADC601	TCGA-2A-A8VT-01A-11D-A376-01	2e80aebe-77b5-496c-bde9-494b9b94ee3f	TCGA-2A-A8VT-01	TCGA-2A-A8VT-01		TCGA-2A-A8VT-01A-11D-A377-08	2e80aebe-77b5-496c-bde9-494b9b94ee3f
TCGA-2A-A8VV-01	0	TCGA-2A-A8VV-01	671	0	days	TCGA-2A-A8VV	671	0	days	671	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			52	TCGA-2A-A8VV-F71800	TCGA-2A-A8VV	TCGA-2A-A8VV-01A	NO	Equivocal	M0	T2b	-19065	167	1155		29	204		0	671		560			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	140		NO	Right		NO	YES				NO	16	0	true	No	N0	T2b	TCGA-2A-A8VV.E42BC148-77A7-4FEB-9ACE-8BC2FFD33BF7.pdf		A8VV	TUMOR FREE	3		0.05	NO	R0	Primary Tumor	01	3			NO	4	NO	YES	2A	Apex|Middle		Prostate		A	LIVING	2010	Peripheral Zone	45eca81f-9ce2-4de6-b970-65959d76398c	TCGA-2A-A8VV-01A-11D-A376-01	TCGA-2A-A8VV-01A-11D-A378-05		TCGA-2A-A8VV-01A-11D-A377-08	45eca81f-9ce2-4de6-b970-65959d76398c	TCGA-2A-A8VV-01	TCGA-2A-A8VV-01	443A2276-226E-4D27-936C-3B25B14E7121	TCGA-2A-A8VV-01A-11D-A376-01	45eca81f-9ce2-4de6-b970-65959d76398c	TCGA-2A-A8VV-01	TCGA-2A-A8VV-01		TCGA-2A-A8VV-01A-11D-A377-08	45eca81f-9ce2-4de6-b970-65959d76398c
TCGA-2A-A8VX-01	0	TCGA-2A-A8VX-01	1378	0	days	TCGA-2A-A8VX	1378	0	days	1378	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			70	TCGA-2A-A8VX-F71804	TCGA-2A-A8VX	TCGA-2A-A8VX-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-25904	32	922		32	89		0	1378		1033			YES	Extraprostatic Extension  Localized (e.g. seminal vesicles)	YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	160		NO	Bilateral		NO	YES				NO	16	0	true	No	N0	T3b	TCGA-2A-A8VX.418E80EE-4886-43F5-9FB9-2619BC89351E.pdf		A8VX	TUMOR FREE	4		0.05	NO	R0	Primary Tumor	01	4			NO		NO	YES	2A	Middle		Prostate		A	LIVING	2011	Peripheral Zone	0ff237d2-9283-44c7-bfae-c2020c73b94c	TCGA-2A-A8VX-01A-11D-A376-01	TCGA-2A-A8VX-01A-11D-A378-05		TCGA-2A-A8VX-01A-11D-A377-08	0ff237d2-9283-44c7-bfae-c2020c73b94c	TCGA-2A-A8VX-01	TCGA-2A-A8VX-01	1A003DC8-7045-4F90-A768-F2E88FE31242	TCGA-2A-A8VX-01A-11D-A376-01	0ff237d2-9283-44c7-bfae-c2020c73b94c	TCGA-2A-A8VX-01	TCGA-2A-A8VX-01			0ff237d2-9283-44c7-bfae-c2020c73b94c
TCGA-2A-A8W1-01	0	TCGA-2A-A8W1-01	112	0	days	TCGA-2A-A8W1	112	0	days	112	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			54	TCGA-2A-A8W1-F71808	TCGA-2A-A8W1	TCGA-2A-A8W1-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-19964	27	888					0	112		-122			NO		NO		Scheduled Follow-up Submission		2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	140		NO	Left		NO	YES				NO	12	0	true	No	N0	T3a	TCGA-2A-A8W1.3A4CC21B-D751-49EA-BCFB-785B683423A0.pdf		A8W1		4		0.05		R1	Primary Tumor	01	3					NO	YES	2A	Middle|Base		Prostate		A	LIVING	2011	Peripheral Zone	6b22709e-8b89-4a67-9530-3004467b91f6	TCGA-2A-A8W1-01A-11D-A376-01	TCGA-2A-A8W1-01A-11D-A378-05		TCGA-2A-A8W1-01A-11D-A377-08	6b22709e-8b89-4a67-9530-3004467b91f6	TCGA-2A-A8W1-01	TCGA-2A-A8W1-01	D7CB443D-93C9-44D5-BAE3-7213ED9AFA1B	TCGA-2A-A8W1-01A-11D-A376-01	6b22709e-8b89-4a67-9530-3004467b91f6	TCGA-2A-A8W1-01	TCGA-2A-A8W1-01		TCGA-2A-A8W1-01A-11D-A377-08	6b22709e-8b89-4a67-9530-3004467b91f6
TCGA-2A-A8W3-01	0	TCGA-2A-A8W3-01	863	0	days	TCGA-2A-A8W3	198	1	days	863	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			69	TCGA-2A-A8W3-F71815	TCGA-2A-A8W3	TCGA-2A-A8W3-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-25557	13	882		13	-14	198	0	863	198	771			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission		2015-3-31	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	150		NO	Left		NO	YES		Biochemical evidence of disease		YES	3	0	true	No	N0	T3a	TCGA-2A-A8W3.EC74AC3A-610D-46E0-A4DA-1904E42E1EF8.pdf		A8W3	TUMOR FREE	4		.36	NO	R0	Primary Tumor	01	5			NO		NO	YES	2A	Apex|Middle|Base		Prostate		A	LIVING	2011	Peripheral Zone	a6841939-e9fa-43cf-9f64-b1b3c57a2576	TCGA-2A-A8W3-01A-11D-A376-01	TCGA-2A-A8W3-01A-11D-A378-05		TCGA-2A-A8W3-01A-11D-A377-08	a6841939-e9fa-43cf-9f64-b1b3c57a2576	TCGA-2A-A8W3-01	TCGA-2A-A8W3-01	9A1F9418-B028-436F-AE81-76CC55BC5C26	TCGA-2A-A8W3-01A-11D-A376-01	a6841939-e9fa-43cf-9f64-b1b3c57a2576	TCGA-2A-A8W3-01	TCGA-2A-A8W3-01		TCGA-2A-A8W3-01A-11D-A377-08	a6841939-e9fa-43cf-9f64-b1b3c57a2576
TCGA-2A-AAYF-01	0	TCGA-2A-AAYF-01	1364	0	days	TCGA-2A-AAYF	1364	0	days	1364	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57	TCGA-2A-AAYF-F71830	TCGA-2A-AAYF	TCGA-2A-AAYF-01A	NO		M0	T1c	-20866		897			186		0	1364		972			NO		YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	150		NO	Right		NO	NO				NO			true	No		T3a	TCGA-2A-AAYF.106166DD-946C-4DD0-85CA-5400104959DB.pdf		AAYF	TUMOR FREE	3	Complete Remission/Response	.05	NO	R0	Primary Tumor	01	4			NO		NO	YES	2A	Apex|Middle|Base		Prostate		A	LIVING	2011	Overlapping / Multiple Zones	fe001be4-0c13-4754-8888-3961c98ccfe9	TCGA-2A-AAYF-01A-11D-A41J-01	TCGA-2A-AAYF-01A-11D-A41L-05		TCGA-2A-AAYF-01A-11D-A41K-08	fe001be4-0c13-4754-8888-3961c98ccfe9	TCGA-2A-AAYF-01	TCGA-2A-AAYF-01	2EEECFF8-7822-40F0-97C8-109349680B9C	TCGA-2A-AAYF-01A-11D-A41J-01	fe001be4-0c13-4754-8888-3961c98ccfe9	TCGA-2A-AAYF-01	TCGA-2A-AAYF-01			fe001be4-0c13-4754-8888-3961c98ccfe9
TCGA-2A-AAYO-01	0	TCGA-2A-AAYO-01	1272	0	days	TCGA-2A-AAYO	1272	0	days	1272	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57	TCGA-2A-AAYO-F71840	TCGA-2A-AAYO	TCGA-2A-AAYO-01A	NO		M0	T1c	-21183		854			180		0	1272		922			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	80		NO	Bilateral		NO	NO				NO			true	No		T2c	TCGA-2A-AAYO.3889AA76-F350-4DA4-987B-79E8D2349262.pdf		AAYO	TUMOR FREE	3	Complete Remission/Response	.05	NO	R0	Primary Tumor	01	3			NO		NO	YES	2A	Apex|Middle		Prostate		A	LIVING	2011	Overlapping / Multiple Zones	024fc1c9-4502-4293-a555-9bb7e5536f45	TCGA-2A-AAYO-01A-11D-A41J-01	TCGA-2A-AAYO-01A-11D-A41L-05		TCGA-2A-AAYO-01A-11D-A41K-08	024fc1c9-4502-4293-a555-9bb7e5536f45	TCGA-2A-AAYO-01	TCGA-2A-AAYO-01	178E05AC-820A-47B5-9541-4E0CA13BFBF2	TCGA-2A-AAYO-01A-11D-A41J-01	024fc1c9-4502-4293-a555-9bb7e5536f45	TCGA-2A-AAYO-01	TCGA-2A-AAYO-01			024fc1c9-4502-4293-a555-9bb7e5536f45
TCGA-2A-AAYU-01	0	TCGA-2A-AAYU-01	615	0	days	TCGA-2A-AAYU	615	0	days	615	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			56	TCGA-2A-AAYU-F71848	TCGA-2A-AAYU	TCGA-2A-AAYU-01A	NO		M0	T1c	-20582		693			52		0	615		269			NO		YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Scheduled Follow-up Submission		2015-3-31	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	140		NO	Left		NO	YES				NO	28	0	true	No	N0	T3a	TCGA-2A-AAYU.6CD9378F-F5A6-4214-8685-3D56ED6ADB0B.pdf		AAYU	TUMOR FREE	3	Complete Remission/Response	.05	NO	R1	Primary Tumor	01	3			NO	4	NO	YES	2A	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones	a16dcbd7-29fc-4dc3-8b6b-43a06c355e9d	TCGA-2A-AAYU-01A-11D-A41J-01	TCGA-2A-AAYU-01A-11D-A41L-05		TCGA-2A-AAYU-01A-11D-A41K-08	a16dcbd7-29fc-4dc3-8b6b-43a06c355e9d	TCGA-2A-AAYU-01	TCGA-2A-AAYU-01	38546E10-2A73-4CF8-B1F7-C70FDFFC57E3	TCGA-2A-AAYU-01A-11D-A41J-01	a16dcbd7-29fc-4dc3-8b6b-43a06c355e9d	TCGA-2A-AAYU-01	TCGA-2A-AAYU-01			a16dcbd7-29fc-4dc3-8b6b-43a06c355e9d
TCGA-4L-AA1F-01	0	TCGA-4L-AA1F-01	350	0	days	TCGA-4L-AA1F	350	0	days	350	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			64		TCGA-4L-AA1F	TCGA-4L-AA1F-01A	NO	Abnormal (not related to prostate cancer)	M1a	T2c	-23665	0	64		4	5		0	350		350			YES	Extraprostatic Extension  Localized (e.g. seminal vesicles)	YES	Extraprostatic Extension Localized (e.g. seminal vesicles)			2014-11-14	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	380		NO	Bilateral			YES				NO	4	0	false	No	N0	T3b	TCGA-4L-AA1F.A9DCC04F-A189-408C-9EE0-9F36F388068D.pdf		AA1F	TUMOR FREE	4	Complete Remission/Response	3.5	NO	R1	Primary Tumor	01	4			YES		YES	NO	4L	Middle		Prostate		A	LIVING	2013	Overlapping / Multiple Zones	824f212a-b8a3-429e-a8f1-df83302fa1cf	TCGA-4L-AA1F-01A-11D-A41J-01	TCGA-4L-AA1F-01A-11D-A41L-05		TCGA-4L-AA1F-01A-11D-A41K-08	824f212a-b8a3-429e-a8f1-df83302fa1cf	TCGA-4L-AA1F-01	TCGA-4L-AA1F-01	E46ACD7E-6629-4640-806B-53A68045B5A6	TCGA-4L-AA1F-01A-11D-A41J-01	824f212a-b8a3-429e-a8f1-df83302fa1cf	TCGA-4L-AA1F-01	TCGA-4L-AA1F-01			824f212a-b8a3-429e-a8f1-df83302fa1cf
TCGA-CH-5737-01	0	TCGA-CH-5737-01	91	0	days	TCGA-CH-5737			days	91	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			73		TCGA-CH-5737	TCGA-CH-5737-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-26753	91			91	91		0	91		[Discrepancy]			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension			2012-3-16	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.2		YES					8	0		No	N0	T2c	TCGA-CH-5737.dbf280bb-fb7c-422f-b772-a62381c19afa.pdf		5737	TUMOR FREE	4		14.69		R0	Primary Tumor	01	3	0.4				YES	NO	CH			Prostate		A	LIVING	2007	Peripheral Zone	b966ca07-fd34-4428-a460-1ba57a3e519d	TCGA-CH-5737-01A-11D-1574-01	TCGA-CH-5737-01A-11D-1578-05	TCGA-CH-5737-01A-11D-1576-08	TCGA-CH-5737-01A-11D-1576-08	b966ca07-fd34-4428-a460-1ba57a3e519d	TCGA-CH-5737-01	TCGA-CH-5737-01	8F22ABA7-7F51-4F7B-BD3B-E4A9A194A146	TCGA-CH-5737-01A-11D-1574-01	b966ca07-fd34-4428-a460-1ba57a3e519d	TCGA-CH-5737-01	TCGA-CH-5737-01	TCGA-CH-5737-01A-11D-1576-08	TCGA-CH-5737-01A-11D-1576-08	b966ca07-fd34-4428-a460-1ba57a3e519d
TCGA-CH-5738-01	0	TCGA-CH-5738-01	212	0	days	TCGA-CH-5738	212	0	days	212	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			72	TCGA-CH-5738-F28982	TCGA-CH-5738	TCGA-CH-5738-01A	NO		M0		-26329							0	212		195			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.3		NO				NO				No		[Discrepancy]	TCGA-CH-5738.3e17e46c-0c96-4930-b8ac-7acee8d40750.pdf		5738	TUMOR FREE	3	Complete Remission/Response	0.01	NO	R0	Primary Tumor	01	3	0.4		NO	4	YES	NO	CH			Prostate		A	LIVING	2006		e5db7986-223c-4ee2-a4c8-c4e8bbb510f3	TCGA-CH-5738-01A-11D-1574-01	TCGA-CH-5738-01A-11D-1578-05	TCGA-CH-5738-01A-11D-1576-08	TCGA-CH-5738-01A-11D-1576-08	e5db7986-223c-4ee2-a4c8-c4e8bbb510f3	TCGA-CH-5738-01	TCGA-CH-5738-01	65BA7F91-6227-4E96-9C20-EE84A8BFF2A5	TCGA-CH-5738-01A-11D-1574-01	e5db7986-223c-4ee2-a4c8-c4e8bbb510f3	TCGA-CH-5738-01	TCGA-CH-5738-01	TCGA-CH-5738-01A-11D-1576-08	TCGA-CH-5738-01A-11D-1576-08	e5db7986-223c-4ee2-a4c8-c4e8bbb510f3
TCGA-CH-5739-01	0	TCGA-CH-5739-01	671	0	days	TCGA-CH-5739	671	0	days	671	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			65	TCGA-CH-5739-F28977	TCGA-CH-5739	TCGA-CH-5739-01A	NO		M0		-23953							0	671		586			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Left	0.9		YES				NO	8	0		No	N0	T3a	TCGA-CH-5739.6db82b14-85e4-40c4-9827-a588c4a25ce8.pdf		5739	TUMOR FREE	3	Complete Remission/Response	0.02	NO	R0	Primary Tumor	01	4	0.4		NO		YES	NO	CH			Prostate		A	LIVING	2006	Peripheral Zone	26c39f49-cf54-41d6-8c46-c089f4a57002	TCGA-CH-5739-01A-11D-1574-01	TCGA-CH-5739-01A-11D-1578-05	TCGA-CH-5739-01A-11D-1576-08	TCGA-CH-5739-01A-11D-1576-08	26c39f49-cf54-41d6-8c46-c089f4a57002	TCGA-CH-5739-01	TCGA-CH-5739-01	16485141-1F4F-49FC-A8A8-85229B96D859	TCGA-CH-5739-01A-11D-1574-01	26c39f49-cf54-41d6-8c46-c089f4a57002	TCGA-CH-5739-01	TCGA-CH-5739-01	TCGA-CH-5739-01A-11D-1576-08	TCGA-CH-5739-01A-11D-1576-08	26c39f49-cf54-41d6-8c46-c089f4a57002
TCGA-CH-5740-01	0	TCGA-CH-5740-01	31	0	days	TCGA-CH-5740			days	31	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57		TCGA-CH-5740	TCGA-CH-5740-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-20880	31				31		0	31		[Discrepancy]			NO		YES	No Evidence of Extraprostatic Extension			2012-3-21	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1		YES					4	0		No	N0	T2c	TCGA-CH-5740.25992d81-7441-4d60-a773-457618dcedbc.pdf		5740	TUMOR FREE	3		1.6		R0	Primary Tumor	01	4	0.3				YES	NO	CH			Prostate		A	LIVING	2009		59173676-8eca-4a03-b37c-c726208a961a	TCGA-CH-5740-01A-11D-1574-01	TCGA-CH-5740-01A-11D-1578-05	TCGA-CH-5740-01A-11D-1576-08	TCGA-CH-5740-01A-11D-1576-08	59173676-8eca-4a03-b37c-c726208a961a	TCGA-CH-5740-01	TCGA-CH-5740-01	3E98A3E2-8D5D-4383-B8DE-EA3A0DEF3BE4	TCGA-CH-5740-01A-11D-1574-01	59173676-8eca-4a03-b37c-c726208a961a	TCGA-CH-5740-01	TCGA-CH-5740-01	TCGA-CH-5740-01A-11D-1576-08	TCGA-CH-5740-01A-11D-1576-08	59173676-8eca-4a03-b37c-c726208a961a
TCGA-CH-5741-01	0	TCGA-CH-5741-01	395	0	days	TCGA-CH-5741	395	0	days	395	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			56	TCGA-CH-5741-F29006	TCGA-CH-5741	TCGA-CH-5741-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-20759	30			30			0	395		339			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.1		YES				NO	5	1		No	N1	T3b	TCGA-CH-5741.87c977cc-2a28-49c9-adaf-f67c0bc208c2.pdf		5741	TUMOR FREE	4	Complete Remission/Response	0.02	YES	R1	Primary Tumor	01	5	0.4		YES		YES	NO	CH			Prostate		A	LIVING	2008	Overlapping / Multiple Zones	639c8d3c-8719-49ca-8812-af6480b164ae	TCGA-CH-5741-01A-11D-1574-01	TCGA-CH-5741-01A-11D-1578-05	TCGA-CH-5741-01A-11D-1576-08	TCGA-CH-5741-01A-11D-1576-08	639c8d3c-8719-49ca-8812-af6480b164ae	TCGA-CH-5741-01	TCGA-CH-5741-01	F9B2036F-7247-4D9E-8793-3E1418064091	TCGA-CH-5741-01A-11D-1574-01	639c8d3c-8719-49ca-8812-af6480b164ae	TCGA-CH-5741-01	TCGA-CH-5741-01	TCGA-CH-5741-01A-11D-1576-08	TCGA-CH-5741-01A-11D-1576-08	639c8d3c-8719-49ca-8812-af6480b164ae
TCGA-CH-5743-01	0	TCGA-CH-5743-01	425	0	days	TCGA-CH-5743	425	1	days	425	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	66	TCGA-CH-5743-F29001	TCGA-CH-5743	TCGA-CH-5743-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-24321	29			29			0	425	425	394			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.2		YES		New Primary Tumor		YES	1	0		No	N0	T2c	TCGA-CH-5743.e4f18f30-a6f0-4262-8f34-ce32db5cbe4a.pdf		5743	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.4		NO		YES	NO	CH			Prostate		A	LIVING	2008	Peripheral Zone	8f097693-4c17-42f4-b319-dd3b4ae93005	TCGA-CH-5743-01A-21D-1574-01	TCGA-CH-5743-01A-21D-1578-05	TCGA-CH-5743-01A-21D-1576-08	TCGA-CH-5743-01A-21D-1576-08	8f097693-4c17-42f4-b319-dd3b4ae93005	TCGA-CH-5743-01	TCGA-CH-5743-01	6C0A6447-8972-4D51-A953-658CF56860E6	TCGA-CH-5743-01A-21D-1574-01	8f097693-4c17-42f4-b319-dd3b4ae93005	TCGA-CH-5743-01	TCGA-CH-5743-01	TCGA-CH-5743-01A-21D-1576-08		8f097693-4c17-42f4-b319-dd3b4ae93005
TCGA-CH-5744-01	0	TCGA-CH-5744-01	60	0	days	TCGA-CH-5744			days	60	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			64		TCGA-CH-5744	TCGA-CH-5744-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-23621	60			60			0	60		48			YES	No Evidence of Extraprostatic Extension	NO				2012-3-16	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	0.5		YES					3	0		No	N0	T2c	TCGA-CH-5744.797db4c8-a9d9-4404-a520-9be024ced9d5.pdf		5744	TUMOR FREE	4		9.63		R0	Primary Tumor	01	3	0.2			5	YES	NO	CH			Prostate		A	LIVING	2008	Peripheral Zone	abf9624e-048a-412b-a0a8-331bb6fc5e16	TCGA-CH-5744-01A-11D-1574-01	TCGA-CH-5744-01A-11D-1578-05	TCGA-CH-5744-01A-11D-1576-08	TCGA-CH-5744-01A-11D-1576-08	abf9624e-048a-412b-a0a8-331bb6fc5e16	TCGA-CH-5744-01	TCGA-CH-5744-01	6A474A8E-78CD-4DFF-96B2-19A9C3F27541	TCGA-CH-5744-01A-11D-1574-01	abf9624e-048a-412b-a0a8-331bb6fc5e16	TCGA-CH-5744-01	TCGA-CH-5744-01	TCGA-CH-5744-01A-11D-1576-08	TCGA-CH-5744-01A-11D-1576-08	abf9624e-048a-412b-a0a8-331bb6fc5e16
TCGA-CH-5745-01	0	TCGA-CH-5745-01	91	0	days	TCGA-CH-5745			days	91	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			68		TCGA-CH-5745	TCGA-CH-5745-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-24837	91						0	91		84			NO		NO				2012-3-16	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO		0.8		YES					5	0		No	N0	T3a	TCGA-CH-5745.43e941e9-cfbd-45bc-91bb-28e5f5d9b767.pdf		5745	TUMOR FREE	3		4.3		R0	Primary Tumor	01	4	0.4				YES	NO	CH			Prostate		A	LIVING	2008	Overlapping / Multiple Zones	4ca3b9ec-cd21-46fc-9a44-05d5225f0c57		TCGA-CH-5745-01A-11D-1578-05	TCGA-CH-5745-01A-11D-1576-08	TCGA-CH-5745-01A-11D-1576-08	4ca3b9ec-cd21-46fc-9a44-05d5225f0c57	TCGA-CH-5745-01	TCGA-CH-5745-01	0F81C1A9-AF7E-44C9-8E30-F3AB5933967F		4ca3b9ec-cd21-46fc-9a44-05d5225f0c57		TCGA-CH-5745-01	TCGA-CH-5745-01A-11D-1576-08		4ca3b9ec-cd21-46fc-9a44-05d5225f0c57
TCGA-CH-5746-01	0	TCGA-CH-5746-01	731	0	days	TCGA-CH-5746	731	0	days	731	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57	TCGA-CH-5746-F28996	TCGA-CH-5746		NO	Normal (no evidence of prostate cancer) [cM0]	M0		-20941	59			59			0	731		693			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral			YES				NO	2	0		No	N0	T2c			5746	TUMOR FREE	3	Complete Remission/Response	0.1	YES	R1	Primary Tumor	01	4			NO		YES	NO	CH			Prostate			LIVING	2007		e129e211-8237-4842-a5f5-c3dc05607527	TCGA-CH-5746-01A-11D-1574-01	TCGA-CH-5746-01A-11D-1578-05	TCGA-CH-5746-01A-11D-1576-08	TCGA-CH-5746-01A-11D-1576-08	e129e211-8237-4842-a5f5-c3dc05607527	TCGA-CH-5746-01	TCGA-CH-5746-01		TCGA-CH-5746-01A-11D-1574-01	e129e211-8237-4842-a5f5-c3dc05607527	TCGA-CH-5746-01	TCGA-CH-5746-01	TCGA-CH-5746-01A-11D-1576-08	TCGA-CH-5746-01A-11D-1576-08	e129e211-8237-4842-a5f5-c3dc05607527
TCGA-CH-5748-01	0	TCGA-CH-5748-01	31	0	days	TCGA-CH-5748			days	31	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			64		TCGA-CH-5748	TCGA-CH-5748-01A					-23649							0	31					NO		NO				2012-3-21	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.3		YES					2	0		No	N0	T3a	TCGA-CH-5748.7d2d5d7d-481b-445d-8505-42564e11fce4.pdf		5748	WITH TUMOR	4				R1	Primary Tumor	01	3	0.4				YES	NO	CH			Prostate		A	LIVING	2009		8d91b55d-0a51-44d3-bcc7-d6d95027683a	TCGA-CH-5748-01A-11D-1574-01	TCGA-CH-5748-01A-11D-1578-05	TCGA-CH-5748-01A-11D-1576-08	TCGA-CH-5748-01A-11D-1576-08	8d91b55d-0a51-44d3-bcc7-d6d95027683a	TCGA-CH-5748-01	TCGA-CH-5748-01	F750FE39-81B7-498B-BB7E-651A578395C3	TCGA-CH-5748-01A-11D-1574-01	8d91b55d-0a51-44d3-bcc7-d6d95027683a	TCGA-CH-5748-01	TCGA-CH-5748-01	TCGA-CH-5748-01A-11D-1576-08	TCGA-CH-5748-01A-11D-1576-08	8d91b55d-0a51-44d3-bcc7-d6d95027683a
TCGA-CH-5750-01	0	TCGA-CH-5750-01	396	0	days	TCGA-CH-5750	396	0	days	396	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			72	TCGA-CH-5750-F29002	TCGA-CH-5750	TCGA-CH-5750-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-26389	31			31			0	396		337			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	0.9		YES				NO	7	0		No	N0	T2c	TCGA-CH-5750.4cbd15a8-2912-4a6d-bdc3-38a4ae4e1381.pdf		5750	TUMOR FREE	3	Complete Remission/Response	0.02	NO	R0	Primary Tumor	01	4	0.3		NO		YES	NO	CH			Prostate		A	LIVING	2008	Peripheral Zone	3d9ba7bd-ff22-44cf-ae6a-7588f5aa857f	TCGA-CH-5750-01A-11D-1574-01	TCGA-CH-5750-01A-11D-1578-05	TCGA-CH-5750-01A-11D-1576-08	TCGA-CH-5750-01A-11D-1576-08	3d9ba7bd-ff22-44cf-ae6a-7588f5aa857f	TCGA-CH-5750-01	TCGA-CH-5750-01	CD65E017-AF63-4C06-8DCF-A85B8602827E	TCGA-CH-5750-01A-11D-1574-01	3d9ba7bd-ff22-44cf-ae6a-7588f5aa857f	TCGA-CH-5750-01	TCGA-CH-5750-01	TCGA-CH-5750-01A-11D-1576-08	TCGA-CH-5750-01A-11D-1576-08	3d9ba7bd-ff22-44cf-ae6a-7588f5aa857f
TCGA-CH-5751-01	0	TCGA-CH-5751-01	1065	0	days	TCGA-CH-5751	365	1	days	1065	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	NO	68	TCGA-CH-5751-F28978	TCGA-CH-5751	TCGA-CH-5751-01A	NO	Equivocal	M0		-24957	92			92	92		0	1065	365	1004			YES	Equivocal	YES	Equivocal	Scheduled Follow-up Submission	Stable Disease	2012-2-15	MALE	10	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.5		YES	Bone	Distant Metastasis		YES	3	1		No	N1	T4	TCGA-CH-5751.c4240096-b982-4b8a-b871-677a94cfd6cc.pdf		5751	WITH TUMOR	5	Complete Remission/Response	0.01	NO	R1	Primary Tumor	01	5	0.5		YES		YES	NO	CH		YES	Prostate	Distant Metastasis	A	LIVING	2006	Overlapping / Multiple Zones	063f416b-291b-4242-acb4-9587a2dc3244	TCGA-CH-5751-01A-11D-1574-01	TCGA-CH-5751-01A-11D-1578-05	TCGA-CH-5751-01A-11D-1576-08	TCGA-CH-5751-01A-11D-1576-08	063f416b-291b-4242-acb4-9587a2dc3244	TCGA-CH-5751-01		05E7E615-27D5-4FAC-AB73-59CE4E5AAC57	TCGA-CH-5751-01A-11D-1574-01	063f416b-291b-4242-acb4-9587a2dc3244	TCGA-CH-5751-01		TCGA-CH-5751-01A-11D-1576-08	TCGA-CH-5751-01A-11D-1576-08	063f416b-291b-4242-acb4-9587a2dc3244
TCGA-CH-5752-01	0	TCGA-CH-5752-01	943	0	days	TCGA-CH-5752	943	0	days	943	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-CH-5752-F28987	TCGA-CH-5752	TCGA-CH-5752-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-24290	30			30			0	943		868			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	0.9		YES				NO	9	0		No	N0	T3a	TCGA-CH-5752.d3549715-b952-479c-8edf-86e424811095.pdf		5752	TUMOR FREE	4	Complete Remission/Response	0.02	YES	R0	Primary Tumor	01	4	0.5		YES		YES	NO	CH			Prostate		A	LIVING	2006	Overlapping / Multiple Zones	30861ba6-6539-47a5-82df-5f89d8101d05	TCGA-CH-5752-01A-11D-1574-01	TCGA-CH-5752-01A-11D-1578-05	TCGA-CH-5752-01A-11D-1576-08	TCGA-CH-5752-01A-11D-1576-08	30861ba6-6539-47a5-82df-5f89d8101d05	TCGA-CH-5752-01	TCGA-CH-5752-01	F80CE98E-5CF5-4CC1-8AE3-AFCF5CDA4DC2	TCGA-CH-5752-01A-11D-1574-01	30861ba6-6539-47a5-82df-5f89d8101d05	TCGA-CH-5752-01	TCGA-CH-5752-01	TCGA-CH-5752-01A-11D-1576-08	TCGA-CH-5752-01A-11D-1576-08	30861ba6-6539-47a5-82df-5f89d8101d05
TCGA-CH-5753-01	0	TCGA-CH-5753-01	31	0	days	TCGA-CH-5753			days	31	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			70		TCGA-CH-5753	TCGA-CH-5753-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-25780	31			31			0	31		31			YES	No Evidence of Extraprostatic Extension	NO				2012-3-21	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	1		YES					10	3		Yes	N1	T3b	TCGA-CH-5753.4e86e7fc-a1c5-4d3b-a0b3-23187adfd096.pdf		5753	TUMOR FREE	4		4.53		R0	Primary Tumor	01	5	0.2				YES	NO	CH			Prostate		A	LIVING	2008	Overlapping / Multiple Zones	2031e5cb-18c3-421e-b8af-d5dab73e3a89	TCGA-CH-5753-01A-11D-1574-01	TCGA-CH-5753-01A-11D-1578-05	TCGA-CH-5753-01A-11D-1576-08	TCGA-CH-5753-01A-11D-1576-08	2031e5cb-18c3-421e-b8af-d5dab73e3a89	TCGA-CH-5753-01	TCGA-CH-5753-01	0F729F85-0E45-4F8B-9E26-7F9589111251	TCGA-CH-5753-01A-11D-1574-01	2031e5cb-18c3-421e-b8af-d5dab73e3a89	TCGA-CH-5753-01	TCGA-CH-5753-01	TCGA-CH-5753-01A-11D-1576-08	TCGA-CH-5753-01A-11D-1576-08	2031e5cb-18c3-421e-b8af-d5dab73e3a89
TCGA-CH-5754-01	0	TCGA-CH-5754-01	62	0	days	TCGA-CH-5754			days	62	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			65		TCGA-CH-5754	TCGA-CH-5754-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-23803	62			62			0	62		62			YES	No Evidence of Extraprostatic Extension	NO				2012-3-21	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.2		YES					11	3		No	N1	T3b	TCGA-CH-5754.6c02cb0e-6826-46f0-8a9f-90f43cc1405c.pdf		5754	WITH TUMOR	4		37.36		R1	Primary Tumor	01	5	0.2			3	YES	NO	CH			Prostate		A	LIVING	2008	Peripheral Zone	51cd07b8-f680-4bc2-a207-d0317f5f9358	TCGA-CH-5754-01A-11D-1574-01	TCGA-CH-5754-01A-11D-1578-05	TCGA-CH-5754-01A-11D-1576-08	TCGA-CH-5754-01A-11D-1576-08	51cd07b8-f680-4bc2-a207-d0317f5f9358	TCGA-CH-5754-01	TCGA-CH-5754-01	8D5A8DE4-0020-4BDC-A119-E1A7698707BF	TCGA-CH-5754-01A-11D-1574-01	51cd07b8-f680-4bc2-a207-d0317f5f9358	TCGA-CH-5754-01	TCGA-CH-5754-01	TCGA-CH-5754-01A-11D-1576-08	TCGA-CH-5754-01A-11D-1576-08	51cd07b8-f680-4bc2-a207-d0317f5f9358
TCGA-CH-5761-01	0	TCGA-CH-5761-01	28	0	days	TCGA-CH-5761			days	28	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61		TCGA-CH-5761	TCGA-CH-5761-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-22433	28			28	28		0	28		39			YES	Equivocal	YES	Equivocal			2012-3-16	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Left	1		YES					5	0		No	N0	T3b	TCGA-CH-5761.205f9f59-486c-4211-aa60-0a5b4f746a74.pdf		5761	TUMOR FREE	5		8.49		R0	Primary Tumor	01	4	0.2			3	YES	NO	CH			Prostate		A	LIVING	2007	Peripheral Zone	e0f1b805-f155-47d8-a97e-7e611382cb76	TCGA-CH-5761-01A-11D-1574-01	TCGA-CH-5761-01A-11D-1578-05	TCGA-CH-5761-01A-11D-1576-08	TCGA-CH-5761-01A-11D-1576-08	e0f1b805-f155-47d8-a97e-7e611382cb76	TCGA-CH-5761-01	TCGA-CH-5761-01	ADAC7F52-F712-4716-970F-A1A57B09AAC1	TCGA-CH-5761-01A-11D-1574-01	e0f1b805-f155-47d8-a97e-7e611382cb76	TCGA-CH-5761-01	TCGA-CH-5761-01	TCGA-CH-5761-01A-11D-1576-08	TCGA-CH-5761-01A-11D-1576-08	e0f1b805-f155-47d8-a97e-7e611382cb76
TCGA-CH-5761-11	0	TCGA-CH-5761-11	28	0	days	TCGA-CH-5761			days	28	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61		TCGA-CH-5761		NO	Normal (no evidence of prostate cancer) [cM0]	M0		-22433	28			28	28		0	28		39			YES	Equivocal	YES	Equivocal			2012-3-16	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Left			YES					5	0		No	N0	T3b			5761	TUMOR FREE	5		8.49		R0	Solid Tissue Normal	11	4				3	YES	NO	CH			Prostate			LIVING	2007	Peripheral Zone	e3d00d08-5395-48b0-bd95-0c945e2a33fe		TCGA-CH-5761-11A-01D-1578-05			e3d00d08-5395-48b0-bd95-0c945e2a33fe		TCGA-CH-5761-11			e3d00d08-5395-48b0-bd95-0c945e2a33fe		TCGA-CH-5761-11			e3d00d08-5395-48b0-bd95-0c945e2a33fe
TCGA-CH-5762-01	0	TCGA-CH-5762-01	1339	0	days	TCGA-CH-5762	1339	0	days	1339	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			60	TCGA-CH-5762-F28975	TCGA-CH-5762	TCGA-CH-5762-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-22068	92			92			0	1339		1313			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-14	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.2		YES				NO	7	0		No	N0	T3b	TCGA-CH-5762.21608393-74f2-4a7b-aaf4-9b02cb7afc94.pdf		5762	WITH TUMOR	4	Complete Remission/Response	.01	YES	R1	Primary Tumor	01	3	0.4		NO		YES	NO	CH			Prostate		A	LIVING	2005	Peripheral Zone	bb36bff9-44fd-4f93-a82f-8c23658c335c	TCGA-CH-5762-01A-11D-1574-01	TCGA-CH-5762-01A-11D-1578-05	TCGA-CH-5762-01A-11D-1576-08	TCGA-CH-5762-01A-11D-1576-08	bb36bff9-44fd-4f93-a82f-8c23658c335c	TCGA-CH-5762-01	TCGA-CH-5762-01	B0A6FB3E-767B-424F-9DE3-51780E3190BD	TCGA-CH-5762-01A-11D-1574-01	bb36bff9-44fd-4f93-a82f-8c23658c335c	TCGA-CH-5762-01	TCGA-CH-5762-01	TCGA-CH-5762-01A-11D-1576-08	TCGA-CH-5762-01A-11D-1576-08	bb36bff9-44fd-4f93-a82f-8c23658c335c
TCGA-CH-5762-11	0	TCGA-CH-5762-11	1339	0	days	TCGA-CH-5762	1339	0	days	1339	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			60	TCGA-CH-5762-F28975	TCGA-CH-5762	TCGA-CH-5762-11A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-22068	92			92			0	1339		1313			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-14	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.1		YES				NO	7	0		No	N0	T3b			5762	WITH TUMOR	4	Complete Remission/Response	.01	YES	R1	Solid Tissue Normal	11	3	0.2		NO		YES	NO	CH			Prostate		A	LIVING	2005	Peripheral Zone			TCGA-CH-5762-11A-01D-1578-05													
TCGA-CH-5763-01	0	TCGA-CH-5763-01	365	0	days	TCGA-CH-5763	365	0	days	365	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-CH-5763-F28974	TCGA-CH-5763	TCGA-CH-5763-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-24380	0			0			0	365		360			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-14	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.5		YES				NO	5	0		Yes	N0	T3a	TCGA-CH-5763.8722bfbe-6db5-41ca-9ac4-004b999a772d.pdf		5763	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.4		NO		YES	NO	CH			Prostate		A	LIVING	2008	Peripheral Zone	40eb0b4a-3863-403f-a90b-919bfa24237e	TCGA-CH-5763-01A-11D-1574-01	TCGA-CH-5763-01A-11D-1578-05	TCGA-CH-5763-01A-11D-1576-08	TCGA-CH-5763-01A-11D-1576-08	40eb0b4a-3863-403f-a90b-919bfa24237e	TCGA-CH-5763-01	TCGA-CH-5763-01	6818B0E0-1156-48C3-9FBE-C38F045E740E	TCGA-CH-5763-01A-11D-1574-01	40eb0b4a-3863-403f-a90b-919bfa24237e	TCGA-CH-5763-01	TCGA-CH-5763-01	TCGA-CH-5763-01A-11D-1576-08	TCGA-CH-5763-01A-11D-1576-08	40eb0b4a-3863-403f-a90b-919bfa24237e
TCGA-CH-5763-11	0	TCGA-CH-5763-11	365	0	days	TCGA-CH-5763	365	0	days	365	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-CH-5763-F28974	TCGA-CH-5763	TCGA-CH-5763-11A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-24380	0			0			0	365		360			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-14	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.6		YES				NO	5	0		Yes	N0	T3a			5763	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Solid Tissue Normal	11	4	0.1		NO		YES	NO	CH			Prostate		A	LIVING	2008	Peripheral Zone			TCGA-CH-5763-11A-01D-1578-05													
TCGA-CH-5764-01	0	TCGA-CH-5764-01	31	0	days	TCGA-CH-5764			days	31	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66		TCGA-CH-5764	TCGA-CH-5764-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-24257	31			31			0	31		29			YES	No Evidence of Extraprostatic Extension	NO				2012-3-16	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.3	NO	Bilateral	1.5		YES					8	0		Yes	N0	T3b	TCGA-CH-5764.e7f4fceb-1960-44f0-8e0b-fde2337011ce.pdf		5764	TUMOR FREE	4		13.95		R0	Primary Tumor	01	3	0.3				YES	NO	CH			Prostate		A	LIVING	2008	Peripheral Zone	5bd95b46-d04b-49a9-964a-dd49570f4960	TCGA-CH-5764-01A-21D-1574-01	TCGA-CH-5764-01A-21D-1578-05	TCGA-CH-5764-01A-21D-1576-08	TCGA-CH-5764-01A-21D-1576-08	5bd95b46-d04b-49a9-964a-dd49570f4960	TCGA-CH-5764-01	TCGA-CH-5764-01	84F92AD0-2522-43F9-A6A6-51590A00CABD	TCGA-CH-5764-01A-21D-1574-01	5bd95b46-d04b-49a9-964a-dd49570f4960	TCGA-CH-5764-01	TCGA-CH-5764-01	TCGA-CH-5764-01A-21D-1576-08	TCGA-CH-5764-01A-21D-1576-08	5bd95b46-d04b-49a9-964a-dd49570f4960
TCGA-CH-5764-11	0	TCGA-CH-5764-11	31	0	days	TCGA-CH-5764			days	31	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66		TCGA-CH-5764	TCGA-CH-5764-11A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-24257	31			31			0	31		29			YES	No Evidence of Extraprostatic Extension	NO				2012-3-16	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	0.8		YES					8	0		Yes	N0	T3b			5764	TUMOR FREE	4		13.95		R0	Solid Tissue Normal	11	3	0.2				YES	NO	CH			Prostate		A	LIVING	2008	Peripheral Zone			TCGA-CH-5764-11A-01D-1578-05													
TCGA-CH-5765-01	0	TCGA-CH-5765-01	700	0	days	TCGA-CH-5765	700	0	days	700	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55	TCGA-CH-5765-F28995	TCGA-CH-5765	TCGA-CH-5765-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-20364	31			31			0	700		694			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.4		YES				NO	7	0		No	N0	T3a	TCGA-CH-5765.bf80f60e-d5c8-4a5b-b523-358c51ad7d2c.pdf		5765	TUMOR FREE	3	Complete Remission/Response	0.02	NO	R0	Primary Tumor	01	4	0.4		NO		YES	NO	CH			Prostate		A	LIVING	2007		b8cc1fb1-5944-431c-aeec-a4301721f667	TCGA-CH-5765-01A-11D-1574-01	TCGA-CH-5765-01A-11D-1578-05	TCGA-CH-5765-01A-11D-1576-08	TCGA-CH-5765-01A-11D-1576-08	b8cc1fb1-5944-431c-aeec-a4301721f667	TCGA-CH-5765-01	TCGA-CH-5765-01	8DBE9F5E-D6A3-4ADC-8FFA-DFCD1A93FBA0	TCGA-CH-5765-01A-11D-1574-01	b8cc1fb1-5944-431c-aeec-a4301721f667	TCGA-CH-5765-01	TCGA-CH-5765-01	TCGA-CH-5765-01A-11D-1576-08	TCGA-CH-5765-01A-11D-1576-08	b8cc1fb1-5944-431c-aeec-a4301721f667
TCGA-CH-5765-11	0	TCGA-CH-5765-11	700	0	days	TCGA-CH-5765	700	0	days	700	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55	TCGA-CH-5765-F28995	TCGA-CH-5765	TCGA-CH-5765-11A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-20364	31			31			0	700		694			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.1		YES				NO	7	0		No	N0	T3a			5765	TUMOR FREE	3	Complete Remission/Response	0.02	NO	R0	Solid Tissue Normal	11	4	0.2		NO		YES	NO	CH			Prostate		A	LIVING	2007				TCGA-CH-5765-11A-01D-1578-05													
TCGA-CH-5766-01	0	TCGA-CH-5766-01	31	0	days	TCGA-CH-5766			days	31	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55		TCGA-CH-5766	TCGA-CH-5766-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-20392	31			31			0	31		39			YES	No Evidence of Extraprostatic Extension	NO				2012-3-16	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	0.8		YES					4	1		No	N1	T3a	TCGA-CH-5766.f6f3fdff-8296-449a-9a1c-d23803cf078a.pdf		5766	TUMOR FREE	4		13.9		R0	Primary Tumor	01	3	0.4				YES	NO	CH			Prostate		A	LIVING	2007	Peripheral Zone	f44cdc06-35ed-42dc-b4b2-fdd19399c7d3	TCGA-CH-5766-01A-11D-1574-01	TCGA-CH-5766-01A-11D-1578-05	TCGA-CH-5766-01A-11D-1576-08	TCGA-CH-5766-01A-11D-1576-08	f44cdc06-35ed-42dc-b4b2-fdd19399c7d3	TCGA-CH-5766-01	TCGA-CH-5766-01	02514EB6-8CF8-4DED-9761-895DA6563B93	TCGA-CH-5766-01A-11D-1574-01	f44cdc06-35ed-42dc-b4b2-fdd19399c7d3	TCGA-CH-5766-01	TCGA-CH-5766-01	TCGA-CH-5766-01A-11D-1576-08	TCGA-CH-5766-01A-11D-1576-08	f44cdc06-35ed-42dc-b4b2-fdd19399c7d3
TCGA-CH-5766-11	0	TCGA-CH-5766-11	31	0	days	TCGA-CH-5766			days	31	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55		TCGA-CH-5766	TCGA-CH-5766-11A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-20392	31			31			0	31		39			YES	No Evidence of Extraprostatic Extension	NO				2012-3-16	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1		YES					4	1		No	N1	T3a			5766	TUMOR FREE	4		13.9		R0	Solid Tissue Normal	11	3	0.2				YES	NO	CH			Prostate		A	LIVING	2007	Peripheral Zone			TCGA-CH-5766-11A-01D-1578-05													
TCGA-CH-5767-01	0	TCGA-CH-5767-01	458	0	days	TCGA-CH-5767	458	0	days	458	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-CH-5767-F28999	TCGA-CH-5767	TCGA-CH-5767-01A	NO		M0		-24287							0	458		377			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.3		YES				NO	19	0		No	N0	T2c	TCGA-CH-5767.237374e0-5b18-407c-ae42-898a95c14fa2.pdf		5767	TUMOR FREE	4	Complete Remission/Response	0.04	NO	R0	Primary Tumor	01	3	0.2		NO		YES	NO	CH			Prostate		A	LIVING	2007	Peripheral Zone	07f49527-0833-481f-b172-cb67601f8b03	TCGA-CH-5767-01A-11D-1785-01	TCGA-CH-5767-01A-11D-1787-05	TCGA-CH-5767-01A-11D-1786-08	TCGA-CH-5767-01A-11D-1786-08	07f49527-0833-481f-b172-cb67601f8b03	TCGA-CH-5767-01	TCGA-CH-5767-01	97F044F9-0CAA-46A2-B22A-97FD42326745	TCGA-CH-5767-01A-11D-1785-01	07f49527-0833-481f-b172-cb67601f8b03	TCGA-CH-5767-01	TCGA-CH-5767-01	TCGA-CH-5767-01A-11D-1786-08	TCGA-CH-5767-01A-11D-1786-08	07f49527-0833-481f-b172-cb67601f8b03
TCGA-CH-5767-11	0	TCGA-CH-5767-11	458	0	days	TCGA-CH-5767	458	0	days	458	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-CH-5767-F28999	TCGA-CH-5767	TCGA-CH-5767-11B	NO		M0		-24287							0	458		377			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.2	NO	Bilateral	1.4		YES				NO	19	0		No	N0	T2c			5767	TUMOR FREE	4	Complete Remission/Response	0.04	NO	R0	Solid Tissue Normal	11	3	0.2		NO		YES	NO	CH			Prostate		B	LIVING	2007	Peripheral Zone	6eb0d270-797d-49ab-9bda-a5f0a70a6695		TCGA-CH-5767-11B-01D-1787-05			6eb0d270-797d-49ab-9bda-a5f0a70a6695		TCGA-CH-5767-11			6eb0d270-797d-49ab-9bda-a5f0a70a6695		TCGA-CH-5767-11			6eb0d270-797d-49ab-9bda-a5f0a70a6695
TCGA-CH-5768-01	0	TCGA-CH-5768-01	731	0	days	TCGA-CH-5768	731	0	days	731	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			72	TCGA-CH-5768-F28998	TCGA-CH-5768	TCGA-CH-5768-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-26480	30			30			0	731		634			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.1		YES				NO	16	0		No	N0	T3a	TCGA-CH-5768.619201a3-bfe0-473c-83f2-76028455fcb5.pdf		5768	TUMOR FREE	2	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.3		NO	3	YES	NO	CH			Prostate		A	LIVING	2007	Overlapping / Multiple Zones	78808f76-820b-439f-8223-38f2899cad5f	TCGA-CH-5768-01A-11D-1574-01	TCGA-CH-5768-01A-11D-1578-05	TCGA-CH-5768-01A-11D-1576-08	TCGA-CH-5768-01A-11D-1576-08	78808f76-820b-439f-8223-38f2899cad5f	TCGA-CH-5768-01	TCGA-CH-5768-01	AB12065D-3680-4DE2-942D-ECCD6C5C5281	TCGA-CH-5768-01A-11D-1574-01	78808f76-820b-439f-8223-38f2899cad5f	TCGA-CH-5768-01	TCGA-CH-5768-01	TCGA-CH-5768-01A-11D-1576-08	TCGA-CH-5768-01A-11D-1576-08	78808f76-820b-439f-8223-38f2899cad5f
TCGA-CH-5768-11	0	TCGA-CH-5768-11	731	0	days	TCGA-CH-5768	731	0	days	731	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			72	TCGA-CH-5768-F28998	TCGA-CH-5768	TCGA-CH-5768-11A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-26480	30			30			0	731		634			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.2		YES				NO	16	0		No	N0	T3a			5768	TUMOR FREE	2	Complete Remission/Response	0.1	NO	R0	Solid Tissue Normal	11	4	0.3		NO	3	YES	NO	CH			Prostate		A	LIVING	2007	Overlapping / Multiple Zones	3c3a7016-6270-4c87-af7d-53b46f7f8fd1		TCGA-CH-5768-11A-01D-1578-05			3c3a7016-6270-4c87-af7d-53b46f7f8fd1		TCGA-CH-5768-11			3c3a7016-6270-4c87-af7d-53b46f7f8fd1		TCGA-CH-5768-11			3c3a7016-6270-4c87-af7d-53b46f7f8fd1
TCGA-CH-5769-01	0	TCGA-CH-5769-01	62	0	days	TCGA-CH-5769			days	62	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			48		TCGA-CH-5769	TCGA-CH-5769-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-17807	62			62			0	62		60			YES	No Evidence of Extraprostatic Extension	NO				2012-3-16	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1		YES					8	0		No	N0	T3b	TCGA-CH-5769.7d49b105-6652-41b9-8e3a-e806a14de604.pdf		5769	WITH TUMOR	5		11.16		R1	Primary Tumor	01	4	0.4				YES	NO	CH			Prostate		A	LIVING	2007		2d12fd80-ba3f-49c3-aa15-1f67b9bbd443	TCGA-CH-5769-01A-11D-1574-01	TCGA-CH-5769-01A-11D-1578-05	TCGA-CH-5769-01A-11D-1576-08	TCGA-CH-5769-01A-11D-1576-08	2d12fd80-ba3f-49c3-aa15-1f67b9bbd443	TCGA-CH-5769-01	TCGA-CH-5769-01	545B68DC-C3D2-42E6-8ACC-61E81CEEB8B2	TCGA-CH-5769-01A-11D-1574-01	2d12fd80-ba3f-49c3-aa15-1f67b9bbd443	TCGA-CH-5769-01	TCGA-CH-5769-01	TCGA-CH-5769-01A-11D-1576-08	TCGA-CH-5769-01A-11D-1576-08	2d12fd80-ba3f-49c3-aa15-1f67b9bbd443
TCGA-CH-5769-11	0	TCGA-CH-5769-11	62	0	days	TCGA-CH-5769			days	62	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			48		TCGA-CH-5769	TCGA-CH-5769-11A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-17807	62			62			0	62		60			YES	No Evidence of Extraprostatic Extension	NO				2012-3-16	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy	80	0.4	NO	Bilateral	1		YES					8	0		No	N0	T3b			5769	WITH TUMOR	5		11.16		R1	Solid Tissue Normal	11	4	0.2				YES	NO	CH			Prostate		A	LIVING	2007		4e169e09-37da-42c9-bed4-2649212d9c6b		TCGA-CH-5769-11A-01D-1578-05			4e169e09-37da-42c9-bed4-2649212d9c6b		TCGA-CH-5769-11			4e169e09-37da-42c9-bed4-2649212d9c6b		TCGA-CH-5769-11			4e169e09-37da-42c9-bed4-2649212d9c6b
TCGA-CH-5771-01	0	TCGA-CH-5771-01	396	0	days	TCGA-CH-5771	396	0	days	396	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63	TCGA-CH-5771-F29003	TCGA-CH-5771	TCGA-CH-5771-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-23101	31			31			0	396		396			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.3		YES				NO	2	0		No	N0	T2c	TCGA-CH-5771.7c775a61-67f6-42a1-84e6-5cf8cd66a038.pdf		5771	TUMOR FREE	4	Complete Remission/Response	0.03	NO	R0	Primary Tumor	01	3	0.3		NO	5	YES	NO	CH			Prostate		A	LIVING	2008		a771088e-45e1-4e67-8e3e-88c65d0b0618	TCGA-CH-5771-01A-21D-1574-01	TCGA-CH-5771-01A-21D-1578-05	TCGA-CH-5771-01A-21D-1576-08	TCGA-CH-5771-01A-21D-1576-08	a771088e-45e1-4e67-8e3e-88c65d0b0618	TCGA-CH-5771-01	TCGA-CH-5771-01	AA8280D0-C22E-45CF-B8E1-C2F060CB04FC	TCGA-CH-5771-01A-21D-1574-01	a771088e-45e1-4e67-8e3e-88c65d0b0618	TCGA-CH-5771-01	TCGA-CH-5771-01	TCGA-CH-5771-01A-21D-1576-08	TCGA-CH-5771-01A-21D-1576-08	a771088e-45e1-4e67-8e3e-88c65d0b0618
TCGA-CH-5771-11	0	TCGA-CH-5771-11	396	0	days	TCGA-CH-5771	396	0	days	396	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63	TCGA-CH-5771-F29003	TCGA-CH-5771	TCGA-CH-5771-11A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-23101	31			31			0	396		396			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.3	NO	Bilateral	1.8		YES				NO	2	0		No	N0	T2c			5771	TUMOR FREE	4	Complete Remission/Response	0.03	NO	R0	Solid Tissue Normal	11	3	0.2		NO	5	YES	NO	CH			Prostate		A	LIVING	2008				TCGA-CH-5771-11A-01D-1578-05													
TCGA-CH-5772-01	0	TCGA-CH-5772-01	486	0	days	TCGA-CH-5772	486	0	days	486	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63	TCGA-CH-5772-F29004	TCGA-CH-5772	TCGA-CH-5772-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-23194	90			90	90		0	486		424			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.3	NO	Bilateral	0.9		YES				NO	6	0		Yes	N0	T3a	TCGA-CH-5772.78506402-8bc2-45de-8374-5ddfdc7066eb.pdf		5772	TUMOR FREE	4	Complete Remission/Response	0.03	YES	R1	Primary Tumor	01	5	0.3		NO	3	YES	NO	CH			Prostate		A	LIVING	2008		77e1b878-fcff-4541-9cb5-85e0dce7b721	TCGA-CH-5772-01A-11D-1574-01	TCGA-CH-5772-01A-11D-1578-05	TCGA-CH-5772-01A-11D-1576-08	TCGA-CH-5772-01A-11D-1576-08	77e1b878-fcff-4541-9cb5-85e0dce7b721	TCGA-CH-5772-01	TCGA-CH-5772-01	4AD27CF8-24A8-499A-B363-B39DED558CD7	TCGA-CH-5772-01A-11D-1574-01	77e1b878-fcff-4541-9cb5-85e0dce7b721	TCGA-CH-5772-01	TCGA-CH-5772-01	TCGA-CH-5772-01A-11D-1576-08	TCGA-CH-5772-01A-11D-1576-08	77e1b878-fcff-4541-9cb5-85e0dce7b721
TCGA-CH-5772-11	0	TCGA-CH-5772-11	486	0	days	TCGA-CH-5772	486	0	days	486	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63	TCGA-CH-5772-F29004	TCGA-CH-5772	TCGA-CH-5772-11A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-23194	90			90	90		0	486		424			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.2	NO	Bilateral	1.4		YES				NO	6	0		Yes	N0	T3a			5772	TUMOR FREE	4	Complete Remission/Response	0.03	YES	R1	Solid Tissue Normal	11	5	0.2		NO	3	YES	NO	CH			Prostate		A	LIVING	2008				TCGA-CH-5772-11A-01D-1578-05													
TCGA-CH-5788-01	0	TCGA-CH-5788-01	821	0	days	TCGA-CH-5788			days	821	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			69	TCGA-CH-5788-F28991	TCGA-CH-5788	TCGA-CH-5788-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0		-25233	31			31		786	0	821		786			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Progressive Disease	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	0.8		YES					21	6		No	N1	T3b	TCGA-CH-5788.41e797ae-db60-4653-9e61-4050ec9c05b2.pdf		5788	WITH TUMOR	4	Progressive Disease	3.58	NO	R0	Primary Tumor	01	3	0.2		YES	5	YES	NO	CH	Base		Prostate		A	LIVING	2007		9caa440e-a8a6-4851-b62e-4ebb09412fad	TCGA-CH-5788-01A-11D-1574-01	TCGA-CH-5788-01A-11D-1578-05	TCGA-CH-5788-01A-11D-1576-08	TCGA-CH-5788-01A-11D-1576-08	9caa440e-a8a6-4851-b62e-4ebb09412fad	TCGA-CH-5788-01	TCGA-CH-5788-01	4B319620-E1EC-4186-A856-257A95BD5D16	TCGA-CH-5788-01A-11D-1574-01	9caa440e-a8a6-4851-b62e-4ebb09412fad	TCGA-CH-5788-01	TCGA-CH-5788-01	TCGA-CH-5788-01A-11D-1576-08	TCGA-CH-5788-01A-11D-1576-08	9caa440e-a8a6-4851-b62e-4ebb09412fad
TCGA-CH-5789-01	0	TCGA-CH-5789-01	304	0	days	TCGA-CH-5789	304	0	days	304	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61	TCGA-CH-5789-F28990	TCGA-CH-5789	TCGA-CH-5789-01A	NO		M0		-22494				61			0	304		229			YES	No Evidence of Extraprostatic Extension			Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1						NO	4	0		No	N0	T3a	TCGA-CH-5789.50e47b92-4c6a-4fca-8d01-0b4abc61bd0e.pdf		5789	TUMOR FREE	3	Complete Remission/Response	0.02	NO	R0	Primary Tumor	01	4	0.4		NO		YES	NO	CH			Prostate		A	LIVING	2006	Peripheral Zone	f659e8f2-3d29-4170-bd40-84e54c70fcd4	TCGA-CH-5789-01A-11D-1574-01	TCGA-CH-5789-01A-11D-1578-05	TCGA-CH-5789-01A-11D-1576-08	TCGA-CH-5789-01A-11D-1576-08	f659e8f2-3d29-4170-bd40-84e54c70fcd4	TCGA-CH-5789-01	TCGA-CH-5789-01	12F2FBEB-2CF8-4C5D-90C6-F960AACA4092	TCGA-CH-5789-01A-11D-1574-01	f659e8f2-3d29-4170-bd40-84e54c70fcd4	TCGA-CH-5789-01	TCGA-CH-5789-01	TCGA-CH-5789-01A-11D-1576-08	TCGA-CH-5789-01A-11D-1576-08	f659e8f2-3d29-4170-bd40-84e54c70fcd4
TCGA-CH-5790-01	0	TCGA-CH-5790-01	974	0	days	TCGA-CH-5790	974	0	days	974	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			64	TCGA-CH-5790-F28986	TCGA-CH-5790	TCGA-CH-5790-01A	NO		M0		-23529							0	974		914			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1		YES				NO	5	0		Yes	N0	T2c	TCGA-CH-5790.0f2f0a80-6a25-4374-96ad-0dbd6d136906.pdf		5790	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.3		NO		YES	NO	CH			Prostate		A	LIVING	2006		743ad0e2-903e-4438-a575-1f06c286c079	TCGA-CH-5790-01A-11D-1574-01	TCGA-CH-5790-01A-11D-1578-05	TCGA-CH-5790-01A-11D-1576-08	TCGA-CH-5790-01A-11D-1576-08	743ad0e2-903e-4438-a575-1f06c286c079	TCGA-CH-5790-01	TCGA-CH-5790-01	0F699258-4F1D-478B-B860-5108C509E56D	TCGA-CH-5790-01A-11D-1574-01	743ad0e2-903e-4438-a575-1f06c286c079	TCGA-CH-5790-01	TCGA-CH-5790-01	TCGA-CH-5790-01A-11D-1576-08	TCGA-CH-5790-01A-11D-1576-08	743ad0e2-903e-4438-a575-1f06c286c079
TCGA-CH-5791-01	0	TCGA-CH-5791-01	1004	0	days	TCGA-CH-5791	396	1	days	1004	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	72	TCGA-CH-5791-F28985	TCGA-CH-5791	TCGA-CH-5791-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-26390	61						0	1004	396	882			NO		NO		Scheduled Follow-up Submission	Partial Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	0.8		YES		New Primary Tumor		YES	2	0		Yes	N0	T3a	TCGA-CH-5791.009bf26f-b3df-4f10-b496-a4304af1e091.pdf		5791		3	Complete Remission/Response	0.18	NO	R1	Primary Tumor	01	4	0.2		NO		YES	NO	CH			Prostate		A	LIVING	2006	Peripheral Zone	47faa91b-1bfa-4283-bc9d-dfa958252d6f	TCGA-CH-5791-01A-11D-1574-01	TCGA-CH-5791-01A-11D-1578-05	TCGA-CH-5791-01A-11D-1576-08	TCGA-CH-5791-01A-11D-1576-08	47faa91b-1bfa-4283-bc9d-dfa958252d6f	TCGA-CH-5791-01	TCGA-CH-5791-01	A78ED02E-3618-49BE-8920-F4BA943CC7A4	TCGA-CH-5791-01A-11D-1574-01	47faa91b-1bfa-4283-bc9d-dfa958252d6f	TCGA-CH-5791-01	TCGA-CH-5791-01	TCGA-CH-5791-01A-11D-1576-08	TCGA-CH-5791-01A-11D-1576-08	47faa91b-1bfa-4283-bc9d-dfa958252d6f
TCGA-CH-5792-01	0	TCGA-CH-5792-01	91	0	days	TCGA-CH-5792			days	91	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57		TCGA-CH-5792	TCGA-CH-5792-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-21002	91						0	91		91			NO		NO				2012-3-21	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.4		YES					6	0		No	N0	T3a	TCGA-CH-5792.72de5993-cad1-4ba0-9ea5-c545799a2f6e.pdf		5792	WITH TUMOR	4		11.49		R1	Primary Tumor	01	5	0.4				YES	NO	CH			Prostate		A	LIVING	2009		4db58676-4bfe-46de-9db9-8270d67b49fe	TCGA-CH-5792-01A-11D-1574-01	TCGA-CH-5792-01A-11D-1578-05	TCGA-CH-5792-01A-11D-1576-08	TCGA-CH-5792-01A-11D-1576-08	4db58676-4bfe-46de-9db9-8270d67b49fe	TCGA-CH-5792-01	TCGA-CH-5792-01	0AC4DEF1-BF7D-4C6C-BFFD-95873ABD655D	TCGA-CH-5792-01A-11D-1574-01	4db58676-4bfe-46de-9db9-8270d67b49fe	TCGA-CH-5792-01	TCGA-CH-5792-01	TCGA-CH-5792-01A-11D-1576-08	TCGA-CH-5792-01A-11D-1576-08	4db58676-4bfe-46de-9db9-8270d67b49fe
TCGA-CH-5794-01	0	TCGA-CH-5794-01	882	0	days	TCGA-CH-5794	882	0	days	882	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			65	TCGA-CH-5794-F28994	TCGA-CH-5794	TCGA-CH-5794-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-23924	62			62			0	882		821			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1.1		YES				NO	4	0		No	N0	T2b	TCGA-CH-5794.2bdbd62b-c2a0-4cdd-8187-6cf1db227e7e.pdf		5794	TUMOR FREE	3	Complete Remission/Response	0.01	NO	R0	Primary Tumor	01	4	0.4		NO		YES	NO	CH			Prostate		A	LIVING	2006	Peripheral Zone	5c6bca7d-7dcc-4908-add3-c56606b313a7	TCGA-CH-5794-01A-11D-1574-01	TCGA-CH-5794-01A-11D-1578-05	TCGA-CH-5794-01A-11D-1576-08	TCGA-CH-5794-01A-11D-1576-08	5c6bca7d-7dcc-4908-add3-c56606b313a7	TCGA-CH-5794-01	TCGA-CH-5794-01	538DEA11-0D68-4013-B3EC-BEDAED2F90FA	TCGA-CH-5794-01A-11D-1574-01	5c6bca7d-7dcc-4908-add3-c56606b313a7	TCGA-CH-5794-01	TCGA-CH-5794-01	TCGA-CH-5794-01A-11D-1576-08	TCGA-CH-5794-01A-11D-1576-08	5c6bca7d-7dcc-4908-add3-c56606b313a7
TCGA-EJ-5494-01	0	TCGA-EJ-5494-01	1477	0	days	TCGA-EJ-5494	1477	0	days	1477	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			50	TCGA-EJ-5494-F71910	TCGA-EJ-5494	TCGA-EJ-5494-01A	NO		M0	T2a	-18596							0	1477		184							Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.7	NO	YES				NO	17	0		No	N0	T3a	TCGA-EJ-5494.e52eefbc-e27d-4a5d-a261-d06a2dcf5d53.pdf		5494	TUMOR FREE	4	Complete Remission/Response		NO	R0	Primary Tumor	01	3	0.3		NO	4	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2009		fb687a9b-dcb1-46e9-b175-fd28c7242c2b	TCGA-EJ-5494-01A-01D-1574-01	TCGA-EJ-5494-01A-01D-1578-05	TCGA-EJ-5494-01A-01D-1576-08	TCGA-EJ-5494-01A-01D-1576-08	fb687a9b-dcb1-46e9-b175-fd28c7242c2b	TCGA-EJ-5494-01	TCGA-EJ-5494-01	BA260C91-7D20-4B44-B383-19314D60631D	TCGA-EJ-5494-01A-01D-1574-01	fb687a9b-dcb1-46e9-b175-fd28c7242c2b	TCGA-EJ-5494-01	TCGA-EJ-5494-01	TCGA-EJ-5494-01A-01D-1576-08	TCGA-EJ-5494-01A-01D-1576-08	fb687a9b-dcb1-46e9-b175-fd28c7242c2b
TCGA-EJ-5495-01	0	TCGA-EJ-5495-01	1760	0	days	TCGA-EJ-5495	1760	0	days	1760	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			68	TCGA-EJ-5495-F71913	TCGA-EJ-5495	TCGA-EJ-5495-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24904	26						0	1760		606			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.3	NO	YES				NO	18	1		No	N1	T3b	TCGA-EJ-5495.5c549c39-b223-49eb-aa93-0298cdf33370.pdf		5495	TUMOR FREE	5	Complete Remission/Response	0.13	NO	R0	Primary Tumor	01	3	0.4		NO	4	YES	NO	EJ	Middle|Base		Prostate		A	LIVING	2009		c07b7746-e340-4679-99bb-531c2d93b4e5	TCGA-EJ-5495-01A-01D-1574-01	TCGA-EJ-5495-01A-01D-1578-05	TCGA-EJ-5495-01A-01D-1576-08	TCGA-EJ-5495-01A-01D-1576-08	c07b7746-e340-4679-99bb-531c2d93b4e5	TCGA-EJ-5495-01	TCGA-EJ-5495-01	E7B35738-2222-4A08-AA6B-8352D26BEC92	TCGA-EJ-5495-01A-01D-1574-01	c07b7746-e340-4679-99bb-531c2d93b4e5	TCGA-EJ-5495-01	TCGA-EJ-5495-01	TCGA-EJ-5495-01A-01D-1576-08	TCGA-EJ-5495-01A-01D-1576-08	c07b7746-e340-4679-99bb-531c2d93b4e5
TCGA-EJ-5496-01	0	TCGA-EJ-5496-01	595	0	days	TCGA-EJ-5496			days	595	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			59	TCGA-EJ-5496-F60309	TCGA-EJ-5496	TCGA-EJ-5496-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-21897	15			15			0	595		595			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-6-5	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	2	YES	YES					26	0		No	N0	T2c	TCGA-EJ-5496.80e82784-0bca-4657-9c9f-e9b860dc09bc.pdf		5496	TUMOR FREE	3		0.1		R0	Primary Tumor	01	4	0.3			4	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2009	Overlapping / Multiple Zones	1059fbc0-46bf-4135-99d0-080ec225391b	TCGA-EJ-5496-01A-01D-1574-01	TCGA-EJ-5496-01A-01D-1578-05	TCGA-EJ-5496-01A-01D-1576-08	TCGA-EJ-5496-01A-01D-1576-08	1059fbc0-46bf-4135-99d0-080ec225391b	TCGA-EJ-5496-01	TCGA-EJ-5496-01	B724F938-FEE2-4AD6-99C3-838742A70AF9	TCGA-EJ-5496-01A-01D-1574-01	1059fbc0-46bf-4135-99d0-080ec225391b	TCGA-EJ-5496-01	TCGA-EJ-5496-01	TCGA-EJ-5496-01A-01D-1576-08	TCGA-EJ-5496-01A-01D-1576-08	1059fbc0-46bf-4135-99d0-080ec225391b
TCGA-EJ-5497-01	0	TCGA-EJ-5497-01	405	0	days	TCGA-EJ-5497			days	405	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			47	TCGA-EJ-5497-F60311	TCGA-EJ-5497	TCGA-EJ-5497-01A	NO		M0	T2c	-17523							0	405		204			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-6-5	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1.5	YES	YES					10	0		No	N0	T2c	TCGA-EJ-5497.4c6ab617-53f7-4556-a1a0-b44df4f67b6b.pdf		5497	TUMOR FREE	3		0.1		R0	Primary Tumor	01	4	0.5			3	YES	NO	EJ	Middle		Prostate		A	LIVING	2009	Overlapping / Multiple Zones	86961468-9e93-469a-b812-03ef327bf5fb	TCGA-EJ-5497-01A-02D-1574-01	TCGA-EJ-5497-01A-02D-1578-05	TCGA-EJ-5497-01A-02D-1576-08	TCGA-EJ-5497-01A-02D-1576-08	86961468-9e93-469a-b812-03ef327bf5fb	TCGA-EJ-5497-01	TCGA-EJ-5497-01	C7EF553E-B25E-42A5-8C05-6F16BBAFC14B	TCGA-EJ-5497-01A-02D-1574-01	86961468-9e93-469a-b812-03ef327bf5fb	TCGA-EJ-5497-01	TCGA-EJ-5497-01	TCGA-EJ-5497-01A-02D-1576-08	TCGA-EJ-5497-01A-02D-1576-08	86961468-9e93-469a-b812-03ef327bf5fb
TCGA-EJ-5498-01	0	TCGA-EJ-5498-01	1720	0	days	TCGA-EJ-5498	1720	0	days	1720	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			56	TCGA-EJ-5498-F71919	TCGA-EJ-5498	TCGA-EJ-5498-01A	NO	Normal (no evidence of prostate cancer) [cM0]		T2c	-20472	12			12			0	1720		537			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	1.4	NO	YES				NO	26	0		No	N0	T2c	TCGA-EJ-5498.53d058fd-5faa-43ab-8a5e-b6f95134970b.pdf		5498	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3	0.5		NO	3	YES	NO	EJ	Middle		Prostate		A	LIVING	2010	Overlapping / Multiple Zones	2bc25263-18b8-4ed5-b986-e9b54f734596	TCGA-EJ-5498-01A-01D-1574-01	TCGA-EJ-5498-01A-01D-1578-05	TCGA-EJ-5498-01A-01D-1576-08	TCGA-EJ-5498-01A-01D-1576-08	2bc25263-18b8-4ed5-b986-e9b54f734596	TCGA-EJ-5498-01	TCGA-EJ-5498-01	C2B3E926-0662-4245-AFA5-C19AEDF7A673	TCGA-EJ-5498-01A-01D-1574-01	2bc25263-18b8-4ed5-b986-e9b54f734596	TCGA-EJ-5498-01	TCGA-EJ-5498-01	TCGA-EJ-5498-01A-01D-1576-08	TCGA-EJ-5498-01A-01D-1576-08	2bc25263-18b8-4ed5-b986-e9b54f734596
TCGA-EJ-5499-01	0	TCGA-EJ-5499-01	1415	0	days	TCGA-EJ-5499	1415	0	days	1415	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61	TCGA-EJ-5499-F60312	TCGA-EJ-5499	TCGA-EJ-5499-01A	NO		M0	T2b	-22286							0	1415		533							Scheduled Follow-up Submission	Complete Remission/Response	2014-6-5	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Bilateral	1.1	NO	YES				NO	19	0		No	N0	T3a	TCGA-EJ-5499.f69e29da-24d1-45f2-9b4f-a32f9e5479a4.pdf		5499	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3	0.4		NO	3	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones	b1d3e9ee-f0d0-4efd-a505-ea1a9f7fa6df	TCGA-EJ-5499-01A-01D-1574-01	TCGA-EJ-5499-01A-01D-1578-05	TCGA-EJ-5499-01A-01D-1576-08	TCGA-EJ-5499-01A-01D-1576-08	b1d3e9ee-f0d0-4efd-a505-ea1a9f7fa6df	TCGA-EJ-5499-01	TCGA-EJ-5499-01	C30416C0-12F3-4C0E-BF4C-73F7F7BA4106	TCGA-EJ-5499-01A-01D-1574-01	b1d3e9ee-f0d0-4efd-a505-ea1a9f7fa6df	TCGA-EJ-5499-01	TCGA-EJ-5499-01	TCGA-EJ-5499-01A-01D-1576-08	TCGA-EJ-5499-01A-01D-1576-08	b1d3e9ee-f0d0-4efd-a505-ea1a9f7fa6df
TCGA-EJ-5501-01	0	TCGA-EJ-5501-01	1365	0	days	TCGA-EJ-5501	1365	0	days	1365	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55	TCGA-EJ-5501-F60313	TCGA-EJ-5501	TCGA-EJ-5501-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-20409	9			9			0	1365		729			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-6-5	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1	NO	YES				NO	11	0		No	N0	T3b	TCGA-EJ-5501.630dee46-15db-4a16-84ee-a9d25fcccb80.pdf		5501	TUMOR FREE	4		0.1		R0	Primary Tumor	01	3	0.3			5	YES	NO	EJ	Middle|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones	b896a143-8a90-424e-9124-45edb6f3f26d	TCGA-EJ-5501-01A-01D-1574-01	TCGA-EJ-5501-01A-01D-1578-05	TCGA-EJ-5501-01A-01D-1576-08	TCGA-EJ-5501-01A-01D-1576-08	b896a143-8a90-424e-9124-45edb6f3f26d	TCGA-EJ-5501-01	TCGA-EJ-5501-01	6979871B-9E73-4200-AED2-92DE897C3053	TCGA-EJ-5501-01A-01D-1574-01	b896a143-8a90-424e-9124-45edb6f3f26d	TCGA-EJ-5501-01	TCGA-EJ-5501-01	TCGA-EJ-5501-01A-01D-1576-08	TCGA-EJ-5501-01A-01D-1576-08	b896a143-8a90-424e-9124-45edb6f3f26d
TCGA-EJ-5502-01	0	TCGA-EJ-5502-01	1171	0	days	TCGA-EJ-5502	1171	0	days	1171	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			50	TCGA-EJ-5502-F71921	TCGA-EJ-5502	TCGA-EJ-5502-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-18447	7			7			0	1171		603			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.7	NO	YES				NO	11	0		No	N0	T2c	TCGA-EJ-5502.173e45e9-e2ab-4a1d-8bcc-15374f1ae511.pdf		5502	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3	0.3		NO	3	YES	NO	EJ	Middle|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones	416bc8ff-9dd9-4b0c-b0f7-66cb8a437aad	TCGA-EJ-5502-01A-01D-1574-01	TCGA-EJ-5502-01A-01D-1578-05	TCGA-EJ-5502-01A-01D-1576-08	TCGA-EJ-5502-01A-01D-1576-08	416bc8ff-9dd9-4b0c-b0f7-66cb8a437aad	TCGA-EJ-5502-01	TCGA-EJ-5502-01	EA44DC8F-0260-437E-BCD3-DC2BD19DD9CE	TCGA-EJ-5502-01A-01D-1574-01	416bc8ff-9dd9-4b0c-b0f7-66cb8a437aad	TCGA-EJ-5502-01	TCGA-EJ-5502-01	TCGA-EJ-5502-01A-01D-1576-08	TCGA-EJ-5502-01A-01D-1576-08	416bc8ff-9dd9-4b0c-b0f7-66cb8a437aad
TCGA-EJ-5503-01	0	TCGA-EJ-5503-01	1391	0	days	TCGA-EJ-5503	1391	0	days	1391	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			50	TCGA-EJ-5503-F60037	TCGA-EJ-5503	TCGA-EJ-5503-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-18395	31			31			0	1391		530			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-5-28	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.3	NO	YES				NO	21	0		No	N0	T3a	TCGA-EJ-5503.81ca6538-6023-4e21-bd59-0b248e5642ac.pdf		5503	TUMOR FREE	5	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3	0.4		NO	4	YES	NO	EJ	Middle|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones	aa181d66-d198-43ab-920e-a351454194a0	TCGA-EJ-5503-01A-01D-1574-01	TCGA-EJ-5503-01A-01D-1578-05	TCGA-EJ-5503-01A-01D-1576-08	TCGA-EJ-5503-01A-01D-1576-08	aa181d66-d198-43ab-920e-a351454194a0	TCGA-EJ-5503-01	TCGA-EJ-5503-01	DA70ADB1-141C-472A-BE95-D7B1DD00C689	TCGA-EJ-5503-01A-01D-1574-01	aa181d66-d198-43ab-920e-a351454194a0	TCGA-EJ-5503-01	TCGA-EJ-5503-01	TCGA-EJ-5503-01A-01D-1576-08	TCGA-EJ-5503-01A-01D-1576-08	aa181d66-d198-43ab-920e-a351454194a0
TCGA-EJ-5504-01	0	TCGA-EJ-5504-01	1427	0	days	TCGA-EJ-5504	1427	0	days	1427	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			65	TCGA-EJ-5504-F71923	TCGA-EJ-5504	TCGA-EJ-5504-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-24072	25			25		77	0	1427		77			YES	Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1]	NO		Scheduled Follow-up Submission	Progressive Disease	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	0.9	NO	YES				NO	18	1		No	N1	T3a	TCGA-EJ-5504.74f98316-075f-45e1-9bca-3d885a070fa8.pdf		5504	WITH TUMOR	4	Progressive Disease	1.0	NO	R1	Primary Tumor	01	3	0.4		NO	5	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones	70779173-6a72-45e4-bf43-91ee9baba55f	TCGA-EJ-5504-01A-01D-1574-01	TCGA-EJ-5504-01A-01D-1578-05	TCGA-EJ-5504-01A-01D-1576-08	TCGA-EJ-5504-01A-01D-1576-08	70779173-6a72-45e4-bf43-91ee9baba55f	TCGA-EJ-5504-01	TCGA-EJ-5504-01	0D99F039-663F-4BA6-8F9C-DD72439BE2CA	TCGA-EJ-5504-01A-01D-1574-01	70779173-6a72-45e4-bf43-91ee9baba55f	TCGA-EJ-5504-01	TCGA-EJ-5504-01	TCGA-EJ-5504-01A-01D-1576-08	TCGA-EJ-5504-01A-01D-1576-08	70779173-6a72-45e4-bf43-91ee9baba55f
TCGA-EJ-5505-01	0	TCGA-EJ-5505-01	922	0	days	TCGA-EJ-5505	922	0	days	922	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57	TCGA-EJ-5505-F46206	TCGA-EJ-5505	TCGA-EJ-5505-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-21164	12			12			0	922		448			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1	NO	YES				NO	24	0		No	N0	T2c	TCGA-EJ-5505.b8c31900-c8a8-45a7-a71a-fa356bf78511.pdf		5505	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3	0.6		NO	3	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2010		b304cf7b-274d-4617-9830-459601eedc10	TCGA-EJ-5505-01A-01D-1574-01	TCGA-EJ-5505-01A-01D-1578-05	TCGA-EJ-5505-01A-01D-1576-08	TCGA-EJ-5505-01A-01D-1576-08	b304cf7b-274d-4617-9830-459601eedc10	TCGA-EJ-5505-01	TCGA-EJ-5505-01	FB410C59-87B2-422F-9CA2-78D5DCBDCA3C	TCGA-EJ-5505-01A-01D-1574-01	b304cf7b-274d-4617-9830-459601eedc10	TCGA-EJ-5505-01	TCGA-EJ-5505-01	TCGA-EJ-5505-01A-01D-1576-08	TCGA-EJ-5505-01A-01D-1576-08	b304cf7b-274d-4617-9830-459601eedc10
TCGA-EJ-5506-01	0	TCGA-EJ-5506-01	1381	0	days	TCGA-EJ-5506	1381	0	days	1381	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			67	TCGA-EJ-5506-F71924	TCGA-EJ-5506	TCGA-EJ-5506-01A	NO		M0	T3b	-24617							0	1381		356			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.5	NO	YES				NO	7	1		No	N1	T3b	TCGA-EJ-5506.4b6b88e5-b9f5-4bed-8320-b227a30bd1a9.pdf		5506	TUMOR FREE	5	Complete Remission/Response	0.1	NO	RX	Primary Tumor	01	3	0.5		NO	4	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2010		e67b3b01-fdd5-49de-8829-84298c131a5f	TCGA-EJ-5506-01A-01D-1574-01	TCGA-EJ-5506-01A-01D-1578-05	TCGA-EJ-5506-01A-01D-1576-08	TCGA-EJ-5506-01A-01D-1576-08	e67b3b01-fdd5-49de-8829-84298c131a5f	TCGA-EJ-5506-01	TCGA-EJ-5506-01	B6C93974-DA24-476B-A742-2F25DA08AE0F	TCGA-EJ-5506-01A-01D-1574-01	e67b3b01-fdd5-49de-8829-84298c131a5f	TCGA-EJ-5506-01	TCGA-EJ-5506-01	TCGA-EJ-5506-01A-01D-1576-08	TCGA-EJ-5506-01A-01D-1576-08	e67b3b01-fdd5-49de-8829-84298c131a5f
TCGA-EJ-5507-01	0	TCGA-EJ-5507-01	1457	0	days	TCGA-EJ-5507	1457	0	days	1457	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			54	TCGA-EJ-5507-F71926	TCGA-EJ-5507	TCGA-EJ-5507-01A	NO		M0	T2c	-19759							0	1457		182			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1.4	NO	YES				NO	21	2		No	N1	T3b	TCGA-EJ-5507.153de441-fbe9-4c8b-9a84-9cdf9c5edcf2.pdf		5507	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	5	0.3		NO	4	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2010		487c555b-81bb-4b70-8219-9abac8394b9f	TCGA-EJ-5507-01A-01D-1574-01	TCGA-EJ-5507-01A-01D-1578-05	TCGA-EJ-5507-01A-01D-1576-08	TCGA-EJ-5507-01A-01D-1576-08	487c555b-81bb-4b70-8219-9abac8394b9f	TCGA-EJ-5507-01	TCGA-EJ-5507-01	4E3D63A2-D726-4EBD-B4BA-49DC9D345796	TCGA-EJ-5507-01A-01D-1574-01	487c555b-81bb-4b70-8219-9abac8394b9f	TCGA-EJ-5507-01	TCGA-EJ-5507-01	TCGA-EJ-5507-01A-01D-1576-08	TCGA-EJ-5507-01A-01D-1576-08	487c555b-81bb-4b70-8219-9abac8394b9f
TCGA-EJ-5508-01	0	TCGA-EJ-5508-01	1965	0	days	TCGA-EJ-5508	1965	0	days	1965	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			65	TCGA-EJ-5508-F71929	TCGA-EJ-5508	TCGA-EJ-5508-01A	NO		M0	T1c	-23758							0	1965		907			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	0.7	NO	YES				NO	17	0		No	N0	T3a	TCGA-EJ-5508.d2590559-0eb6-479e-ba3a-b59c3429ca6d.pdf		5508	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.3		NO	4	YES	NO	EJ	Middle|Base		Prostate		A	LIVING	2008		f4463436-536d-412e-824c-0c623a244da5	TCGA-EJ-5508-01A-02D-1574-01	TCGA-EJ-5508-01A-02D-1578-05	TCGA-EJ-5508-01A-02D-1576-08	TCGA-EJ-5508-01A-02D-1576-08	f4463436-536d-412e-824c-0c623a244da5	TCGA-EJ-5508-01	TCGA-EJ-5508-01	64181246-E4A9-4A96-B510-12D30DB1E16C	TCGA-EJ-5508-01A-02D-1574-01	f4463436-536d-412e-824c-0c623a244da5	TCGA-EJ-5508-01	TCGA-EJ-5508-01	TCGA-EJ-5508-01A-02D-1576-08	TCGA-EJ-5508-01A-02D-1576-08	f4463436-536d-412e-824c-0c623a244da5
TCGA-EJ-5509-01	0	TCGA-EJ-5509-01	1464	0	days	TCGA-EJ-5509	1464	0	days	1464	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63	TCGA-EJ-5509-F60376	TCGA-EJ-5509	TCGA-EJ-5509-01A	NO		M0	T2a	-23368							0	1464		1102			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-6-6	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1	NO	YES				NO	10	0		No	N0	T2c	TCGA-EJ-5509.672ff51d-12ba-402a-b6d6-87cc9c91e7ad.pdf		5509	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.2		NO	3	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2009		1c809dd1-f790-458d-9722-c3262afcd416	TCGA-EJ-5509-01A-01D-1574-01	TCGA-EJ-5509-01A-01D-1578-05	TCGA-EJ-5509-01A-01D-1576-08	TCGA-EJ-5509-01A-01D-1576-08	1c809dd1-f790-458d-9722-c3262afcd416	TCGA-EJ-5509-01	TCGA-EJ-5509-01	88604FC1-618E-4581-99DA-AB89129977E3	TCGA-EJ-5509-01A-01D-1574-01	1c809dd1-f790-458d-9722-c3262afcd416	TCGA-EJ-5509-01	TCGA-EJ-5509-01	TCGA-EJ-5509-01A-01D-1576-08	TCGA-EJ-5509-01A-01D-1576-08	1c809dd1-f790-458d-9722-c3262afcd416
TCGA-EJ-5510-01	0	TCGA-EJ-5510-01	1887	0	days	TCGA-EJ-5510	1887	0	days	1887	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			48	TCGA-EJ-5510-F71933	TCGA-EJ-5510	TCGA-EJ-5510-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-17895	14			14			0	1887		738			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1.3	NO	YES				NO	17	0		No	N0	T2c	TCGA-EJ-5510.9f549743-cbb3-46bb-9356-40f80e961b4d.pdf		5510	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3	0.4		NO	3	YES	NO	EJ			Prostate		A	LIVING	2009		787d4d9f-1c69-406f-8e1c-2458d77085e7	TCGA-EJ-5510-01A-01D-1574-01	TCGA-EJ-5510-01A-01D-1578-05	TCGA-EJ-5510-01A-01D-1576-08	TCGA-EJ-5510-01A-01D-1576-08	787d4d9f-1c69-406f-8e1c-2458d77085e7	TCGA-EJ-5510-01	TCGA-EJ-5510-01	BA5FB8F4-DF35-48CB-888D-0A80C184A03F	TCGA-EJ-5510-01A-01D-1574-01	787d4d9f-1c69-406f-8e1c-2458d77085e7	TCGA-EJ-5510-01	TCGA-EJ-5510-01	TCGA-EJ-5510-01A-01D-1576-08	TCGA-EJ-5510-01A-01D-1576-08	787d4d9f-1c69-406f-8e1c-2458d77085e7
TCGA-EJ-5511-01	0	TCGA-EJ-5511-01	1476	0	days	TCGA-EJ-5511	1476	0	days	1476	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55	TCGA-EJ-5511-F60377	TCGA-EJ-5511	TCGA-EJ-5511-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-20409	18						0	1476		788			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-6-6	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.2	NO	Bilateral	2	NO	YES				NO	15	0		No	N0	T3a	TCGA-EJ-5511.4e4d79fc-ecc3-4533-ac69-9bdec44a080c.pdf		5511	TUMOR FREE	3	Complete Remission/Response	0.04	NO	R0	Primary Tumor	01	4	0.3		NO	4	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2009		488dc8bd-9e74-48b2-a407-914f6e0ba0b6	TCGA-EJ-5511-01A-01D-1574-01	TCGA-EJ-5511-01A-01D-1578-05	TCGA-EJ-5511-01A-01D-1576-08	TCGA-EJ-5511-01A-01D-1576-08	488dc8bd-9e74-48b2-a407-914f6e0ba0b6	TCGA-EJ-5511-01	TCGA-EJ-5511-01	6FC09B2E-53B1-4802-BF39-076F080FCC06	TCGA-EJ-5511-01A-01D-1574-01	488dc8bd-9e74-48b2-a407-914f6e0ba0b6	TCGA-EJ-5511-01	TCGA-EJ-5511-01	TCGA-EJ-5511-01A-01D-1576-08	TCGA-EJ-5511-01A-01D-1576-08	488dc8bd-9e74-48b2-a407-914f6e0ba0b6
TCGA-EJ-5512-01	0	TCGA-EJ-5512-01	1733	0	days	TCGA-EJ-5512	1733	0	days	1733	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			46	TCGA-EJ-5512-F71934	TCGA-EJ-5512	TCGA-EJ-5512-01A	NO		M0	T1c	-17127							0	1733		782							Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.1	NO	YES				NO	13	0		No	N0	T2c	TCGA-EJ-5512.8b273389-2655-4ac1-bcf0-b64505fe7b3d.pdf		5512	TUMOR FREE	3	Complete Remission/Response	0	NO	R0	Primary Tumor	01	4	0.5		NO	3	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2009		d0617c13-ba48-44d9-807f-29a9ee7ebf39	TCGA-EJ-5512-01A-01D-1574-01	TCGA-EJ-5512-01A-01D-1578-05	TCGA-EJ-5512-01A-01D-1576-08	TCGA-EJ-5512-01A-01D-1576-08	d0617c13-ba48-44d9-807f-29a9ee7ebf39	TCGA-EJ-5512-01	TCGA-EJ-5512-01	09112836-8FB3-4DCE-B041-DE03ED385768	TCGA-EJ-5512-01A-01D-1574-01	d0617c13-ba48-44d9-807f-29a9ee7ebf39	TCGA-EJ-5512-01	TCGA-EJ-5512-01	TCGA-EJ-5512-01A-01D-1576-08	TCGA-EJ-5512-01A-01D-1576-08	d0617c13-ba48-44d9-807f-29a9ee7ebf39
TCGA-EJ-5514-01	0	TCGA-EJ-5514-01	1829	0	days	TCGA-EJ-5514	1829	0	days	1829	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-EJ-5514-F71935	TCGA-EJ-5514	TCGA-EJ-5514-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24165	7						0	1829		724			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.4	NO	YES				NO	12	0		No	N0	T2c	TCGA-EJ-5514.5b64ad18-513e-422d-a847-d1862dd0e453.pdf		5514	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	5	0.4		NO	4	YES	NO	EJ			Prostate		A	LIVING	2009		10892e71-cd86-4bcf-9da9-5faa081d1b0a	TCGA-EJ-5514-01A-01D-1574-01	TCGA-EJ-5514-01A-01D-1578-05	TCGA-EJ-5514-01A-01D-1576-08	TCGA-EJ-5514-01A-01D-1576-08	10892e71-cd86-4bcf-9da9-5faa081d1b0a	TCGA-EJ-5514-01	TCGA-EJ-5514-01	12F1A7B6-283C-4F2B-A3A8-E434E56DEA6F	TCGA-EJ-5514-01A-01D-1574-01	10892e71-cd86-4bcf-9da9-5faa081d1b0a	TCGA-EJ-5514-01	TCGA-EJ-5514-01	TCGA-EJ-5514-01A-01D-1576-08	TCGA-EJ-5514-01A-01D-1576-08	10892e71-cd86-4bcf-9da9-5faa081d1b0a
TCGA-EJ-5515-01	0	TCGA-EJ-5515-01	1832	0	days	TCGA-EJ-5515	1832	0	days	1832	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			60	TCGA-EJ-5515-F60378	TCGA-EJ-5515	TCGA-EJ-5515-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22097	30			30			0	1832		1061			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-6-6	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Right	2	NO	YES				NO	20	0		No	N0	T3a	TCGA-EJ-5515.1029ba11-efb4-42b7-871c-c97192a40e12.pdf		5515	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.4		NO	4	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2009		7e81cb8c-9d91-4679-8a96-12365c19119b	TCGA-EJ-5515-01A-01D-1574-01	TCGA-EJ-5515-01A-01D-1578-05	TCGA-EJ-5515-01A-01D-1576-08	TCGA-EJ-5515-01A-01D-1576-08	7e81cb8c-9d91-4679-8a96-12365c19119b	TCGA-EJ-5515-01	TCGA-EJ-5515-01	34C05945-D438-422F-8673-E8BCBCF9E78B	TCGA-EJ-5515-01A-01D-1574-01	7e81cb8c-9d91-4679-8a96-12365c19119b	TCGA-EJ-5515-01	TCGA-EJ-5515-01	TCGA-EJ-5515-01A-01D-1576-08	TCGA-EJ-5515-01A-01D-1576-08	7e81cb8c-9d91-4679-8a96-12365c19119b
TCGA-EJ-5516-01	0	TCGA-EJ-5516-01	1889	0	days	TCGA-EJ-5516	1889	0	days	1889	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			49	TCGA-EJ-5516-F71936	TCGA-EJ-5516	TCGA-EJ-5516-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-17980	0						0	1889		730			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.6	NO	YES				NO	6	0		No	N0	T3a	TCGA-EJ-5516.b15c052e-04f9-49d7-bca9-dddf59a7e9da.pdf		5516	TUMOR FREE	3	Complete Remission/Response	0.12	NO	R0	Primary Tumor	01	4	0.3		NO	3	YES	NO	EJ			Prostate		A	LIVING	2009		6320daab-3fdb-45d2-bbc8-bbba33e4af37	TCGA-EJ-5516-01A-01D-1574-01	TCGA-EJ-5516-01A-01D-1578-05	TCGA-EJ-5516-01A-01D-1576-08	TCGA-EJ-5516-01A-01D-1576-08	6320daab-3fdb-45d2-bbc8-bbba33e4af37	TCGA-EJ-5516-01	TCGA-EJ-5516-01	480DA000-4D66-4E54-9F00-4ADCB83B6A7E	TCGA-EJ-5516-01A-01D-1574-01	6320daab-3fdb-45d2-bbc8-bbba33e4af37	TCGA-EJ-5516-01	TCGA-EJ-5516-01	TCGA-EJ-5516-01A-01D-1576-08	TCGA-EJ-5516-01A-01D-1576-08	6320daab-3fdb-45d2-bbc8-bbba33e4af37
TCGA-EJ-5517-01	0	TCGA-EJ-5517-01	1889	0	days	TCGA-EJ-5517	1889	0	days	1889	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55	TCGA-EJ-5517-F71937	TCGA-EJ-5517	TCGA-EJ-5517-01A	NO		M0	T1c	-20422							0	1889		187			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.4	NO	YES				NO	4	0		No	N0	T2c	TCGA-EJ-5517.67b66178-bd1b-44a8-9a30-762b0fc7c1ba.pdf		5517	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3	0.2		NO	2	YES	NO	EJ			Prostate		A	LIVING	2008		bfdc11be-a30b-498b-bdf6-4b98ec4f1ea1	TCGA-EJ-5517-01A-01D-1574-01	TCGA-EJ-5517-01A-01D-1578-05	TCGA-EJ-5517-01A-01D-1576-08	TCGA-EJ-5517-01A-01D-1576-08	bfdc11be-a30b-498b-bdf6-4b98ec4f1ea1	TCGA-EJ-5517-01	TCGA-EJ-5517-01	C7B12E0C-ACAF-403B-89AB-4998E1072A96	TCGA-EJ-5517-01A-01D-1574-01	bfdc11be-a30b-498b-bdf6-4b98ec4f1ea1	TCGA-EJ-5517-01	TCGA-EJ-5517-01	TCGA-EJ-5517-01A-01D-1576-08	TCGA-EJ-5517-01A-01D-1576-08	bfdc11be-a30b-498b-bdf6-4b98ec4f1ea1
TCGA-EJ-5518-01	0	TCGA-EJ-5518-01	2118	0	days	TCGA-EJ-5518	2104	1	days	2118	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	66	TCGA-EJ-5518-F71938	TCGA-EJ-5518	TCGA-EJ-5518-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T3b	-24313	32					2104	0	2118	2104	1195			NO		NO		Scheduled Follow-up Submission	Progressive Disease	2015-3-31	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.9	NO	[Discrepancy]	Bone	Distant Metastasis		YES	3	0		No	N0	T4	TCGA-EJ-5518.8299ff67-bed6-462f-87ad-3c8be45e1453.pdf		5518	WITH TUMOR	4	Progressive Disease	0.1	NO	R1	Primary Tumor	01	5	0.3		NO	4	YES	NO	EJ			Prostate		A	LIVING	2008	Overlapping / Multiple Zones	01d4c289-6d85-4119-86f5-bcf3de30d0f7	TCGA-EJ-5518-01A-01D-1574-01	TCGA-EJ-5518-01A-01D-1578-05	TCGA-EJ-5518-01A-01D-1576-08	TCGA-EJ-5518-01A-01D-1576-08	01d4c289-6d85-4119-86f5-bcf3de30d0f7	TCGA-EJ-5518-01	TCGA-EJ-5518-01	95F2803A-BFFF-43D8-9818-F042F82A052A	TCGA-EJ-5518-01A-01D-1574-01	01d4c289-6d85-4119-86f5-bcf3de30d0f7	TCGA-EJ-5518-01	TCGA-EJ-5518-01	TCGA-EJ-5518-01A-01D-1576-08	TCGA-EJ-5518-01A-01D-1576-08	01d4c289-6d85-4119-86f5-bcf3de30d0f7
TCGA-EJ-5519-01	0	TCGA-EJ-5519-01	1962	0	days	TCGA-EJ-5519	1962	0	days	1962	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			64	TCGA-EJ-5519-F60379	TCGA-EJ-5519	TCGA-EJ-5519-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-23669	13					84	0	1962		1153			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-6-6	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.2	NO	Bilateral	1.2	NO	YES				NO	12	3		No	N1	T3b	TCGA-EJ-5519.57861c52-0d80-484a-a800-65c3481327db.pdf		5519	TUMOR FREE	4	Complete Remission/Response	0.2	NO	R0	Primary Tumor	01	4	0.4		NO	3	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2008	Overlapping / Multiple Zones	4be2bce2-2032-41a4-af3a-5f01a698e143	TCGA-EJ-5519-01A-01D-1574-01	TCGA-EJ-5519-01A-01D-1578-05	TCGA-EJ-5519-01A-01D-1576-08	TCGA-EJ-5519-01A-01D-1576-08	4be2bce2-2032-41a4-af3a-5f01a698e143	TCGA-EJ-5519-01	TCGA-EJ-5519-01	A213FE4D-5339-4167-869C-F23252C89EEF	TCGA-EJ-5519-01A-01D-1574-01	4be2bce2-2032-41a4-af3a-5f01a698e143	TCGA-EJ-5519-01	TCGA-EJ-5519-01	TCGA-EJ-5519-01A-01D-1576-08	TCGA-EJ-5519-01A-01D-1576-08	4be2bce2-2032-41a4-af3a-5f01a698e143
TCGA-EJ-5521-01	0	TCGA-EJ-5521-01	2279	0	days	TCGA-EJ-5521	2279	0	days	2279	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63	TCGA-EJ-5521-F71942	TCGA-EJ-5521	TCGA-EJ-5521-01A	NO		M0	T1c	-23304							0	2279		240			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Right	1.2	NO	YES				NO	2	0		No	N0	T3a	TCGA-EJ-5521.0c816088-3fe4-4646-abaa-94095efd0b26.pdf		5521	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.3		NO	3	YES	NO	EJ	Middle|Base		Prostate		A	LIVING	2008		f18be8ba-45a0-4db4-90e7-9f0998eb959e	TCGA-EJ-5521-01A-01D-1574-01	TCGA-EJ-5521-01A-01D-1578-05	TCGA-EJ-5521-01A-01D-1576-08	TCGA-EJ-5521-01A-01D-1576-08	f18be8ba-45a0-4db4-90e7-9f0998eb959e	TCGA-EJ-5521-01	TCGA-EJ-5521-01	0B7031DA-2008-4320-9C04-C23D9FA44F24	TCGA-EJ-5521-01A-01D-1574-01	f18be8ba-45a0-4db4-90e7-9f0998eb959e	TCGA-EJ-5521-01	TCGA-EJ-5521-01	TCGA-EJ-5521-01A-01D-1576-08	TCGA-EJ-5521-01A-01D-1576-08	f18be8ba-45a0-4db4-90e7-9f0998eb959e
TCGA-EJ-5522-01	0	TCGA-EJ-5522-01	2079	0	days	TCGA-EJ-5522	2079	0	days	2079	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			51	TCGA-EJ-5522-F60380	TCGA-EJ-5522	TCGA-EJ-5522-01A	NO		M0	T2a	-18802							0	2079		1403			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-6-6	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Bilateral	1.3	NO	YES				NO	22	0		No	N0	T2c	TCGA-EJ-5522.756659d2-5e97-40d4-aa4e-c6d777153d0c.pdf		5522	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.3		NO	3	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2008	Overlapping / Multiple Zones	f1441277-65a1-486c-b8e1-2b947734cb17	TCGA-EJ-5522-01A-01D-1574-01	TCGA-EJ-5522-01A-01D-1578-05	TCGA-EJ-5522-01A-01D-1576-08	TCGA-EJ-5522-01A-01D-1576-08	f1441277-65a1-486c-b8e1-2b947734cb17	TCGA-EJ-5522-01	TCGA-EJ-5522-01	F38D9CB6-E73A-4260-8602-22BFA64FD07A	TCGA-EJ-5522-01A-01D-1574-01	f1441277-65a1-486c-b8e1-2b947734cb17	TCGA-EJ-5522-01	TCGA-EJ-5522-01	TCGA-EJ-5522-01A-01D-1576-08	TCGA-EJ-5522-01A-01D-1576-08	f1441277-65a1-486c-b8e1-2b947734cb17
TCGA-EJ-5524-01	0	TCGA-EJ-5524-01	1882	0	days	TCGA-EJ-5524	1882	0	days	1882	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57	TCGA-EJ-5524-F71944	TCGA-EJ-5524	TCGA-EJ-5524-01A	NO		M0	T2b	-20854							0	1882		811			NO		NO		Scheduled Follow-up Submission	Progressive Disease	2015-3-31	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.7	NO	YES				NO	17	0		No	N0	T3a	TCGA-EJ-5524.1f767c93-41f5-45d1-917f-3f1fc5330fb9.pdf		5524	WITH TUMOR	4	Progressive Disease	0.1	NO	R0	Primary Tumor	01	5	0.2		NO	3	YES	NO	EJ	Base		Prostate		A	LIVING	2009		c88d608d-79c7-41af-a3b3-e27b413cba28	TCGA-EJ-5524-01A-01D-1574-01	TCGA-EJ-5524-01A-01D-1578-05	TCGA-EJ-5524-01A-01D-1576-08	TCGA-EJ-5524-01A-01D-1576-08	c88d608d-79c7-41af-a3b3-e27b413cba28	TCGA-EJ-5524-01	TCGA-EJ-5524-01	30854379-BFCC-46F4-81B5-8BA4136F47E9	TCGA-EJ-5524-01A-01D-1574-01	c88d608d-79c7-41af-a3b3-e27b413cba28	TCGA-EJ-5524-01	TCGA-EJ-5524-01	TCGA-EJ-5524-01A-01D-1576-08	TCGA-EJ-5524-01A-01D-1576-08	c88d608d-79c7-41af-a3b3-e27b413cba28
TCGA-EJ-5525-01	0	TCGA-EJ-5525-01	1115	0	days	TCGA-EJ-5525	546	1	days	1115	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	67	TCGA-EJ-5525-F46762	TCGA-EJ-5525	TCGA-EJ-5525-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-24535	-6			-6		338	0	1115	546	521			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Progressive Disease	2013-8-16	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.6	NO	YES	Bone	Distant Metastasis		YES	8	0		No	N0	T2c	TCGA-EJ-5525.ab82e8b9-a3ba-48ef-ac3e-fd35c67a13e4.pdf		5525	WITH TUMOR	4	Progressive Disease	3.0	NO	R0	Primary Tumor	01	5	0.2		NO	3	YES	NO	EJ	Apex|Base		Prostate		A	LIVING	2009		ad22630d-693d-46c9-b785-5343b08679b5	TCGA-EJ-5525-01A-01D-1574-01	TCGA-EJ-5525-01A-01D-1578-05	TCGA-EJ-5525-01A-01D-1576-08	TCGA-EJ-5525-01A-01D-1576-08	ad22630d-693d-46c9-b785-5343b08679b5	TCGA-EJ-5525-01	TCGA-EJ-5525-01	D2D649A9-54E5-4091-9C84-6D76D51AD9F1	TCGA-EJ-5525-01A-01D-1574-01	ad22630d-693d-46c9-b785-5343b08679b5	TCGA-EJ-5525-01	TCGA-EJ-5525-01	TCGA-EJ-5525-01A-01D-1576-08	TCGA-EJ-5525-01A-01D-1576-08	ad22630d-693d-46c9-b785-5343b08679b5
TCGA-EJ-5526-01	0	TCGA-EJ-5526-01	1909	0	days	TCGA-EJ-5526	1909	1	days	1909	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	56	TCGA-EJ-5526-F71950	TCGA-EJ-5526	TCGA-EJ-5526-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-20558	19			19			0	1909	1909	175			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Progressive Disease	2015-3-31	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.5	NO	YES		Biochemical evidence of disease		YES	27	1		No	N1	T3a	TCGA-EJ-5526.5afeeeba-2a19-4042-acdc-8dad10ca31f9.pdf		5526	WITH TUMOR	4	Progressive Disease	0.1	NO	R0	Primary Tumor	01	4	0.3		NO	3	YES	NO	EJ	Middle|Base		Prostate		A	LIVING	2009		8536a0fb-4aed-4db0-80b0-994606c87ace	TCGA-EJ-5526-01A-01D-1574-01	TCGA-EJ-5526-01A-01D-1578-05	TCGA-EJ-5526-01A-01D-1576-08	TCGA-EJ-5526-01A-01D-1576-08	8536a0fb-4aed-4db0-80b0-994606c87ace	TCGA-EJ-5526-01	TCGA-EJ-5526-01	B6A40EC1-49E5-46DC-B8C1-FE2489A3640D	TCGA-EJ-5526-01A-01D-1574-01	8536a0fb-4aed-4db0-80b0-994606c87ace	TCGA-EJ-5526-01	TCGA-EJ-5526-01	TCGA-EJ-5526-01A-01D-1576-08	TCGA-EJ-5526-01A-01D-1576-08	8536a0fb-4aed-4db0-80b0-994606c87ace
TCGA-EJ-5527-01	0	TCGA-EJ-5527-01	1778	0	days	TCGA-EJ-5527	1778	0	days	1778	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			69	TCGA-EJ-5527-F71952	TCGA-EJ-5527	TCGA-EJ-5527-01A	NO		M0	T2a	-25234							0	1778		217			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	1.5	NO	YES				NO	9	0		No	N0	T3a	TCGA-EJ-5527.b4c74b9e-b639-4488-aef1-8bf008324f73.pdf		5527	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3	0.3		NO	3	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2009		2bd35c12-2701-45c4-a6ea-981667028597	TCGA-EJ-5527-01A-01D-1574-01	TCGA-EJ-5527-01A-01D-1578-05	TCGA-EJ-5527-01A-01D-1576-08	TCGA-EJ-5527-01A-01D-1576-08	2bd35c12-2701-45c4-a6ea-981667028597	TCGA-EJ-5527-01	TCGA-EJ-5527-01	8134B0C5-9EDD-4E20-8CE5-E07292233534	TCGA-EJ-5527-01A-01D-1574-01	2bd35c12-2701-45c4-a6ea-981667028597	TCGA-EJ-5527-01	TCGA-EJ-5527-01	TCGA-EJ-5527-01A-01D-1576-08	TCGA-EJ-5527-01A-01D-1576-08	2bd35c12-2701-45c4-a6ea-981667028597
TCGA-EJ-5530-01	0	TCGA-EJ-5530-01	1832	0	days	TCGA-EJ-5530	1832	0	days	1832	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61	TCGA-EJ-5530-F46774	TCGA-EJ-5530	TCGA-EJ-5530-01A	NO		M0	T2c	-22316							0	1832		586			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-16	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.8	NO	Bilateral	2	NO	YES				NO	6	0		No	N0	T2c	TCGA-EJ-5530.03cb0863-99db-411a-a347-a8675a65cb5a.pdf		5530	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.3		NO	3	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2008		314e8006-a060-4b71-a51e-ba450bbbb86c	TCGA-EJ-5530-01A-01D-1574-01	TCGA-EJ-5530-01A-01D-1578-05	TCGA-EJ-5530-01A-01D-1576-08	TCGA-EJ-5530-01A-01D-1576-08	314e8006-a060-4b71-a51e-ba450bbbb86c	TCGA-EJ-5530-01	TCGA-EJ-5530-01	FA2D5EAA-F949-4055-96A2-AA66B1BD92A4	TCGA-EJ-5530-01A-01D-1574-01	314e8006-a060-4b71-a51e-ba450bbbb86c	TCGA-EJ-5530-01	TCGA-EJ-5530-01	TCGA-EJ-5530-01A-01D-1576-08	TCGA-EJ-5530-01A-01D-1576-08	314e8006-a060-4b71-a51e-ba450bbbb86c
TCGA-EJ-5531-01	0	TCGA-EJ-5531-01	1273	0	days	TCGA-EJ-5531	1273	0	days	1273	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			62	TCGA-EJ-5531-F60382	TCGA-EJ-5531	TCGA-EJ-5531-01A	NO		M0	T2b	-22760							0	1273		724			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-6-6	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1	NO	YES				NO	35	0		No	N0	T3a	TCGA-EJ-5531.0f235aad-3f99-4ac4-919e-0a4290c02075.pdf		5531	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3	0.8		NO	3	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2009		49dda006-76b0-4088-8221-2bbfb1ac22f7	TCGA-EJ-5531-01A-01D-1574-01	TCGA-EJ-5531-01A-01D-1578-05	TCGA-EJ-5531-01A-01D-1576-08	TCGA-EJ-5531-01A-01D-1576-08	49dda006-76b0-4088-8221-2bbfb1ac22f7	TCGA-EJ-5531-01	TCGA-EJ-5531-01	FA6526B7-E5CE-4F77-93F2-19EB45C6D0EC	TCGA-EJ-5531-01A-01D-1574-01	49dda006-76b0-4088-8221-2bbfb1ac22f7	TCGA-EJ-5531-01	TCGA-EJ-5531-01	TCGA-EJ-5531-01A-01D-1576-08	TCGA-EJ-5531-01A-01D-1576-08	49dda006-76b0-4088-8221-2bbfb1ac22f7
TCGA-EJ-5532-01	0	TCGA-EJ-5532-01	1828	0	days	TCGA-EJ-5532	1828	0	days	1828	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57	TCGA-EJ-5532-F71956	TCGA-EJ-5532	TCGA-EJ-5532-01A	NO		M0	T1c	-21110							0	1828		926			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.7	NO	YES				NO	8	0		No	N0	T3a	TCGA-EJ-5532.11afaa3c-a99c-4e43-b4cb-eb139c9b1dab.pdf		5532	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.4		NO	3	YES	NO	EJ	Middle|Base		Prostate		A	LIVING	2009		51d276c8-e669-48c9-92d8-676a348249d5	TCGA-EJ-5532-01A-01D-1574-01	TCGA-EJ-5532-01A-01D-1578-05	TCGA-EJ-5532-01A-01D-1576-08	TCGA-EJ-5532-01A-01D-1576-08	51d276c8-e669-48c9-92d8-676a348249d5	TCGA-EJ-5532-01	TCGA-EJ-5532-01	4B1CD569-388D-42B3-B26B-F71A360AB2D2	TCGA-EJ-5532-01A-01D-1574-01	51d276c8-e669-48c9-92d8-676a348249d5	TCGA-EJ-5532-01	TCGA-EJ-5532-01	TCGA-EJ-5532-01A-01D-1576-08	TCGA-EJ-5532-01A-01D-1576-08	51d276c8-e669-48c9-92d8-676a348249d5
TCGA-EJ-5542-01	0	TCGA-EJ-5542-01	1513	0	days	TCGA-EJ-5542	1513	0	days	1513	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			60	TCGA-EJ-5542-F71959	TCGA-EJ-5542	TCGA-EJ-5542-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-21942	8			9	-21		0	1513		519			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Bilateral	1.7	NO	YES				NO	17	0		Yes	N0	T3a	TCGA-EJ-5542.d6fe7cc6-45e5-4b6c-b1f4-1dd7fd3c27be.pdf		5542	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.4		NO	3	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2010		71b37147-df4c-40ef-b57a-57c2f692de06	TCGA-EJ-5542-01A-01D-1574-01	TCGA-EJ-5542-01A-01D-1578-05	TCGA-EJ-5542-01A-01D-1576-08	TCGA-EJ-5542-01A-01D-1576-08	71b37147-df4c-40ef-b57a-57c2f692de06	TCGA-EJ-5542-01	TCGA-EJ-5542-01	C8C9F531-0F7E-437F-A593-39612548858E	TCGA-EJ-5542-01A-01D-1574-01	71b37147-df4c-40ef-b57a-57c2f692de06	TCGA-EJ-5542-01	TCGA-EJ-5542-01	TCGA-EJ-5542-01A-01D-1576-08	TCGA-EJ-5542-01A-01D-1576-08	71b37147-df4c-40ef-b57a-57c2f692de06
TCGA-EJ-7115-01	0	TCGA-EJ-7115-01	2687	0	days	TCGA-EJ-7115	2687	0	days	2687	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			65	TCGA-EJ-7115-F64799	TCGA-EJ-7115	TCGA-EJ-7115-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-23986	10			10			0	2687		204			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Bilateral	1.1	NO	YES				NO	21	0		No	N0	T3a	TCGA-EJ-7115.1638ac15-f8d6-4c88-b91e-e21033ae09db.pdf		7115	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3	0.4		NO	2	YES	NO	EJ			Prostate		A	LIVING	2006		c5dbae69-fb0e-458b-81ce-1f64c391cfe1	TCGA-EJ-7115-01A-11D-2112-01	TCGA-EJ-7115-01A-11D-2116-05		TCGA-EJ-7115-01A-11D-2114-08	c5dbae69-fb0e-458b-81ce-1f64c391cfe1	TCGA-EJ-7115-01	TCGA-EJ-7115-01	C57E396B-8F17-4ACF-A298-9CEE180D644C	TCGA-EJ-7115-01A-11D-2112-01	c5dbae69-fb0e-458b-81ce-1f64c391cfe1	TCGA-EJ-7115-01	TCGA-EJ-7115-01	TCGA-EJ-7115-01A-11D-2114-08	TCGA-EJ-7115-01A-11D-2114-08	c5dbae69-fb0e-458b-81ce-1f64c391cfe1
TCGA-EJ-7115-11	0	TCGA-EJ-7115-11	2687	0	days	TCGA-EJ-7115	2687	0	days	2687	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			65	TCGA-EJ-7115-F64799	TCGA-EJ-7115		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-23986	10			10			0	2687		204			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	21	0		No	N0	T3a			7115	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Solid Tissue Normal	11	3			NO	2	YES	NO	EJ			Prostate			LIVING	2006		b2b21d28-08c6-43e3-8b64-e9cdc913b15e					b2b21d28-08c6-43e3-8b64-e9cdc913b15e		TCGA-EJ-7115-11			b2b21d28-08c6-43e3-8b64-e9cdc913b15e		TCGA-EJ-7115-11			b2b21d28-08c6-43e3-8b64-e9cdc913b15e
TCGA-EJ-7123-01	0	TCGA-EJ-7123-01	2572	0	days	TCGA-EJ-7123	2572	0	days	2572	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			59	TCGA-EJ-7123-F71960	TCGA-EJ-7123	TCGA-EJ-7123-01A	NO		M0	T1c	-21741							0	2572		1491			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	0.7	NO	YES				NO	22	0		Yes	N0	T2c	TCGA-EJ-7123.1ba8d08d-0be5-46a6-9540-8f6d028e0dea.pdf		7123	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.1		NO	3	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2007		12e19460-da9a-4ff4-8664-801e7f8829b7	TCGA-EJ-7123-01A-11D-1959-01	TCGA-EJ-7123-01A-11D-1963-05		TCGA-EJ-7123-01A-11D-1961-08	12e19460-da9a-4ff4-8664-801e7f8829b7	TCGA-EJ-7123-01	TCGA-EJ-7123-01		TCGA-EJ-7123-01A-11D-1959-01	12e19460-da9a-4ff4-8664-801e7f8829b7	TCGA-EJ-7123-01	TCGA-EJ-7123-01	TCGA-EJ-7123-01A-11D-1961-08	TCGA-EJ-7123-01A-11D-1961-08	12e19460-da9a-4ff4-8664-801e7f8829b7
TCGA-EJ-7123-11	0	TCGA-EJ-7123-11	2572	0	days	TCGA-EJ-7123	2572	0	days	2572	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			59	TCGA-EJ-7123-F71960	TCGA-EJ-7123	TCGA-EJ-7123-11A	NO		M0	T1c	-21741							0	2572		1491			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	2	NO	YES				NO	22	0		Yes	N0	T2c			7123	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Solid Tissue Normal	11	4	0.4		NO	3	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2007		8dfd97d6-25a9-4579-80a7-b3bb0ef53074		TCGA-EJ-7123-11A-01D-1963-05			8dfd97d6-25a9-4579-80a7-b3bb0ef53074		TCGA-EJ-7123-11			8dfd97d6-25a9-4579-80a7-b3bb0ef53074		TCGA-EJ-7123-11			8dfd97d6-25a9-4579-80a7-b3bb0ef53074
TCGA-EJ-7125-01	0	TCGA-EJ-7125-01	2850	0	days	TCGA-EJ-7125	2850	0	days	2850	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			44	TCGA-EJ-7125-F64801	TCGA-EJ-7125	TCGA-EJ-7125-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-16425	12						0	2850		1860			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1	NO	YES				NO	13	0		No	N0	T2c	TCGA-EJ-7125.3565cc83-8305-490f-a47a-dc71b36a9044.pdf		7125	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.4		NO	3	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2005		a15d99f4-2e43-4fb8-93d5-6cc582b12237	TCGA-EJ-7125-01A-11D-1959-01	TCGA-EJ-7125-01A-11D-1963-05		TCGA-EJ-7125-01A-11D-1961-08	a15d99f4-2e43-4fb8-93d5-6cc582b12237	TCGA-EJ-7125-01	TCGA-EJ-7125-01	A83D9347-6980-4561-BEAE-55A44B4D254A	TCGA-EJ-7125-01A-11D-1959-01	a15d99f4-2e43-4fb8-93d5-6cc582b12237	TCGA-EJ-7125-01	TCGA-EJ-7125-01	TCGA-EJ-7125-01A-11D-1961-08	TCGA-EJ-7125-01A-11D-1961-08	a15d99f4-2e43-4fb8-93d5-6cc582b12237
TCGA-EJ-7125-11	0	TCGA-EJ-7125-11	2850	0	days	TCGA-EJ-7125	2850	0	days	2850	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			44	TCGA-EJ-7125-F64801	TCGA-EJ-7125		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-16425	12						0	2850		1860			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	13	0		No	N0	T2c			7125	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Solid Tissue Normal	11	4			NO	3	YES	NO	EJ	Apex|Middle		Prostate			LIVING	2005		ab016062-694f-4925-934e-0ea8b62bc2a9		TCGA-EJ-7125-11A-01D-1963-05			ab016062-694f-4925-934e-0ea8b62bc2a9		TCGA-EJ-7125-11			ab016062-694f-4925-934e-0ea8b62bc2a9		TCGA-EJ-7125-11			ab016062-694f-4925-934e-0ea8b62bc2a9
TCGA-EJ-7218-01	0	TCGA-EJ-7218-01	2542	0	days	TCGA-EJ-7218	2542	0	days	2542	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			71	TCGA-EJ-7218-F64802	TCGA-EJ-7218	TCGA-EJ-7218-01B	NO		M0	T2a	-26181		2397					0	2542		1473							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy	850		NO	Bilateral		NO	YES				NO	3	0	true	No	N0	T2c	TCGA-EJ-7218.D1D8A1D3-24B1-4787-8925-A5A8FC19DF74.pdf		7218	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate		B	LIVING	2006		0502e061-ae1d-4384-b2a5-24091a92eeab	TCGA-EJ-7218-01B-11D-A32A-01	TCGA-EJ-7218-01B-11D-A32C-05		TCGA-EJ-7218-01B-11D-A32B-08	0502e061-ae1d-4384-b2a5-24091a92eeab	TCGA-EJ-7218-01	TCGA-EJ-7218-01	1E8641F0-B08C-4A21-BA40-7F11A5C3682B	TCGA-EJ-7218-01B-11D-A32A-01	0502e061-ae1d-4384-b2a5-24091a92eeab	TCGA-EJ-7218-01	TCGA-EJ-7218-01		TCGA-EJ-7218-01B-11D-A32B-08	0502e061-ae1d-4384-b2a5-24091a92eeab
TCGA-EJ-7312-01	0	TCGA-EJ-7312-01	1099	0	days	TCGA-EJ-7312	1099	0	days	1099	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			58	TCGA-EJ-7312-F64805	TCGA-EJ-7312	TCGA-EJ-7312-01B	NO		M0	T3b	-21292		832					0	1099		376							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy	320		NO	Bilateral		NO	YES				NO	3	0	true	Yes, History of Prior Malignancy	N0	T3b	TCGA-EJ-7312.92D81258-C134-48A6-8B74-DE3789E1530F.pdf		7312	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3			NO		YES	NO	EJ			Prostate		B	LIVING	2011		43077b04-13be-4fc0-a691-9cb49bdd50d5	TCGA-EJ-7312-01B-21D-A32A-01	TCGA-EJ-7312-01B-21D-A32C-05		TCGA-EJ-7312-01B-21D-A32B-08	43077b04-13be-4fc0-a691-9cb49bdd50d5	TCGA-EJ-7312-01		443ADFE3-1595-4B68-A511-940D255A7023	TCGA-EJ-7312-01B-21D-A32A-01	43077b04-13be-4fc0-a691-9cb49bdd50d5	TCGA-EJ-7312-01				43077b04-13be-4fc0-a691-9cb49bdd50d5
TCGA-EJ-7314-01	0	TCGA-EJ-7314-01	1150	0	days	TCGA-EJ-7314	1150	0	days	1150	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			62	TCGA-EJ-7314-F64807	TCGA-EJ-7314	TCGA-EJ-7314-01A	NO		M0	T2c	-22766				14			0	1150		295			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.5	NO	YES				NO	14	0		No	N0	T3b	TCGA-EJ-7314.bbd6fa31-f4d4-4c06-aa64-1e263ccd8844.pdf		7314	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3	0.3		NO	5	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2011		cd77237d-0598-41cd-b12c-eea4b9c06e6d	TCGA-EJ-7314-01A-31D-2112-01	TCGA-EJ-7314-01A-31D-2116-05		TCGA-EJ-7314-01A-31D-2114-08	cd77237d-0598-41cd-b12c-eea4b9c06e6d	TCGA-EJ-7314-01	TCGA-EJ-7314-01	DC6ADA36-C498-434F-8E25-D17A78ED67F1	TCGA-EJ-7314-01A-31D-2112-01	cd77237d-0598-41cd-b12c-eea4b9c06e6d	TCGA-EJ-7314-01	TCGA-EJ-7314-01	TCGA-EJ-7314-01A-31D-2114-08	TCGA-EJ-7314-01A-31D-2114-08	cd77237d-0598-41cd-b12c-eea4b9c06e6d
TCGA-EJ-7314-11	0	TCGA-EJ-7314-11	1150	0	days	TCGA-EJ-7314	1150	0	days	1150	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			62	TCGA-EJ-7314-F64807	TCGA-EJ-7314		NO		M0	T2c	-22766				14			0	1150		295			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	14	0		No	N0	T3b			7314	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Solid Tissue Normal	11	3			NO	5	YES	NO	EJ	Apex|Middle|Base		Prostate			LIVING	2011		cc827a61-5c7d-41a0-a677-35a52e5eb471					cc827a61-5c7d-41a0-a677-35a52e5eb471		TCGA-EJ-7314-11			cc827a61-5c7d-41a0-a677-35a52e5eb471		TCGA-EJ-7314-11			cc827a61-5c7d-41a0-a677-35a52e5eb471
TCGA-EJ-7315-01	0	TCGA-EJ-7315-01	1008	0	days	TCGA-EJ-7315	1008	0	days	1008	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			68	TCGA-EJ-7315-F64804	TCGA-EJ-7315	TCGA-EJ-7315-01A	NO		M0	T2a	-25154							0	1008		289			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.5	NO	Bilateral	2.5	NO	YES				NO	7	0		No	N0	T3a	TCGA-EJ-7315.6afa83ac-9060-4b49-90a3-dc19824822e3.pdf		7315	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3	0.5		NO	5	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2011		5e185249-6ea1-460b-b841-f40e94ea1ccd	TCGA-EJ-7315-01A-31D-2112-01	TCGA-EJ-7315-01A-31D-2116-05		TCGA-EJ-7315-01A-31D-2114-08	5e185249-6ea1-460b-b841-f40e94ea1ccd	TCGA-EJ-7315-01	TCGA-EJ-7315-01	952C4870-B6EB-4BE0-8769-AEE172D193F8	TCGA-EJ-7315-01A-31D-2112-01	5e185249-6ea1-460b-b841-f40e94ea1ccd	TCGA-EJ-7315-01	TCGA-EJ-7315-01	TCGA-EJ-7315-01A-31D-2114-08	TCGA-EJ-7315-01A-31D-2114-08	5e185249-6ea1-460b-b841-f40e94ea1ccd
TCGA-EJ-7315-11	0	TCGA-EJ-7315-11	1008	0	days	TCGA-EJ-7315	1008	0	days	1008	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			68	TCGA-EJ-7315-F64804	TCGA-EJ-7315	TCGA-EJ-7315-11A	NO		M0	T2a	-25154							0	1008		289			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.8	NO	Bilateral	2.2	NO	YES				NO	7	0		No	N0	T3a			7315	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Solid Tissue Normal	11	3	0.4		NO	5	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2011		85e48131-0ef8-4b94-986a-3829ccad6d25					85e48131-0ef8-4b94-986a-3829ccad6d25		TCGA-EJ-7315-11			85e48131-0ef8-4b94-986a-3829ccad6d25		TCGA-EJ-7315-11			85e48131-0ef8-4b94-986a-3829ccad6d25
TCGA-EJ-7317-01	0	TCGA-EJ-7317-01	771	0	days	TCGA-EJ-7317	771	0	days	771	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			71	TCGA-EJ-7317-F64809	TCGA-EJ-7317	TCGA-EJ-7317-01A	NO		M0	T1c	-26064							0	771		285							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.2	NO	YES				NO	40	0		No	N0	T2c	TCGA-EJ-7317.f1531404-e42a-47a0-bbd7-6b0bd5ebf56b.pdf		7317	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.3		NO	3	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2011		64f48f1f-3d80-43fa-bd06-3a5881291ee3	TCGA-EJ-7317-01A-31D-2112-01	TCGA-EJ-7317-01A-31D-2116-05		TCGA-EJ-7317-01A-31D-2114-08	64f48f1f-3d80-43fa-bd06-3a5881291ee3	TCGA-EJ-7317-01	TCGA-EJ-7317-01	0D44E764-75EA-4F90-961A-15B05A137AAD	TCGA-EJ-7317-01A-31D-2112-01	64f48f1f-3d80-43fa-bd06-3a5881291ee3	TCGA-EJ-7317-01	TCGA-EJ-7317-01	TCGA-EJ-7317-01A-31D-2114-08	TCGA-EJ-7317-01A-31D-2114-08	64f48f1f-3d80-43fa-bd06-3a5881291ee3
TCGA-EJ-7317-11	0	TCGA-EJ-7317-11	771	0	days	TCGA-EJ-7317	771	0	days	771	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			71	TCGA-EJ-7317-F64809	TCGA-EJ-7317	TCGA-EJ-7317-11A	NO		M0	T1c	-26064							0	771		285							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.7	NO	YES				NO	40	0		No	N0	T2c			7317	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Solid Tissue Normal	11	4	0.5		NO	3	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2011		7e9f1df1-e76f-45a0-9f1b-9a0cbd626430		TCGA-EJ-7317-11A-01D-2116-05			7e9f1df1-e76f-45a0-9f1b-9a0cbd626430		TCGA-EJ-7317-11			7e9f1df1-e76f-45a0-9f1b-9a0cbd626430		TCGA-EJ-7317-11			7e9f1df1-e76f-45a0-9f1b-9a0cbd626430
TCGA-EJ-7318-01	0	TCGA-EJ-7318-01	1029	0	days	TCGA-EJ-7318	1029	0	days	1029	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			51	TCGA-EJ-7318-F64810	TCGA-EJ-7318	TCGA-EJ-7318-01B	YES		M0	T3a	-18686		757				189	0	1029		189							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy	650		NO	Bilateral		NO	NO				NO			true	No		T3a	TCGA-EJ-7318.B31F5757-0D35-4436-8F26-9AFE229049CD.pdf		7318	TUMOR FREE	4	Partial Remission/Response	.08	NO	R0	Primary Tumor	01	3			NO		YES	NO	EJ			Prostate		B	LIVING	2011		0b50b27b-e429-41b1-8324-c9e03b6bbaaf	TCGA-EJ-7318-01B-11D-A32A-01	TCGA-EJ-7318-01B-11D-A32C-05		TCGA-EJ-7318-01B-11D-A32B-08	0b50b27b-e429-41b1-8324-c9e03b6bbaaf	TCGA-EJ-7318-01	TCGA-EJ-7318-01	1D0F6289-A6B8-4167-B043-BDEAD4FA9797	TCGA-EJ-7318-01B-11D-A32A-01	0b50b27b-e429-41b1-8324-c9e03b6bbaaf	TCGA-EJ-7318-01	TCGA-EJ-7318-01		TCGA-EJ-7318-01B-11D-A32B-08	0b50b27b-e429-41b1-8324-c9e03b6bbaaf
TCGA-EJ-7321-01	0	TCGA-EJ-7321-01	824	0	days	TCGA-EJ-7321	824	0	days	824	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57	TCGA-EJ-7321-F64812	TCGA-EJ-7321	TCGA-EJ-7321-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-21108	10						0	824		128			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.4	NO	YES				NO	25	0		No	N0	T3a	TCGA-EJ-7321.9d0d3184-b73a-4f24-919d-0ba7d5d32ff2.pdf		7321	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3	0.4		NO	4	YES	NO	EJ			Prostate		A	LIVING	2011		951adcbd-7d7a-466c-bbac-7c7afb8b9df6	TCGA-EJ-7321-01A-31D-2259-01	TCGA-EJ-7321-01A-31D-2261-05		TCGA-EJ-7321-01A-31D-2260-08	951adcbd-7d7a-466c-bbac-7c7afb8b9df6	TCGA-EJ-7321-01	TCGA-EJ-7321-01	C3ADD46F-DA97-482C-AFE3-7CB575D960B9	TCGA-EJ-7321-01A-31D-2259-01	951adcbd-7d7a-466c-bbac-7c7afb8b9df6	TCGA-EJ-7321-01	TCGA-EJ-7321-01	TCGA-EJ-7321-01A-31D-2260-08	TCGA-EJ-7321-01A-31D-2260-08	951adcbd-7d7a-466c-bbac-7c7afb8b9df6
TCGA-EJ-7321-11	0	TCGA-EJ-7321-11	824	0	days	TCGA-EJ-7321	824	0	days	824	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57	TCGA-EJ-7321-F64812	TCGA-EJ-7321		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-21108	10						0	824		128			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	25	0		No	N0	T3a			7321	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Solid Tissue Normal	11	3			NO	4	YES	NO	EJ			Prostate			LIVING	2011		fff1f232-8978-406d-a6fc-61df98382b86					fff1f232-8978-406d-a6fc-61df98382b86		TCGA-EJ-7321-11			fff1f232-8978-406d-a6fc-61df98382b86		TCGA-EJ-7321-11			fff1f232-8978-406d-a6fc-61df98382b86
TCGA-EJ-7325-01	0	TCGA-EJ-7325-01	1070	0	days	TCGA-EJ-7325	1070	0	days	1070	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63	TCGA-EJ-7325-F64803	TCGA-EJ-7325	TCGA-EJ-7325-01B	NO		M0	T3b	-23029		855					0	1070		507							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy	480		NO	Bilateral		NO	YES				NO	9	0	true	Yes, History of Prior Malignancy	N0	T3b	TCGA-EJ-7325.6E9EC98C-FD89-47DA-BF8A-B7F4229C9E09.pdf		7325	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate		B	LIVING	2011		3c6d1cda-258e-42f4-ad31-16069e437ac3	TCGA-EJ-7325-01B-11D-A32A-01	TCGA-EJ-7325-01B-11D-A32C-05		TCGA-EJ-7325-01B-11D-A32B-08	3c6d1cda-258e-42f4-ad31-16069e437ac3	TCGA-EJ-7325-01	TCGA-EJ-7325-01	B4CB51C2-A8E4-45F6-AAC9-B2B88E89EC05	TCGA-EJ-7325-01B-11D-A32A-01	3c6d1cda-258e-42f4-ad31-16069e437ac3	TCGA-EJ-7325-01	TCGA-EJ-7325-01			3c6d1cda-258e-42f4-ad31-16069e437ac3
TCGA-EJ-7327-01	0	TCGA-EJ-7327-01	923	0	days	TCGA-EJ-7327	923	0	days	923	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61	TCGA-EJ-7327-F64808	TCGA-EJ-7327		NO		M0	T2a	-22475							0	923		175			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	17	0		No	N0	T3b			7327	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO	5	YES	NO	EJ	Apex|Middle|Base		Prostate			LIVING	2011		bc6a091a-720d-4a70-b3de-66db6b240669	TCGA-EJ-7327-01A-11D-2112-01	TCGA-EJ-7327-01A-11D-2116-05		TCGA-EJ-7327-01A-11D-2114-08	bc6a091a-720d-4a70-b3de-66db6b240669	TCGA-EJ-7327-01	TCGA-EJ-7327-01		TCGA-EJ-7327-01A-11D-2112-01	bc6a091a-720d-4a70-b3de-66db6b240669	TCGA-EJ-7327-01	TCGA-EJ-7327-01	TCGA-EJ-7327-01A-11D-2114-08	TCGA-EJ-7327-01A-11D-2114-08	bc6a091a-720d-4a70-b3de-66db6b240669
TCGA-EJ-7327-11	0	TCGA-EJ-7327-11	923	0	days	TCGA-EJ-7327	923	0	days	923	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61	TCGA-EJ-7327-F64808	TCGA-EJ-7327	TCGA-EJ-7327-11A	NO		M0	T2a	-22475							0	923		175			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.5	NO	Bilateral	1.9	NO	YES				NO	17	0		No	N0	T3b			7327	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Solid Tissue Normal	11	4	0.7		NO	5	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2011		63cd2e90-2a03-406a-a094-b855c02b0c04		TCGA-EJ-7327-11A-01D-2116-05			63cd2e90-2a03-406a-a094-b855c02b0c04		TCGA-EJ-7327-11			63cd2e90-2a03-406a-a094-b855c02b0c04		TCGA-EJ-7327-11			63cd2e90-2a03-406a-a094-b855c02b0c04
TCGA-EJ-7328-01	0	TCGA-EJ-7328-01	842	0	days	TCGA-EJ-7328	842	0	days	842	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			70	TCGA-EJ-7328-F64806	TCGA-EJ-7328	TCGA-EJ-7328-01A			M0	T1c	-25756							0	842					NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.8	NO	YES				NO	9	0		No	N0	T3a	TCGA-EJ-7328.30c9c833-ae7e-46de-951c-a488df1d723a.pdf		7328	TUMOR FREE	4	Complete Remission/Response		NO	R0	Primary Tumor	01	3	0.5		NO	5	YES	NO	EJ	Middle|Base		Prostate		A	LIVING	2011		bd8a26e3-ddaf-405d-9b32-bd6adb09024f	TCGA-EJ-7328-01A-31D-2112-01	TCGA-EJ-7328-01A-31D-2116-05		TCGA-EJ-7328-01A-31D-2114-08	bd8a26e3-ddaf-405d-9b32-bd6adb09024f	TCGA-EJ-7328-01	TCGA-EJ-7328-01	7E4BA80A-1D78-491D-BFB2-F624B8B4F89E	TCGA-EJ-7328-01A-31D-2112-01	bd8a26e3-ddaf-405d-9b32-bd6adb09024f	TCGA-EJ-7328-01	TCGA-EJ-7328-01	TCGA-EJ-7328-01A-31D-2114-08	TCGA-EJ-7328-01A-31D-2114-08	bd8a26e3-ddaf-405d-9b32-bd6adb09024f
TCGA-EJ-7328-11	0	TCGA-EJ-7328-11	842	0	days	TCGA-EJ-7328	842	0	days	842	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			70	TCGA-EJ-7328-F64806	TCGA-EJ-7328				M0	T1c	-25756							0	842					NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	9	0		No	N0	T3a			7328	TUMOR FREE	4	Complete Remission/Response		NO	R0	Solid Tissue Normal	11	3			NO	5	YES	NO	EJ	Middle|Base		Prostate			LIVING	2011		cbc2c758-bf49-4165-bbb1-30c046caf99c		TCGA-EJ-7328-11A-01D-2116-05			cbc2c758-bf49-4165-bbb1-30c046caf99c		TCGA-EJ-7328-11			cbc2c758-bf49-4165-bbb1-30c046caf99c		TCGA-EJ-7328-11			cbc2c758-bf49-4165-bbb1-30c046caf99c
TCGA-EJ-7330-01	0	TCGA-EJ-7330-01	191	0	days	TCGA-EJ-7330			days	191	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			68		TCGA-EJ-7330	TCGA-EJ-7330-01A	NO		M0	T1c	-25050							0	191		191			NO		NO				2012-4-5	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.3	NO	Bilateral	1.5		YES					18	0		No	N0	T3a	TCGA-EJ-7330.d910cd86-89be-4fc9-8f9d-497692a6face.pdf		7330	TUMOR FREE	4		0.1		R0	Primary Tumor	01	3	0.4			5	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2011		07b4fdf4-19af-42f6-8c17-520047dce246	TCGA-EJ-7330-01A-11D-2112-01	TCGA-EJ-7330-01A-11D-2116-05		TCGA-EJ-7330-01A-11D-2114-08	07b4fdf4-19af-42f6-8c17-520047dce246	TCGA-EJ-7330-01	TCGA-EJ-7330-01	3BD9A152-B0AC-440D-B2B3-E465FF1BD0E1	TCGA-EJ-7330-01A-11D-2112-01	07b4fdf4-19af-42f6-8c17-520047dce246	TCGA-EJ-7330-01	TCGA-EJ-7330-01	TCGA-EJ-7330-01A-11D-2114-08	TCGA-EJ-7330-01A-11D-2114-08	07b4fdf4-19af-42f6-8c17-520047dce246
TCGA-EJ-7330-11	0	TCGA-EJ-7330-11	191	0	days	TCGA-EJ-7330			days	191	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			68		TCGA-EJ-7330	TCGA-EJ-7330-11A	NO		M0	T1c	-25050							0	191		191			NO		NO				2012-4-5	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	2.3		YES					18	0		No	N0	T3a			7330	TUMOR FREE	4		0.1		R0	Solid Tissue Normal	11	3	0.4			5	YES	NO	EJ	Apex|Middle|Base		Prostate		A	LIVING	2011		15602b9c-e496-4b8b-a416-82db780d8f28					15602b9c-e496-4b8b-a416-82db780d8f28		TCGA-EJ-7330-11			15602b9c-e496-4b8b-a416-82db780d8f28		TCGA-EJ-7330-11			15602b9c-e496-4b8b-a416-82db780d8f28
TCGA-EJ-7331-01	0	TCGA-EJ-7331-01	742	0	days	TCGA-EJ-7331	742	0	days	742	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			64	TCGA-EJ-7331-F64813	TCGA-EJ-7331	TCGA-EJ-7331-01A	YES		M0	T1c	-23458						189	0	742		189			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.4	NO	Bilateral	1.9	NO	YES				NO	7	0		No	N0	T2c	TCGA-EJ-7331.84790d75-bbef-49b0-9486-94e049c13ddd.pdf		7331	TUMOR FREE	3	Complete Remission/Response	0.8	NO	R0	Primary Tumor	01	4	0.3		NO	3	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2011		0c4495e4-b826-45ee-9ad3-873266b4585b	TCGA-EJ-7331-01A-11D-2112-01	TCGA-EJ-7331-01A-11D-2116-05		TCGA-EJ-7331-01A-11D-2114-08	0c4495e4-b826-45ee-9ad3-873266b4585b	TCGA-EJ-7331-01	TCGA-EJ-7331-01	29032C53-2573-4E12-BD74-01229692E6B8	TCGA-EJ-7331-01A-11D-2112-01	0c4495e4-b826-45ee-9ad3-873266b4585b	TCGA-EJ-7331-01	TCGA-EJ-7331-01	TCGA-EJ-7331-01A-11D-2114-08	TCGA-EJ-7331-01A-11D-2114-08	0c4495e4-b826-45ee-9ad3-873266b4585b
TCGA-EJ-7331-11	0	TCGA-EJ-7331-11	742	0	days	TCGA-EJ-7331	742	0	days	742	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			64	TCGA-EJ-7331-F64813	TCGA-EJ-7331	TCGA-EJ-7331-11A	YES		M0	T1c	-23458						189	0	742		189			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.4	NO	Bilateral	2.5	NO	YES				NO	7	0		No	N0	T2c			7331	TUMOR FREE	3	Complete Remission/Response	0.8	NO	R0	Solid Tissue Normal	11	4	0.3		NO	3	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2011		9356c4e0-eb35-4e70-85da-10ad2ae535a6		TCGA-EJ-7331-11A-01D-2116-05			9356c4e0-eb35-4e70-85da-10ad2ae535a6		TCGA-EJ-7331-11			9356c4e0-eb35-4e70-85da-10ad2ae535a6		TCGA-EJ-7331-11			9356c4e0-eb35-4e70-85da-10ad2ae535a6
TCGA-EJ-7781-01	0	TCGA-EJ-7781-01	1073	0	days	TCGA-EJ-7781	1073	0	days	1073	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			65	TCGA-EJ-7781-F60365	TCGA-EJ-7781	TCGA-EJ-7781-01A	NO		M0	T1c	-23937							0	1073		169			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-6-6	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	2	NO	YES				NO	17	0		No	N0	T2c	TCGA-EJ-7781.3582ff42-09f7-4ffb-9421-60f3cba1ff28.pdf		7781	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.3		NO	5	YES	NO	EJ			Prostate		A	LIVING	2011		26cd2872-7067-4cd7-bf85-4f028d9a819d	TCGA-EJ-7781-01A-11D-2112-01	TCGA-EJ-7781-01A-11D-2116-05		TCGA-EJ-7781-01A-11D-2114-08	26cd2872-7067-4cd7-bf85-4f028d9a819d	TCGA-EJ-7781-01	TCGA-EJ-7781-01	1F6DDC7F-411E-4B6C-8EA5-A3B79D27E921	TCGA-EJ-7781-01A-11D-2112-01	26cd2872-7067-4cd7-bf85-4f028d9a819d	TCGA-EJ-7781-01	TCGA-EJ-7781-01	TCGA-EJ-7781-01A-11D-2114-08	TCGA-EJ-7781-01A-11D-2114-08	26cd2872-7067-4cd7-bf85-4f028d9a819d
TCGA-EJ-7781-11	0	TCGA-EJ-7781-11	1073	0	days	TCGA-EJ-7781	1073	0	days	1073	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			65	TCGA-EJ-7781-F60365	TCGA-EJ-7781		NO		M0	T1c	-23937							0	1073		169			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-6-6	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	17	0		No	N0	T2c			7781	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Solid Tissue Normal	11	4			NO	5	YES	NO	EJ			Prostate			LIVING	2011		d75a22a0-a230-4ac8-a3db-96ea29ca95b9		TCGA-EJ-7781-11A-01D-2116-05			d75a22a0-a230-4ac8-a3db-96ea29ca95b9		TCGA-EJ-7781-11			d75a22a0-a230-4ac8-a3db-96ea29ca95b9		TCGA-EJ-7781-11			d75a22a0-a230-4ac8-a3db-96ea29ca95b9
TCGA-EJ-7782-01	0	TCGA-EJ-7782-01	1167	0	days	TCGA-EJ-7782	1167	0	days	1167	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			71	TCGA-EJ-7782-F60366	TCGA-EJ-7782	TCGA-EJ-7782-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-25965	49						0	1167		350			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-6-6	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.2	NO	Bilateral	1.5	NO	YES				NO	17	0		No	N0	T2c	TCGA-EJ-7782.d8500e84-1aa4-4a3b-874c-563d520dec03.pdf		7782	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.5		NO	4	YES	NO	EJ			Prostate		A	LIVING	2010		0d9fb905-5374-4054-b799-9c4c4efd36d6	TCGA-EJ-7782-01A-11D-2112-01	TCGA-EJ-7782-01A-11D-2116-05		TCGA-EJ-7782-01A-11D-2114-08	0d9fb905-5374-4054-b799-9c4c4efd36d6	TCGA-EJ-7782-01	TCGA-EJ-7782-01	875D4449-957F-414F-8835-C9C0E35BA249	TCGA-EJ-7782-01A-11D-2112-01	0d9fb905-5374-4054-b799-9c4c4efd36d6	TCGA-EJ-7782-01	TCGA-EJ-7782-01	TCGA-EJ-7782-01A-11D-2114-08	TCGA-EJ-7782-01A-11D-2114-08	0d9fb905-5374-4054-b799-9c4c4efd36d6
TCGA-EJ-7782-11	0	TCGA-EJ-7782-11	1167	0	days	TCGA-EJ-7782	1167	0	days	1167	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			71	TCGA-EJ-7782-F60366	TCGA-EJ-7782		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-25965	49						0	1167		350			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-6-6	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	17	0		No	N0	T2c			7782	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Solid Tissue Normal	11	4			NO	4	YES	NO	EJ			Prostate			LIVING	2010		e74de9a3-6dd4-42b7-b92c-eba3e3827bed		TCGA-EJ-7782-11A-01D-2116-05			e74de9a3-6dd4-42b7-b92c-eba3e3827bed		TCGA-EJ-7782-11			e74de9a3-6dd4-42b7-b92c-eba3e3827bed		TCGA-EJ-7782-11			e74de9a3-6dd4-42b7-b92c-eba3e3827bed
TCGA-EJ-7783-01	0	TCGA-EJ-7783-01	787	0	days	TCGA-EJ-7783	787	0	days	787	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			70	TCGA-EJ-7783-F60370	TCGA-EJ-7783	TCGA-EJ-7783-01A	YES		M0	T2c	-25600						81	0	787		172			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-6-6	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.3	NO	Bilateral	1.4	NO	YES				NO	17	0		No	N0	T3a	TCGA-EJ-7783.8c4eab7f-e0e2-4cad-b06c-ae2d3ed11052.pdf		7783	TUMOR FREE	4	Complete Remission/Response	0.7	NO	R0	Primary Tumor	01	3	0.3		NO	4	YES	NO	EJ			Prostate		A	LIVING	2011		e6f20d5c-1cb3-4e65-aeaf-1cbe64e440bf	TCGA-EJ-7783-01A-11D-2112-01	TCGA-EJ-7783-01A-11D-2116-05		TCGA-EJ-7783-01A-11D-2114-08	e6f20d5c-1cb3-4e65-aeaf-1cbe64e440bf	TCGA-EJ-7783-01	TCGA-EJ-7783-01	1CECAFF4-5B92-46E3-990E-A69030E24E21	TCGA-EJ-7783-01A-11D-2112-01	e6f20d5c-1cb3-4e65-aeaf-1cbe64e440bf	TCGA-EJ-7783-01	TCGA-EJ-7783-01	TCGA-EJ-7783-01A-11D-2114-08	TCGA-EJ-7783-01A-11D-2114-08	e6f20d5c-1cb3-4e65-aeaf-1cbe64e440bf
TCGA-EJ-7783-11	0	TCGA-EJ-7783-11	787	0	days	TCGA-EJ-7783	787	0	days	787	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			70	TCGA-EJ-7783-F60370	TCGA-EJ-7783	TCGA-EJ-7783-11A	YES		M0	T2c	-25600						81	0	787		172			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-6-6	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.3	NO	Bilateral	1.4	NO	YES				NO	17	0		No	N0	T3a			7783	TUMOR FREE	4	Complete Remission/Response	0.7	NO	R0	Solid Tissue Normal	11	3	0.4		NO	4	YES	NO	EJ			Prostate		A	LIVING	2011		7afedcd4-d921-4996-9587-a8faa03dcea0					7afedcd4-d921-4996-9587-a8faa03dcea0		TCGA-EJ-7783-11			7afedcd4-d921-4996-9587-a8faa03dcea0		TCGA-EJ-7783-11			7afedcd4-d921-4996-9587-a8faa03dcea0
TCGA-EJ-7784-01	0	TCGA-EJ-7784-01	781	0	days	TCGA-EJ-7784	781	0	days	781	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63	TCGA-EJ-7784-F60372	TCGA-EJ-7784	TCGA-EJ-7784-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-23183	0			0			0	781		167			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-6-6	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.1	NO	YES				NO	13	0		No	N0	T2c	TCGA-EJ-7784.d140c74d-8e74-43da-a181-63a7bbe718af.pdf		7784	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3	0.3		NO	4	YES	NO	EJ			Prostate		A	LIVING	2011		731721fa-4ced-445d-855f-e4ded85f9726	TCGA-EJ-7784-01A-11D-2112-01	TCGA-EJ-7784-01A-11D-2116-05		TCGA-EJ-7784-01A-11D-2114-08	731721fa-4ced-445d-855f-e4ded85f9726	TCGA-EJ-7784-01	TCGA-EJ-7784-01	CC78BF20-57A1-4F83-B519-6672553F20DD	TCGA-EJ-7784-01A-11D-2112-01	731721fa-4ced-445d-855f-e4ded85f9726	TCGA-EJ-7784-01	TCGA-EJ-7784-01	TCGA-EJ-7784-01A-11D-2114-08	TCGA-EJ-7784-01A-11D-2114-08	731721fa-4ced-445d-855f-e4ded85f9726
TCGA-EJ-7784-11	0	TCGA-EJ-7784-11	781	0	days	TCGA-EJ-7784	781	0	days	781	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63	TCGA-EJ-7784-F60372	TCGA-EJ-7784		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-23183	0			0			0	781		167			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-6-6	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	13	0		No	N0	T2c			7784	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Solid Tissue Normal	11	3			NO	4	YES	NO	EJ			Prostate			LIVING	2011		bb77b27a-0450-4874-b46f-ab9505681648		TCGA-EJ-7784-11A-01D-2116-05			bb77b27a-0450-4874-b46f-ab9505681648		TCGA-EJ-7784-11			bb77b27a-0450-4874-b46f-ab9505681648		TCGA-EJ-7784-11			bb77b27a-0450-4874-b46f-ab9505681648
TCGA-EJ-7785-01	0	TCGA-EJ-7785-01	1177	0	days	TCGA-EJ-7785	1177	0	days	1177	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			54	TCGA-EJ-7785-F71967	TCGA-EJ-7785	TCGA-EJ-7785-01A	NO		M0	T2b	-19939							0	1177		259			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1	NO	YES				NO	7	0		No	N0	T3a	TCGA-EJ-7785.01ed5c8e-64f0-4e58-bd52-92a0d4f4af2b.pdf		7785	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.3		NO	3	YES	NO	EJ	Middle|Base		Prostate		A	LIVING	2011		0cc5f629-5046-4d05-8a5f-923ce5c04b9e	TCGA-EJ-7785-01A-11D-2112-01	TCGA-EJ-7785-01A-11D-2116-05		TCGA-EJ-7785-01A-11D-2114-08	0cc5f629-5046-4d05-8a5f-923ce5c04b9e	TCGA-EJ-7785-01	TCGA-EJ-7785-01	25F1DC25-C819-4C02-8394-8226BDE2896D	TCGA-EJ-7785-01A-11D-2112-01	0cc5f629-5046-4d05-8a5f-923ce5c04b9e	TCGA-EJ-7785-01	TCGA-EJ-7785-01	TCGA-EJ-7785-01A-11D-2114-08	TCGA-EJ-7785-01A-11D-2114-08	0cc5f629-5046-4d05-8a5f-923ce5c04b9e
TCGA-EJ-7785-11	0	TCGA-EJ-7785-11	1177	0	days	TCGA-EJ-7785	1177	0	days	1177	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			54	TCGA-EJ-7785-F71967	TCGA-EJ-7785	TCGA-EJ-7785-11A	NO		M0	T2b	-19939							0	1177		259			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.5	NO	Bilateral	2.2	NO	YES				NO	7	0		No	N0	T3a			7785	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Solid Tissue Normal	11	4	0.4		NO	3	YES	NO	EJ	Middle|Base		Prostate		A	LIVING	2011		2d8faa2d-336f-46e9-992d-4a5a5dbc4ece		TCGA-EJ-7785-11A-01D-2116-05			2d8faa2d-336f-46e9-992d-4a5a5dbc4ece		TCGA-EJ-7785-11			2d8faa2d-336f-46e9-992d-4a5a5dbc4ece		TCGA-EJ-7785-11			2d8faa2d-336f-46e9-992d-4a5a5dbc4ece
TCGA-EJ-7786-01	0	TCGA-EJ-7786-01	1096	0	days	TCGA-EJ-7786	1096	0	days	1096	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			62	TCGA-EJ-7786-F71968	TCGA-EJ-7786	TCGA-EJ-7786-01A	NO		M0	T1c	-22793							0	1096		79			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	0.9	NO	YES				NO	5	0		No	N0	T2c	TCGA-EJ-7786.3b3ac042-2bb6-445b-a82b-eea969f0bd33.pdf		7786	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.6		NO	3	YES	NO	EJ			Prostate		A	LIVING	2011		d444c3d1-235a-413c-8e5c-4f4465b378e1	TCGA-EJ-7786-01A-11D-2112-01	TCGA-EJ-7786-01A-11D-2116-05		TCGA-EJ-7786-01A-11D-2114-08	d444c3d1-235a-413c-8e5c-4f4465b378e1	TCGA-EJ-7786-01	TCGA-EJ-7786-01	CB2FF7FE-0571-494A-A39B-3CF58DDCA502	TCGA-EJ-7786-01A-11D-2112-01	d444c3d1-235a-413c-8e5c-4f4465b378e1	TCGA-EJ-7786-01	TCGA-EJ-7786-01	TCGA-EJ-7786-01A-11D-2114-08	TCGA-EJ-7786-01A-11D-2114-08	d444c3d1-235a-413c-8e5c-4f4465b378e1
TCGA-EJ-7786-11	0	TCGA-EJ-7786-11	1096	0	days	TCGA-EJ-7786	1096	0	days	1096	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			62	TCGA-EJ-7786-F71968	TCGA-EJ-7786		NO		M0	T1c	-22793							0	1096		79			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	5	0		No	N0	T2c			7786	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Solid Tissue Normal	11	4			NO	3	YES	NO	EJ			Prostate			LIVING	2011		c4aa58a3-f1ef-489f-be76-ce0f20a5446f		TCGA-EJ-7786-11A-01D-2116-05			c4aa58a3-f1ef-489f-be76-ce0f20a5446f		TCGA-EJ-7786-11			c4aa58a3-f1ef-489f-be76-ce0f20a5446f		TCGA-EJ-7786-11			c4aa58a3-f1ef-489f-be76-ce0f20a5446f
TCGA-EJ-7788-01	0	TCGA-EJ-7788-01	859	0	days	TCGA-EJ-7788	859	0	days	859	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			53	TCGA-EJ-7788-F60375	TCGA-EJ-7788	TCGA-EJ-7788-01A	NO		M0	T3b	-19623							0	859		52			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-6-6	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.2	NO	Bilateral	2	NO	YES				NO	6	0		No	N0	T3b	TCGA-EJ-7788.b66a0868-e91c-4ebf-be9c-ba55e94552fd.pdf		7788	TUMOR FREE	3	Complete Remission/Response	0.2	NO	R0	Primary Tumor	01	4	0.4		NO	5	YES	NO	EJ	Middle|Base		Prostate		A	LIVING	2011		83fedf64-9e72-4f9c-ab33-166dc0202cc9	TCGA-EJ-7788-01A-11D-2112-01	TCGA-EJ-7788-01A-11D-2116-05		TCGA-EJ-7788-01A-11D-2114-08	83fedf64-9e72-4f9c-ab33-166dc0202cc9	TCGA-EJ-7788-01	TCGA-EJ-7788-01	429F179D-1B60-4097-ADCC-C126936A19D6	TCGA-EJ-7788-01A-11D-2112-01	83fedf64-9e72-4f9c-ab33-166dc0202cc9	TCGA-EJ-7788-01	TCGA-EJ-7788-01	TCGA-EJ-7788-01A-11D-2114-08	TCGA-EJ-7788-01A-11D-2114-08	83fedf64-9e72-4f9c-ab33-166dc0202cc9
TCGA-EJ-7789-01	0	TCGA-EJ-7789-01	1105	0	days	TCGA-EJ-7789	1105	0	days	1105	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-EJ-7789-F71969	TCGA-EJ-7789	TCGA-EJ-7789-01A			M0	T1c	-24107							0	1105					NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.5	NO	Bilateral	1.8	NO	YES				NO	14	0		No	N0	T3a	TCGA-EJ-7789.7483212d-f96c-4afd-b817-74517b54de53.pdf		7789	TUMOR FREE	4	Complete Remission/Response		NO	R0	Primary Tumor	01	3	0.3		NO	5	YES	NO	EJ	Base		Prostate		A	LIVING	2011		784cb488-904d-49e4-b63e-bb0e5bacb6e3	TCGA-EJ-7789-01A-11D-2112-01	TCGA-EJ-7789-01A-11D-2116-05		TCGA-EJ-7789-01A-11D-2114-08	784cb488-904d-49e4-b63e-bb0e5bacb6e3	TCGA-EJ-7789-01	TCGA-EJ-7789-01	18796055-6F9D-478E-89FB-3FDC019C8119	TCGA-EJ-7789-01A-11D-2112-01	784cb488-904d-49e4-b63e-bb0e5bacb6e3	TCGA-EJ-7789-01	TCGA-EJ-7789-01	TCGA-EJ-7789-01A-11D-2114-08	TCGA-EJ-7789-01A-11D-2114-08	784cb488-904d-49e4-b63e-bb0e5bacb6e3
TCGA-EJ-7789-11	0	TCGA-EJ-7789-11	1105	0	days	TCGA-EJ-7789	1105	0	days	1105	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-EJ-7789-F71969	TCGA-EJ-7789	TCGA-EJ-7789-11A			M0	T1c	-24107							0	1105					NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.8	NO	YES				NO	14	0		No	N0	T3a			7789	TUMOR FREE	4	Complete Remission/Response		NO	R0	Solid Tissue Normal	11	3	0.5		NO	5	YES	NO	EJ	Base		Prostate		A	LIVING	2011		8666da07-07d0-417e-954b-c18e107bdeb1		TCGA-EJ-7789-11A-01D-2116-05			8666da07-07d0-417e-954b-c18e107bdeb1		TCGA-EJ-7789-11			8666da07-07d0-417e-954b-c18e107bdeb1		TCGA-EJ-7789-11			8666da07-07d0-417e-954b-c18e107bdeb1
TCGA-EJ-7791-01	0	TCGA-EJ-7791-01	1118	0	days	TCGA-EJ-7791	1118	0	days	1118	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			67	TCGA-EJ-7791-F71964	TCGA-EJ-7791	TCGA-EJ-7791-01A	NO		M0	T1c	-24621							0	1118		217			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.5	NO	Bilateral	2	NO	YES				NO	18	0		No	N0	T2c	TCGA-EJ-7791.001c43cb-3e9b-43db-b6d0-61e67d058c9f.pdf		7791	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.3		NO	4	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2011		14830a14-5495-4425-b6ef-78ccffafe03c	TCGA-EJ-7791-01A-11D-2112-01	TCGA-EJ-7791-01A-11D-2116-05		TCGA-EJ-7791-01A-11D-2114-08	14830a14-5495-4425-b6ef-78ccffafe03c	TCGA-EJ-7791-01	TCGA-EJ-7791-01	74CA9A60-9C42-4A7C-9407-DBAF152289EB	TCGA-EJ-7791-01A-11D-2112-01	14830a14-5495-4425-b6ef-78ccffafe03c	TCGA-EJ-7791-01	TCGA-EJ-7791-01	TCGA-EJ-7791-01A-11D-2114-08	TCGA-EJ-7791-01A-11D-2114-08	14830a14-5495-4425-b6ef-78ccffafe03c
TCGA-EJ-7792-01	0	TCGA-EJ-7792-01	1396	0	days	TCGA-EJ-7792	1396	0	days	1396	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			53	TCGA-EJ-7792-F71965	TCGA-EJ-7792	TCGA-EJ-7792-01A	NO		M0	T1c	-19454							0	1396		526			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.3	NO	Bilateral	1.4	NO	YES				NO	35	0		No	N0	T2c	TCGA-EJ-7792.607fd612-7ab9-475b-8c22-fd7cdbaccb37.pdf		7792	TUMOR FREE	3	Complete Remission/Response	0.13	NO	R0	Primary Tumor	01	4	0.3		NO	4	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2010		310d0da6-5694-4dc0-82f7-3fe0f6699271	TCGA-EJ-7792-01A-11D-2112-01	TCGA-EJ-7792-01A-11D-2116-05		TCGA-EJ-7792-01A-11D-2114-08	310d0da6-5694-4dc0-82f7-3fe0f6699271	TCGA-EJ-7792-01	TCGA-EJ-7792-01	A8CB42CF-915F-4CC4-80CE-337A822EC406	TCGA-EJ-7792-01A-11D-2112-01	310d0da6-5694-4dc0-82f7-3fe0f6699271	TCGA-EJ-7792-01	TCGA-EJ-7792-01	TCGA-EJ-7792-01A-11D-2114-08	TCGA-EJ-7792-01A-11D-2114-08	310d0da6-5694-4dc0-82f7-3fe0f6699271
TCGA-EJ-7792-11	0	TCGA-EJ-7792-11	1396	0	days	TCGA-EJ-7792	1396	0	days	1396	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			53	TCGA-EJ-7792-F71965	TCGA-EJ-7792	TCGA-EJ-7792-11A	NO		M0	T1c	-19454							0	1396		526			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.7	NO	YES				NO	35	0		No	N0	T2c			7792	TUMOR FREE	3	Complete Remission/Response	0.13	NO	R0	Solid Tissue Normal	11	4	0.3		NO	4	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2010		3f8c4a26-6796-4070-aea8-a7507103cfc7		TCGA-EJ-7792-11A-01D-2116-05			3f8c4a26-6796-4070-aea8-a7507103cfc7		TCGA-EJ-7792-11			3f8c4a26-6796-4070-aea8-a7507103cfc7		TCGA-EJ-7792-11			3f8c4a26-6796-4070-aea8-a7507103cfc7
TCGA-EJ-7793-01	0	TCGA-EJ-7793-01	114	0	days	TCGA-EJ-7793			days	114	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			49	TCGA-EJ-7793-F60362	TCGA-EJ-7793	TCGA-EJ-7793-01A	NO		M0	T2c	-17982							0	114		114			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-6-6	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.3	NO	Bilateral	1.7	YES	NO								No		T2c	TCGA-EJ-7793.c9d3d69c-f362-454f-a8ff-cbda4d713c41.pdf		7793	TUMOR FREE	3		0.1		R0	Primary Tumor	01	4	0.3			4	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2011		8a63eeeb-2e0d-466f-a446-ac6649cba90c	TCGA-EJ-7793-01A-31D-2259-01	TCGA-EJ-7793-01A-31D-2261-05		TCGA-EJ-7793-01A-31D-2260-08	8a63eeeb-2e0d-466f-a446-ac6649cba90c	TCGA-EJ-7793-01	TCGA-EJ-7793-01	97BBA440-7AFC-4EF1-B98D-EC635488B1D0	TCGA-EJ-7793-01A-31D-2259-01	8a63eeeb-2e0d-466f-a446-ac6649cba90c	TCGA-EJ-7793-01	TCGA-EJ-7793-01	TCGA-EJ-7793-01A-31D-2260-08	TCGA-EJ-7793-01A-31D-2260-08	8a63eeeb-2e0d-466f-a446-ac6649cba90c
TCGA-EJ-7793-11	0	TCGA-EJ-7793-11	114	0	days	TCGA-EJ-7793			days	114	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			49	TCGA-EJ-7793-F60362	TCGA-EJ-7793	TCGA-EJ-7793-11A	NO		M0	T2c	-17982							0	114		114			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-6-6	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.3	NO	Bilateral	2	YES	NO								No		T2c			7793	TUMOR FREE	3		0.1		R0	Solid Tissue Normal	11	4	0.5			4	YES	NO	EJ	Apex|Middle		Prostate		A	LIVING	2011		5b2c7f9e-d8f2-44db-8981-5acefbfd38c8					5b2c7f9e-d8f2-44db-8981-5acefbfd38c8		TCGA-EJ-7793-11			5b2c7f9e-d8f2-44db-8981-5acefbfd38c8		TCGA-EJ-7793-11			5b2c7f9e-d8f2-44db-8981-5acefbfd38c8
TCGA-EJ-7794-01	0	TCGA-EJ-7794-01	1306	0	days	TCGA-EJ-7794	1306	0	days	1306	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			67	TCGA-EJ-7794-F71966	TCGA-EJ-7794	TCGA-EJ-7794-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-24478	35			35			0	1306		285			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.4	NO	YES				NO	11	0		No	N0	T2c	TCGA-EJ-7794.73164d62-bc3a-4dd3-8201-86c5f35ef168.pdf		7794	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.4		NO	3	YES	NO	EJ			Prostate		A	LIVING	2010		cecb86b2-f20c-4fde-b9b6-c87e95f2e390	TCGA-EJ-7794-01A-11D-2112-01	TCGA-EJ-7794-01A-11D-2116-05		TCGA-EJ-7794-01A-11D-2114-08	cecb86b2-f20c-4fde-b9b6-c87e95f2e390	TCGA-EJ-7794-01	TCGA-EJ-7794-01	28E1D66C-1D4C-48FB-9583-1896B7759EFB	TCGA-EJ-7794-01A-11D-2112-01	cecb86b2-f20c-4fde-b9b6-c87e95f2e390	TCGA-EJ-7794-01	TCGA-EJ-7794-01	TCGA-EJ-7794-01A-11D-2114-08	TCGA-EJ-7794-01A-11D-2114-08	cecb86b2-f20c-4fde-b9b6-c87e95f2e390
TCGA-EJ-7794-11	0	TCGA-EJ-7794-11	1306	0	days	TCGA-EJ-7794	1306	0	days	1306	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			67	TCGA-EJ-7794-F71966	TCGA-EJ-7794	TCGA-EJ-7794-11A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-24478	35			35			0	1306		285			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.5	NO	YES				NO	11	0		No	N0	T2c			7794	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Solid Tissue Normal	11	4	0.4		NO	3	YES	NO	EJ			Prostate		A	LIVING	2010		6970283b-3673-49bc-9b2b-bd268140327f		TCGA-EJ-7794-11A-01D-2116-05			6970283b-3673-49bc-9b2b-bd268140327f		TCGA-EJ-7794-11			6970283b-3673-49bc-9b2b-bd268140327f		TCGA-EJ-7794-11			6970283b-3673-49bc-9b2b-bd268140327f
TCGA-EJ-7797-01	0	TCGA-EJ-7797-01	983	0	days	TCGA-EJ-7797	983	0	days	983	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			53	TCGA-EJ-7797-F60374	TCGA-EJ-7797	TCGA-EJ-7797-01A	NO		M0	T1c	-19616							0	983		187			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-6-6	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1	NO	YES				NO	14	0		No	N0	T2c	TCGA-EJ-7797.d9d6f871-c436-469e-9d7f-9684c379a320.pdf		7797	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.4		NO	4	YES	NO	EJ			Prostate		A	LIVING	2011		960c1e43-d2be-41f0-9f3a-8234cddb84be	TCGA-EJ-7797-01A-11D-2259-01	TCGA-EJ-7797-01A-11D-2261-05		TCGA-EJ-7797-01A-11D-2260-08	960c1e43-d2be-41f0-9f3a-8234cddb84be	TCGA-EJ-7797-01	TCGA-EJ-7797-01	B43E0A20-FE97-46E4-A509-CD8497EC0A2B	TCGA-EJ-7797-01A-11D-2259-01	960c1e43-d2be-41f0-9f3a-8234cddb84be	TCGA-EJ-7797-01	TCGA-EJ-7797-01	TCGA-EJ-7797-01A-11D-2260-08	TCGA-EJ-7797-01A-11D-2260-08	960c1e43-d2be-41f0-9f3a-8234cddb84be
TCGA-EJ-7797-11	0	TCGA-EJ-7797-11	983	0	days	TCGA-EJ-7797	983	0	days	983	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			53	TCGA-EJ-7797-F60374	TCGA-EJ-7797		NO		M0	T1c	-19616							0	983		187			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-6-6	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	14	0		No	N0	T2c			7797	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Solid Tissue Normal	11	4			NO	4	YES	NO	EJ			Prostate			LIVING	2011		a461340b-d5cd-4600-9046-f3942bec1c19					a461340b-d5cd-4600-9046-f3942bec1c19		TCGA-EJ-7797-11			a461340b-d5cd-4600-9046-f3942bec1c19		TCGA-EJ-7797-11			a461340b-d5cd-4600-9046-f3942bec1c19
TCGA-EJ-8468-01	0	TCGA-EJ-8468-01	2347	0	days	TCGA-EJ-8468	2347	0	days	2347	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63	TCGA-EJ-8468-F64614	TCGA-EJ-8468	TCGA-EJ-8468-01A	NO	Normal (no evidence of prostate cancer) [cM0]		T3a	-23371	23			23			0	2347		1961			YES				Scheduled Follow-up Submission	Complete Remission/Response	2014-9-5	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Left	1.9	NO	YES				NO	7	0		No	N0	T3a	TCGA-EJ-8468.84d3bc2c-122e-45e7-b9af-e5f409c95a56.pdf		8468	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.4		NO	3	YES	NO	EJ			Prostate		A	LIVING	2007		2c178e64-b87b-4887-b599-cc928e45db86	TCGA-EJ-8468-01A-21D-2391-01	TCGA-EJ-8468-01A-21D-2399-05		TCGA-EJ-8468-01A-21D-2395-08	2c178e64-b87b-4887-b599-cc928e45db86	TCGA-EJ-8468-01	TCGA-EJ-8468-01	67EC88F5-6AA2-403F-A61C-68BA66BAA9BC	TCGA-EJ-8468-01A-21D-2391-01	2c178e64-b87b-4887-b599-cc928e45db86	TCGA-EJ-8468-01	TCGA-EJ-8468-01	TCGA-EJ-8468-01A-21D-2395-08	TCGA-EJ-8468-01A-21D-2395-08	2c178e64-b87b-4887-b599-cc928e45db86
TCGA-EJ-8469-01	0	TCGA-EJ-8469-01	2324	0	days	TCGA-EJ-8469	1925	1	days	2324	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	46	TCGA-EJ-8469-F64636	TCGA-EJ-8469	TCGA-EJ-8469-01A	YES		M0	T3a	-17014				30		1925	0	2324	1925	1925			YES	No Evidence of Extraprostatic Extension			Scheduled Follow-up Submission	Partial Remission/Response	2014-9-8	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	2.3	NO	YES		Locoregional Recurrence		YES	57	0		No	N0	T3a	TCGA-EJ-8469.15db2c5f-2ba9-4fc8-b941-ae57e265c757.pdf		8469	WITH TUMOR	4	Partial Remission/Response	3.1	NO	RX	Primary Tumor	01	5	0.5		NO	3	YES	NO	EJ			Prostate		A	LIVING	2007		6fb7bc7b-2198-410d-998d-fb9a3f8cb3fe	TCGA-EJ-8469-01A-11D-2391-01	TCGA-EJ-8469-01A-11D-2399-05		TCGA-EJ-8469-01A-11D-2395-08	6fb7bc7b-2198-410d-998d-fb9a3f8cb3fe	TCGA-EJ-8469-01	TCGA-EJ-8469-01	D7E8BC9A-83B5-47EE-A1C9-CA1D8689DB42	TCGA-EJ-8469-01A-11D-2391-01	6fb7bc7b-2198-410d-998d-fb9a3f8cb3fe	TCGA-EJ-8469-01	TCGA-EJ-8469-01	TCGA-EJ-8469-01A-11D-2395-08	TCGA-EJ-8469-01A-11D-2395-08	6fb7bc7b-2198-410d-998d-fb9a3f8cb3fe
TCGA-EJ-8470-01	0	TCGA-EJ-8470-01	1159	0	days	TCGA-EJ-8470	1159	0	days	1159	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			58	TCGA-EJ-8470-F64637	TCGA-EJ-8470	TCGA-EJ-8470-01A			M0	T2c	-21209							0	1159									Scheduled Follow-up Submission	Complete Remission/Response	2014-9-8	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.6	NO	Bilateral	1.9	NO	YES				NO	21	0		No	N0	T2c	TCGA-EJ-8470.e53212bf-d686-4acc-8859-00cbdddd627c.pdf		8470	TUMOR FREE	4	Complete Remission/Response		NO		Primary Tumor	01	3	0.4		NO		YES	NO	EJ			Prostate		A	LIVING	2010		33f711ae-41c4-415e-8faf-3d7984c4b5cb	TCGA-EJ-8470-01A-11D-2391-01	TCGA-EJ-8470-01A-11D-2399-05		TCGA-EJ-8470-01A-11D-2395-08	33f711ae-41c4-415e-8faf-3d7984c4b5cb	TCGA-EJ-8470-01	TCGA-EJ-8470-01	07951FC5-7A6B-4735-B060-3FE8AA58B959	TCGA-EJ-8470-01A-11D-2391-01	33f711ae-41c4-415e-8faf-3d7984c4b5cb	TCGA-EJ-8470-01	TCGA-EJ-8470-01	TCGA-EJ-8470-01A-11D-2395-08	TCGA-EJ-8470-01A-11D-2395-08	33f711ae-41c4-415e-8faf-3d7984c4b5cb
TCGA-EJ-8472-01	0	TCGA-EJ-8472-01	756	0	days	TCGA-EJ-8472	756	0	days	756	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63	TCGA-EJ-8472-F64638	TCGA-EJ-8472	TCGA-EJ-8472-01A	YES		M0	T3a	-23104						196	0	756		196							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-8	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO		0.8	NO	YES				NO	12	0		No	N0	T3a	TCGA-EJ-8472.d45b6fd0-5e0a-4a20-ab47-c8cc1fb32c86.pdf		8472	TUMOR FREE	4	Partial Remission/Response	0.4	NO	R0	Primary Tumor	01	4	0.2		NO	3	YES	NO	EJ			Prostate		A	LIVING	2011		139abcca-ef3c-4520-9829-ebf4915d6b92	TCGA-EJ-8472-01A-11D-2391-01	TCGA-EJ-8472-01A-11D-2399-05		TCGA-EJ-8472-01A-11D-2395-08	139abcca-ef3c-4520-9829-ebf4915d6b92	TCGA-EJ-8472-01	TCGA-EJ-8472-01		TCGA-EJ-8472-01A-11D-2391-01	139abcca-ef3c-4520-9829-ebf4915d6b92	TCGA-EJ-8472-01	TCGA-EJ-8472-01	TCGA-EJ-8472-01A-11D-2395-08	TCGA-EJ-8472-01A-11D-2395-08	139abcca-ef3c-4520-9829-ebf4915d6b92
TCGA-EJ-8474-01	0	TCGA-EJ-8474-01	766	0	days	TCGA-EJ-8474	766	0	days	766	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			69	TCGA-EJ-8474-F64640	TCGA-EJ-8474	TCGA-EJ-8474-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-25561	51			7			0	766		766			YES	No Evidence of Extraprostatic Extension			Scheduled Follow-up Submission	Complete Remission/Response	2014-9-8	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	0.9	NO	YES				NO	15	0		No	N0	T3a	TCGA-EJ-8474.f68bb2bf-d38c-4d21-91cd-e714c71a6ff5.pdf		8474	TUMOR FREE	4	Complete Remission/Response	0.01	NO	R0	Primary Tumor	01	4	0.3		NO		YES	NO	EJ			Prostate		A	LIVING	2011		1c78c6f8-4e3c-40f1-afb2-b83a316b4c1a	TCGA-EJ-8474-01A-11D-2391-01	TCGA-EJ-8474-01A-11D-2399-05		TCGA-EJ-8474-01A-11D-2395-08	1c78c6f8-4e3c-40f1-afb2-b83a316b4c1a	TCGA-EJ-8474-01	TCGA-EJ-8474-01	2E549886-7E39-4F40-AE00-325886B78B9E	TCGA-EJ-8474-01A-11D-2391-01	1c78c6f8-4e3c-40f1-afb2-b83a316b4c1a	TCGA-EJ-8474-01	TCGA-EJ-8474-01	TCGA-EJ-8474-01A-11D-2395-08	TCGA-EJ-8474-01A-11D-2395-08	1c78c6f8-4e3c-40f1-afb2-b83a316b4c1a
TCGA-EJ-A46B-01	0	TCGA-EJ-A46B-01	657	0	days	TCGA-EJ-A46B	657	0	days	657	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-EJ-A46B-F64641	TCGA-EJ-A46B	TCGA-EJ-A46B-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24305	10	114		10			0	657		157			YES	No Evidence of Extraprostatic Extension			Scheduled Follow-up Submission	Complete Remission/Response	2014-9-8	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	420		NO	Bilateral		NO	YES				NO	10	0	true	Yes, History of Prior Malignancy	N0	T3a	TCGA-EJ-A46B.4B418B68-7866-45C1-8728-9D61BF5A9273.pdf		A46B	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO	3	YES	NO	EJ			Prostate		A	LIVING	2012		112e7329-5135-4307-bda5-d041bc04f0ea	TCGA-EJ-A46B-01A-31D-A256-01	TCGA-EJ-A46B-01A-31D-A258-05		TCGA-EJ-A46B-01A-31D-A257-08	112e7329-5135-4307-bda5-d041bc04f0ea	TCGA-EJ-A46B-01	TCGA-EJ-A46B-01	1BE1E342-BF2D-44B3-9A06-831B4561FA70	TCGA-EJ-A46B-01A-31D-A256-01	112e7329-5135-4307-bda5-d041bc04f0ea	TCGA-EJ-A46B-01	TCGA-EJ-A46B-01	TCGA-EJ-A46B-01A-31D-A257-08		112e7329-5135-4307-bda5-d041bc04f0ea
TCGA-EJ-A46D-01	0	TCGA-EJ-A46D-01	626	0	days	TCGA-EJ-A46D	626	0	days	626	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			53	TCGA-EJ-A46D-F64643	TCGA-EJ-A46D	TCGA-EJ-A46D-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-19466	42	181					0	626		122							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-8	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	940		NO	Bilateral		NO	YES				NO	6	0	true	No	N0	T2c	TCGA-EJ-A46D.A0EF60EA-85C2-40AA-9162-E8C96748F94D.pdf		A46D	TUMOR FREE	3	Complete Remission/Response	.03	NO		Primary Tumor	01	5			NO	4	YES	NO	EJ			Prostate		A	LIVING	2012		dbde3775-bbbc-4492-8449-6f04c4edc65d	TCGA-EJ-A46D-01A-21D-A256-01	TCGA-EJ-A46D-01A-21D-A258-05		TCGA-EJ-A46D-01A-21D-A257-08	dbde3775-bbbc-4492-8449-6f04c4edc65d	TCGA-EJ-A46D-01	TCGA-EJ-A46D-01	15A79981-3C10-431E-94BB-2F6F357BEEFF	TCGA-EJ-A46D-01A-21D-A256-01	dbde3775-bbbc-4492-8449-6f04c4edc65d	TCGA-EJ-A46D-01	TCGA-EJ-A46D-01	TCGA-EJ-A46D-01A-21D-A257-08	TCGA-EJ-A46D-01A-21D-A257-08	dbde3775-bbbc-4492-8449-6f04c4edc65d
TCGA-EJ-A46E-01	0	TCGA-EJ-A46E-01	524	0	days	TCGA-EJ-A46E	524	0	days	524	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57	TCGA-EJ-A46E-F64644	TCGA-EJ-A46E	TCGA-EJ-A46E-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-21054		489					0	524		503			YES	No Evidence of Extraprostatic Extension			Scheduled Follow-up Submission	Complete Remission/Response	2014-9-8	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	760		NO	Bilateral		YES	YES				NO	9	0	true	No	N0		TCGA-EJ-A46E.F2A59B31-7CFE-4DA8-A7B7-229021357746.pdf		A46E	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate		A	LIVING	2011		369853c1-dc8d-45cc-8131-7ce625ac3020	TCGA-EJ-A46E-01A-31D-A256-01	TCGA-EJ-A46E-01A-31D-A258-05		TCGA-EJ-A46E-01A-31D-A257-08	369853c1-dc8d-45cc-8131-7ce625ac3020	TCGA-EJ-A46E-01	TCGA-EJ-A46E-01	85F7E0C3-9BA7-4C02-953E-D3AB67D54648	TCGA-EJ-A46E-01A-31D-A256-01	369853c1-dc8d-45cc-8131-7ce625ac3020	TCGA-EJ-A46E-01	TCGA-EJ-A46E-01	TCGA-EJ-A46E-01A-31D-A257-08		369853c1-dc8d-45cc-8131-7ce625ac3020
TCGA-EJ-A46F-01	0	TCGA-EJ-A46F-01	783	0	days	TCGA-EJ-A46F	783	0	days	783	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57	TCGA-EJ-A46F-F64645	TCGA-EJ-A46F	TCGA-EJ-A46F-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-21160	166	286		166		215	0	783		215			YES				Scheduled Follow-up Submission	Complete Remission/Response	2014-9-8	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	580		NO	Bilateral		NO	YES				NO	23	1	true	No	N1	T3b	TCGA-EJ-A46F.E424A7C8-4DDD-4ECC-A0B4-DF22A9996D01.pdf		A46F	TUMOR FREE	4	Partial Remission/Response	19.8	NO	R0	Primary Tumor	01	4			NO	3	YES	NO	EJ			Prostate		A	LIVING	2011		a4f08d6b-fdb9-406c-9e55-d03fa1a7ad78	TCGA-EJ-A46F-01A-31D-A256-01	TCGA-EJ-A46F-01A-31D-A258-05		TCGA-EJ-A46F-01A-31D-A257-08	a4f08d6b-fdb9-406c-9e55-d03fa1a7ad78	TCGA-EJ-A46F-01	TCGA-EJ-A46F-01	BF4BE828-8FC8-42E3-A77C-706D6AA1B3F8	TCGA-EJ-A46F-01A-31D-A256-01	a4f08d6b-fdb9-406c-9e55-d03fa1a7ad78	TCGA-EJ-A46F-01	TCGA-EJ-A46F-01	TCGA-EJ-A46F-01A-31D-A257-08		a4f08d6b-fdb9-406c-9e55-d03fa1a7ad78
TCGA-EJ-A46G-01	0	TCGA-EJ-A46G-01	668	0	days	TCGA-EJ-A46G	668	0	days	668	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			71	TCGA-EJ-A46G-F64646	TCGA-EJ-A46G	TCGA-EJ-A46G-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-26219	28	219					0	668		93							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-8	MALE	8	Prostate Adenocarcinoma, Other Subtype	No	C61	8500/3	C61.9	YES	Core needle biopsy	430		NO	Bilateral		NO	YES				NO	17	0	true	Yes, History of Prior Malignancy	N0	T3a	TCGA-EJ-A46G.ACBA1CE1-E248-47D3-B03D-BE0C1B4A6F21.pdf		A46G	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO	5	YES	NO	EJ			Prostate		A	LIVING	2012		db968587-1271-4b4a-8195-f17a06085ae5	TCGA-EJ-A46G-01A-31D-A26L-01	TCGA-EJ-A46G-01A-31D-A26N-05		TCGA-EJ-A46G-01A-31D-A26M-08	db968587-1271-4b4a-8195-f17a06085ae5	TCGA-EJ-A46G-01	TCGA-EJ-A46G-01	DE0677A3-E5C4-42C4-8A19-C69F4269939D	TCGA-EJ-A46G-01A-31D-A26L-01	db968587-1271-4b4a-8195-f17a06085ae5	TCGA-EJ-A46G-01	TCGA-EJ-A46G-01	TCGA-EJ-A46G-01A-31D-A26M-08	TCGA-EJ-A46G-01A-31D-A26M-08	db968587-1271-4b4a-8195-f17a06085ae5
TCGA-EJ-A46H-01	0	TCGA-EJ-A46H-01	724	0	days	TCGA-EJ-A46H	724	0	days	724	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			60	TCGA-EJ-A46H-F64713	TCGA-EJ-A46H		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22059	-6						0	724		131							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	6			No	N0	T2c			A46H	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate			LIVING	2012		da936a2e-af10-4496-8fa7-00742c30c766	TCGA-EJ-A46H-01A-31D-A26L-01	TCGA-EJ-A46H-01A-31D-A26N-05		TCGA-EJ-A46H-01A-31D-A26M-08	da936a2e-af10-4496-8fa7-00742c30c766	TCGA-EJ-A46H-01	TCGA-EJ-A46H-01		TCGA-EJ-A46H-01A-31D-A26L-01	da936a2e-af10-4496-8fa7-00742c30c766	TCGA-EJ-A46H-01	TCGA-EJ-A46H-01	TCGA-EJ-A46H-01A-31D-A26M-08		da936a2e-af10-4496-8fa7-00742c30c766
TCGA-EJ-A46I-01	0	TCGA-EJ-A46I-01	668	0	days	TCGA-EJ-A46I	668	0	days	668	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57	TCGA-EJ-A46I-F64714	TCGA-EJ-A46I	TCGA-EJ-A46I-01A	NO		M0	T1c	-21046		520					0	668		484							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES		150		NO	Bilateral		NO					NO			true	No	N0	T3a	TCGA-EJ-A46I.741CC282-0593-45E4-BEEB-343339F891AA.pdf		A46I	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate		A	LIVING	2011		7c901d39-8b22-4fc7-8995-2511507b741e	TCGA-EJ-A46I-01A-12D-A26L-01	TCGA-EJ-A46I-01A-12D-A26N-05		TCGA-EJ-A46I-01A-12D-A26M-08	7c901d39-8b22-4fc7-8995-2511507b741e	TCGA-EJ-A46I-01	TCGA-EJ-A46I-01		TCGA-EJ-A46I-01A-12D-A26L-01	7c901d39-8b22-4fc7-8995-2511507b741e	TCGA-EJ-A46I-01	TCGA-EJ-A46I-01	TCGA-EJ-A46I-01A-12D-A26M-08	TCGA-EJ-A46I-01A-12D-A26M-08	7c901d39-8b22-4fc7-8995-2511507b741e
TCGA-EJ-A65B-01	0	TCGA-EJ-A65B-01	710	0	days	TCGA-EJ-A65B	710	0	days	710	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55	TCGA-EJ-A65B-F64715	TCGA-EJ-A65B	TCGA-EJ-A65B-01A	NO		M0	T3b	-20204		359					0	710		536							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	9	Prostate Adenocarcinoma, Other Subtype	No	C61	8255/3	C61.9	YES	Core needle biopsy	300		NO			NO	YES				NO	13	0	true	No	N0	T3b	TCGA-EJ-A65B.007E056B-1675-4639-9978-05C7EDEA1D74.pdf		A65B	TUMOR FREE	4	Complete Remission/Response	.01	NO	R1	Primary Tumor	01	5			NO		YES	NO	EJ			Prostate		A	LIVING	2012		55753ec3-4f9f-439b-908f-43e4053ca8cb	TCGA-EJ-A65B-01A-12D-A30D-01	TCGA-EJ-A65B-01A-12D-A30F-05		TCGA-EJ-A65B-01A-12D-A30E-08	55753ec3-4f9f-439b-908f-43e4053ca8cb	TCGA-EJ-A65B-01	TCGA-EJ-A65B-01	1BBABA32-99D6-4A4F-A64E-8958B9C4D334	TCGA-EJ-A65B-01A-12D-A30D-01	55753ec3-4f9f-439b-908f-43e4053ca8cb	TCGA-EJ-A65B-01	TCGA-EJ-A65B-01	TCGA-EJ-A65B-01A-12D-A30E-08		55753ec3-4f9f-439b-908f-43e4053ca8cb
TCGA-EJ-A65D-01	0	TCGA-EJ-A65D-01	393	0	days	TCGA-EJ-A65D	393	0	days	393	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-EJ-A65D-F64716	TCGA-EJ-A65D	TCGA-EJ-A65D-01A	NO		M0	T3a	-24297		240					0	393		393							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	8	Prostate Adenocarcinoma, Other Subtype	No	C61	8500/3	C61.9	YES	Core needle biopsy	270		NO	Bilateral		NO	YES				NO	34	0	true	No	N0	T3a	TCGA-EJ-A65D.AD3DEFE9-4977-4334-A197-159F043C92A6.pdf		A65D	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate		A	LIVING	2012		6f5b0c12-0853-49c8-8421-58faa14b3955	TCGA-EJ-A65D-01A-11D-A30D-01	TCGA-EJ-A65D-01A-11D-A30F-05		TCGA-EJ-A65D-01A-11D-A30E-08	6f5b0c12-0853-49c8-8421-58faa14b3955	TCGA-EJ-A65D-01	TCGA-EJ-A65D-01	9F6C59B3-93D2-4CAA-861D-F503D1A23F61	TCGA-EJ-A65D-01A-11D-A30D-01	6f5b0c12-0853-49c8-8421-58faa14b3955	TCGA-EJ-A65D-01	TCGA-EJ-A65D-01	TCGA-EJ-A65D-01A-11D-A30E-08		6f5b0c12-0853-49c8-8421-58faa14b3955
TCGA-EJ-A65E-01	0	TCGA-EJ-A65E-01	417	0	days	TCGA-EJ-A65E	417	0	days	417	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			67	TCGA-EJ-A65E-F64717	TCGA-EJ-A65E	TCGA-EJ-A65E-01A	NO		M0	T3b	-24558		289					0	417		254							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	7	Prostate Adenocarcinoma, Other Subtype	No	C61	8255/3	C61.9	YES	Core needle biopsy	240		NO	Bilateral		NO	YES				NO	23	0	true	No	N0	T3b	TCGA-EJ-A65E.4B502278-393D-4B65-A424-B795547938ED.pdf		A65E	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3			NO		YES	NO	EJ			Prostate		A	LIVING	2012		d28ba0e6-a04b-4341-95c2-f03b6d894a5e	TCGA-EJ-A65E-01A-11D-A323-01	TCGA-EJ-A65E-01A-11D-A29T-05		TCGA-EJ-A65E-01A-11D-A29Q-08	d28ba0e6-a04b-4341-95c2-f03b6d894a5e	TCGA-EJ-A65E-01	TCGA-EJ-A65E-01	A9C1464F-B927-426E-A862-EDCEC264C79E	TCGA-EJ-A65E-01A-11D-A323-01	d28ba0e6-a04b-4341-95c2-f03b6d894a5e	TCGA-EJ-A65E-01	TCGA-EJ-A65E-01	TCGA-EJ-A65E-01A-11D-A29Q-08	TCGA-EJ-A65E-01A-11D-A29Q-08	d28ba0e6-a04b-4341-95c2-f03b6d894a5e
TCGA-EJ-A65F-01	0	TCGA-EJ-A65F-01	560	0	days	TCGA-EJ-A65F	560	0	days	560	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate		YES	59	TCGA-EJ-A65F-F64718	TCGA-EJ-A65F	TCGA-EJ-A65F-01A	YES		M0	T3b	-21681		293				75	0	560		75							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	9	Prostate Adenocarcinoma, Other Subtype	No	C61	8255/3	C61.9	YES	Core needle biopsy	360		NO	Bilateral		NO	YES				NO	4	0	true	No	N0	T3b	TCGA-EJ-A65F.635A6F68-B3A7-4856-BE21-C2DC0AADAA59.pdf		A65F	TUMOR FREE	4	Complete Remission/Response	0.8	YES	R0	Primary Tumor	01	5			NO		YES	NO	EJ			Prostate		A	LIVING	2012		3479eef9-e120-4723-b333-cd4623de6499	TCGA-EJ-A65F-01A-21D-A30W-01	TCGA-EJ-A65F-01A-21D-A30Z-05		TCGA-EJ-A65F-01A-21D-A30X-08	3479eef9-e120-4723-b333-cd4623de6499	TCGA-EJ-A65F-01	TCGA-EJ-A65F-01	B82CB5F3-1C0A-4993-8A5B-AE41FE7168A2	TCGA-EJ-A65F-01A-21D-A30W-01	3479eef9-e120-4723-b333-cd4623de6499	TCGA-EJ-A65F-01	TCGA-EJ-A65F-01	TCGA-EJ-A65F-01A-21D-A30X-08	TCGA-EJ-A65F-01A-21D-A30X-08	3479eef9-e120-4723-b333-cd4623de6499
TCGA-EJ-A65G-01	0	TCGA-EJ-A65G-01	666	0	days	TCGA-EJ-A65G	666	0	days	666	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57	TCGA-EJ-A65G-F64719	TCGA-EJ-A65G	TCGA-EJ-A65G-01A	NO		M0	T2c	-20821		299					0	666		152							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Transurethral resection (TURBT)	140		NO	Bilateral		NO	YES				NO	24	0	true	No	N0	T2c	TCGA-EJ-A65G.A04673B5-5B72-4D0F-B12A-BC2663A2855B.pdf		A65G	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	5			NO		YES	NO	EJ			Prostate		A	LIVING	2012		32e41154-dbcb-474c-8605-67c0ae0ed85e	TCGA-EJ-A65G-01A-21D-A323-01	TCGA-EJ-A65G-01A-21D-A29T-05		TCGA-EJ-A65G-01A-21D-A29Q-08	32e41154-dbcb-474c-8605-67c0ae0ed85e	TCGA-EJ-A65G-01	TCGA-EJ-A65G-01		TCGA-EJ-A65G-01A-21D-A323-01	32e41154-dbcb-474c-8605-67c0ae0ed85e	TCGA-EJ-A65G-01	TCGA-EJ-A65G-01	TCGA-EJ-A65G-01A-21D-A29Q-08	TCGA-EJ-A65G-01A-21D-A29Q-08	32e41154-dbcb-474c-8605-67c0ae0ed85e
TCGA-EJ-A65J-01	0	TCGA-EJ-A65J-01	451	0	days	TCGA-EJ-A65J	451	0	days	451	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			62	TCGA-EJ-A65J-F64720	TCGA-EJ-A65J	TCGA-EJ-A65J-01A	NO		M0	T3a	-22904		218					0	451		91							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	970		NO	Bilateral		NO	YES				NO	11	0	true	Yes, History of Prior Malignancy	N0	T3a	TCGA-EJ-A65J.DBB16691-F1A8-40B8-99E7-FB206B3B680C.pdf		A65J	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	5			NO		YES	NO	EJ			Prostate		A	LIVING	2012		3be6c54c-f606-4eba-8242-8dff705fa2d0	TCGA-EJ-A65J-01A-11D-A30W-01	TCGA-EJ-A65J-01A-11D-A30Z-05		TCGA-EJ-A65J-01A-11D-A30X-08	3be6c54c-f606-4eba-8242-8dff705fa2d0	TCGA-EJ-A65J-01	TCGA-EJ-A65J-01	28242B19-CD4F-4829-A3AF-2FDB30A11DCC	TCGA-EJ-A65J-01A-11D-A30W-01	3be6c54c-f606-4eba-8242-8dff705fa2d0	TCGA-EJ-A65J-01	TCGA-EJ-A65J-01	TCGA-EJ-A65J-01A-11D-A30X-08	TCGA-EJ-A65J-01A-11D-A30X-08	3be6c54c-f606-4eba-8242-8dff705fa2d0
TCGA-EJ-A65M-01	0	TCGA-EJ-A65M-01	230	0	days	TCGA-EJ-A65M	230	0	days	230	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			65	TCGA-EJ-A65M-F64721	TCGA-EJ-A65M	TCGA-EJ-A65M-01A	NO		M0	T2c	-23767		69					0	230		230							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Transurethral resection (TURBT)	340		NO	Bilateral		NO	YES				NO	30	0	true	No	N0	T2c	TCGA-EJ-A65M.E0FB271C-8BC6-43FB-BE90-85A28009D962.pdf		A65M	TUMOR FREE	3	Complete Remission/Response	0.1	NO		Primary Tumor	01	3			NO		YES	NO	EJ			Prostate		A	LIVING	2013		9d16eccb-44fa-4188-9ad2-3a17ed821247	TCGA-EJ-A65M-01A-11D-A323-01	TCGA-EJ-A65M-01A-11D-A29T-05		TCGA-EJ-A65M-01A-11D-A29Q-08	9d16eccb-44fa-4188-9ad2-3a17ed821247	TCGA-EJ-A65M-01	TCGA-EJ-A65M-01	7F4408EE-6B45-4B45-95B9-887D81BE65ED	TCGA-EJ-A65M-01A-11D-A323-01	9d16eccb-44fa-4188-9ad2-3a17ed821247	TCGA-EJ-A65M-01	TCGA-EJ-A65M-01	TCGA-EJ-A65M-01A-11D-A29Q-08		9d16eccb-44fa-4188-9ad2-3a17ed821247
TCGA-EJ-A6RA-01	0	TCGA-EJ-A6RA-01	353	0	days	TCGA-EJ-A6RA	353	0	days	353	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			70	TCGA-EJ-A6RA-F64722	TCGA-EJ-A6RA	TCGA-EJ-A6RA-01A	YES		M0	T3b	-25679		213				353	0	353		353							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	250		NO	Bilateral		NO	YES				NO	18	1	true	No	N1	T3b	TCGA-EJ-A6RA.556DE138-DE44-471D-94ED-CB755E3221C2.pdf		A6RA	TUMOR FREE	4	Complete Remission/Response	0.652	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate		A	LIVING	2012		ae29efe9-4446-4f0a-b765-f04e3935d7a8	TCGA-EJ-A6RA-01A-11D-A33S-01	TCGA-EJ-A6RA-01A-11D-A33U-05		TCGA-EJ-A6RA-01A-11D-A33T-08	ae29efe9-4446-4f0a-b765-f04e3935d7a8	TCGA-EJ-A6RA-01	TCGA-EJ-A6RA-01	F5E509C5-BC34-48C6-8A6C-1FF0E6AB35EB	TCGA-EJ-A6RA-01A-11D-A33S-01	ae29efe9-4446-4f0a-b765-f04e3935d7a8	TCGA-EJ-A6RA-01	TCGA-EJ-A6RA-01		TCGA-EJ-A6RA-01A-11D-A33T-08	ae29efe9-4446-4f0a-b765-f04e3935d7a8
TCGA-EJ-A6RC-01	0	TCGA-EJ-A6RC-01	873	0	days	TCGA-EJ-A6RC	873	0	days	873	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	64	TCGA-EJ-A6RC-F64723	TCGA-EJ-A6RC	TCGA-EJ-A6RC-01A	NO		M0	T1c	-23598		631					0	873		693							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Transurethral resection (TURBT)	450		NO	Bilateral		NO	YES				NO	38	0	true	Yes, History of Prior Malignancy	N0		TCGA-EJ-A6RC.3DB930C6-0B64-4FBF-8BB8-5FA4EBC122CA.pdf		A6RC	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3			NO		YES	NO	EJ			Prostate		A	LIVING	2011		ea34e227-a427-42a6-9f42-80069e972764	TCGA-EJ-A6RC-01A-11D-A32A-01	TCGA-EJ-A6RC-01A-11D-A32C-05		TCGA-EJ-A6RC-01A-11D-A32B-08	ea34e227-a427-42a6-9f42-80069e972764	TCGA-EJ-A6RC-01	TCGA-EJ-A6RC-01	6A0937DE-EB47-4357-8115-729EB785BEE9	TCGA-EJ-A6RC-01A-11D-A32A-01	ea34e227-a427-42a6-9f42-80069e972764	TCGA-EJ-A6RC-01	TCGA-EJ-A6RC-01		TCGA-EJ-A6RC-01A-11D-A32B-08	ea34e227-a427-42a6-9f42-80069e972764
TCGA-EJ-A7NF-01	0	TCGA-EJ-A7NF-01	250	0	days	TCGA-EJ-A7NF	250	0	days	250	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			56	TCGA-EJ-A7NF-F64724	TCGA-EJ-A7NF	TCGA-EJ-A7NF-01A	NO		M0	T2c	-20587		195					0	250		117							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Transurethral resection (TURBT)	150		NO	Bilateral		NO	YES				NO	29	0	true	No	N0	T2c	TCGA-EJ-A7NF.1487F0B2-58BB-41C3-B23F-F51676796AA7.pdf		A7NF	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate		A	LIVING	2013		d94972a7-535d-4bb8-b221-d3c22a120d01	TCGA-EJ-A7NF-01A-11D-A33S-01	TCGA-EJ-A7NF-01A-11D-A33U-05		TCGA-EJ-A7NF-01A-11D-A33T-08	d94972a7-535d-4bb8-b221-d3c22a120d01	TCGA-EJ-A7NF-01	TCGA-EJ-A7NF-01	23E96E8D-9AD1-457D-A617-0D3DE4600803	TCGA-EJ-A7NF-01A-11D-A33S-01	d94972a7-535d-4bb8-b221-d3c22a120d01	TCGA-EJ-A7NF-01	TCGA-EJ-A7NF-01		TCGA-EJ-A7NF-01A-11D-A33T-08	d94972a7-535d-4bb8-b221-d3c22a120d01
TCGA-EJ-A7NG-01	0	TCGA-EJ-A7NG-01	432	0	days	TCGA-EJ-A7NG	432	0	days	432	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			64	TCGA-EJ-A7NG-F64725	TCGA-EJ-A7NG	TCGA-EJ-A7NG-01A	NO		M0	T3a	-23458		209					0	432		264							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	300		NO	Bilateral		NO	YES				NO	6	0	true	No	N0	T3a	TCGA-EJ-A7NG.05993405-656B-4DB6-98BC-8359E16AC6AB.pdf		A7NG	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate		A	LIVING	2013		06c95ac2-2f97-4200-9a29-a3ff8cce8697	TCGA-EJ-A7NG-01A-31D-A33S-01	TCGA-EJ-A7NG-01A-31D-A33U-05		TCGA-EJ-A7NG-01A-31D-A33T-08	06c95ac2-2f97-4200-9a29-a3ff8cce8697	TCGA-EJ-A7NG-01	TCGA-EJ-A7NG-01	8BF5A499-EE3C-440E-BDF2-8C9D8C239A49	TCGA-EJ-A7NG-01A-31D-A33S-01	06c95ac2-2f97-4200-9a29-a3ff8cce8697	TCGA-EJ-A7NG-01	TCGA-EJ-A7NG-01		TCGA-EJ-A7NG-01A-31D-A33T-08	06c95ac2-2f97-4200-9a29-a3ff8cce8697
TCGA-EJ-A7NH-01	0	TCGA-EJ-A7NH-01	474	0	days	TCGA-EJ-A7NH	474	0	days	474	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			56	TCGA-EJ-A7NH-F64726	TCGA-EJ-A7NH	TCGA-EJ-A7NH-01A	NO		M0	T2c	-20734		230					0	474		105							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	210		NO	Bilateral		NO	YES				NO	4		true	No	N0	T2c	TCGA-EJ-A7NH.87E5A9C3-9C6F-4452-9D52-FAD4F7FC66C1.pdf		A7NH	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate		A	LIVING	2013		a4e4f617-d329-4c8f-8cbd-f6111c427f71	TCGA-EJ-A7NH-01A-12D-A33S-01	TCGA-EJ-A7NH-01A-12D-A33U-05		TCGA-EJ-A7NH-01A-12D-A33T-08	a4e4f617-d329-4c8f-8cbd-f6111c427f71	TCGA-EJ-A7NH-01	TCGA-EJ-A7NH-01	778F2F34-4266-4338-A5B0-F3C745CFCE84	TCGA-EJ-A7NH-01A-12D-A33S-01	a4e4f617-d329-4c8f-8cbd-f6111c427f71	TCGA-EJ-A7NH-01	TCGA-EJ-A7NH-01		TCGA-EJ-A7NH-01A-12D-A33T-08	a4e4f617-d329-4c8f-8cbd-f6111c427f71
TCGA-EJ-A7NJ-01	0	TCGA-EJ-A7NJ-01	197	0	days	TCGA-EJ-A7NJ	197	0	days	197	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			59	TCGA-EJ-A7NJ-F64727	TCGA-EJ-A7NJ	TCGA-EJ-A7NJ-01A	NO		M0	T2c	-21748		211					0	197		92							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	250		NO	Bilateral		NO	YES				NO	16	0	true	No	N0	T2c	TCGA-EJ-A7NJ.B6D55BEF-A9C3-4092-AE17-FB6790EC65AD.pdf		A7NJ	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate		A	LIVING	2013		1f891baf-2b98-4c2f-8f5f-799018220513	TCGA-EJ-A7NJ-01A-22D-A34T-01	TCGA-EJ-A7NJ-01A-22D-A34V-05		TCGA-EJ-A7NJ-01A-22D-A34U-08	1f891baf-2b98-4c2f-8f5f-799018220513	TCGA-EJ-A7NJ-01	TCGA-EJ-A7NJ-01	825423E3-4CC3-4082-80B6-234E46E852A5	TCGA-EJ-A7NJ-01A-22D-A34T-01	1f891baf-2b98-4c2f-8f5f-799018220513	TCGA-EJ-A7NJ-01	TCGA-EJ-A7NJ-01		TCGA-EJ-A7NJ-01A-22D-A34U-08	1f891baf-2b98-4c2f-8f5f-799018220513
TCGA-EJ-A7NK-01	0	TCGA-EJ-A7NK-01	476	0	days	TCGA-EJ-A7NK	476	0	days	476	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			58	TCGA-EJ-A7NK-F64761	TCGA-EJ-A7NK	TCGA-EJ-A7NK-01A	NO		M0	T3a	-21530		254					0	476		295							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Transurethral resection (TURBT)	140		NO	Bilateral		NO	YES				NO	48	0	true	No	N0	T3a	TCGA-EJ-A7NK.E1362D2A-6ED3-4BA3-A92D-63C5024946A6.pdf		A7NK	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate		A	LIVING	2012		107d849f-0497-4daa-bd4e-d82570909838	TCGA-EJ-A7NK-01A-12D-A34T-01	TCGA-EJ-A7NK-01A-12D-A34V-05		TCGA-EJ-A7NK-01A-12D-A34U-08	107d849f-0497-4daa-bd4e-d82570909838	TCGA-EJ-A7NK-01	TCGA-EJ-A7NK-01	6377B90F-C552-45B6-B84D-D757F51A1C00	TCGA-EJ-A7NK-01A-12D-A34T-01	107d849f-0497-4daa-bd4e-d82570909838	TCGA-EJ-A7NK-01	TCGA-EJ-A7NK-01		TCGA-EJ-A7NK-01A-12D-A34U-08	107d849f-0497-4daa-bd4e-d82570909838
TCGA-EJ-A7NM-01	0	TCGA-EJ-A7NM-01	128	0	days	TCGA-EJ-A7NM	128	0	days	128	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			64	TCGA-EJ-A7NM-F64762	TCGA-EJ-A7NM	TCGA-EJ-A7NM-01A	NO		M0	T3b	-23603		115					0	128		128							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	9	Prostate Adenocarcinoma, Other Subtype	No	C61	8500/3	C61.9	YES	Core needle biopsy	410		NO	Bilateral		NO	YES				NO	29	3	true	No	N1	T3b	TCGA-EJ-A7NM.D7D49539-80E3-4A37-BEEB-FA75951947F8.pdf		A7NM	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	5			NO		YES	NO	EJ			Prostate		A	LIVING	2013		e311b8ad-1c32-4ccc-8e42-f7a8bae8b7d9	TCGA-EJ-A7NM-01A-21D-A33S-01	TCGA-EJ-A7NM-01A-21D-A33U-05		TCGA-EJ-A7NM-01A-21D-A33T-08	e311b8ad-1c32-4ccc-8e42-f7a8bae8b7d9	TCGA-EJ-A7NM-01	TCGA-EJ-A7NM-01	BAEA99A1-A645-4D7C-97F1-137E6CEB9038	TCGA-EJ-A7NM-01A-21D-A33S-01	e311b8ad-1c32-4ccc-8e42-f7a8bae8b7d9	TCGA-EJ-A7NM-01	TCGA-EJ-A7NM-01		TCGA-EJ-A7NM-01A-21D-A33T-08	e311b8ad-1c32-4ccc-8e42-f7a8bae8b7d9
TCGA-EJ-A7NN-01	0	TCGA-EJ-A7NN-01	197	0	days	TCGA-EJ-A7NN	197	0	days	197	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61	TCGA-EJ-A7NN-F64763	TCGA-EJ-A7NN	TCGA-EJ-A7NN-01A	YES		M0	T3b	-22499		191				197	0	197		197							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	240		NO	Bilateral		NO	YES				NO	25	3	true	No	N1	T3b	TCGA-EJ-A7NN.4027496E-5E84-4502-BD86-980339AD9896.pdf		A7NN	TUMOR FREE	4	Complete Remission/Response	0.3	NO	R1	Primary Tumor	01	3			NO		YES	NO	EJ			Prostate		A	LIVING	2013		f46d3930-be89-420e-b0b7-ffad2c8149e7		TCGA-EJ-A7NN-01A-11D-A33U-05		TCGA-EJ-A7NN-01A-11D-A33T-08	f46d3930-be89-420e-b0b7-ffad2c8149e7	TCGA-EJ-A7NN-01	TCGA-EJ-A7NN-01	7B1E4C11-AF47-425F-909D-E10AC1CBE6FD		f46d3930-be89-420e-b0b7-ffad2c8149e7		TCGA-EJ-A7NN-01			f46d3930-be89-420e-b0b7-ffad2c8149e7
TCGA-EJ-A8FN-01	0	TCGA-EJ-A8FN-01	329	0	days	TCGA-EJ-A8FN	329	0	days	329	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			58	TCGA-EJ-A8FN-F64780	TCGA-EJ-A8FN	TCGA-EJ-A8FN-01A	NO		M0	T2c	-21506		203					0	329		203							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	330		NO	Bilateral		NO	YES				NO	25	0	true	No	N0	T2c	TCGA-EJ-A8FN.FCAC56D3-5775-4A05-A739-108C8FBC9FD8.pdf		A8FN	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate		A	LIVING	2013		0984a482-7559-48b4-a09d-d95f78816f23	TCGA-EJ-A8FN-01A-11D-A34T-01	TCGA-EJ-A8FN-01A-11D-A34V-05		TCGA-EJ-A8FN-01A-11D-A34U-08	0984a482-7559-48b4-a09d-d95f78816f23	TCGA-EJ-A8FN-01	TCGA-EJ-A8FN-01	F1611C3D-6100-471B-859C-40E31E3888E3	TCGA-EJ-A8FN-01A-11D-A34T-01	0984a482-7559-48b4-a09d-d95f78816f23	TCGA-EJ-A8FN-01	TCGA-EJ-A8FN-01		TCGA-EJ-A8FN-01A-11D-A34U-08	0984a482-7559-48b4-a09d-d95f78816f23
TCGA-EJ-A8FO-01	0	TCGA-EJ-A8FO-01	282	0	days	TCGA-EJ-A8FO	282	0	days	282	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			51	TCGA-EJ-A8FO-F64781	TCGA-EJ-A8FO	TCGA-EJ-A8FO-01A	NO		M0	T3a	-18875		177					0	282		156							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma, Other Subtype	No	C61	8500/3	C61.9	YES	Core needle biopsy	240		NO	Bilateral		NO	YES				NO	37	0	true	No	N0	T3a	TCGA-EJ-A8FO.72728A33-3CFC-43B5-B88C-B2DC34C83207.pdf		A8FO	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3			NO		YES	NO	EJ			Prostate		A	LIVING	2013		56336ee0-a1f8-4426-adec-b1c92d96891f	TCGA-EJ-A8FO-01A-21D-A363-01	TCGA-EJ-A8FO-01A-21D-A365-05		TCGA-EJ-A8FO-01A-21D-A364-08	56336ee0-a1f8-4426-adec-b1c92d96891f	TCGA-EJ-A8FO-01	TCGA-EJ-A8FO-01	FDF37A07-FD07-4BA1-AF95-1A9DBCB40159	TCGA-EJ-A8FO-01A-21D-A363-01	56336ee0-a1f8-4426-adec-b1c92d96891f	TCGA-EJ-A8FO-01	TCGA-EJ-A8FO-01			56336ee0-a1f8-4426-adec-b1c92d96891f
TCGA-EJ-A8FO-11	0	TCGA-EJ-A8FO-11	282	0	days	TCGA-EJ-A8FO	282	0	days	282	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			51	TCGA-EJ-A8FO-F64781	TCGA-EJ-A8FO		NO		M0	T3a	-18875							0	282		156							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma, Other Subtype	No	C61	8500/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	37	0		No	N0	T3a			A8FO	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Solid Tissue Normal	11	3			NO		YES	NO	EJ			Prostate			LIVING	2013		edeacf74-688e-4996-868e-e78277d17415					edeacf74-688e-4996-868e-e78277d17415		TCGA-EJ-A8FO-11			edeacf74-688e-4996-868e-e78277d17415		TCGA-EJ-A8FO-11			edeacf74-688e-4996-868e-e78277d17415
TCGA-EJ-A8FP-01	0	TCGA-EJ-A8FP-01	299	0	days	TCGA-EJ-A8FP	299	0	days	299	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	59	TCGA-EJ-A8FP-F64784	TCGA-EJ-A8FP		YES		M0	T2c	-21769						117	0	299		117							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	8	Prostate Adenocarcinoma, Other Subtype	No	C61	8500/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	40	0		No	N0	T2c			A8FP	TUMOR FREE	3	Complete Remission/Response	0.2	NO	R0	Primary Tumor	01	5			NO		YES	NO	EJ			Prostate			LIVING	2013		b9ec6c3f-9801-4c81-9c80-fabc85306c31	TCGA-EJ-A8FP-01A-21D-A363-01	TCGA-EJ-A8FP-01A-21D-A365-05		TCGA-EJ-A8FP-01A-21D-A364-08	b9ec6c3f-9801-4c81-9c80-fabc85306c31	TCGA-EJ-A8FP-01	TCGA-EJ-A8FP-01		TCGA-EJ-A8FP-01A-21D-A363-01	b9ec6c3f-9801-4c81-9c80-fabc85306c31	TCGA-EJ-A8FP-01	TCGA-EJ-A8FP-01			b9ec6c3f-9801-4c81-9c80-fabc85306c31
TCGA-EJ-A8FS-01	0	TCGA-EJ-A8FS-01	266	0	days	TCGA-EJ-A8FS	266	0	days	266	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-EJ-A8FS-F64787	TCGA-EJ-A8FS	TCGA-EJ-A8FS-01A	YES		M0	T3a	-24380		126				216	0	266		216							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Transurethral resection (TURBT)	130		NO	Bilateral		NO	YES				NO	69	0	true	No	N0	T3a	TCGA-EJ-A8FS.18FF4FBA-0D6B-44D5-B5B5-68CD8DADF716.pdf		A8FS	TUMOR FREE	3	Complete Remission/Response	0.3	NO	R0	Primary Tumor	01	4			NO		YES	NO	EJ			Prostate		A	LIVING	2013		b31f1e9a-cc4d-4e17-ab88-d88e234df83d	TCGA-EJ-A8FS-01A-11D-A34T-01	TCGA-EJ-A8FS-01A-11D-A34V-05		TCGA-EJ-A8FS-01A-11D-A34U-08	b31f1e9a-cc4d-4e17-ab88-d88e234df83d	TCGA-EJ-A8FS-01	TCGA-EJ-A8FS-01	CEEB54AF-A48E-4549-B69A-3A1A8FEC2C37	TCGA-EJ-A8FS-01A-11D-A34T-01	b31f1e9a-cc4d-4e17-ab88-d88e234df83d	TCGA-EJ-A8FS-01	TCGA-EJ-A8FS-01		TCGA-EJ-A8FS-01A-11D-A34U-08	b31f1e9a-cc4d-4e17-ab88-d88e234df83d
TCGA-EJ-A8FU-01	0	TCGA-EJ-A8FU-01	138	0	days	TCGA-EJ-A8FU	138	0	days	138	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			64	TCGA-EJ-A8FU-F64788	TCGA-EJ-A8FU	TCGA-EJ-A8FU-01A			M0	T3a	-23472		89					0	138									Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	210		NO	Bilateral		NO	YES				NO	29	0	true	No	N0	T3a	TCGA-EJ-A8FU.613A9A17-E6E6-4A15-A06A-FB3D91D7459A.pdf		A8FU	TUMOR FREE	5	Complete Remission/Response		NO	R0	Primary Tumor	01	3			NO		YES	NO	EJ			Prostate		A	LIVING	2013		7adcdf73-3ad3-4da7-ab27-2888f1d4f53a	TCGA-EJ-A8FU-01A-11D-A363-01	TCGA-EJ-A8FU-01A-11D-A365-05		TCGA-EJ-A8FU-01A-11D-A364-08	7adcdf73-3ad3-4da7-ab27-2888f1d4f53a	TCGA-EJ-A8FU-01	TCGA-EJ-A8FU-01	48A36EB4-79FB-45E7-8BB1-0FA1D5FCDA2C	TCGA-EJ-A8FU-01A-11D-A363-01	7adcdf73-3ad3-4da7-ab27-2888f1d4f53a	TCGA-EJ-A8FU-01	TCGA-EJ-A8FU-01		TCGA-EJ-A8FU-01A-11D-A364-08	7adcdf73-3ad3-4da7-ab27-2888f1d4f53a
TCGA-EJ-AB20-01	0	TCGA-EJ-AB20-01	131	0	days	TCGA-EJ-AB20	131	0	days	131	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61	TCGA-EJ-AB20-F64790	TCGA-EJ-AB20	TCGA-EJ-AB20-01A	NO		M0	T2c	-22626		136					0	131		131							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	180		NO	Bilateral		NO	YES				NO	18	0	true	No	N0	T2c	TCGA-EJ-AB20.C1D97704-7C64-4C39-8812-BD8B95C2299F.pdf		AB20	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3			NO		YES	NO	EJ			Prostate		A	LIVING	2013		4e640b86-66f7-458c-af5c-b195778aa295	TCGA-EJ-AB20-01A-12D-A41J-01	TCGA-EJ-AB20-01A-12D-A41L-05		TCGA-EJ-AB20-01A-12D-A41K-08	4e640b86-66f7-458c-af5c-b195778aa295	TCGA-EJ-AB20-01	TCGA-EJ-AB20-01	44B3263E-DF68-4D34-A432-90A0A37198BF	TCGA-EJ-AB20-01A-12D-A41J-01	4e640b86-66f7-458c-af5c-b195778aa295	TCGA-EJ-AB20-01	TCGA-EJ-AB20-01			4e640b86-66f7-458c-af5c-b195778aa295
TCGA-EJ-AB27-01	0	TCGA-EJ-AB27-01	145	0	days	TCGA-EJ-AB27	145	0	days	145	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			51	TCGA-EJ-AB27-F64798	TCGA-EJ-AB27	TCGA-EJ-AB27-01A	NO		M0	T1c	-18648		130					0	145		145							Scheduled Follow-up Submission	Complete Remission/Response	2014-9-11	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	490		NO	Bilateral		NO	YES				NO	15	0	true	No	N0	T2c	TCGA-EJ-AB27.83FBE69E-525B-4833-BD10-AE4360BFF925.pdf		AB27	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3			NO		YES	NO	EJ			Prostate		A	LIVING	2013		7ea62df0-1cc5-4bd9-ad9e-3d68aa965731	TCGA-EJ-AB27-01A-11D-A41J-01	TCGA-EJ-AB27-01A-11D-A41L-05		TCGA-EJ-AB27-01A-11D-A41K-08	7ea62df0-1cc5-4bd9-ad9e-3d68aa965731	TCGA-EJ-AB27-01	TCGA-EJ-AB27-01	409CD05B-3C7C-47EF-91CD-F3D730230A79	TCGA-EJ-AB27-01A-11D-A41J-01	7ea62df0-1cc5-4bd9-ad9e-3d68aa965731	TCGA-EJ-AB27-01	TCGA-EJ-AB27-01			7ea62df0-1cc5-4bd9-ad9e-3d68aa965731
TCGA-FC-7708-01	0	TCGA-FC-7708-01	864	0	days	TCGA-FC-7708	864	0	days	864	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			52	TCGA-FC-7708-F55508	TCGA-FC-7708	TCGA-FC-7708-01A	NO		M0	T1c	-19144							0	864					NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-1-8	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Bilateral	1.3	YES	YES				NO	4	0		No	N0	T3a	TCGA-FC-7708.da17eddc-be95-4387-9c6a-fa647f33ceb7.pdf		7708	TUMOR FREE	4	Complete Remission/Response		NO	RX	Primary Tumor	01	3	0.2		NO		YES	NO	FC	Apex|Middle		Prostate		A	LIVING	2011	Overlapping / Multiple Zones	39239ac6-7757-43ca-928a-4885260ecbc7	TCGA-FC-7708-01A-11D-2112-01	TCGA-FC-7708-01A-11D-2116-05		TCGA-FC-7708-01A-11D-2114-08	39239ac6-7757-43ca-928a-4885260ecbc7	TCGA-FC-7708-01	TCGA-FC-7708-01	AD6852A9-511A-4380-80DD-ACEC1139B9E9	TCGA-FC-7708-01A-11D-2112-01	39239ac6-7757-43ca-928a-4885260ecbc7	TCGA-FC-7708-01	TCGA-FC-7708-01	TCGA-FC-7708-01A-11D-2114-08	TCGA-FC-7708-01A-11D-2114-08	39239ac6-7757-43ca-928a-4885260ecbc7
TCGA-FC-7961-01	0	TCGA-FC-7961-01	469	0	days	TCGA-FC-7961	469	0	days	469	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			62	TCGA-FC-7961-F33190	TCGA-FC-7961	TCGA-FC-7961-01A			M0	T1c	-22888				65			0	469					YES	No Evidence of Extraprostatic Extension			Scheduled Follow-up Submission	Complete Remission/Response	2012-6-22	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.9	YES	YES				NO	3	0		No	N0	T3a	TCGA-FC-7961.38213CCD-4ED4-43B8-BFA0-38300DD35095.pdf		7961	TUMOR FREE	4	Complete Remission/Response		NO		Primary Tumor	01	5	0.3		NO		YES	NO	FC	Apex		Prostate		A	LIVING	2011	Peripheral Zone	038600cd-c0ca-4de4-9539-570f7b960793	TCGA-FC-7961-01A-11D-A323-01	TCGA-FC-7961-01A-11D-A29T-05		TCGA-FC-7961-01A-11D-A29Q-08	038600cd-c0ca-4de4-9539-570f7b960793	TCGA-FC-7961-01	TCGA-FC-7961-01	3B491827-1556-45E0-B647-AB15B3716C84	TCGA-FC-7961-01A-11D-A323-01	038600cd-c0ca-4de4-9539-570f7b960793	TCGA-FC-7961-01	TCGA-FC-7961-01	TCGA-FC-7961-01A-11D-A29Q-08	TCGA-FC-7961-01A-11D-A29Q-08	038600cd-c0ca-4de4-9539-570f7b960793
TCGA-FC-A4JI-01	0	TCGA-FC-A4JI-01	877	0	days	TCGA-FC-A4JI	877	0	days	877	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			70	TCGA-FC-A4JI-F68094	TCGA-FC-A4JI	TCGA-FC-A4JI-01A		Normal (no evidence of prostate cancer) [cM0]	M0	T4	-25931	12	101		16			0	877					YES	Extraprostatic Extension  Localized (e.g. seminal vesicles)	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-21	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	630		NO	Bilateral		NO	NO				NO			true	No		T3a	TCGA-FC-A4JI.BEFDDE59-6838-433A-BAFC-82B4D3802349.pdf		A4JI	TUMOR FREE	5	Complete Remission/Response		YES	R0	Primary Tumor	01	3			YES		YES	NO	FC	Apex|Middle|Base		Prostate		A	LIVING	2012	Central Zone	4351923f-0818-42f3-9869-6963bcd2e98d	TCGA-FC-A4JI-01A-11D-A256-01	TCGA-FC-A4JI-01A-11D-A258-05		TCGA-FC-A4JI-01A-11D-A257-08	4351923f-0818-42f3-9869-6963bcd2e98d	TCGA-FC-A4JI-01	TCGA-FC-A4JI-01	9ECD6E03-86DE-4395-9BCF-34A4AD7369C8	TCGA-FC-A4JI-01A-11D-A256-01	4351923f-0818-42f3-9869-6963bcd2e98d	TCGA-FC-A4JI-01	TCGA-FC-A4JI-01	TCGA-FC-A4JI-01A-11D-A257-08	TCGA-FC-A4JI-01A-11D-A257-08	4351923f-0818-42f3-9869-6963bcd2e98d
TCGA-FC-A5OB-01	0	TCGA-FC-A5OB-01	680	0	days	TCGA-FC-A5OB	680	0	days	680	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			53	TCGA-FC-A5OB-F61434	TCGA-FC-A5OB	TCGA-FC-A5OB-01A	NO	Abnormal (not related to prostate cancer)	M0	T3a	-19413	9	162		9			0	680		110			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission		2014-6-30	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	210		NO	Bilateral		NO	YES				NO	9	0	true	No	N0	T3b	TCGA-FC-A5OB.E54208A5-C6DA-450A-AA5D-9A8FE5F6ECD6.pdf		A5OB	WITH TUMOR	4		5.22	YES	R1	Primary Tumor	01	5			YES		YES	NO	FC	Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones	131d97b1-b0d3-41d1-8fba-aaaa9eabdf9d	TCGA-FC-A5OB-01A-11D-A323-01	TCGA-FC-A5OB-01A-11D-A29T-05		TCGA-FC-A5OB-01A-11D-A29Q-08	131d97b1-b0d3-41d1-8fba-aaaa9eabdf9d	TCGA-FC-A5OB-01	TCGA-FC-A5OB-01	D10ACA59-D338-42DF-98CF-3700E1685EE7	TCGA-FC-A5OB-01A-11D-A323-01	131d97b1-b0d3-41d1-8fba-aaaa9eabdf9d	TCGA-FC-A5OB-01	TCGA-FC-A5OB-01	TCGA-FC-A5OB-01A-11D-A29Q-08	TCGA-FC-A5OB-01A-11D-A29Q-08	131d97b1-b0d3-41d1-8fba-aaaa9eabdf9d
TCGA-FC-A66V-01	0	TCGA-FC-A66V-01	524	0	days	TCGA-FC-A66V	524	0	days	524	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			74	TCGA-FC-A66V-F52816	TCGA-FC-A66V	TCGA-FC-A66V-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T3b	-27282	28	287		27			0	524		-164			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-12-6	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	180		NO	Bilateral		YES	YES				NO	2	0	true	No	N0	T3b	TCGA-FC-A66V.3C1BD6CD-0915-4DEA-A013-F2DE554C267F.pdf		A66V	TUMOR FREE	4	Complete Remission/Response	10.8	NO	R0	Primary Tumor	01	3			NO		YES	NO	FC	Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones	60448472-d440-4608-8fca-b54c41c5cde1	TCGA-FC-A66V-01A-21D-A30D-01	TCGA-FC-A66V-01A-21D-A30F-05		TCGA-FC-A66V-01A-21D-A30E-08	60448472-d440-4608-8fca-b54c41c5cde1	TCGA-FC-A66V-01	TCGA-FC-A66V-01	371030A1-7FA0-4209-9BF5-BADF2AC4F795	TCGA-FC-A66V-01A-21D-A30D-01	60448472-d440-4608-8fca-b54c41c5cde1	TCGA-FC-A66V-01	TCGA-FC-A66V-01			60448472-d440-4608-8fca-b54c41c5cde1
TCGA-FC-A6HD-01	0	TCGA-FC-A6HD-01	789	0	days	TCGA-FC-A6HD	789	0	days	789	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			77	TCGA-FC-A6HD-F71333	TCGA-FC-A6HD	TCGA-FC-A6HD-01A		Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-28197	33	140		33			0	789					YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	210		NO	Bilateral		NO	YES				NO	10	0	true	No	N0	T3a	TCGA-FC-A6HD.7452FEB1-FFB9-4DD2-8CD7-5BEB2B108208.pdf		A6HD	TUMOR FREE	4	Complete Remission/Response		NO	R0	Primary Tumor	01	3			NO		YES	NO	FC	Middle		Prostate		A	LIVING	2013	Overlapping / Multiple Zones	6b96fce2-199f-463c-982e-4ed8179ddd90	TCGA-FC-A6HD-01A-11D-A31K-01	TCGA-FC-A6HD-01A-11D-A31M-05		TCGA-FC-A6HD-01A-11D-A31L-08	6b96fce2-199f-463c-982e-4ed8179ddd90	TCGA-FC-A6HD-01	TCGA-FC-A6HD-01	038EF7E4-5CAF-4197-AE7F-DFD662D046C4	TCGA-FC-A6HD-01A-11D-A31K-01	6b96fce2-199f-463c-982e-4ed8179ddd90	TCGA-FC-A6HD-01	TCGA-FC-A6HD-01	TCGA-FC-A6HD-01A-11D-A31L-08		6b96fce2-199f-463c-982e-4ed8179ddd90
TCGA-FC-A8O0-01	0	TCGA-FC-A8O0-01	616	0	days	TCGA-FC-A8O0	616	0	days	616	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			68	TCGA-FC-A8O0-F71394	TCGA-FC-A8O0	TCGA-FC-A8O0-01A	NO		M0	T2c	-25115		168		10	-8		0	616		18			YES	Extraprostatic Extension  Localized (e.g. seminal vesicles)	YES	Extraprostatic Extension Localized (e.g. seminal vesicles)|Extraprostatic Extension (regional lymphadenopathy) [e.g. cN1]	Scheduled Follow-up Submission	Complete Remission/Response	2015-3-25	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	430		NO	Bilateral		NO	YES				NO	12	0	true	No	N0	T3a	TCGA-FC-A8O0.4DC18F34-9319-45E5-8ECA-D86E9CD81EE6.pdf		A8O0	TUMOR FREE	3	Complete Remission/Response	7.82		R0	Primary Tumor	01	3				4	YES	NO	FC	Base		Prostate		A	LIVING	2013	Peripheral Zone	e5b8a092-0e86-4003-9ba6-112006161e93	TCGA-FC-A8O0-01A-41D-A376-01	TCGA-FC-A8O0-01A-41D-A378-05		TCGA-FC-A8O0-01A-41D-A377-08	e5b8a092-0e86-4003-9ba6-112006161e93	TCGA-FC-A8O0-01	TCGA-FC-A8O0-01	8CE26D55-72E6-4DBB-A99A-B5CB7594C7A8	TCGA-FC-A8O0-01A-41D-A376-01	e5b8a092-0e86-4003-9ba6-112006161e93	TCGA-FC-A8O0-01	TCGA-FC-A8O0-01		TCGA-FC-A8O0-01A-41D-A377-08	e5b8a092-0e86-4003-9ba6-112006161e93
TCGA-G9-6329-01	0	TCGA-G9-6329-01	1266	0	days	TCGA-G9-6329	1266	0	days	1266	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			67	TCGA-G9-6329-F40680	TCGA-G9-6329	TCGA-G9-6329-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24797	10			10			0	1266		923			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	1.3	NO	NO				NO				No		T2c	TCGA-G9-6329.fd7b8f28-b1ee-428e-859c-c888c459a3b0.pdf		6329	TUMOR FREE	3	Complete Remission/Response	0.03	NO	R0	Primary Tumor	01	4	0.2		NO		NO	YES	G9			Prostate		A	LIVING	2009		3b6f54f6-1812-474f-aced-f6790e59611c	TCGA-G9-6329-01A-13D-1959-01	TCGA-G9-6329-01A-13D-1963-05		TCGA-G9-6329-01A-13D-1961-08	3b6f54f6-1812-474f-aced-f6790e59611c	TCGA-G9-6329-01	TCGA-G9-6329-01	41AF7C4D-6EF8-49D7-9F6A-2A84A4BB23BB	TCGA-G9-6329-01A-13D-1959-01	3b6f54f6-1812-474f-aced-f6790e59611c	TCGA-G9-6329-01	TCGA-G9-6329-01	TCGA-G9-6329-01A-13D-1961-08	TCGA-G9-6329-01A-13D-1961-08	3b6f54f6-1812-474f-aced-f6790e59611c
TCGA-G9-6332-01	0	TCGA-G9-6332-01	2657	0	days	TCGA-G9-6332	1285	1	days	2657	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	YES	55	TCGA-G9-6332-F40976	TCGA-G9-6332	TCGA-G9-6332-01A		Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-20166	11			11			0	2657	1285	2090			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Progressive Disease	2013-3-8	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.2	NO	Bilateral	0.4	NO	YES		New Primary Tumor		YES	7	0		No	N0	T3a	TCGA-G9-6332.18b9fda1-2d69-4c5e-94ba-bfbbcd742bdd.pdf		6332	WITH TUMOR	4	Complete Remission/Response	0.73	NO	R0	Primary Tumor	01	3	0.1		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2005		22ec0a34-74ad-48d6-80f4-b88ef082101d	TCGA-G9-6332-01A-11D-1785-01	TCGA-G9-6332-01A-11D-1787-05	TCGA-G9-6332-01A-11D-1786-08	TCGA-G9-6332-01A-11D-1786-08	22ec0a34-74ad-48d6-80f4-b88ef082101d	TCGA-G9-6332-01	TCGA-G9-6332-01		TCGA-G9-6332-01A-11D-1785-01	22ec0a34-74ad-48d6-80f4-b88ef082101d	TCGA-G9-6332-01	TCGA-G9-6332-01	TCGA-G9-6332-01A-11D-1786-08		22ec0a34-74ad-48d6-80f4-b88ef082101d
TCGA-G9-6332-11	0	TCGA-G9-6332-11	2657	0	days	TCGA-G9-6332	1285	1	days	2657	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	YES	55	TCGA-G9-6332-F40976	TCGA-G9-6332	TCGA-G9-6332-11A		Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-20166	11			11			0	2657	1285	2090			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Progressive Disease	2013-3-8	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1	NO	YES		New Primary Tumor		YES	7	0		No	N0	T3a			6332	WITH TUMOR	4	Complete Remission/Response	0.73	NO	R0	Solid Tissue Normal	11	3	0.5		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2005				TCGA-G9-6332-11A-01D-1787-05													
TCGA-G9-6333-01	0	TCGA-G9-6333-01	2465	0	days	TCGA-G9-6333	2465	0	days	2465	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-G9-6333-F42766	TCGA-G9-6333	TCGA-G9-6333-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24249	1102			1102			0	2465		1920			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-4-30	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1	NO	YES				NO	13	0		No	N0	T2c	TCGA-G9-6333.df50612f-a299-468b-b6bf-226366f4cf42.pdf		6333	TUMOR FREE	4	Complete Remission/Response	0.03	NO	R0	Primary Tumor	01	3	0.2		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2006		644e2830-703e-4a1f-86e3-f9cea798c1eb	TCGA-G9-6333-01A-12D-1959-01	TCGA-G9-6333-01A-12D-1963-05		TCGA-G9-6333-01A-12D-1961-08	644e2830-703e-4a1f-86e3-f9cea798c1eb	TCGA-G9-6333-01	TCGA-G9-6333-01		TCGA-G9-6333-01A-12D-1959-01	644e2830-703e-4a1f-86e3-f9cea798c1eb	TCGA-G9-6333-01	TCGA-G9-6333-01	TCGA-G9-6333-01A-12D-1961-08	TCGA-G9-6333-01A-12D-1961-08	644e2830-703e-4a1f-86e3-f9cea798c1eb
TCGA-G9-6333-11	0	TCGA-G9-6333-11	2465	0	days	TCGA-G9-6333	2465	0	days	2465	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-G9-6333-F42766	TCGA-G9-6333	TCGA-G9-6333-11A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24249	1102			1102			0	2465		1920			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-4-30	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Bilateral	1.4	NO	YES				NO	13	0		No	N0	T2c			6333	TUMOR FREE	4	Complete Remission/Response	0.03	NO	R0	Solid Tissue Normal	11	3	0.4		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2006		7e787a16-e77d-46eb-8666-7489349b5c82		TCGA-G9-6333-11A-01D-1963-05			7e787a16-e77d-46eb-8666-7489349b5c82		TCGA-G9-6333-11			7e787a16-e77d-46eb-8666-7489349b5c82		TCGA-G9-6333-11			7e787a16-e77d-46eb-8666-7489349b5c82
TCGA-G9-6336-01	0	TCGA-G9-6336-01	2068	0	days	TCGA-G9-6336	2068	0	days	2068	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57	TCGA-G9-6336-F40679	TCGA-G9-6336	TCGA-G9-6336-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-20851	98			104			0	2068		1669			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.3	NO	Bilateral	0.4	NO	YES				NO	5	0		No	N0		TCGA-G9-6336.ceda2ffb-b844-4f89-baba-82a66e6f3f0e.pdf		6336	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R1	Primary Tumor	01	4	0.2		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2007		9cbe4eef-89aa-453e-b22b-1c1256bf3c51	TCGA-G9-6336-01A-11D-1785-01	TCGA-G9-6336-01A-11D-1787-05	TCGA-G9-6336-01A-11D-1786-08	TCGA-G9-6336-01A-11D-1786-08	9cbe4eef-89aa-453e-b22b-1c1256bf3c51	TCGA-G9-6336-01	TCGA-G9-6336-01		TCGA-G9-6336-01A-11D-1785-01	9cbe4eef-89aa-453e-b22b-1c1256bf3c51	TCGA-G9-6336-01	TCGA-G9-6336-01	TCGA-G9-6336-01A-11D-1786-08	TCGA-G9-6336-01A-11D-1786-08	9cbe4eef-89aa-453e-b22b-1c1256bf3c51
TCGA-G9-6338-01	0	TCGA-G9-6338-01	2028	0	days	TCGA-G9-6338	2028	0	days	2028	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61	TCGA-G9-6338-F42755	TCGA-G9-6338	TCGA-G9-6338-01A		Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22360	13			82			0	2028		1634			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-4-30	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1	NO	YES				NO	2	0		No	N0	T3a	TCGA-G9-6338.d3962697-f160-4a76-bfbe-81c06c89d5c3.pdf		6338	TUMOR FREE	4	Complete Remission/Response	0.05	NO	R1	Primary Tumor	01	3	0.2		NO		NO	YES	G9	Apex		Prostate		A	LIVING	2007		3790dc43-aa3d-4d1b-aa7a-340675c98bd4	TCGA-G9-6338-01A-12D-1959-01	TCGA-G9-6338-01A-12D-1963-05		TCGA-G9-6338-01A-12D-1961-08	3790dc43-aa3d-4d1b-aa7a-340675c98bd4	TCGA-G9-6338-01	TCGA-G9-6338-01	186A0C7B-C4BC-47F6-A2B3-43D06A5E72A1	TCGA-G9-6338-01A-12D-1959-01	3790dc43-aa3d-4d1b-aa7a-340675c98bd4	TCGA-G9-6338-01	TCGA-G9-6338-01	TCGA-G9-6338-01A-12D-1961-08		3790dc43-aa3d-4d1b-aa7a-340675c98bd4
TCGA-G9-6339-01	0	TCGA-G9-6339-01	2551	0	days	TCGA-G9-6339	2551	0	days	2551	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			58	TCGA-G9-6339-F66665	TCGA-G9-6339	TCGA-G9-6339-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T3b	-21305	4					1634	0	2551		2110			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-10-22	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.3	NO	YES				NO	6	0		No	N0	T3b	TCGA-G9-6339.10FA561E-76C7-4F83-BC1C-B858DF9CCC46.pdf		6339	TUMOR FREE	3	Complete Remission/Response	0.03	NO	R0	Primary Tumor	01	4	0.3		NO		NO	YES	G9	Apex|Middle|Base		Prostate		A	LIVING	2007		18c4e2fd-5696-4577-bd9d-019a402f7c81	TCGA-G9-6339-01A-12D-A30W-01	TCGA-G9-6339-01A-12D-A30Z-05		TCGA-G9-6339-01A-12D-A30X-08	18c4e2fd-5696-4577-bd9d-019a402f7c81	TCGA-G9-6339-01	TCGA-G9-6339-01	0DEC7849-6BCD-40D9-89E3-4E1C08BEF242	TCGA-G9-6339-01A-12D-A30W-01	18c4e2fd-5696-4577-bd9d-019a402f7c81	TCGA-G9-6339-01	TCGA-G9-6339-01	TCGA-G9-6339-01A-12D-A30X-08		18c4e2fd-5696-4577-bd9d-019a402f7c81
TCGA-G9-6342-01	0	TCGA-G9-6342-01	1696	0	days	TCGA-G9-6342	1696	0	days	1696	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61	TCGA-G9-6342-F40650	TCGA-G9-6342	TCGA-G9-6342-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-22472	32			36			0	1696		1338			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	0.8	NO	NO				NO				No		T3a	TCGA-G9-6342.80379cb8-9fb7-4e01-9e4a-2bf7813dc839.pdf		6342	TUMOR FREE	3	Complete Remission/Response	0.05	NO	R0	Primary Tumor	01	3	0.3		NO	4	NO	YES	G9	Apex|Base		Prostate		A	LIVING	2008		07384291-d5cc-44d8-a025-f10636c91691	TCGA-G9-6342-01A-11D-1959-01	TCGA-G9-6342-01A-11D-1963-05		TCGA-G9-6342-01A-11D-1961-08	07384291-d5cc-44d8-a025-f10636c91691	TCGA-G9-6342-01	TCGA-G9-6342-01	78676530-C980-4B09-984C-A54A0B59899D	TCGA-G9-6342-01A-11D-1959-01	07384291-d5cc-44d8-a025-f10636c91691	TCGA-G9-6342-01	TCGA-G9-6342-01	TCGA-G9-6342-01A-11D-1961-08	TCGA-G9-6342-01A-11D-1961-08	07384291-d5cc-44d8-a025-f10636c91691
TCGA-G9-6342-11	0	TCGA-G9-6342-11	1696	0	days	TCGA-G9-6342	1696	0	days	1696	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61	TCGA-G9-6342-F40650	TCGA-G9-6342	TCGA-G9-6342-11A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-22472	32			36			0	1696		1338			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.2	NO	NO				NO				No		T3a			6342	TUMOR FREE	3	Complete Remission/Response	0.05	NO	R0	Solid Tissue Normal	11	3	0.5		NO	4	NO	YES	G9	Apex|Base		Prostate		A	LIVING	2008		35c918eb-2a20-4e32-93d4-ae2c80d6cee7		TCGA-G9-6342-11A-02D-1963-05			35c918eb-2a20-4e32-93d4-ae2c80d6cee7		TCGA-G9-6342-11			35c918eb-2a20-4e32-93d4-ae2c80d6cee7		TCGA-G9-6342-11			35c918eb-2a20-4e32-93d4-ae2c80d6cee7
TCGA-G9-6343-01	0	TCGA-G9-6343-01	2450	0	days	TCGA-G9-6343			days	2450	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			62	TCGA-G9-6343-F68582	TCGA-G9-6343	TCGA-G9-6343-01A	NO		M0	T2a	-22843							0	2450		554			NO		NO		Scheduled Follow-up Submission		2014-12-1	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1.5	NO	NO								No		T2c	TCGA-G9-6343.3d7d837b-a09e-4281-93af-a789123a9356.pdf		6343	TUMOR FREE	4	Complete Remission/Response	0.03	NO	R0	Primary Tumor	01	3	0.2		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2008		938046b4-330f-49e1-99b3-4cc4a1a1e48d	TCGA-G9-6343-01A-21D-1959-01	TCGA-G9-6343-01A-21D-1963-05		TCGA-G9-6343-01A-21D-1961-08	938046b4-330f-49e1-99b3-4cc4a1a1e48d	TCGA-G9-6343-01	TCGA-G9-6343-01	16D4166B-4EF0-476D-AD9A-7A2D8CD0E180	TCGA-G9-6343-01A-21D-1959-01	938046b4-330f-49e1-99b3-4cc4a1a1e48d	TCGA-G9-6343-01	TCGA-G9-6343-01	TCGA-G9-6343-01A-21D-1961-08		938046b4-330f-49e1-99b3-4cc4a1a1e48d
TCGA-G9-6347-01	0	TCGA-G9-6347-01	2089	0	days	TCGA-G9-6347	2089	0	days	2089	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			59	TCGA-G9-6347-F61289	TCGA-G9-6347	TCGA-G9-6347-01A	NO		M0	T1c	-21721							0	2089		1718			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-6-26	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	1	NO	NO				NO				No		T2c	TCGA-G9-6347.2ED4FCE8-5DCF-4529-95E5-C454529D7971.pdf		6347	TUMOR FREE	3	Complete Remission/Response	00.03	NO	R0	Primary Tumor	01	3	0.1		NO		NO	YES	G9	Apex|Middle		Prostate		A	LIVING	2008	Peripheral Zone	817b51f3-fa06-4c82-956e-220b4396d30b	TCGA-G9-6347-01A-11D-A31K-01	TCGA-G9-6347-01A-11D-A31M-05		TCGA-G9-6347-01A-11D-A31L-08	817b51f3-fa06-4c82-956e-220b4396d30b	TCGA-G9-6347-01	TCGA-G9-6347-01	28F07B17-A295-4C80-814E-1A7FA932D08E	TCGA-G9-6347-01A-11D-A31K-01	817b51f3-fa06-4c82-956e-220b4396d30b	TCGA-G9-6347-01	TCGA-G9-6347-01	TCGA-G9-6347-01A-11D-A31L-08		817b51f3-fa06-4c82-956e-220b4396d30b
TCGA-G9-6348-01	0	TCGA-G9-6348-01	1515	0	days	TCGA-G9-6348	1515	0	days	1515	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			68	TCGA-G9-6348-F40648	TCGA-G9-6348		NO	Abnormal (not related to prostate cancer)	M0	T3a	-24936	31			31			0	1515		1136			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	[Discrepancy]				NO	15	0		No	N0	T2c			6348	TUMOR FREE	3	Complete Remission/Response	0.02	NO	R0	Primary Tumor	01	4			NO		NO	YES	G9	Apex|Base		Prostate			LIVING	2008		f1647dd0-3eda-473f-9902-12d0817ee165	TCGA-G9-6348-01A-11D-1785-01	TCGA-G9-6348-01A-11D-1787-05	TCGA-G9-6348-01A-11D-1786-08	TCGA-G9-6348-01A-11D-1786-08	f1647dd0-3eda-473f-9902-12d0817ee165	TCGA-G9-6348-01	TCGA-G9-6348-01		TCGA-G9-6348-01A-11D-1785-01	f1647dd0-3eda-473f-9902-12d0817ee165	TCGA-G9-6348-01	TCGA-G9-6348-01	TCGA-G9-6348-01A-11D-1786-08	TCGA-G9-6348-01A-11D-1786-08	f1647dd0-3eda-473f-9902-12d0817ee165
TCGA-G9-6348-11	0	TCGA-G9-6348-11	1515	0	days	TCGA-G9-6348	1515	0	days	1515	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			68	TCGA-G9-6348-F40648	TCGA-G9-6348		NO	Abnormal (not related to prostate cancer)	M0	T3a	-24936	31			31			0	1515		1136			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	[Discrepancy]				NO	15	0		No	N0	T2c			6348	TUMOR FREE	3	Complete Remission/Response	0.02	NO	R0	Solid Tissue Normal	11	4			NO		NO	YES	G9	Apex|Base		Prostate			LIVING	2008		f2ad4c22-c476-44af-a8ca-dffcae313ae2		TCGA-G9-6348-11A-01D-1787-05			f2ad4c22-c476-44af-a8ca-dffcae313ae2		TCGA-G9-6348-11			f2ad4c22-c476-44af-a8ca-dffcae313ae2		TCGA-G9-6348-11			f2ad4c22-c476-44af-a8ca-dffcae313ae2
TCGA-G9-6351-01	0	TCGA-G9-6351-01	2048	0	days	TCGA-G9-6351	2048	0	days	2048	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			51	TCGA-G9-6351-F68538	TCGA-G9-6351	TCGA-G9-6351-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-18723	8			11			0	2048		1215			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-25	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.3	NO	Bilateral	0.6	NO	NO				NO				No		T2c	TCGA-G9-6351.7942304b-0a3d-492c-bbb2-65695f1958e4.pdf		6351	TUMOR FREE	3	Complete Remission/Response	0.03	YES	R1	Primary Tumor	01	4	0.3		NO		NO	YES	G9	Apex		Prostate		A	LIVING	2008		5b656979-9a9f-4ef2-8948-2979d1db0c68	TCGA-G9-6351-01A-21D-1959-01	TCGA-G9-6351-01A-21D-1963-05		TCGA-G9-6351-01A-21D-1961-08	5b656979-9a9f-4ef2-8948-2979d1db0c68	TCGA-G9-6351-01	TCGA-G9-6351-01	0CC4613B-D3AE-44E1-86B8-BF52A68C44CD	TCGA-G9-6351-01A-21D-1959-01	5b656979-9a9f-4ef2-8948-2979d1db0c68	TCGA-G9-6351-01	TCGA-G9-6351-01	TCGA-G9-6351-01A-21D-1961-08	TCGA-G9-6351-01A-21D-1961-08	5b656979-9a9f-4ef2-8948-2979d1db0c68
TCGA-G9-6351-11	0	TCGA-G9-6351-11	2048	0	days	TCGA-G9-6351	2048	0	days	2048	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			51	TCGA-G9-6351-F68538	TCGA-G9-6351	TCGA-G9-6351-11A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-18723	8			11			0	2048		1215			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-25	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy	120	1	NO	Bilateral	1.4	NO	NO				NO				No		T2c			6351	TUMOR FREE	3	Complete Remission/Response	0.03	YES	R1	Solid Tissue Normal	11	4	0.3		NO		NO	YES	G9	Apex		Prostate		A	LIVING	2008		6b264e41-b852-4221-8e09-692a6a639ccf		TCGA-G9-6351-11A-01D-1963-05			6b264e41-b852-4221-8e09-692a6a639ccf		TCGA-G9-6351-11			6b264e41-b852-4221-8e09-692a6a639ccf		TCGA-G9-6351-11			6b264e41-b852-4221-8e09-692a6a639ccf
TCGA-G9-6353-01	0	TCGA-G9-6353-01	1542	0	days	TCGA-G9-6353	1542	0	days	1542	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			58	TCGA-G9-6353-F42753	TCGA-G9-6353	TCGA-G9-6353-01A	NO		M0	T1c	-21221							0	1542		590			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-4-30	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1	NO	NO				NO				No		T3a	TCGA-G9-6353.72b2694f-8b37-402a-a75a-2a50372a789e.pdf		6353	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R1	Primary Tumor	01	4	0.5		NO		NO	YES	G9	Apex|Middle		Prostate		A	LIVING	2009	Peripheral Zone	f8cdc431-ee4c-4337-975f-eb380faebb8c	TCGA-G9-6353-01A-11D-1959-01	TCGA-G9-6353-01A-11D-1963-05		TCGA-G9-6353-01A-11D-1961-08	f8cdc431-ee4c-4337-975f-eb380faebb8c	TCGA-G9-6353-01	TCGA-G9-6353-01	0B613135-6859-4DD9-9090-C52376CEA024	TCGA-G9-6353-01A-11D-1959-01	f8cdc431-ee4c-4337-975f-eb380faebb8c	TCGA-G9-6353-01	TCGA-G9-6353-01	TCGA-G9-6353-01A-11D-1961-08	TCGA-G9-6353-01A-11D-1961-08	f8cdc431-ee4c-4337-975f-eb380faebb8c
TCGA-G9-6353-11	0	TCGA-G9-6353-11	1542	0	days	TCGA-G9-6353	1542	0	days	1542	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			58	TCGA-G9-6353-F42753	TCGA-G9-6353	TCGA-G9-6353-11A	NO		M0	T1c	-21221							0	1542		590			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-4-30	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.1	NO	NO				NO				No		T3a			6353	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R1	Solid Tissue Normal	11	4	0.6		NO		NO	YES	G9	Apex|Middle		Prostate		A	LIVING	2009	Peripheral Zone			TCGA-G9-6353-11A-02D-1963-05													
TCGA-G9-6354-01	0	TCGA-G9-6354-01	2066	0	days	TCGA-G9-6354	2066	0	days	2066	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55	TCGA-G9-6354-F70314	TCGA-G9-6354	TCGA-G9-6354-01A	NO		M0	T1c	-20403							0	2066		525			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-2-9	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.1	NO	Right	0.6	NO	NO				NO				No		T2b	TCGA-G9-6354.CFFC4C63-D738-41CD-8EE3-25C190A9638C.pdf		6354	TUMOR FREE	3	Complete Remission/Response	00.03	NO	R0	Primary Tumor	01	4	0.1		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009		99b27a89-5e60-4b2f-8d54-2bea08ac897c	TCGA-G9-6354-01A-11D-A30W-01	TCGA-G9-6354-01A-11D-A30Z-05		TCGA-G9-6354-01A-11D-A30X-08	99b27a89-5e60-4b2f-8d54-2bea08ac897c	TCGA-G9-6354-01	TCGA-G9-6354-01		TCGA-G9-6354-01A-11D-A30W-01	99b27a89-5e60-4b2f-8d54-2bea08ac897c	TCGA-G9-6354-01	TCGA-G9-6354-01	TCGA-G9-6354-01A-11D-A30X-08		99b27a89-5e60-4b2f-8d54-2bea08ac897c
TCGA-G9-6356-01	0	TCGA-G9-6356-01	1434	0	days	TCGA-G9-6356	1434	0	days	1434	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			60	TCGA-G9-6356-F40973	TCGA-G9-6356	TCGA-G9-6356-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22010	24			21			0	1434		986			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-3-8	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1.3	NO	YES				NO	5	0		No	N0	T3b	TCGA-G9-6356.818a2716-ca81-4534-ba13-a0fe3a18b2e9.pdf		6356	TUMOR FREE	4	Complete Remission/Response	0.13	NO	R1	Primary Tumor	01	5	0.6		NO	3	NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009		9584ae14-c30b-421b-8975-b5b1bb94a465	TCGA-G9-6356-01A-11D-1785-01	TCGA-G9-6356-01A-11D-1787-05	TCGA-G9-6356-01A-11D-1786-08	TCGA-G9-6356-01A-11D-1786-08	9584ae14-c30b-421b-8975-b5b1bb94a465	TCGA-G9-6356-01	TCGA-G9-6356-01	64132E9C-00E9-4F9B-8DBB-63B39E1CFFC9	TCGA-G9-6356-01A-11D-1785-01	9584ae14-c30b-421b-8975-b5b1bb94a465	TCGA-G9-6356-01	TCGA-G9-6356-01	TCGA-G9-6356-01A-11D-1786-08	TCGA-G9-6356-01A-11D-1786-08	9584ae14-c30b-421b-8975-b5b1bb94a465
TCGA-G9-6356-11	0	TCGA-G9-6356-11	1434	0	days	TCGA-G9-6356	1434	0	days	1434	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			60	TCGA-G9-6356-F40973	TCGA-G9-6356		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22010	24			21			0	1434		986			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-3-8	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	5	0		No	N0	T3b			6356	TUMOR FREE	4	Complete Remission/Response	0.13	NO	R1	Solid Tissue Normal	11	5			NO	3	NO	YES	G9	Apex|Base		Prostate			LIVING	2009		aabc18c1-ba2e-40a8-b564-eb97b2a188f8		TCGA-G9-6356-11A-01D-1787-05			aabc18c1-ba2e-40a8-b564-eb97b2a188f8		TCGA-G9-6356-11			aabc18c1-ba2e-40a8-b564-eb97b2a188f8		TCGA-G9-6356-11			aabc18c1-ba2e-40a8-b564-eb97b2a188f8
TCGA-G9-6361-01	0	TCGA-G9-6361-01	1415	0	days	TCGA-G9-6361	1415	0	days	1415	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61	TCGA-G9-6361-F42767	TCGA-G9-6361	TCGA-G9-6361-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-22565	38			31			0	1415		1002			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-4-30	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	1.3	NO	YES				NO	12	0		No	N0	T3a	TCGA-G9-6361.49fe865a-79e8-4ff3-a52e-9888c4514cf2.pdf		6361	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R1	Primary Tumor	01	4	0.2		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009		011453b6-9736-4ea4-8845-bbe4416783d3	TCGA-G9-6361-01A-21D-1959-01	TCGA-G9-6361-01A-21D-1963-05		TCGA-G9-6361-01A-21D-1961-08	011453b6-9736-4ea4-8845-bbe4416783d3	TCGA-G9-6361-01	TCGA-G9-6361-01	E7B28BAE-ED87-4EF9-A0C9-A32D513CE718	TCGA-G9-6361-01A-21D-1959-01	011453b6-9736-4ea4-8845-bbe4416783d3	TCGA-G9-6361-01	TCGA-G9-6361-01	TCGA-G9-6361-01A-21D-1961-08	TCGA-G9-6361-01A-21D-1961-08	011453b6-9736-4ea4-8845-bbe4416783d3
TCGA-G9-6362-01	0	TCGA-G9-6362-01	1443	0	days	TCGA-G9-6362			days	1443	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	57	TCGA-G9-6362-F44046	TCGA-G9-6362	TCGA-G9-6362-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-21149	8					1443	0	1443		815			NO		NO		Scheduled Follow-up Submission	Progressive Disease	2013-6-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.2	NO	YES		Biochemical evidence of disease		YES	2	0		No	N0	T3a	TCGA-G9-6362.fc8bac85-e3c5-47c1-b4c1-9b8834e01780.pdf		6362	WITH TUMOR	4	Progressive Disease	0.07	NO	R1	Primary Tumor	01	3	0.2		NO	5	NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009		986964bc-b680-4fc1-8f93-20772f0a8949	TCGA-G9-6362-01A-11D-1785-01	TCGA-G9-6362-01A-11D-1787-05	TCGA-G9-6362-01A-11D-1786-08	TCGA-G9-6362-01A-11D-1786-08	986964bc-b680-4fc1-8f93-20772f0a8949	TCGA-G9-6362-01	TCGA-G9-6362-01	3840697C-A557-4C88-BE3D-8FE326DE6C5E	TCGA-G9-6362-01A-11D-1785-01	986964bc-b680-4fc1-8f93-20772f0a8949	TCGA-G9-6362-01	TCGA-G9-6362-01	TCGA-G9-6362-01A-11D-1786-08		986964bc-b680-4fc1-8f93-20772f0a8949
TCGA-G9-6362-11	0	TCGA-G9-6362-11	1443	0	days	TCGA-G9-6362			days	1443	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	57	TCGA-G9-6362-F44046	TCGA-G9-6362		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-21149	8					1443	0	1443		815			NO		NO		Scheduled Follow-up Submission	Progressive Disease	2013-6-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES		Biochemical evidence of disease		YES	2	0		No	N0	T3a			6362	WITH TUMOR	4	Progressive Disease	0.07	NO	R1	Solid Tissue Normal	11	3			NO	5	NO	YES	G9	Apex|Base		Prostate			LIVING	2009		d5a6b5e2-f1af-4b1f-bfbe-2b3c05f3f642		TCGA-G9-6362-11A-01D-1787-05			d5a6b5e2-f1af-4b1f-bfbe-2b3c05f3f642		TCGA-G9-6362-11			d5a6b5e2-f1af-4b1f-bfbe-2b3c05f3f642		TCGA-G9-6362-11			d5a6b5e2-f1af-4b1f-bfbe-2b3c05f3f642
TCGA-G9-6363-01	0	TCGA-G9-6363-01	1378	0	days	TCGA-G9-6363	1378	0	days	1378	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			64	TCGA-G9-6363-F44074	TCGA-G9-6363	TCGA-G9-6363-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-23480	58			23			0	1378		993			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-6-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Bilateral	1.2	NO	YES				NO	6	0		No	N0	T4	TCGA-G9-6363.bd52ccc2-462d-41df-a5a4-dc45bd78aea4.pdf		6363	TUMOR FREE	4	Complete Remission/Response	0.03	NO	R0	Primary Tumor	01	3	0.3		NO		NO	YES	G9	Base		Prostate		A	LIVING	2009		766eb893-3bc9-4a17-9b66-7eed2b1c01c3	TCGA-G9-6363-01A-21D-1785-01	TCGA-G9-6363-01A-21D-1787-05	TCGA-G9-6363-01A-21D-1786-08	TCGA-G9-6363-01A-21D-1786-08	766eb893-3bc9-4a17-9b66-7eed2b1c01c3	TCGA-G9-6363-01	TCGA-G9-6363-01	6E48E2C0-5361-44BC-B94A-EC324A89657D	TCGA-G9-6363-01A-21D-1785-01	766eb893-3bc9-4a17-9b66-7eed2b1c01c3	TCGA-G9-6363-01	TCGA-G9-6363-01	TCGA-G9-6363-01A-21D-1786-08	TCGA-G9-6363-01A-21D-1786-08	766eb893-3bc9-4a17-9b66-7eed2b1c01c3
TCGA-G9-6363-11	0	TCGA-G9-6363-11	1378	0	days	TCGA-G9-6363	1378	0	days	1378	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			64	TCGA-G9-6363-F44074	TCGA-G9-6363	TCGA-G9-6363-11A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-23480	58			23			0	1378		993			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-6-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy	100	0.7	NO	Bilateral	1.8	NO	YES				NO	6	0		No	N0	T4			6363	TUMOR FREE	4	Complete Remission/Response	0.03	NO	R0	Solid Tissue Normal	11	3	0.4		NO		NO	YES	G9	Base		Prostate		A	LIVING	2009		1eda4d9f-e9a1-4ee7-8c71-559c8940b751		TCGA-G9-6363-11A-01D-1787-05			1eda4d9f-e9a1-4ee7-8c71-559c8940b751		TCGA-G9-6363-11			1eda4d9f-e9a1-4ee7-8c71-559c8940b751		TCGA-G9-6363-11			1eda4d9f-e9a1-4ee7-8c71-559c8940b751
TCGA-G9-6364-01	0	TCGA-G9-6364-01	1198	0	days	TCGA-G9-6364	1198	0	days	1198	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			72	TCGA-G9-6364-F40643	TCGA-G9-6364	TCGA-G9-6364-01A	NO		M0		-26603							0	1198		841			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Transurethral resection (TURBT)		0.8	NO	Bilateral	1.7	NO	YES				NO	25	0		Yes	N0	T3a	TCGA-G9-6364.81deb5a1-4d5d-490a-a956-a64a4e6763f8.pdf		6364	TUMOR FREE	3	Complete Remission/Response	0.03	NO	R0	Primary Tumor	01	4	0.4		NO		NO	YES	G9			Prostate		A	LIVING	2009		e9de50a5-d753-40f8-bb1f-3602ad9627ca	TCGA-G9-6364-01A-21D-1785-01	TCGA-G9-6364-01A-21D-1787-05	TCGA-G9-6364-01A-21D-1786-08	TCGA-G9-6364-01A-21D-1786-08	e9de50a5-d753-40f8-bb1f-3602ad9627ca	TCGA-G9-6364-01	TCGA-G9-6364-01	9813C17B-FBC4-4064-AA64-7F4C4AAEDD00	TCGA-G9-6364-01A-21D-1785-01	e9de50a5-d753-40f8-bb1f-3602ad9627ca	TCGA-G9-6364-01	TCGA-G9-6364-01	TCGA-G9-6364-01A-21D-1786-08	TCGA-G9-6364-01A-21D-1786-08	e9de50a5-d753-40f8-bb1f-3602ad9627ca
TCGA-G9-6364-11	0	TCGA-G9-6364-11	1198	0	days	TCGA-G9-6364	1198	0	days	1198	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			72	TCGA-G9-6364-F40643	TCGA-G9-6364	TCGA-G9-6364-11A	NO		M0		-26603							0	1198		841			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Transurethral resection (TURBT)		1	NO	Bilateral	2	NO	YES				NO	25	0		Yes	N0	T3a			6364	TUMOR FREE	3	Complete Remission/Response	0.03	NO	R0	Solid Tissue Normal	11	4	0.3		NO		NO	YES	G9			Prostate		A	LIVING	2009				TCGA-G9-6364-11A-01D-1787-05													
TCGA-G9-6365-01	0	TCGA-G9-6365-01	1363	0	days	TCGA-G9-6365	1363	0	days	1363	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			71	TCGA-G9-6365-F42754	TCGA-G9-6365	TCGA-G9-6365-01A	NO			T2a	-26207							0	1363		804			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-4-30	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	2	NO	YES				NO	13	0		No	N0	T4	TCGA-G9-6365.0f1f5e1b-4086-4a77-96ba-2108abdde80f.pdf		6365	TUMOR FREE	3	Complete Remission/Response	0.01	NO	R1	Primary Tumor	01	4	0.3		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009		67816085-c038-4c4f-86f0-b03e6da18aee	TCGA-G9-6365-01A-11D-1785-01	TCGA-G9-6365-01A-11D-1787-05	TCGA-G9-6365-01A-11D-1786-08	TCGA-G9-6365-01A-11D-1786-08	67816085-c038-4c4f-86f0-b03e6da18aee	TCGA-G9-6365-01	TCGA-G9-6365-01	2FD641B9-006D-40FE-8E01-678EEC130C6E	TCGA-G9-6365-01A-11D-1785-01	67816085-c038-4c4f-86f0-b03e6da18aee	TCGA-G9-6365-01	TCGA-G9-6365-01	TCGA-G9-6365-01A-11D-1786-08	TCGA-G9-6365-01A-11D-1786-08	67816085-c038-4c4f-86f0-b03e6da18aee
TCGA-G9-6365-11	0	TCGA-G9-6365-11	1363	0	days	TCGA-G9-6365	1363	0	days	1363	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			71	TCGA-G9-6365-F42754	TCGA-G9-6365	TCGA-G9-6365-11A	NO			T2a	-26207							0	1363		804			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-4-30	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	2.2	NO	YES				NO	13	0		No	N0	T4			6365	TUMOR FREE	3	Complete Remission/Response	0.01	NO	R1	Solid Tissue Normal	11	4	0.2		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009		40c411e7-c0cb-4aff-8418-fd7400562bad		TCGA-G9-6365-11A-01D-1787-05			40c411e7-c0cb-4aff-8418-fd7400562bad		TCGA-G9-6365-11			40c411e7-c0cb-4aff-8418-fd7400562bad		TCGA-G9-6365-11			40c411e7-c0cb-4aff-8418-fd7400562bad
TCGA-G9-6366-01	0	TCGA-G9-6366-01	1947	0	days	TCGA-G9-6366			days	1947	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61	TCGA-G9-6366-F68583	TCGA-G9-6366	TCGA-G9-6366-01A	NO			T1c	-22428							0	1947		101			NO		NO		Scheduled Follow-up Submission		2014-12-1	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.2	NO	Left	1.8	NO	NO								No		T3b	TCGA-G9-6366.6ef07861-a4db-4aa2-ba73-4cd43e10d72f.pdf		6366		4	Complete Remission/Response	0.1		R0	Primary Tumor	01	3	0.2				NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009		27357b4d-5d44-4c5e-bb80-0d5f68c3db8e	TCGA-G9-6366-01A-11D-2112-01	TCGA-G9-6366-01A-11D-2116-05		TCGA-G9-6366-01A-11D-2114-08	27357b4d-5d44-4c5e-bb80-0d5f68c3db8e	TCGA-G9-6366-01	TCGA-G9-6366-01	5675FF17-E0DA-44EC-81FE-892D96FF7ECA	TCGA-G9-6366-01A-11D-2112-01	27357b4d-5d44-4c5e-bb80-0d5f68c3db8e	TCGA-G9-6366-01	TCGA-G9-6366-01	TCGA-G9-6366-01A-11D-2114-08	TCGA-G9-6366-01A-11D-2114-08	27357b4d-5d44-4c5e-bb80-0d5f68c3db8e
TCGA-G9-6367-01	0	TCGA-G9-6367-01	1222	0	days	TCGA-G9-6367	1222	0	days	1222	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			60	TCGA-G9-6367-F40631	TCGA-G9-6367	TCGA-G9-6367-01A		Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-22176	30			30			0	1222		836			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Progressive Disease	2013-3-8	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.6	NO	YES				NO	5	0		No	N0	T3a	TCGA-G9-6367.1306f52c-6633-4ca8-8998-c5306e0c34be.pdf		6367	WITH TUMOR	4	Progressive Disease	0.42	NO	R1	Primary Tumor	01	5	0.4		NO	3	NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009		e0881b2c-c095-4742-ba07-71286ed84d93	TCGA-G9-6367-01A-11D-1785-01	TCGA-G9-6367-01A-11D-1787-05	TCGA-G9-6367-01A-11D-1786-08	TCGA-G9-6367-01A-11D-1786-08	e0881b2c-c095-4742-ba07-71286ed84d93	TCGA-G9-6367-01	TCGA-G9-6367-01	236D0F90-0152-4454-ACC2-D0F5316627CE	TCGA-G9-6367-01A-11D-1785-01	e0881b2c-c095-4742-ba07-71286ed84d93	TCGA-G9-6367-01	TCGA-G9-6367-01	TCGA-G9-6367-01A-11D-1786-08	TCGA-G9-6367-01A-11D-1786-08	e0881b2c-c095-4742-ba07-71286ed84d93
TCGA-G9-6367-11	0	TCGA-G9-6367-11	1222	0	days	TCGA-G9-6367	1222	0	days	1222	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			60	TCGA-G9-6367-F40631	TCGA-G9-6367	TCGA-G9-6367-11A		Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-22176	30			30			0	1222		836			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Progressive Disease	2013-3-8	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.5	NO	YES				NO	5	0		No	N0	T3a			6367	WITH TUMOR	4	Progressive Disease	0.42	NO	R1	Solid Tissue Normal	11	5	0.4		NO	3	NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009				TCGA-G9-6367-11A-01D-1787-05													
TCGA-G9-6369-01	0	TCGA-G9-6369-01	1215	0	days	TCGA-G9-6369	1215	0	days	1215	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55	TCGA-G9-6369-F40640	TCGA-G9-6369	TCGA-G9-6369-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-20238	35			23			0	1215		851			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1	NO	YES				NO	21	0		No	N0	T2c	TCGA-G9-6369.8da381e8-6bab-4b75-9ae3-d7b76f90f044.pdf		6369	TUMOR FREE	4	Complete Remission/Response	0.03	NO	R0	Primary Tumor	01	3	0.2		NO		NO	YES	G9	Base		Prostate		A	LIVING	2009		3d626bcf-fa11-443c-ac02-b2a099494189	TCGA-G9-6369-01A-21D-1959-01	TCGA-G9-6369-01A-21D-1963-05		TCGA-G9-6369-01A-21D-1961-08	3d626bcf-fa11-443c-ac02-b2a099494189	TCGA-G9-6369-01	TCGA-G9-6369-01		TCGA-G9-6369-01A-21D-1959-01	3d626bcf-fa11-443c-ac02-b2a099494189	TCGA-G9-6369-01	TCGA-G9-6369-01	TCGA-G9-6369-01A-21D-1961-08		3d626bcf-fa11-443c-ac02-b2a099494189
TCGA-G9-6370-01	0	TCGA-G9-6370-01	1156	0	days	TCGA-G9-6370	1156	0	days	1156	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			52	TCGA-G9-6370-F40638	TCGA-G9-6370	TCGA-G9-6370-01A	NO		M0	T1c	-19149							0	1156		806			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1.2	NO	YES				NO	1	0		No	N0	T3b	TCGA-G9-6370.fa0332e6-d535-45c0-8ed9-9b36816f1350.pdf		6370	TUMOR FREE	3	Complete Remission/Response	0.03	NO	R0	Primary Tumor	01	4	0.4		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009		d964a3c5-aa6c-431c-b179-7e0b70e26e2d	TCGA-G9-6370-01A-11D-1785-01	TCGA-G9-6370-01A-11D-1787-05	TCGA-G9-6370-01A-11D-1786-08	TCGA-G9-6370-01A-11D-1786-08	d964a3c5-aa6c-431c-b179-7e0b70e26e2d	TCGA-G9-6370-01	TCGA-G9-6370-01	661EDA4E-9E63-4FDD-BDB4-9010BA2B499A	TCGA-G9-6370-01A-11D-1785-01	d964a3c5-aa6c-431c-b179-7e0b70e26e2d	TCGA-G9-6370-01	TCGA-G9-6370-01	TCGA-G9-6370-01A-11D-1786-08	TCGA-G9-6370-01A-11D-1786-08	d964a3c5-aa6c-431c-b179-7e0b70e26e2d
TCGA-G9-6371-01	0	TCGA-G9-6371-01	1226	0	days	TCGA-G9-6371	1226	0	days	1226	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			58	TCGA-G9-6371-F40637	TCGA-G9-6371	TCGA-G9-6371-01A	NO		M0	T1c	-21365							0	1226		846			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1	NO	NO				NO				No		T2c	TCGA-G9-6371.26034718-f43a-491d-99fb-934d99ba4a6a.pdf		6371	TUMOR FREE	3	Complete Remission/Response	0.03	NO	R1	Primary Tumor	01	3	0.3		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009		f1503f33-421a-4d7b-8e87-d73f5cbcc760	TCGA-G9-6371-01A-11D-1785-01	TCGA-G9-6371-01A-11D-1787-05	TCGA-G9-6371-01A-11D-1786-08	TCGA-G9-6371-01A-11D-1786-08	f1503f33-421a-4d7b-8e87-d73f5cbcc760	TCGA-G9-6371-01	TCGA-G9-6371-01	837A890A-ED54-4C9F-8A65-A3A1E2391267	TCGA-G9-6371-01A-11D-1785-01	f1503f33-421a-4d7b-8e87-d73f5cbcc760	TCGA-G9-6371-01	TCGA-G9-6371-01	TCGA-G9-6371-01A-11D-1786-08	TCGA-G9-6371-01A-11D-1786-08	f1503f33-421a-4d7b-8e87-d73f5cbcc760
TCGA-G9-6373-01	0	TCGA-G9-6373-01	811	0	days	TCGA-G9-6373	811	0	days	811	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			68	TCGA-G9-6373-F40635	TCGA-G9-6373	TCGA-G9-6373-01A		Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-24887	29						0	811					NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Bilateral	1	NO	NO				NO				No		T3a	TCGA-G9-6373.ed631fb0-95e4-4b30-963f-1ff4cb4f0ece.pdf		6373	TUMOR FREE	4	Complete Remission/Response		NO	R0	Primary Tumor	01	3	0.1		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009		5ed0de42-f949-4046-895b-f97853201a8d	TCGA-G9-6373-01A-11D-1785-01	TCGA-G9-6373-01A-11D-1787-05	TCGA-G9-6373-01A-11D-1786-08	TCGA-G9-6373-01A-11D-1786-08	5ed0de42-f949-4046-895b-f97853201a8d	TCGA-G9-6373-01	TCGA-G9-6373-01	E22A00A4-A324-478F-BCBD-623FED9198EA	TCGA-G9-6373-01A-11D-1785-01	5ed0de42-f949-4046-895b-f97853201a8d	TCGA-G9-6373-01	TCGA-G9-6373-01	TCGA-G9-6373-01A-11D-1786-08		5ed0de42-f949-4046-895b-f97853201a8d
TCGA-G9-6373-11	0	TCGA-G9-6373-11	811	0	days	TCGA-G9-6373	811	0	days	811	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			68	TCGA-G9-6373-F40635	TCGA-G9-6373	TCGA-G9-6373-11A		Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-24887	29						0	811					NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	2.5	NO	NO				NO				No		T3a			6373	TUMOR FREE	4	Complete Remission/Response		NO	R0	Solid Tissue Normal	11	3	0.2		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009				TCGA-G9-6373-11A-01D-1787-05													
TCGA-G9-6377-01	0	TCGA-G9-6377-01	958	0	days	TCGA-G9-6377	958	0	days	958	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61	TCGA-G9-6377-F40633	TCGA-G9-6377	TCGA-G9-6377-01A	NO	Abnormal (not related to prostate cancer)	M0	T2b	-22419	36			11			0	958		518			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.4	NO	YES				NO	6	0		No	N0	T2c	TCGA-G9-6377.520abbf9-817a-45db-aecc-22c4fc80ddae.pdf		6377	TUMOR FREE	3	Complete Remission/Response	0.03	NO	R0	Primary Tumor	01	4	0.2		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009		47d13480-7771-450a-ab70-07c8ca2eb14f	TCGA-G9-6377-01A-11D-1959-01	TCGA-G9-6377-01A-11D-1963-05		TCGA-G9-6377-01A-11D-1961-08	47d13480-7771-450a-ab70-07c8ca2eb14f	TCGA-G9-6377-01	TCGA-G9-6377-01	6BA4F223-DC52-474F-87C0-A362EA498FB0	TCGA-G9-6377-01A-11D-1959-01	47d13480-7771-450a-ab70-07c8ca2eb14f	TCGA-G9-6377-01	TCGA-G9-6377-01	TCGA-G9-6377-01A-11D-1961-08	TCGA-G9-6377-01A-11D-1961-08	47d13480-7771-450a-ab70-07c8ca2eb14f
TCGA-G9-6378-01	0	TCGA-G9-6378-01	1155	0	days	TCGA-G9-6378	1155	0	days	1155	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			54	TCGA-G9-6378-F40630	TCGA-G9-6378	TCGA-G9-6378-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-19879	-176			100			0	1155		223			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Bilateral	1.2	NO	NO				NO				No		T2c	TCGA-G9-6378.425008c5-919c-45b3-beb7-2392d6866ffb.pdf		6378	TUMOR FREE	3	Complete Remission/Response	0.03	NO	R1	Primary Tumor	01	4	0.2		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2009		02334a5d-c3a2-4ea6-8e4e-d603a8fbc43c	TCGA-G9-6378-01A-11D-1785-01	TCGA-G9-6378-01A-11D-1787-05	TCGA-G9-6378-01A-11D-1786-08	TCGA-G9-6378-01A-11D-1786-08	02334a5d-c3a2-4ea6-8e4e-d603a8fbc43c	TCGA-G9-6378-01	TCGA-G9-6378-01	9EE8BD41-956E-4AB2-B578-5C05E9E08578	TCGA-G9-6378-01A-11D-1785-01	02334a5d-c3a2-4ea6-8e4e-d603a8fbc43c	TCGA-G9-6378-01	TCGA-G9-6378-01	TCGA-G9-6378-01A-11D-1786-08	TCGA-G9-6378-01A-11D-1786-08	02334a5d-c3a2-4ea6-8e4e-d603a8fbc43c
TCGA-G9-6379-01	0	TCGA-G9-6379-01	1778	0	days	TCGA-G9-6379	1778	0	days	1778	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			68	TCGA-G9-6379-F66664	TCGA-G9-6379	TCGA-G9-6379-01A	NO		M0	T1b	-25126							0	1778		1393			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-10-22	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.5	NO	YES				NO	6	0		No	N0	T3b	TCGA-G9-6379.A097CB29-5440-45F9-B261-025603C37CEF.pdf		6379	TUMOR FREE	4	Complete Remission/Response	00.03	NO	R1	Primary Tumor	01	3	0.4		NO	5	NO	YES	G9	Apex		Prostate		A	LIVING	2009		edc61caa-7008-45ba-b69b-8998ad510549	TCGA-G9-6379-01A-11D-A31K-01	TCGA-G9-6379-01A-11D-A31M-05		TCGA-G9-6379-01A-11D-A31L-08	edc61caa-7008-45ba-b69b-8998ad510549	TCGA-G9-6379-01	TCGA-G9-6379-01	6C9DE27B-1BA3-4466-8D4C-21875C2A0364	TCGA-G9-6379-01A-11D-A31K-01	edc61caa-7008-45ba-b69b-8998ad510549	TCGA-G9-6379-01	TCGA-G9-6379-01	TCGA-G9-6379-01A-11D-A31L-08		edc61caa-7008-45ba-b69b-8998ad510549
TCGA-G9-6384-01	0	TCGA-G9-6384-01	765	0	days	TCGA-G9-6384	765	0	days	765	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			53	TCGA-G9-6384-F40625	TCGA-G9-6384	TCGA-G9-6384-01A	NO		M0	T1c	-19620							0	765		390			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	1.2	NO	YES				NO	14	0		No	N0	T3a	TCGA-G9-6384.6987c1c1-6e23-44f0-bba8-6bba4a288025.pdf		6384	TUMOR FREE	3	Complete Remission/Response	0.03	NO	R0	Primary Tumor	01	4	0.6		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2010		30e19950-9bbe-4952-8308-41689e57430c	TCGA-G9-6384-01A-11D-1785-01	TCGA-G9-6384-01A-11D-1787-05	TCGA-G9-6384-01A-11D-1786-08	TCGA-G9-6384-01A-11D-1786-08	30e19950-9bbe-4952-8308-41689e57430c	TCGA-G9-6384-01	TCGA-G9-6384-01	7AEAE7AC-64AC-472B-B93E-362036E8C058	TCGA-G9-6384-01A-11D-1785-01	30e19950-9bbe-4952-8308-41689e57430c	TCGA-G9-6384-01	TCGA-G9-6384-01	TCGA-G9-6384-01A-11D-1786-08	TCGA-G9-6384-01A-11D-1786-08	30e19950-9bbe-4952-8308-41689e57430c
TCGA-G9-6384-11	0	TCGA-G9-6384-11	765	0	days	TCGA-G9-6384	765	0	days	765	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			53	TCGA-G9-6384-F40625	TCGA-G9-6384	TCGA-G9-6384-11A	NO		M0	T1c	-19620							0	765		390			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	1	NO	YES				NO	14	0		No	N0	T3a			6384	TUMOR FREE	3	Complete Remission/Response	0.03	NO	R0	Solid Tissue Normal	11	4	0.3		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2010		36973833-7245-444f-94e9-062e6b83df14		TCGA-G9-6384-11A-01D-1787-05			36973833-7245-444f-94e9-062e6b83df14		TCGA-G9-6384-11			36973833-7245-444f-94e9-062e6b83df14		TCGA-G9-6384-11			36973833-7245-444f-94e9-062e6b83df14
TCGA-G9-6385-01	0	TCGA-G9-6385-01	830	0	days	TCGA-G9-6385	830	0	days	830	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-G9-6385-F40620	TCGA-G9-6385		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24399	12						0	830		336			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	NO				NO				No		T2c			6385	TUMOR FREE	3	Complete Remission/Response	0.064	NO	R0	Primary Tumor	01	4			NO		NO	YES	G9	Base		Prostate			LIVING	2010		c72a1f85-6eb7-45ef-ac30-f695d87226ed	TCGA-G9-6385-01A-11D-1785-01	TCGA-G9-6385-01A-11D-1787-05	TCGA-G9-6385-01A-11D-1786-08	TCGA-G9-6385-01A-11D-1786-08	c72a1f85-6eb7-45ef-ac30-f695d87226ed	TCGA-G9-6385-01	TCGA-G9-6385-01		TCGA-G9-6385-01A-11D-1785-01	c72a1f85-6eb7-45ef-ac30-f695d87226ed	TCGA-G9-6385-01	TCGA-G9-6385-01	TCGA-G9-6385-01A-11D-1786-08	TCGA-G9-6385-01A-11D-1786-08	c72a1f85-6eb7-45ef-ac30-f695d87226ed
TCGA-G9-6385-11	0	TCGA-G9-6385-11	830	0	days	TCGA-G9-6385	830	0	days	830	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-G9-6385-F40620	TCGA-G9-6385	TCGA-G9-6385-11A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24399	12						0	830		336			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.3	NO	NO				NO				No		T2c			6385	TUMOR FREE	3	Complete Remission/Response	0.064	NO	R0	Solid Tissue Normal	11	4	0.3		NO		NO	YES	G9	Base		Prostate		A	LIVING	2010				TCGA-G9-6385-11A-01D-1787-05													
TCGA-G9-6494-01	0	TCGA-G9-6494-01	1771	0	days	TCGA-G9-6494	1771	0	days	1771	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-G9-6494-F41058	TCGA-G9-6494	TCGA-G9-6494-01A		Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24381	-13			-13			0	1771		1423			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Progressive Disease	2013-3-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.7	NO	YES				NO	2	0		No	N0	T4	TCGA-G9-6494.9aad0222-0731-498b-a9c2-400ce0ccfa0d.pdf		6494	WITH TUMOR	4	Progressive Disease	1.13	NO	R1	Primary Tumor	01	3	0.4		NO		NO	YES	G9	Base		Prostate		A	LIVING	2008		8a2f149d-34a9-4be2-8bc5-d3d25f1df7e3	TCGA-G9-6494-01A-11D-1785-01	TCGA-G9-6494-01A-11D-1787-05	TCGA-G9-6494-01A-11D-1786-08	TCGA-G9-6494-01A-11D-1786-08	8a2f149d-34a9-4be2-8bc5-d3d25f1df7e3	TCGA-G9-6494-01	TCGA-G9-6494-01	F22871CE-C484-455D-8446-DBE2A62AE7C4	TCGA-G9-6494-01A-11D-1785-01	8a2f149d-34a9-4be2-8bc5-d3d25f1df7e3	TCGA-G9-6494-01	TCGA-G9-6494-01	TCGA-G9-6494-01A-11D-1786-08	TCGA-G9-6494-01A-11D-1786-08	8a2f149d-34a9-4be2-8bc5-d3d25f1df7e3
TCGA-G9-6494-11	0	TCGA-G9-6494-11	1771	0	days	TCGA-G9-6494	1771	0	days	1771	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-G9-6494-F41058	TCGA-G9-6494	TCGA-G9-6494-11A		Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24381	-13			-13			0	1771		1423			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Progressive Disease	2013-3-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.5	NO	YES				NO	2	0		No	N0	T4			6494	WITH TUMOR	4	Progressive Disease	1.13	NO	R1	Solid Tissue Normal	11	3	0.5		NO		NO	YES	G9	Base		Prostate		A	LIVING	2008				TCGA-G9-6494-11A-01D-1787-05													
TCGA-G9-6496-01	0	TCGA-G9-6496-01	1726	0	days	TCGA-G9-6496	1726	0	days	1726	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61	TCGA-G9-6496-F41001	TCGA-G9-6496	TCGA-G9-6496-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22602	19			20			0	1726		703			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-3-8	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.2	NO	YES				NO	15	0		No	N0	T2c	TCGA-G9-6496.193cca51-2d1f-49aa-afdb-63a55d689c86.pdf		6496	TUMOR FREE	4	Complete Remission/Response	0.03	NO	R0	Primary Tumor	01	3	0.5		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2008		6a2c4d22-f7b6-4e0a-bd71-a669786da5b1	TCGA-G9-6496-01A-11D-1785-01	TCGA-G9-6496-01A-11D-1787-05	TCGA-G9-6496-01A-11D-1786-08	TCGA-G9-6496-01A-11D-1786-08	6a2c4d22-f7b6-4e0a-bd71-a669786da5b1	TCGA-G9-6496-01	TCGA-G9-6496-01	E5EBFB91-E2C6-47C1-8719-F596466B36A7	TCGA-G9-6496-01A-11D-1785-01	6a2c4d22-f7b6-4e0a-bd71-a669786da5b1	TCGA-G9-6496-01	TCGA-G9-6496-01	TCGA-G9-6496-01A-11D-1786-08		6a2c4d22-f7b6-4e0a-bd71-a669786da5b1
TCGA-G9-6496-11	0	TCGA-G9-6496-11	1726	0	days	TCGA-G9-6496	1726	0	days	1726	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61	TCGA-G9-6496-F41001	TCGA-G9-6496	TCGA-G9-6496-11A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22602	19			20			0	1726		703			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-3-8	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1.2	NO	Bilateral	1.7	NO	YES				NO	15	0		No	N0	T2c			6496	TUMOR FREE	4	Complete Remission/Response	0.03	NO	R0	Solid Tissue Normal	11	3	0.5		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2008		7aa49ecf-9e25-4166-9ed2-487c41f1066c		TCGA-G9-6496-11A-01D-1787-05			7aa49ecf-9e25-4166-9ed2-487c41f1066c		TCGA-G9-6496-11			7aa49ecf-9e25-4166-9ed2-487c41f1066c		TCGA-G9-6496-11			7aa49ecf-9e25-4166-9ed2-487c41f1066c
TCGA-G9-6498-01	0	TCGA-G9-6498-01	1952	0	days	TCGA-G9-6498	1952	0	days	1952	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			53	TCGA-G9-6498-F65343	TCGA-G9-6498	TCGA-G9-6498-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-19568	47					1342	0	1952		1608			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-22	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.3	NO	NO				NO				No		T3a	TCGA-G9-6498.0F610D96-54E9-4E40-B3D4-19554C782057.pdf		6498	TUMOR FREE	3	Complete Remission/Response	00.03	NO	R1	Primary Tumor	01	4	0.4		NO		NO	YES	G9	Apex		Prostate		A	LIVING	2008		1b8f8f6d-a1c4-43b3-ae29-7fb64e512b83	TCGA-G9-6498-01A-12D-A30W-01	TCGA-G9-6498-01A-12D-A30Z-05		TCGA-G9-6498-01A-12D-A30X-08	1b8f8f6d-a1c4-43b3-ae29-7fb64e512b83	TCGA-G9-6498-01	TCGA-G9-6498-01	E8DBE708-FF85-4793-8778-8DC3EA7542EE	TCGA-G9-6498-01A-12D-A30W-01	1b8f8f6d-a1c4-43b3-ae29-7fb64e512b83	TCGA-G9-6498-01	TCGA-G9-6498-01	TCGA-G9-6498-01A-12D-A30X-08		1b8f8f6d-a1c4-43b3-ae29-7fb64e512b83
TCGA-G9-6499-01	0	TCGA-G9-6499-01	1543	0	days	TCGA-G9-6499	1543	0	days	1543	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-G9-6499-F41000	TCGA-G9-6499	TCGA-G9-6499-01A	NO	Equivocal	M0	T3a	-24388	56			421			0	1543		1109			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-3-8	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.4	NO	YES				NO	13	0		No	N0	T3a	TCGA-G9-6499.8e1d4212-b252-4019-b188-3cdd60be733d.pdf		6499	TUMOR FREE	4	Complete Remission/Response	0.11	NO	R0	Primary Tumor	01	5	0.3		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2008		a597168e-2c74-4e79-b863-45c94ac8efa1	TCGA-G9-6499-01A-12D-1959-01	TCGA-G9-6499-01A-12D-1963-05		TCGA-G9-6499-01A-12D-1961-08	a597168e-2c74-4e79-b863-45c94ac8efa1	TCGA-G9-6499-01	TCGA-G9-6499-01	8452B7C0-AB4D-402F-A9FF-513FABC3E7ED	TCGA-G9-6499-01A-12D-1959-01	a597168e-2c74-4e79-b863-45c94ac8efa1	TCGA-G9-6499-01	TCGA-G9-6499-01	TCGA-G9-6499-01A-12D-1961-08	TCGA-G9-6499-01A-12D-1961-08	a597168e-2c74-4e79-b863-45c94ac8efa1
TCGA-G9-6499-11	0	TCGA-G9-6499-11	1543	0	days	TCGA-G9-6499	1543	0	days	1543	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-G9-6499-F41000	TCGA-G9-6499	TCGA-G9-6499-11A	NO	Equivocal	M0	T3a	-24388	56			421			0	1543		1109			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-3-8	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy	60	1	NO	Bilateral	1.5	NO	YES				NO	13	0		No	N0	T3a			6499	TUMOR FREE	4	Complete Remission/Response	0.11	NO	R0	Solid Tissue Normal	11	5	0.5		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2008		0cb961d7-87be-40c2-b703-3e424b8c8e78		TCGA-G9-6499-11A-02D-1963-05			0cb961d7-87be-40c2-b703-3e424b8c8e78		TCGA-G9-6499-11			0cb961d7-87be-40c2-b703-3e424b8c8e78		TCGA-G9-6499-11			0cb961d7-87be-40c2-b703-3e424b8c8e78
TCGA-G9-7509-01	0	TCGA-G9-7509-01	1610	0	days	TCGA-G9-7509	1610	0	days	1610	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			48	TCGA-G9-7509-F65350	TCGA-G9-7509		NO		M0	T1c	-17538							0	1610		352			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-22	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	NO				NO				No		T2c			7509	TUMOR FREE	3	Complete Remission/Response	0.03	NO	R0	Primary Tumor	01	3			NO	4	NO	YES	G9	Apex|Middle|Base		Prostate			LIVING	2009		b5d317d7-382e-4695-9f30-bb6664b3189f	TCGA-G9-7509-01A-11D-A41J-01	TCGA-G9-7509-01A-11D-A41L-05		TCGA-G9-7509-01A-11D-A41K-08	b5d317d7-382e-4695-9f30-bb6664b3189f	TCGA-G9-7509-01	TCGA-G9-7509-01		TCGA-G9-7509-01A-11D-A41J-01	b5d317d7-382e-4695-9f30-bb6664b3189f	TCGA-G9-7509-01	TCGA-G9-7509-01			b5d317d7-382e-4695-9f30-bb6664b3189f
TCGA-G9-7510-01	0	TCGA-G9-7510-01	1185	0	days	TCGA-G9-7510	1185	0	days	1185	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-G9-7510-F48752	TCGA-G9-7510	TCGA-G9-7510-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24187	22			22			0	1185		674			YES	Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1]	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Bilateral	1.6	NO	YES				NO	10	0		No	N0	T3a	TCGA-G9-7510.11c8711a-57c0-41fe-82fa-2e9592fef570.pdf		7510	TUMOR FREE	4	Complete Remission/Response	0.03	NO	R1	Primary Tumor	01	4	0.5		NO	5	NO	YES	G9	Apex		Prostate		A	LIVING	2010		c969c5c7-c72e-4e8f-9213-8ab2f192c845	TCGA-G9-7510-01A-11D-2259-01	TCGA-G9-7510-01A-11D-2261-05		TCGA-G9-7510-01A-11D-2260-08	c969c5c7-c72e-4e8f-9213-8ab2f192c845	TCGA-G9-7510-01	TCGA-G9-7510-01	075BD106-9C0B-424C-90D1-BDECE264407C	TCGA-G9-7510-01A-11D-2259-01	c969c5c7-c72e-4e8f-9213-8ab2f192c845	TCGA-G9-7510-01	TCGA-G9-7510-01	TCGA-G9-7510-01A-11D-2260-08	TCGA-G9-7510-01A-11D-2260-08	c969c5c7-c72e-4e8f-9213-8ab2f192c845
TCGA-G9-7519-01	0	TCGA-G9-7519-01	849	0	days	TCGA-G9-7519	849	0	days	849	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			58	TCGA-G9-7519-F48751	TCGA-G9-7519	TCGA-G9-7519-01A	NO	Abnormal (not related to prostate cancer)	M0	T1c	-21276	7			7			0	849		457			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.1	NO	NO				NO				No		T2c	TCGA-G9-7519.07227b7d-9285-4d1b-9484-ccdb20841905.pdf		7519	TUMOR FREE	3	Complete Remission/Response	0.03	NO	R0	Primary Tumor	01	4	0.7		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2010		104e14d3-f1d5-443f-88fd-6d67c98b1eff	TCGA-G9-7519-01A-11D-2259-01	TCGA-G9-7519-01A-11D-2261-05		TCGA-G9-7519-01A-11D-2260-08	104e14d3-f1d5-443f-88fd-6d67c98b1eff	TCGA-G9-7519-01	TCGA-G9-7519-01		TCGA-G9-7519-01A-11D-2259-01	104e14d3-f1d5-443f-88fd-6d67c98b1eff	TCGA-G9-7519-01	TCGA-G9-7519-01	TCGA-G9-7519-01A-11D-2260-08	TCGA-G9-7519-01A-11D-2260-08	104e14d3-f1d5-443f-88fd-6d67c98b1eff
TCGA-G9-7521-01	0	TCGA-G9-7521-01	942	0	days	TCGA-G9-7521	942	0	days	942	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			52	TCGA-G9-7521-F48747	TCGA-G9-7521	TCGA-G9-7521-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-19216	13			12	45		0	942		487			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Progressive Disease	2013-9-20	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	0.9	NO	YES				NO	9	1		No	N1	T3a	TCGA-G9-7521.b0a188e3-c084-4e2d-93dd-31de3a3f47e6.pdf		7521	TUMOR FREE	4	[Discrepancy]	0.06	NO	R0	Primary Tumor	01	4	0.2		YES	5	NO	YES	G9	Apex|Base		Prostate		A	LIVING	2010		c3841b03-197a-4cd1-9331-02fde85bcb55	TCGA-G9-7521-01A-11D-2259-01	TCGA-G9-7521-01A-11D-2261-05		TCGA-G9-7521-01A-11D-2260-08	c3841b03-197a-4cd1-9331-02fde85bcb55	TCGA-G9-7521-01	TCGA-G9-7521-01	28F62670-5FB9-4BCC-9E9F-AF8119B2A924	TCGA-G9-7521-01A-11D-2259-01	c3841b03-197a-4cd1-9331-02fde85bcb55	TCGA-G9-7521-01	TCGA-G9-7521-01	TCGA-G9-7521-01A-11D-2260-08	TCGA-G9-7521-01A-11D-2260-08	c3841b03-197a-4cd1-9331-02fde85bcb55
TCGA-G9-7522-01	0	TCGA-G9-7522-01	1078	0	days	TCGA-G9-7522	1078	0	days	1078	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			49	TCGA-G9-7522-F61288	TCGA-G9-7522	TCGA-G9-7522-01A	NO		M0	T1c	-18033							0	1078		452			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-6-26	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Bilateral	1.1	NO	YES				NO	9	0		No	N0	T2c	TCGA-G9-7522.8d3c4720-f528-4a73-b2f0-95b2aac093f2.pdf		7522	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.4		NO		NO	YES	G9	Apex		Prostate		A	LIVING	2011		79ff57d5-3224-4195-aa64-32ccd6d23e27	TCGA-G9-7522-01A-11D-2259-01	TCGA-G9-7522-01A-11D-2261-05		TCGA-G9-7522-01A-11D-2260-08	79ff57d5-3224-4195-aa64-32ccd6d23e27	TCGA-G9-7522-01	TCGA-G9-7522-01	D7FFB71D-C1DE-4BE4-8BDC-68CF02134A65	TCGA-G9-7522-01A-11D-2259-01	79ff57d5-3224-4195-aa64-32ccd6d23e27	TCGA-G9-7522-01	TCGA-G9-7522-01	TCGA-G9-7522-01A-11D-2260-08	TCGA-G9-7522-01A-11D-2260-08	79ff57d5-3224-4195-aa64-32ccd6d23e27
TCGA-G9-7523-01	0	TCGA-G9-7523-01	857	0	days	TCGA-G9-7523	857	0	days	857	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			44	TCGA-G9-7523-F48753	TCGA-G9-7523	TCGA-G9-7523-01A	NO	Abnormal (not related to prostate cancer)	M0	T1c	-16269	20			20			0	857		324			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	10	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.4	NO	YES				NO	10	0		No	N0	T3a	TCGA-G9-7523.8a16d779-bcf3-4371-87ec-3cd68330b1d6.pdf		7523	TUMOR FREE	5	Complete Remission/Response	0.03	NO	R1	Primary Tumor	01	5	0.3		NO		NO	YES	G9	Apex|Base		Prostate		A	LIVING	2011		5f4f5adc-cebd-473a-94c7-b93426be2b95	TCGA-G9-7523-01A-11D-2259-01	TCGA-G9-7523-01A-11D-2261-05		TCGA-G9-7523-01A-11D-2260-08	5f4f5adc-cebd-473a-94c7-b93426be2b95	TCGA-G9-7523-01	TCGA-G9-7523-01	75D8D91C-63A8-46D0-A807-6E9866561892	TCGA-G9-7523-01A-11D-2259-01	5f4f5adc-cebd-473a-94c7-b93426be2b95	TCGA-G9-7523-01	TCGA-G9-7523-01	TCGA-G9-7523-01A-11D-2260-08	TCGA-G9-7523-01A-11D-2260-08	5f4f5adc-cebd-473a-94c7-b93426be2b95
TCGA-G9-7525-01	0	TCGA-G9-7525-01	994	0	days	TCGA-G9-7525	994	0	days	994	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			64	TCGA-G9-7525-F48745	TCGA-G9-7525	TCGA-G9-7525-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-23481	12			12			0	994		512			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Bilateral	1.8	NO	YES				NO	6	0		No	N0	T2c	TCGA-G9-7525.837a5284-61ec-4a13-9743-010fc6a8df6a.pdf		7525	TUMOR FREE	4	Complete Remission/Response	0.03	NO	R0	Primary Tumor	01	3	0.4		NO		NO	YES	G9	Base		Prostate		A	LIVING	2010		e0888e7a-a0d3-4016-8ed2-8818c332aeea	TCGA-G9-7525-01A-31D-2259-01	TCGA-G9-7525-01A-31D-2261-05		TCGA-G9-7525-01A-31D-2260-08	e0888e7a-a0d3-4016-8ed2-8818c332aeea	TCGA-G9-7525-01	TCGA-G9-7525-01	05FBCA7E-B3A1-4E9D-8B97-9B99184A6FE9	TCGA-G9-7525-01A-31D-2259-01	e0888e7a-a0d3-4016-8ed2-8818c332aeea	TCGA-G9-7525-01	TCGA-G9-7525-01	TCGA-G9-7525-01A-31D-2260-08		e0888e7a-a0d3-4016-8ed2-8818c332aeea
TCGA-G9-A9S0-01	1	TCGA-G9-A9S0-01	791	1	days	TCGA-G9-A9S0	650	1	days	791	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	53	TCGA-G9-A9S0-F60806	TCGA-G9-A9S0	TCGA-G9-A9S0-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-19530	73	840	791	73		429	0		650	759			YES	No Evidence of Extraprostatic Extension	NO		Additional New Tumor Event	Progressive Disease	2014-6-17	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Transurethral resection (TURBT)	130		NO	Bilateral		NO	YES	Other, specify	Distant Metastasis	Lung and Liver	YES	13	5	true	No	N1	T3b	TCGA-G9-A9S0.2E6B54C4-BC0A-46E3-A3F9-B55CEB1B1ECD.pdf	Prostate Cancer	A9S0	WITH TUMOR	4	Complete Remission/Response	10.87	YES	R1	Primary Tumor	01	4		Medical Record	YES	5	NO	YES	G9	Apex|Middle|Base	YES	Prostate	Distant Metastasis	A	DECEASED	2011	Overlapping / Multiple Zones	22cc7838-fc6a-431b-b25a-07ca943a6f48	TCGA-G9-A9S0-01A-11D-A41J-01	TCGA-G9-A9S0-01A-11D-A41L-05		TCGA-G9-A9S0-01A-11D-A41K-08	22cc7838-fc6a-431b-b25a-07ca943a6f48	TCGA-G9-A9S0-01	TCGA-G9-A9S0-01	D14CE3A5-6656-4629-83C6-1E3F97F5975E	TCGA-G9-A9S0-01A-11D-A41J-01	22cc7838-fc6a-431b-b25a-07ca943a6f48	TCGA-G9-A9S0-01	TCGA-G9-A9S0-01			22cc7838-fc6a-431b-b25a-07ca943a6f48
TCGA-G9-A9S4-01	0	TCGA-G9-A9S4-01	906	0	days	TCGA-G9-A9S4	906	0	days	906	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			62	TCGA-G9-A9S4-F66995	TCGA-G9-A9S4	TCGA-G9-A9S4-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-22684	14	610		14			0	906		753			YES	Extraprostatic Extension  Localized (e.g. seminal vesicles)	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-10-29	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	180		NO	Bilateral		NO	YES				NO	10	4	true	No	N1	T3b	TCGA-G9-A9S4.0507DFC9-971C-46F3-BC03-AACA10A49202.pdf		A9S4	TUMOR FREE	4	Complete Remission/Response	0.03	NO	R1	Primary Tumor	01	4			YES	5	NO	YES	G9	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones	e41ecd5a-af8e-4852-991a-026efa65e442		TCGA-G9-A9S4-01A-11D-A41L-05		TCGA-G9-A9S4-01A-11D-A41K-08	e41ecd5a-af8e-4852-991a-026efa65e442	TCGA-G9-A9S4-01	TCGA-G9-A9S4-01	DABBFE73-E93A-4139-806C-0CB24B428F09		e41ecd5a-af8e-4852-991a-026efa65e442		TCGA-G9-A9S4-01			e41ecd5a-af8e-4852-991a-026efa65e442
TCGA-G9-A9S7-01	0	TCGA-G9-A9S7-01	728	0	days	TCGA-G9-A9S7	728	0	days	728	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55	TCGA-G9-A9S7-F66989	TCGA-G9-A9S7	TCGA-G9-A9S7-01A	NO	Abnormal (not related to prostate cancer)	M0	T2a	-20213	32	452		32			0	728		643			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Partial Remission/Response	2014-10-29	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	170		NO	Bilateral		NO	YES				NO	8	0	true	No	N0	T3a	TCGA-G9-A9S7.32AD969B-10BB-4FA2-872B-D789382CD3CC.pdf		A9S7	WITH TUMOR	4	Partial Remission/Response	0.13	YES	R0	Primary Tumor	01	4			NO		NO	YES	G9	Apex|Middle		Prostate		A	LIVING	2012	Overlapping / Multiple Zones	d04b0992-91fb-4af2-92cd-dbb361a1b83f	TCGA-G9-A9S7-01A-11D-A41J-01	TCGA-G9-A9S7-01A-11D-A41L-05		TCGA-G9-A9S7-01A-11D-A41K-08	d04b0992-91fb-4af2-92cd-dbb361a1b83f	TCGA-G9-A9S7-01	TCGA-G9-A9S7-01	C8A9A75B-19E8-413E-BB04-CCD62A432551	TCGA-G9-A9S7-01A-11D-A41J-01	d04b0992-91fb-4af2-92cd-dbb361a1b83f	TCGA-G9-A9S7-01	TCGA-G9-A9S7-01			d04b0992-91fb-4af2-92cd-dbb361a1b83f
TCGA-H9-7775-01	0	TCGA-H9-7775-01	185	0	days	TCGA-H9-7775	185	0	days	185	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			68	TCGA-H9-7775-F37932	TCGA-H9-7775	TCGA-H9-7775-01A	NO				-24898							0	185		73							Scheduled Follow-up Submission	Complete Remission/Response	2012-12-6	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Right	1	YES	NO				NO				No		T2c	TCGA-H9-7775.2a752788-15f1-4879-96a7-eaf5dfa6921d.pdf		7775	TUMOR FREE	3	Complete Remission/Response	0.04	NO		Primary Tumor	01	4	0.4		NO	0	YES	NO	H9			Prostate		A	LIVING	2011		8c9b95d4-ee46-4312-ba8c-8000c9988ee8	TCGA-H9-7775-01A-11D-2112-01	TCGA-H9-7775-01A-11D-2116-05		TCGA-H9-7775-01A-11D-2114-08	8c9b95d4-ee46-4312-ba8c-8000c9988ee8	TCGA-H9-7775-01	TCGA-H9-7775-01	49F8D1FD-0D46-4BCD-9EDA-5B65E8D44702	TCGA-H9-7775-01A-11D-2112-01	8c9b95d4-ee46-4312-ba8c-8000c9988ee8	TCGA-H9-7775-01	TCGA-H9-7775-01	TCGA-H9-7775-01A-11D-2114-08	TCGA-H9-7775-01A-11D-2114-08	8c9b95d4-ee46-4312-ba8c-8000c9988ee8
TCGA-H9-A6BX-01	0	TCGA-H9-A6BX-01	941	0	days	TCGA-H9-A6BX	941	0	days	941	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			60	TCGA-H9-A6BX-F63936	TCGA-H9-A6BX	TCGA-H9-A6BX-01A	NO				-22039		479					0	941		570			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-8-21	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES		190		NO	Bilateral		NO	NO				NO			false	No		T2c	TCGA-H9-A6BX.5AEA61BF-A79E-4A8A-B3F1-45982DAF288E.pdf		A6BX	TUMOR FREE	3	Complete Remission/Response	0.04	NO	R0	Primary Tumor	01	3			NO		YES	NO	H9			Prostate		A	LIVING	2012		ba7eb097-85ab-40fd-86dc-1e5aeb388843	TCGA-H9-A6BX-01A-31D-A30W-01	TCGA-H9-A6BX-01A-31D-A30Z-05		TCGA-H9-A6BX-01A-31D-A30X-08	ba7eb097-85ab-40fd-86dc-1e5aeb388843	TCGA-H9-A6BX-01	TCGA-H9-A6BX-01	8FFDCA02-C4DE-4D31-8543-7A991F96C0F3	TCGA-H9-A6BX-01A-31D-A30W-01	ba7eb097-85ab-40fd-86dc-1e5aeb388843	TCGA-H9-A6BX-01	TCGA-H9-A6BX-01	TCGA-H9-A6BX-01A-31D-A30X-08		ba7eb097-85ab-40fd-86dc-1e5aeb388843
TCGA-H9-A6BY-01	0	TCGA-H9-A6BY-01	112	0	days	TCGA-H9-A6BY	112	0	days	112	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63	TCGA-H9-A6BY-F58346	TCGA-H9-A6BY	TCGA-H9-A6BY-01A				T1c	-23297		303					0	112									Scheduled Follow-up Submission		2014-4-7	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	120		NO	Bilateral		YES	YES				NO	19	0	false	No	N0	T3a	TCGA-H9-A6BY.87EDA3C6-8BAC-49FD-8592-1D38812660E6.pdf		A6BY		3				RX	Primary Tumor	01	4					YES	NO	H9			Prostate		A	LIVING	2012	Overlapping / Multiple Zones	d6c9e56e-c040-40ff-a71b-74bd4a2d431c	TCGA-H9-A6BY-01A-11D-A30D-01	TCGA-H9-A6BY-01A-11D-A30F-05		TCGA-H9-A6BY-01A-11D-A30E-08	d6c9e56e-c040-40ff-a71b-74bd4a2d431c	TCGA-H9-A6BY-01	TCGA-H9-A6BY-01	983C6816-B0C5-431C-9ACE-5287D0F35D5B	TCGA-H9-A6BY-01A-11D-A30D-01	d6c9e56e-c040-40ff-a71b-74bd4a2d431c	TCGA-H9-A6BY-01	TCGA-H9-A6BY-01	TCGA-H9-A6BY-01A-11D-A30E-08		d6c9e56e-c040-40ff-a71b-74bd4a2d431c
TCGA-HC-7075-01	0	TCGA-HC-7075-01	601	0	days	TCGA-HC-7075	601	0	days	601	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63	TCGA-HC-7075-F45566	TCGA-HC-7075				M0	T1c								0	601		96							Scheduled Follow-up Submission	Complete Remission/Response	2013-7-17	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Right		NO	NO				NO				No		T2a			7075	TUMOR FREE	3	Complete Remission/Response	.01	NO	R0	Primary Tumor	01	3			NO		NO	YES	HC			Prostate			LIVING	2010		ee8dbce4-8e78-42dd-b090-8de64629f92f	TCGA-HC-7075-01A-11D-1959-01	TCGA-HC-7075-01A-11D-1963-05		TCGA-HC-7075-01A-11D-1961-08	ee8dbce4-8e78-42dd-b090-8de64629f92f	TCGA-HC-7075-01	TCGA-HC-7075-01		TCGA-HC-7075-01A-11D-1959-01	ee8dbce4-8e78-42dd-b090-8de64629f92f	TCGA-HC-7075-01	TCGA-HC-7075-01	TCGA-HC-7075-01A-11D-1961-08	TCGA-HC-7075-01A-11D-1961-08	ee8dbce4-8e78-42dd-b090-8de64629f92f
TCGA-HC-7077-01	0	TCGA-HC-7077-01	2115	0	days	TCGA-HC-7077	2115	0	days	2115	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			64	TCGA-HC-7077-F47784	TCGA-HC-7077	TCGA-HC-7077-01A		Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-23636	-14						0	2115		1749			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-28	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Transurethral resection (TURBT)		0.5	NO	Bilateral	1.1	NO	NO				NO				No		T3a	TCGA-HC-7077.67940700-dcd0-4e3c-9cca-4f6daeacf34c.pdf		7077	TUMOR FREE	3	Complete Remission/Response	.83	NO	R0	Primary Tumor	01	3	0.1		NO		NO	YES	HC			Prostate		A	LIVING	2006		5330437a-0b3d-4249-9c70-a5f967f989de	TCGA-HC-7077-01A-11D-1959-01	TCGA-HC-7077-01A-11D-1963-05		TCGA-HC-7077-01A-11D-1961-08	5330437a-0b3d-4249-9c70-a5f967f989de	TCGA-HC-7077-01	TCGA-HC-7077-01	9DBBA55C-BD0C-47E4-A1DF-E4F80130BF60	TCGA-HC-7077-01A-11D-1959-01	5330437a-0b3d-4249-9c70-a5f967f989de	TCGA-HC-7077-01	TCGA-HC-7077-01	TCGA-HC-7077-01A-11D-1961-08	TCGA-HC-7077-01A-11D-1961-08	5330437a-0b3d-4249-9c70-a5f967f989de
TCGA-HC-7078-01	0	TCGA-HC-7078-01	1985	0	days	TCGA-HC-7078	1985	0	days	1985	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			69	TCGA-HC-7078-F47785	TCGA-HC-7078			Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-25402							0	1985		1409			NO	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-8-28	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	3	0		No	N0	T3a			7078	TUMOR FREE	3	Complete Remission/Response	.01	NO	R0	Primary Tumor	01	4			NO		NO	YES	HC			Prostate			LIVING	2007		c1188eb0-1e8b-4451-b9bc-312f33bb9fd3	TCGA-HC-7078-01A-11D-2112-01	TCGA-HC-7078-01A-11D-2116-05		TCGA-HC-7078-01A-11D-2114-08	c1188eb0-1e8b-4451-b9bc-312f33bb9fd3	TCGA-HC-7078-01	TCGA-HC-7078-01		TCGA-HC-7078-01A-11D-2112-01	c1188eb0-1e8b-4451-b9bc-312f33bb9fd3	TCGA-HC-7078-01	TCGA-HC-7078-01	TCGA-HC-7078-01A-11D-2114-08	TCGA-HC-7078-01A-11D-2114-08	c1188eb0-1e8b-4451-b9bc-312f33bb9fd3
TCGA-HC-7079-01	0	TCGA-HC-7079-01	1184	0	days	TCGA-HC-7079	380	1	days	1184	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	YES	51	TCGA-HC-7079-F64395	TCGA-HC-7079	TCGA-HC-7079-01A			M0	T3a	-18734						380	0	1184	380	126	929		NO		NO		Scheduled Follow-up Submission	Stable Disease	2014-8-29	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	0.9	NO	YES		Biochemical evidence of disease		YES	4	0		No	N0	T3a	TCGA-HC-7079.8e42fce1-33e7-45e1-b8e9-2faf5a02766d.pdf		7079	WITH TUMOR	3	Partial Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.3		NO		NO	YES	HC	Apex|Middle|Base		Prostate		A	LIVING	2010		0a67e3de-1840-44f1-ae19-14f3c2df230c	TCGA-HC-7079-01A-11D-1959-01	TCGA-HC-7079-01A-11D-1963-05		TCGA-HC-7079-01A-11D-1961-08	0a67e3de-1840-44f1-ae19-14f3c2df230c	TCGA-HC-7079-01	TCGA-HC-7079-01	7E67A6D7-6D0A-44A0-BCB0-0EDF56685FD2	TCGA-HC-7079-01A-11D-1959-01	0a67e3de-1840-44f1-ae19-14f3c2df230c	TCGA-HC-7079-01	TCGA-HC-7079-01	TCGA-HC-7079-01A-11D-1961-08	TCGA-HC-7079-01A-11D-1961-08	0a67e3de-1840-44f1-ae19-14f3c2df230c
TCGA-HC-7080-01	0	TCGA-HC-7080-01	1106	0	days	TCGA-HC-7080	894	1	days	1106	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	66	TCGA-HC-7080-F64334	TCGA-HC-7080	TCGA-HC-7080-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-24243	19			19			0	1106	894	104			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-8-28	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Right	0.5	NO	YES		New Primary Tumor		YES	2	0		No	N0	T2a	TCGA-HC-7080.f2bf590a-9473-47fe-89a9-69c480b6c42b.pdf		7080	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.2		NO		NO	YES	HC	Apex|Middle		Prostate		A	LIVING	2010		8d250084-d374-4ec4-994b-6c5f9c0f1a14	TCGA-HC-7080-01A-11D-1959-01	TCGA-HC-7080-01A-11D-1963-05		TCGA-HC-7080-01A-11D-1961-08	8d250084-d374-4ec4-994b-6c5f9c0f1a14	TCGA-HC-7080-01	TCGA-HC-7080-01		TCGA-HC-7080-01A-11D-1959-01	8d250084-d374-4ec4-994b-6c5f9c0f1a14	TCGA-HC-7080-01	TCGA-HC-7080-01	TCGA-HC-7080-01A-11D-1961-08	TCGA-HC-7080-01A-11D-1961-08	8d250084-d374-4ec4-994b-6c5f9c0f1a14
TCGA-HC-7081-01	0	TCGA-HC-7081-01	1136	0	days	TCGA-HC-7081	1136	0	days	1136	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			62	TCGA-HC-7081-F64330	TCGA-HC-7081	TCGA-HC-7081-01A												0	1136									Scheduled Follow-up Submission	Stable Disease	2014-8-28	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	0.8	NO	NO				NO				No		T3b	TCGA-HC-7081.75d1573a-cbf6-4b3c-93c4-2d410586884c.pdf		7081	WITH TUMOR	4	Partial Remission/Response		YES	R2	Primary Tumor	01	5	0.3		NO		YES	NO	HC			Prostate		A	LIVING	2010		9dcee6b2-ff25-4db1-be9a-9ac5e6e49c90	TCGA-HC-7081-01A-11D-1959-01	TCGA-HC-7081-01A-11D-1963-05		TCGA-HC-7081-01A-11D-1961-08	9dcee6b2-ff25-4db1-be9a-9ac5e6e49c90	TCGA-HC-7081-01	TCGA-HC-7081-01	C39E6101-EF90-4969-9F01-AA137D5370D2	TCGA-HC-7081-01A-11D-1959-01	9dcee6b2-ff25-4db1-be9a-9ac5e6e49c90	TCGA-HC-7081-01	TCGA-HC-7081-01	TCGA-HC-7081-01A-11D-1961-08	TCGA-HC-7081-01A-11D-1961-08	9dcee6b2-ff25-4db1-be9a-9ac5e6e49c90
TCGA-HC-7209-01	0	TCGA-HC-7209-01	440	0	days	TCGA-HC-7209	440	0	days	440	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			60	TCGA-HC-7209-F66045	TCGA-HC-7209	TCGA-HC-7209-01A				T2b	-22129							0	440		108							Scheduled Follow-up Submission	Complete Remission/Response	2014-10-1	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO	Bilateral	0.6	YES	YES				NO	2	0		No	N0	T2c	TCGA-HC-7209.87f8ff1b-d58b-470e-9156-144cbe34b71c.pdf		7209	TUMOR FREE	3	Complete Remission/Response	0.05	NO	R0	Primary Tumor	01	3	0.1		NO		YES	NO	HC	Apex|Middle|Base		Prostate		A	LIVING	2011		9675123f-6606-4e75-be55-3ef938c72178	TCGA-HC-7209-01A-11D-2112-01	TCGA-HC-7209-01A-11D-2116-05		TCGA-HC-7209-01A-11D-2114-08	9675123f-6606-4e75-be55-3ef938c72178	TCGA-HC-7209-01	TCGA-HC-7209-01		TCGA-HC-7209-01A-11D-2112-01	9675123f-6606-4e75-be55-3ef938c72178	TCGA-HC-7209-01	TCGA-HC-7209-01	TCGA-HC-7209-01A-11D-2114-08	TCGA-HC-7209-01A-11D-2114-08	9675123f-6606-4e75-be55-3ef938c72178
TCGA-HC-7210-01	0	TCGA-HC-7210-01	868	0	days	TCGA-HC-7210	868	0	days	868	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			74	TCGA-HC-7210-F64378	TCGA-HC-7210	TCGA-HC-7210-01A					-27343							0	868		149							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-29	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Right	1.1	NO	YES				NO	7	0		No	N0	T2a	TCGA-HC-7210.8398444a-bfad-41d6-94a6-ab85ddf159aa.pdf		7210	TUMOR FREE	3	Complete Remission/Response	.1	NO	R0	Primary Tumor	01	4	0.4		NO		YES	NO	HC			Prostate		A	LIVING	2011		a83b2830-20b3-4773-b929-733f772252ec	TCGA-HC-7210-01A-11D-2112-01	TCGA-HC-7210-01A-11D-2116-05		TCGA-HC-7210-01A-11D-2114-08	a83b2830-20b3-4773-b929-733f772252ec	TCGA-HC-7210-01	TCGA-HC-7210-01	B7EB854F-8169-4DD4-86E5-139AE6F39CB2	TCGA-HC-7210-01A-11D-2112-01	a83b2830-20b3-4773-b929-733f772252ec	TCGA-HC-7210-01	TCGA-HC-7210-01	TCGA-HC-7210-01A-11D-2114-08	TCGA-HC-7210-01A-11D-2114-08	a83b2830-20b3-4773-b929-733f772252ec
TCGA-HC-7211-01	0	TCGA-HC-7211-01	1221	0	days	TCGA-HC-7211	1221	0	days	1221	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			62	TCGA-HC-7211-F64373	TCGA-HC-7211	TCGA-HC-7211-01A		Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-22768	14			14			0	1221		-17			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-8-29	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	0.7	NO	YES				NO	10	0		No	N0	T2c	TCGA-HC-7211.47e4122a-96e7-43d6-9242-ad7bff977ba8.pdf		7211	TUMOR FREE	3	Complete Remission/Response	10.9	NO	R0	Primary Tumor	01	4	0.4		NO		NO	YES	HC	Apex|Middle|Base		Prostate		A	LIVING	2010		3b524c3b-40b6-43bd-8108-5243463ce4a0	TCGA-HC-7211-01A-11D-2112-01	TCGA-HC-7211-01A-11D-2116-05		TCGA-HC-7211-01A-11D-2114-08	3b524c3b-40b6-43bd-8108-5243463ce4a0	TCGA-HC-7211-01	TCGA-HC-7211-01	071088A3-B9EB-44CF-A3DB-ED777A2263C4	TCGA-HC-7211-01A-11D-2112-01	3b524c3b-40b6-43bd-8108-5243463ce4a0	TCGA-HC-7211-01	TCGA-HC-7211-01	TCGA-HC-7211-01A-11D-2114-08	TCGA-HC-7211-01A-11D-2114-08	3b524c3b-40b6-43bd-8108-5243463ce4a0
TCGA-HC-7211-11	0	TCGA-HC-7211-11	1221	0	days	TCGA-HC-7211	1221	0	days	1221	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			62	TCGA-HC-7211-F64373	TCGA-HC-7211	TCGA-HC-7211-11A		Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-22768	14			14			0	1221		-17			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-8-29	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	0.5	NO	YES				NO	10	0		No	N0	T2c			7211	TUMOR FREE	3	Complete Remission/Response	10.9	NO	R0	Solid Tissue Normal	11	4	0.4		NO		NO	YES	HC	Apex|Middle|Base		Prostate		A	LIVING	2010		7dc99228-873b-44e1-a2cb-9bd2fe9d217f		TCGA-HC-7211-11A-01D-2116-05			7dc99228-873b-44e1-a2cb-9bd2fe9d217f		TCGA-HC-7211-11			7dc99228-873b-44e1-a2cb-9bd2fe9d217f		TCGA-HC-7211-11			7dc99228-873b-44e1-a2cb-9bd2fe9d217f
TCGA-HC-7212-01	0	TCGA-HC-7212-01	870	0	days	TCGA-HC-7212			days	870	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			56	TCGA-HC-7212-F45569	TCGA-HC-7212	TCGA-HC-7212-01A			M0		-20576						396	0	870		424							Scheduled Follow-up Submission	Complete Remission/Response	2013-7-17	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Right	1	NO	YES		Biochemical evidence of disease		YES	4	0		No	N0	T2a	TCGA-HC-7212.b401d78b-78c2-4e6e-86db-c93997da85a4.pdf		7212	TUMOR FREE	3	Complete Remission/Response	.28			Primary Tumor	01	4	0.3				YES	NO	HC			Prostate		A	LIVING	2011		23e9edc6-a5ab-4dca-9243-a40e69d65615	TCGA-HC-7212-01A-11D-2112-01	TCGA-HC-7212-01A-11D-2116-05		TCGA-HC-7212-01A-11D-2114-08	23e9edc6-a5ab-4dca-9243-a40e69d65615	TCGA-HC-7212-01	TCGA-HC-7212-01	56489764-D94A-4346-B9E1-5BBD98590625	TCGA-HC-7212-01A-11D-2112-01	23e9edc6-a5ab-4dca-9243-a40e69d65615	TCGA-HC-7212-01	TCGA-HC-7212-01	TCGA-HC-7212-01A-11D-2114-08	TCGA-HC-7212-01A-11D-2114-08	23e9edc6-a5ab-4dca-9243-a40e69d65615
TCGA-HC-7213-01	0	TCGA-HC-7213-01	1219	0	days	TCGA-HC-7213	170	1	days	1219	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	YES	53	TCGA-HC-7213-F66041	TCGA-HC-7213	TCGA-HC-7213-01A	YES		M0	T3b	-19699				22	34	170	0	1219	170	170			YES	No Evidence of Extraprostatic Extension	YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Scheduled Follow-up Submission	Complete Remission/Response	2014-10-1	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.1	NO	YES		Biochemical evidence of disease		YES	4	0		No	N0	T3b	TCGA-HC-7213.8b2f0b23-7a12-432a-b209-37e57a2f112b.pdf		7213	TUMOR FREE	4	Partial Remission/Response	4.09	NO	R0	Primary Tumor	01	5	0.3		NO		YES	NO	HC	Apex|Middle|Base		Prostate		A	LIVING	2010		cf7a71f6-8d7d-4833-b9b2-c40abc1654e6	TCGA-HC-7213-01A-11D-2112-01	TCGA-HC-7213-01A-11D-2116-05		TCGA-HC-7213-01A-11D-2114-08	cf7a71f6-8d7d-4833-b9b2-c40abc1654e6	TCGA-HC-7213-01	TCGA-HC-7213-01	423C67EC-ACA2-4723-8E0C-689CBD6709DA	TCGA-HC-7213-01A-11D-2112-01	cf7a71f6-8d7d-4833-b9b2-c40abc1654e6	TCGA-HC-7213-01	TCGA-HC-7213-01	TCGA-HC-7213-01A-11D-2114-08	TCGA-HC-7213-01A-11D-2114-08	cf7a71f6-8d7d-4833-b9b2-c40abc1654e6
TCGA-HC-7230-01	0	TCGA-HC-7230-01	1001	0	days	TCGA-HC-7230	1001	0	days	1001	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			50	TCGA-HC-7230-F64379	TCGA-HC-7230	TCGA-HC-7230-01A					-18577							0	1001									Scheduled Follow-up Submission	Complete Remission/Response	2014-8-29	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.4	NO		0.5	NO	YES				NO	3	0		No	N0	T2c	TCGA-HC-7230.0c078733-c8ed-4d5c-9da0-979f4af4fc4f.pdf		7230	TUMOR FREE	3	Complete Remission/Response	3	NO	R0	Primary Tumor	01	4	0.1		NO		YES	NO	HC			Prostate		A	LIVING	2011		2ff3af27-d43b-4707-a337-0ff988ac2763	TCGA-HC-7230-01A-11D-2112-01	TCGA-HC-7230-01A-11D-2116-05		TCGA-HC-7230-01A-11D-2114-08	2ff3af27-d43b-4707-a337-0ff988ac2763	TCGA-HC-7230-01	TCGA-HC-7230-01		TCGA-HC-7230-01A-11D-2112-01	2ff3af27-d43b-4707-a337-0ff988ac2763	TCGA-HC-7230-01	TCGA-HC-7230-01	TCGA-HC-7230-01A-11D-2114-08	TCGA-HC-7230-01A-11D-2114-08	2ff3af27-d43b-4707-a337-0ff988ac2763
TCGA-HC-7231-01	0	TCGA-HC-7231-01	939	0	days	TCGA-HC-7231	939	0	days	939	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-HC-7231-F63153	TCGA-HC-7231				M0	T1c	-24278							0	939									Scheduled Follow-up Submission	Complete Remission/Response	2014-7-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	NO				NO				No		T2c			7231	TUMOR FREE	3	Complete Remission/Response		NO	R0	Primary Tumor	01	4			NO		YES	NO	HC			Prostate			LIVING	2011		f7d253d6-fce6-42d3-8926-563e8e7eff7f	TCGA-HC-7231-01A-11D-2112-01	TCGA-HC-7231-01A-11D-2116-05		TCGA-HC-7231-01A-11D-2114-08	f7d253d6-fce6-42d3-8926-563e8e7eff7f	TCGA-HC-7231-01	TCGA-HC-7231-01		TCGA-HC-7231-01A-11D-2112-01	f7d253d6-fce6-42d3-8926-563e8e7eff7f	TCGA-HC-7231-01	TCGA-HC-7231-01	TCGA-HC-7231-01A-11D-2114-08	TCGA-HC-7231-01A-11D-2114-08	f7d253d6-fce6-42d3-8926-563e8e7eff7f
TCGA-HC-7232-01	0	TCGA-HC-7232-01	1161	0	days	TCGA-HC-7232	766	1	days	1161	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	YES	66	TCGA-HC-7232-F64391	TCGA-HC-7232	TCGA-HC-7232-01A					-24324						766	0	1161	766								Scheduled Follow-up Submission	Stable Disease	2014-8-29	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1	NO	NO		Biochemical evidence of disease		YES				No		T3b	TCGA-HC-7232.d5b6e727-43d6-4d27-a7ae-d89c046ef4eb.pdf		7232	WITH TUMOR	4	Complete Remission/Response		NO	R0	Primary Tumor	01	5	0.4		NO		YES	NO	HC			Prostate		A	LIVING	2011		499d25b2-e516-4aea-b732-5c8096dc968a	TCGA-HC-7232-01A-11D-2112-01	TCGA-HC-7232-01A-11D-2116-05		TCGA-HC-7232-01A-11D-2114-08	499d25b2-e516-4aea-b732-5c8096dc968a	TCGA-HC-7232-01	TCGA-HC-7232-01	7B5B1C42-36DB-4D44-96DD-6E8769289C80	TCGA-HC-7232-01A-11D-2112-01	499d25b2-e516-4aea-b732-5c8096dc968a	TCGA-HC-7232-01	TCGA-HC-7232-01	TCGA-HC-7232-01A-11D-2114-08	TCGA-HC-7232-01A-11D-2114-08	499d25b2-e516-4aea-b732-5c8096dc968a
TCGA-HC-7233-01	0	TCGA-HC-7233-01	1355	0	days	TCGA-HC-7233	1355	0	days	1355	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			73	TCGA-HC-7233-F63155	TCGA-HC-7233	TCGA-HC-7233-01A												0	1355									Scheduled Follow-up Submission	Complete Remission/Response	2014-7-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.9	NO	Left	1	NO	YES				NO	2	0		Yes	N0	T2a	TCGA-HC-7233.3531e095-4042-4fc8-aa69-522b16e4e1fc.pdf		7233	TUMOR FREE	4	Complete Remission/Response		NO	R1	Primary Tumor	01	3	0.6		NO		NO	YES	HC	Apex		Prostate		A	LIVING	2010		81388e39-1fc8-47bd-b49b-946bc979996d	TCGA-HC-7233-01A-11D-2112-01	TCGA-HC-7233-01A-11D-2116-05		TCGA-HC-7233-01A-11D-2114-08	81388e39-1fc8-47bd-b49b-946bc979996d	TCGA-HC-7233-01	TCGA-HC-7233-01	A195D5BC-E277-436D-B0F6-1BF27D835B89	TCGA-HC-7233-01A-11D-2112-01	81388e39-1fc8-47bd-b49b-946bc979996d	TCGA-HC-7233-01	TCGA-HC-7233-01	TCGA-HC-7233-01A-11D-2114-08	TCGA-HC-7233-01A-11D-2114-08	81388e39-1fc8-47bd-b49b-946bc979996d
TCGA-HC-7736-01	0	TCGA-HC-7736-01	1103	0	days	TCGA-HC-7736	1103	0	days	1103	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			59	TCGA-HC-7736-F60206	TCGA-HC-7736	TCGA-HC-7736-01A			M0	T2b	-21703				-21			0	1103		102			YES	No Evidence of Extraprostatic Extension			Scheduled Follow-up Submission	Complete Remission/Response	2014-5-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1	NO	YES				NO	13	0		No	N0	T2c	TCGA-HC-7736.d5cb57cb-ff9a-4c83-b019-7b5ed2cd7494.pdf		7736	TUMOR FREE	3	Complete Remission/Response	.02	NO	R0	Primary Tumor	01	4	0.4		NO		NO	YES	HC	Middle|Base		Prostate		A	LIVING	2010		28ebf50e-d63f-439e-8e16-4a815eccb465	TCGA-HC-7736-01A-11D-2112-01	TCGA-HC-7736-01A-11D-2116-05		TCGA-HC-7736-01A-11D-2114-08	28ebf50e-d63f-439e-8e16-4a815eccb465	TCGA-HC-7736-01	TCGA-HC-7736-01	11886AD8-EAB8-4749-A880-4AF10F7EDFC1	TCGA-HC-7736-01A-11D-2112-01	28ebf50e-d63f-439e-8e16-4a815eccb465	TCGA-HC-7736-01	TCGA-HC-7736-01	TCGA-HC-7736-01A-11D-2114-08	TCGA-HC-7736-01A-11D-2114-08	28ebf50e-d63f-439e-8e16-4a815eccb465
TCGA-HC-7737-01	0	TCGA-HC-7737-01	1090	0	days	TCGA-HC-7737	1090	0	days	1090	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55	TCGA-HC-7737-F60207	TCGA-HC-7737			Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-20122	9			9			0	1090		147			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-5-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	8	1		No	N1	T2c			7737	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO		NO	YES	HC			Prostate			LIVING	2010		bdb4a761-71cf-4465-a48f-4f938493ffcb	TCGA-HC-7737-01A-11D-2112-01	TCGA-HC-7737-01A-11D-2116-05		TCGA-HC-7737-01A-11D-2114-08	bdb4a761-71cf-4465-a48f-4f938493ffcb	TCGA-HC-7737-01	TCGA-HC-7737-01		TCGA-HC-7737-01A-11D-2112-01	bdb4a761-71cf-4465-a48f-4f938493ffcb	TCGA-HC-7737-01	TCGA-HC-7737-01	TCGA-HC-7737-01A-11D-2114-08	TCGA-HC-7737-01A-11D-2114-08	bdb4a761-71cf-4465-a48f-4f938493ffcb
TCGA-HC-7737-11	0	TCGA-HC-7737-11	1090	0	days	TCGA-HC-7737	1090	0	days	1090	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55	TCGA-HC-7737-F60207	TCGA-HC-7737	TCGA-HC-7737-11A		Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-20122	9			9			0	1090		147			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-5-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	0.8	NO	YES				NO	8	1		No	N1	T2c			7737	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Solid Tissue Normal	11	4	0.4		NO		NO	YES	HC			Prostate		A	LIVING	2010		801b06ab-6ef3-46ba-af12-3b2230aabf51		TCGA-HC-7737-11A-02D-2116-05			801b06ab-6ef3-46ba-af12-3b2230aabf51		TCGA-HC-7737-11			801b06ab-6ef3-46ba-af12-3b2230aabf51		TCGA-HC-7737-11			801b06ab-6ef3-46ba-af12-3b2230aabf51
TCGA-HC-7738-01	0	TCGA-HC-7738-01	964	0	days	TCGA-HC-7738	420	1	days	964	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	58	TCGA-HC-7738-F63151	TCGA-HC-7738				M0		-21195						420	0	964	420								Scheduled Follow-up Submission	Stable Disease	2014-7-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	NO	Other, specify	Biochemical evidence of disease	biochemical recurrence only	YES				No		T2c			7738	WITH TUMOR	3	Partial Remission/Response		NO	R0	Primary Tumor	01	4			NO		YES	NO	HC	Apex	NO	Prostate			LIVING	2011		b02ac966-c160-4310-a80d-98fdc6134074	TCGA-HC-7738-01A-11D-2112-01	TCGA-HC-7738-01A-11D-2116-05		TCGA-HC-7738-01A-11D-2114-08	b02ac966-c160-4310-a80d-98fdc6134074	TCGA-HC-7738-01	TCGA-HC-7738-01		TCGA-HC-7738-01A-11D-2112-01	b02ac966-c160-4310-a80d-98fdc6134074	TCGA-HC-7738-01	TCGA-HC-7738-01	TCGA-HC-7738-01A-11D-2114-08		b02ac966-c160-4310-a80d-98fdc6134074
TCGA-HC-7738-11	0	TCGA-HC-7738-11	964	0	days	TCGA-HC-7738	420	1	days	964	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	58	TCGA-HC-7738-F63151	TCGA-HC-7738	TCGA-HC-7738-11A			M0		-21195						420	0	964	420								Scheduled Follow-up Submission	Stable Disease	2014-7-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.1	NO	NO	Other, specify	Biochemical evidence of disease	biochemical recurrence only	YES				No		T2c			7738	WITH TUMOR	3	Partial Remission/Response		NO	R0	Solid Tissue Normal	11	4	0.5		NO		YES	NO	HC	Apex	NO	Prostate		A	LIVING	2011		65592ca4-9afc-462c-86ee-a5f352aeb1f0					65592ca4-9afc-462c-86ee-a5f352aeb1f0		TCGA-HC-7738-11			65592ca4-9afc-462c-86ee-a5f352aeb1f0		TCGA-HC-7738-11			65592ca4-9afc-462c-86ee-a5f352aeb1f0
TCGA-HC-7740-01	0	TCGA-HC-7740-01	717	0	days	TCGA-HC-7740	717	0	days	717	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			59	TCGA-HC-7740-F48772	TCGA-HC-7740	TCGA-HC-7740-01A			M0	T2a	-21883							0	717		154							Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	1.2	NO	YES				NO	4	0		No	N0	T2c	TCGA-HC-7740.d2b80346-3a50-4fc3-99c2-0e15225cc433.pdf		7740	TUMOR FREE	3	Complete Remission/Response	0	NO	R0	Primary Tumor	01	4	0.3		NO		YES	NO	HC	Apex|Middle|Base		Prostate		A	LIVING	2011		095f3c80-890e-4529-816c-306daf614ec2	TCGA-HC-7740-01A-11D-2112-01	TCGA-HC-7740-01B-04D-2299-05,TCGA-HC-7740-01A-11D-2116-05		TCGA-HC-7740-01A-11D-2114-08	095f3c80-890e-4529-816c-306daf614ec2	TCGA-HC-7740-01	TCGA-HC-7740-01	23F340A8-0AC4-4218-A18E-4CFDED8782FA	TCGA-HC-7740-01A-11D-2112-01	095f3c80-890e-4529-816c-306daf614ec2	TCGA-HC-7740-01	TCGA-HC-7740-01	TCGA-HC-7740-01A-11D-2114-08,TCGA-HC-7740-01B-04D-2298-08	TCGA-HC-7740-01A-11D-2114-08	095f3c80-890e-4529-816c-306daf614ec2
TCGA-HC-7740-11	0	TCGA-HC-7740-11	717	0	days	TCGA-HC-7740	717	0	days	717	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			59	TCGA-HC-7740-F48772	TCGA-HC-7740	TCGA-HC-7740-11A			M0	T2a	-21883							0	717		154							Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	0.6	NO	YES				NO	4	0		No	N0	T2c			7740	TUMOR FREE	3	Complete Remission/Response	0	NO	R0	Solid Tissue Normal	11	4	0.4		NO		YES	NO	HC	Apex|Middle|Base		Prostate		A	LIVING	2011		0120b5b1-d204-429a-aa21-704fd98624ea					0120b5b1-d204-429a-aa21-704fd98624ea		TCGA-HC-7740-11			0120b5b1-d204-429a-aa21-704fd98624ea		TCGA-HC-7740-11			0120b5b1-d204-429a-aa21-704fd98624ea
TCGA-HC-7742-01	0	TCGA-HC-7742-01	938	0	days	TCGA-HC-7742			days	938	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	NO	58	TCGA-HC-7742-F66039	TCGA-HC-7742		NO		M0		-21323						210	0	938		113	651						Scheduled Follow-up Submission	Stable Disease	2014-10-1	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy						NO	YES		Biochemical evidence of disease		YES	2	0		No	N0	T3a			7742	WITH TUMOR	3	Partial Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	HC			Prostate			LIVING	2011		d8765abc-befa-49b5-893e-04de2ddb2ee1	TCGA-HC-7742-01A-11D-2112-01	TCGA-HC-7742-01A-11D-2116-05		TCGA-HC-7742-01A-11D-2114-08	d8765abc-befa-49b5-893e-04de2ddb2ee1	TCGA-HC-7742-01	TCGA-HC-7742-01		TCGA-HC-7742-01A-11D-2112-01	d8765abc-befa-49b5-893e-04de2ddb2ee1	TCGA-HC-7742-01	TCGA-HC-7742-01	TCGA-HC-7742-01A-11D-2114-08	TCGA-HC-7742-01A-11D-2114-08	d8765abc-befa-49b5-893e-04de2ddb2ee1
TCGA-HC-7742-11	0	TCGA-HC-7742-11	938	0	days	TCGA-HC-7742			days	938	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	NO	58	TCGA-HC-7742-F66039	TCGA-HC-7742	TCGA-HC-7742-11A	NO		M0		-21323						210	0	938		113	651						Scheduled Follow-up Submission	Stable Disease	2014-10-1	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy		0.6	NO		0.7	NO	YES		Biochemical evidence of disease		YES	2	0		No	N0	T3a			7742	WITH TUMOR	3	Partial Remission/Response	0.1	NO	R0	Solid Tissue Normal	11	4	0.3		NO		YES	NO	HC			Prostate		A	LIVING	2011		12358445-06b8-4055-8454-69b8544774fc		TCGA-HC-7742-11A-01D-2116-05			12358445-06b8-4055-8454-69b8544774fc		TCGA-HC-7742-11			12358445-06b8-4055-8454-69b8544774fc		TCGA-HC-7742-11			12358445-06b8-4055-8454-69b8544774fc
TCGA-HC-7744-01	0	TCGA-HC-7744-01	531	0	days	TCGA-HC-7744	531	0	days	531	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			46	TCGA-HC-7744-F46991	TCGA-HC-7744	TCGA-HC-7744-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-17065	10			40	42		0	531		282			YES		YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Scheduled Follow-up Submission	Complete Remission/Response	2013-8-21	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1	NO	YES				NO	8	0		No	N0	T3b	TCGA-HC-7744.01b8c2af-bdf8-4627-bf6e-c7a41d929b94.pdf		7744	TUMOR FREE	4	Complete Remission/Response	0.04	YES	R1	Primary Tumor	01	3	0.3		NO		YES	NO	HC	Apex|Middle|Base		Prostate		A	LIVING	2011		82b1d50a-9ed4-4d42-80d4-59d06b43df3e	TCGA-HC-7744-01A-11D-2112-01	TCGA-HC-7744-01A-11D-2116-05		TCGA-HC-7744-01A-11D-2114-08	82b1d50a-9ed4-4d42-80d4-59d06b43df3e	TCGA-HC-7744-01	TCGA-HC-7744-01	607F5599-9CEB-49A9-8D9D-8EAA0C9ED792	TCGA-HC-7744-01A-11D-2112-01	82b1d50a-9ed4-4d42-80d4-59d06b43df3e	TCGA-HC-7744-01	TCGA-HC-7744-01	TCGA-HC-7744-01A-11D-2114-08	TCGA-HC-7744-01A-11D-2114-08	82b1d50a-9ed4-4d42-80d4-59d06b43df3e
TCGA-HC-7745-01	0	TCGA-HC-7745-01	721	0	days	TCGA-HC-7745	721	0	days	721	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			65	TCGA-HC-7745-F66044	TCGA-HC-7745						-24078							0	721					NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-10-1	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	3	0		No	N0	T3b			7745	TUMOR FREE	4	Complete Remission/Response		NO	R0	Primary Tumor	01	3			YES		YES	NO	HC	Middle		Prostate			LIVING	2011		d26a0c98-2768-48df-ab84-dcce5e18537a	TCGA-HC-7745-01A-11D-2112-01	TCGA-HC-7745-01A-11D-2116-05		TCGA-HC-7745-01A-11D-2114-08	d26a0c98-2768-48df-ab84-dcce5e18537a	TCGA-HC-7745-01	TCGA-HC-7745-01		TCGA-HC-7745-01A-11D-2112-01	d26a0c98-2768-48df-ab84-dcce5e18537a	TCGA-HC-7745-01	TCGA-HC-7745-01	TCGA-HC-7745-01A-11D-2114-08		d26a0c98-2768-48df-ab84-dcce5e18537a
TCGA-HC-7745-11	0	TCGA-HC-7745-11	721	0	days	TCGA-HC-7745	721	0	days	721	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			65	TCGA-HC-7745-F66044	TCGA-HC-7745	TCGA-HC-7745-11A					-24078							0	721					NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-10-1	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.1	NO	YES				NO	3	0		No	N0	T3b			7745	TUMOR FREE	4	Complete Remission/Response		NO	R0	Solid Tissue Normal	11	3	0.3		YES		YES	NO	HC	Middle		Prostate		A	LIVING	2011		3e2b99bc-6a05-4de8-b135-923d443cd4fa		TCGA-HC-7745-11A-01D-2116-05			3e2b99bc-6a05-4de8-b135-923d443cd4fa		TCGA-HC-7745-11			3e2b99bc-6a05-4de8-b135-923d443cd4fa		TCGA-HC-7745-11			3e2b99bc-6a05-4de8-b135-923d443cd4fa
TCGA-HC-7747-01	0	TCGA-HC-7747-01	748	0	days	TCGA-HC-7747	748	0	days	748	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			52	TCGA-HC-7747-F60208	TCGA-HC-7747		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-19188	25			25			0	748		392			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-5-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	4	0		No	N0	T2c			7747	TUMOR FREE	3	Complete Remission/Response	0.19	YES		Primary Tumor	01	4			NO		YES	NO	HC	Apex|Middle|Base		Prostate			LIVING	2011		a88b498e-6e56-4d49-b11d-827ad2b29b5d	TCGA-HC-7747-01A-11D-2112-01	TCGA-HC-7747-01A-11D-2116-05		TCGA-HC-7747-01A-11D-2114-08	a88b498e-6e56-4d49-b11d-827ad2b29b5d	TCGA-HC-7747-01	TCGA-HC-7747-01		TCGA-HC-7747-01A-11D-2112-01	a88b498e-6e56-4d49-b11d-827ad2b29b5d	TCGA-HC-7747-01	TCGA-HC-7747-01	TCGA-HC-7747-01A-11D-2114-08	TCGA-HC-7747-01A-11D-2114-08	a88b498e-6e56-4d49-b11d-827ad2b29b5d
TCGA-HC-7747-11	0	TCGA-HC-7747-11	748	0	days	TCGA-HC-7747	748	0	days	748	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			52	TCGA-HC-7747-F60208	TCGA-HC-7747	TCGA-HC-7747-11A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-19188	25			25			0	748		392			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-5-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	1.1	NO	YES				NO	4	0		No	N0	T2c			7747	TUMOR FREE	3	Complete Remission/Response	0.19	YES		Solid Tissue Normal	11	4	0.4		NO		YES	NO	HC	Apex|Middle|Base		Prostate		A	LIVING	2011		8f9b3818-5334-4aa0-9ad1-22bca0afb925					8f9b3818-5334-4aa0-9ad1-22bca0afb925		TCGA-HC-7747-11			8f9b3818-5334-4aa0-9ad1-22bca0afb925		TCGA-HC-7747-11			8f9b3818-5334-4aa0-9ad1-22bca0afb925
TCGA-HC-7748-01	0	TCGA-HC-7748-01	792	0	days	TCGA-HC-7748	792	0	days	792	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			60	TCGA-HC-7748-F48774	TCGA-HC-7748	TCGA-HC-7748-01A					-22072							0	792		99							Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Right	0.8	NO	YES				NO	10	0		Yes	N0	T2a	TCGA-HC-7748.6516e000-dc8c-4715-a561-ee47a114ad23.pdf		7748	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3	0.4		NO		YES	NO	HC			Prostate		A	LIVING	2011		eb9c4bc2-f85e-4ec1-bd7f-ba2eff32ff1b	TCGA-HC-7748-01A-11D-2112-01	TCGA-HC-7748-01A-11D-2116-05		TCGA-HC-7748-01A-11D-2114-08	eb9c4bc2-f85e-4ec1-bd7f-ba2eff32ff1b	TCGA-HC-7748-01	TCGA-HC-7748-01	09D67575-C709-4A9C-BB42-85F697F4ECAC	TCGA-HC-7748-01A-11D-2112-01	eb9c4bc2-f85e-4ec1-bd7f-ba2eff32ff1b	TCGA-HC-7748-01	TCGA-HC-7748-01	TCGA-HC-7748-01A-11D-2114-08	TCGA-HC-7748-01A-11D-2114-08	eb9c4bc2-f85e-4ec1-bd7f-ba2eff32ff1b
TCGA-HC-7749-01	0	TCGA-HC-7749-01	724	0	days	TCGA-HC-7749	724	0	days	724	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			70	TCGA-HC-7749-F48773	TCGA-HC-7749	TCGA-HC-7749-01A			M0		-25688							0	724		102							Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.3	NO	Right	0.3	NO	YES				NO	10	0		No	N0	T3a	TCGA-HC-7749.35e33cb7-77a7-4d02-b4ec-9374423027c0.pdf		7749	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3	0.2		NO	5	YES	NO	HC	Middle|Base		Prostate		A	LIVING	2011		6551bbb1-297f-41db-969b-17bb3c432426	TCGA-HC-7749-01A-11D-2112-01	TCGA-HC-7749-01A-11D-2116-05		TCGA-HC-7749-01A-11D-2114-08	6551bbb1-297f-41db-969b-17bb3c432426	TCGA-HC-7749-01	TCGA-HC-7749-01		TCGA-HC-7749-01A-11D-2112-01	6551bbb1-297f-41db-969b-17bb3c432426	TCGA-HC-7749-01	TCGA-HC-7749-01	TCGA-HC-7749-01A-11D-2114-08	TCGA-HC-7749-01A-11D-2114-08	6551bbb1-297f-41db-969b-17bb3c432426
TCGA-HC-7750-01	0	TCGA-HC-7750-01	522	0	days	TCGA-HC-7750	522	0	days	522	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			50	TCGA-HC-7750-F46692	TCGA-HC-7750	TCGA-HC-7750-01A			M0	T2b	-18580							0	522		83							Scheduled Follow-up Submission	Complete Remission/Response	2013-8-13	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.3	NO	Left	0.4	NO	NO				NO				No		T2c	TCGA-HC-7750.f05d95fd-391d-49ab-8a2f-039110a654bd.pdf		7750	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.2		NO		YES	NO	HC	Apex|Middle|Base		Prostate		A	LIVING	2011		54ad372c-0c62-42b9-86c4-91cd0e148af2	TCGA-HC-7750-01A-11D-2112-01	TCGA-HC-7750-01A-11D-2116-05		TCGA-HC-7750-01A-11D-2114-08	54ad372c-0c62-42b9-86c4-91cd0e148af2	TCGA-HC-7750-01	TCGA-HC-7750-01		TCGA-HC-7750-01A-11D-2112-01	54ad372c-0c62-42b9-86c4-91cd0e148af2	TCGA-HC-7750-01	TCGA-HC-7750-01	TCGA-HC-7750-01A-11D-2114-08	TCGA-HC-7750-01A-11D-2114-08	54ad372c-0c62-42b9-86c4-91cd0e148af2
TCGA-HC-7752-01	0	TCGA-HC-7752-01	782	0	days	TCGA-HC-7752	782	0	days	782	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61	TCGA-HC-7752-F64386	TCGA-HC-7752				M0		-22366							0	782		138							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-29	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	6	0		No	N0	T2c			7752	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	HC	Base		Prostate			LIVING	2011		f57a7df0-0aaf-4181-b8c1-f50133964823	TCGA-HC-7752-01A-11D-2112-01	TCGA-HC-7752-01A-11D-2116-05		TCGA-HC-7752-01A-11D-2114-08	f57a7df0-0aaf-4181-b8c1-f50133964823	TCGA-HC-7752-01	TCGA-HC-7752-01		TCGA-HC-7752-01A-11D-2112-01	f57a7df0-0aaf-4181-b8c1-f50133964823	TCGA-HC-7752-01	TCGA-HC-7752-01	TCGA-HC-7752-01A-11D-2114-08		f57a7df0-0aaf-4181-b8c1-f50133964823
TCGA-HC-7752-11	0	TCGA-HC-7752-11	782	0	days	TCGA-HC-7752	782	0	days	782	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61	TCGA-HC-7752-F64386	TCGA-HC-7752				M0		-22366							0	782		138							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-29	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	6	0		No	N0	T2c			7752	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Solid Tissue Normal	11	4			NO		YES	NO	HC	Base		Prostate			LIVING	2011		c08293b3-507d-4c7c-8b14-9a328e1d15fe		TCGA-HC-7752-11A-01D-2116-05			c08293b3-507d-4c7c-8b14-9a328e1d15fe		TCGA-HC-7752-11			c08293b3-507d-4c7c-8b14-9a328e1d15fe		TCGA-HC-7752-11			c08293b3-507d-4c7c-8b14-9a328e1d15fe
TCGA-HC-7817-01	0	TCGA-HC-7817-01	928	0	days	TCGA-HC-7817	928	0	days	928	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			52	TCGA-HC-7817-F60204	TCGA-HC-7817	TCGA-HC-7817-01B	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-19207							0	928		171			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2014-5-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy		0.8	NO	Bilateral	1.1	NO	NO				NO				No		T3b	TCGA-HC-7817.A1E3EC71-D7D2-4286-A12F-78ADFD27E53C.pdf		7817	TUMOR FREE	4	Complete Remission/Response	0.1	YES		Primary Tumor	01	3	0.5		NO		YES	NO	HC	Apex|Middle|Base		Prostate		B	LIVING	2011		c995e591-f2b7-4c3e-ae81-9e72b9548b57	TCGA-HC-7817-01B-11D-A323-01	TCGA-HC-7817-01B-11D-A29T-05		TCGA-HC-7817-01B-11D-A29Q-08	c995e591-f2b7-4c3e-ae81-9e72b9548b57	TCGA-HC-7817-01	TCGA-HC-7817-01	1B96882F-EE27-453F-84A4-83C09511A492	TCGA-HC-7817-01B-11D-A323-01	c995e591-f2b7-4c3e-ae81-9e72b9548b57	TCGA-HC-7817-01	TCGA-HC-7817-01	TCGA-HC-7817-01B-11D-A29Q-08		c995e591-f2b7-4c3e-ae81-9e72b9548b57
TCGA-HC-7818-01	0	TCGA-HC-7818-01	938	0	days	TCGA-HC-7818	938	0	days	938	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-HC-7818-F64380	TCGA-HC-7818	TCGA-HC-7818-01A			M0	T2b	-24391							0	938		99							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-29	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.2	NO	Bilateral	0.4	NO	YES				NO	6	0		No	N0	T2c	TCGA-HC-7818.e6f3745f-31bf-4475-85f8-956811ce6cb6.pdf		7818	TUMOR FREE	3	Complete Remission/Response	0.01	NO	R0	Primary Tumor	01	4	0.2		NO		YES	NO	HC	Apex|Middle|Base		Prostate		A	LIVING	2011		776e6a2e-e939-4c92-b8dc-000c91bf5f64	TCGA-HC-7818-01A-11D-2112-01	TCGA-HC-7818-01A-11D-2116-05		TCGA-HC-7818-01A-11D-2114-08	776e6a2e-e939-4c92-b8dc-000c91bf5f64	TCGA-HC-7818-01	TCGA-HC-7818-01		TCGA-HC-7818-01A-11D-2112-01	776e6a2e-e939-4c92-b8dc-000c91bf5f64	TCGA-HC-7818-01	TCGA-HC-7818-01	TCGA-HC-7818-01A-11D-2114-08	TCGA-HC-7818-01A-11D-2114-08	776e6a2e-e939-4c92-b8dc-000c91bf5f64
TCGA-HC-7819-01	0	TCGA-HC-7819-01	543	0	days	TCGA-HC-7819	543	0	days	543	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			53	TCGA-HC-7819-F56150	TCGA-HC-7819	TCGA-HC-7819-01A			M0	T2c	-19663					-73		0	543		172			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2014-1-29	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.3	NO	Bilateral	0.3	NO	YES				NO	3	0		No	N0	T2c	TCGA-HC-7819.ab62f75e-d1f0-47f7-8a78-4151af81d409.pdf		7819	TUMOR FREE	4	Complete Remission/Response	.01	NO	R2	Primary Tumor	01	4	0.3		NO	4	YES	NO	HC			Prostate		A	LIVING	2011	Central Zone	285a1a43-5494-49f4-95bb-671ebc1a953a	TCGA-HC-7819-01A-11D-2112-01	TCGA-HC-7819-01A-11D-2116-05		TCGA-HC-7819-01A-11D-2114-08	285a1a43-5494-49f4-95bb-671ebc1a953a	TCGA-HC-7819-01	TCGA-HC-7819-01		TCGA-HC-7819-01A-11D-2112-01	285a1a43-5494-49f4-95bb-671ebc1a953a	TCGA-HC-7819-01	TCGA-HC-7819-01	TCGA-HC-7819-01A-11D-2114-08		285a1a43-5494-49f4-95bb-671ebc1a953a
TCGA-HC-7819-11	0	TCGA-HC-7819-11	543	0	days	TCGA-HC-7819	543	0	days	543	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			53	TCGA-HC-7819-F56150	TCGA-HC-7819				M0	T2c	-19663					-73		0	543		172			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2014-1-29	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	3	0		No	N0	T2c			7819	TUMOR FREE	4	Complete Remission/Response	.01	NO	R2	Solid Tissue Normal	11	4			NO	4	YES	NO	HC			Prostate			LIVING	2011	Central Zone	e95f79a8-15ea-4b95-9f8e-b63ada04c51e		TCGA-HC-7819-11A-01D-2116-05			e95f79a8-15ea-4b95-9f8e-b63ada04c51e		TCGA-HC-7819-11			e95f79a8-15ea-4b95-9f8e-b63ada04c51e		TCGA-HC-7819-11			e95f79a8-15ea-4b95-9f8e-b63ada04c51e
TCGA-HC-7820-01	0	TCGA-HC-7820-01	747	0	days	TCGA-HC-7820	747	0	days	747	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			72	TCGA-HC-7820-F57012	TCGA-HC-7820	TCGA-HC-7820-01A					-26576							0	747									Scheduled Follow-up Submission	Complete Remission/Response	2014-2-28	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.3	NO	Bilateral	0.4	NO	NO				NO				No		T2c	TCGA-HC-7820.750c91eb-1732-4ca3-8c71-f1309a90e4f5.pdf		7820	TUMOR FREE	3	Complete Remission/Response		NO	R0	Primary Tumor	01	4	0.1		NO		YES	NO	HC			Prostate		A	LIVING	2011		297e88ae-4a8d-4021-825a-8a7d7e2f71d1	TCGA-HC-7820-01A-11D-2112-01	TCGA-HC-7820-01A-11D-2116-05		TCGA-HC-7820-01A-11D-2114-08	297e88ae-4a8d-4021-825a-8a7d7e2f71d1	TCGA-HC-7820-01	TCGA-HC-7820-01		TCGA-HC-7820-01A-11D-2112-01	297e88ae-4a8d-4021-825a-8a7d7e2f71d1	TCGA-HC-7820-01	TCGA-HC-7820-01	TCGA-HC-7820-01A-11D-2114-08	TCGA-HC-7820-01A-11D-2114-08	297e88ae-4a8d-4021-825a-8a7d7e2f71d1
TCGA-HC-7820-11	0	TCGA-HC-7820-11	747	0	days	TCGA-HC-7820	747	0	days	747	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			72	TCGA-HC-7820-F57012	TCGA-HC-7820	TCGA-HC-7820-11A					-26576							0	747									Scheduled Follow-up Submission	Complete Remission/Response	2014-2-28	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	0.9	NO	NO				NO				No		T2c			7820	TUMOR FREE	3	Complete Remission/Response		NO	R0	Solid Tissue Normal	11	4	0.4		NO		YES	NO	HC			Prostate		A	LIVING	2011				TCGA-HC-7820-11A-01D-2116-05													
TCGA-HC-7821-01	0	TCGA-HC-7821-01	956	0	days	TCGA-HC-7821			days	956	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	54	TCGA-HC-7821-F66038	TCGA-HC-7821		NO		M0		-19894						950	0	956		236							Scheduled Follow-up Submission	Progressive Disease	2014-10-1	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES		Biochemical evidence of disease		YES	7	2		Yes	N1	T3b			7821	WITH TUMOR	4	Complete Remission/Response	0.01	YES		Primary Tumor	01	4			YES		YES	NO	HC	Apex|Middle|Base		Prostate			LIVING	2011		df9ee925-86bc-4ccc-b308-0c7d6d1d4fd7	TCGA-HC-7821-01A-12D-2112-01	TCGA-HC-7821-01A-12D-2116-05		TCGA-HC-7821-01A-12D-2114-08	df9ee925-86bc-4ccc-b308-0c7d6d1d4fd7	TCGA-HC-7821-01	TCGA-HC-7821-01		TCGA-HC-7821-01A-12D-2112-01	df9ee925-86bc-4ccc-b308-0c7d6d1d4fd7	TCGA-HC-7821-01	TCGA-HC-7821-01	TCGA-HC-7821-01A-12D-2114-08	TCGA-HC-7821-01A-12D-2114-08	df9ee925-86bc-4ccc-b308-0c7d6d1d4fd7
TCGA-HC-8213-01	0	TCGA-HC-8213-01	589	0	days	TCGA-HC-8213	589	0	days	589	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			48	TCGA-HC-8213-F45567	TCGA-HC-8213	TCGA-HC-8213-01A					-17673							0	589									Scheduled Follow-up Submission	Complete Remission/Response	2013-7-17	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES			0.5	NO	Bilateral	0.7	NO	NO				NO				No		T2c	TCGA-HC-8213.E6CE4E34-DE42-455C-AD93-CCE42FCFE049.pdf		8213	TUMOR FREE	3	Complete Remission/Response		NO	R0	Primary Tumor	01	3	0.3		NO		YES	NO	HC			Prostate		A	LIVING	2011		61843a22-9a35-4370-a301-881d5c967d29	TCGA-HC-8213-01A-11D-A323-01	TCGA-HC-8213-01A-11D-A29T-05		TCGA-HC-8213-01A-11D-A29Q-08	61843a22-9a35-4370-a301-881d5c967d29	TCGA-HC-8213-01	TCGA-HC-8213-01		TCGA-HC-8213-01A-11D-A323-01	61843a22-9a35-4370-a301-881d5c967d29	TCGA-HC-8213-01	TCGA-HC-8213-01	TCGA-HC-8213-01A-11D-A29Q-08	TCGA-HC-8213-01A-11D-A29Q-08	61843a22-9a35-4370-a301-881d5c967d29
TCGA-HC-8216-01	0	TCGA-HC-8216-01	682	0	days	TCGA-HC-8216	682	0	days	682	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			58	TCGA-HC-8216-F48769	TCGA-HC-8216	TCGA-HC-8216-01A		Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-21428	10			10			0	682		137			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.3	NO	Right	0.4	NO	YES				NO	3	0		No	N0	T3a	TCGA-HC-8216.CD881D57-9CCB-4984-8C37-B3DDE9189814.pdf		8216	TUMOR FREE	4	Complete Remission/Response	.19	NO	R0	Primary Tumor	01	3	0.3		NO	5	YES	NO	HC	Middle|Base		Prostate		A	LIVING	2011		98021887-fb82-4cb4-a5f4-c4316901da21	TCGA-HC-8216-01A-11D-A323-01	TCGA-HC-8216-01A-11D-A29T-05		TCGA-HC-8216-01A-11D-A29Q-08	98021887-fb82-4cb4-a5f4-c4316901da21	TCGA-HC-8216-01	TCGA-HC-8216-01		TCGA-HC-8216-01A-11D-A323-01	98021887-fb82-4cb4-a5f4-c4316901da21	TCGA-HC-8216-01	TCGA-HC-8216-01	TCGA-HC-8216-01A-11D-A29Q-08	TCGA-HC-8216-01A-11D-A29Q-08	98021887-fb82-4cb4-a5f4-c4316901da21
TCGA-HC-8256-01	0	TCGA-HC-8256-01	860	0	days	TCGA-HC-8256	860	0	days	860	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			53	TCGA-HC-8256-F64369	TCGA-HC-8256				M0		-19598							0	860									Scheduled Follow-up Submission	Complete Remission/Response	2014-8-29	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	NO				NO				No		T2c			8256	TUMOR FREE	3	Complete Remission/Response		NO	R0	Primary Tumor	01	4			NO		YES	NO	HC			Prostate			LIVING	2011		c7ab83e0-85c1-4224-8f47-746221f66d1e	TCGA-HC-8256-01A-11D-2259-01	TCGA-HC-8256-01A-11D-2261-05		TCGA-HC-8256-01A-11D-2260-08	c7ab83e0-85c1-4224-8f47-746221f66d1e	TCGA-HC-8256-01	TCGA-HC-8256-01		TCGA-HC-8256-01A-11D-2259-01	c7ab83e0-85c1-4224-8f47-746221f66d1e	TCGA-HC-8256-01	TCGA-HC-8256-01	TCGA-HC-8256-01A-11D-2260-08	TCGA-HC-8256-01A-11D-2260-08	c7ab83e0-85c1-4224-8f47-746221f66d1e
TCGA-HC-8257-01	0	TCGA-HC-8257-01	726	0	days	TCGA-HC-8257	726	0	days	726	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			70	TCGA-HC-8257-F57852	TCGA-HC-8257	TCGA-HC-8257-01A	NO				-25629							0	726		726							Scheduled Follow-up Submission	Complete Remission/Response	2014-3-27	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES			0.3	NO	Bilateral	1.1	NO	YES				NO	8	1		No	N1	T3b	TCGA-HC-8257.ff35baf5-f38f-4458-8c20-c61d61c61c19.pdf		8257	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R1	Primary Tumor	01	4	0.1		YES		YES	NO	HC			Prostate		A	LIVING	2011		940cfbb0-1808-41e0-8b13-4447b0d3c8cc	TCGA-HC-8257-01A-11D-2259-01	TCGA-HC-8257-01A-11D-2261-05		TCGA-HC-8257-01A-11D-2260-08	940cfbb0-1808-41e0-8b13-4447b0d3c8cc	TCGA-HC-8257-01	TCGA-HC-8257-01		TCGA-HC-8257-01A-11D-2259-01	940cfbb0-1808-41e0-8b13-4447b0d3c8cc	TCGA-HC-8257-01	TCGA-HC-8257-01	TCGA-HC-8257-01A-11D-2260-08	TCGA-HC-8257-01A-11D-2260-08	940cfbb0-1808-41e0-8b13-4447b0d3c8cc
TCGA-HC-8258-01	0	TCGA-HC-8258-01	847	0	days	TCGA-HC-8258	847	0	days	847	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			56	TCGA-HC-8258-F48771	TCGA-HC-8258		NO				-20703							0	847		162							Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	2	0		No	N0	T2c			8258	TUMOR FREE	3	Complete Remission/Response	.01	NO		Primary Tumor	01	3			NO		YES	NO	HC			Prostate			LIVING	2011		b353ec8f-70d1-40a6-bf94-12662bd11146	TCGA-HC-8258-01A-11D-2259-01	TCGA-HC-8258-01B-05D-2299-05,TCGA-HC-8258-01A-11D-2261-05		TCGA-HC-8258-01A-11D-2260-08	b353ec8f-70d1-40a6-bf94-12662bd11146	TCGA-HC-8258-01	TCGA-HC-8258-01		TCGA-HC-8258-01A-11D-2259-01	b353ec8f-70d1-40a6-bf94-12662bd11146	TCGA-HC-8258-01	TCGA-HC-8258-01	TCGA-HC-8258-01B-05D-2298-08,TCGA-HC-8258-01A-11D-2260-08	TCGA-HC-8258-01A-11D-2260-08	b353ec8f-70d1-40a6-bf94-12662bd11146
TCGA-HC-8258-11	0	TCGA-HC-8258-11	847	0	days	TCGA-HC-8258	847	0	days	847	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			56	TCGA-HC-8258-F48771	TCGA-HC-8258	TCGA-HC-8258-11A	NO				-20703							0	847		162							Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	0.6	NO	YES				NO	2	0		No	N0	T2c			8258	TUMOR FREE	3	Complete Remission/Response	.01	NO		Solid Tissue Normal	11	3	0.3		NO		YES	NO	HC			Prostate		A	LIVING	2011		575740a1-6467-4f58-b462-6fd1a4f63c51					575740a1-6467-4f58-b462-6fd1a4f63c51		TCGA-HC-8258-11			575740a1-6467-4f58-b462-6fd1a4f63c51		TCGA-HC-8258-11			575740a1-6467-4f58-b462-6fd1a4f63c51
TCGA-HC-8259-01	0	TCGA-HC-8259-01	924	0	days	TCGA-HC-8259	924	0	days	924	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			50	TCGA-HC-8259-F66035	TCGA-HC-8259		NO		M0	T1c	-18309							0	924		123							Scheduled Follow-up Submission	Complete Remission/Response	2014-10-1	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Left		NO	NO				NO				No		T2a			8259	TUMOR FREE	3	Complete Remission/Response	0.01	NO	R0	Primary Tumor	01	3			NO		YES	NO	HC			Prostate			LIVING	2011		add784d0-7733-448c-a8b9-53442128d8ac	TCGA-HC-8259-01A-11D-2259-01	TCGA-HC-8259-01A-11D-2261-05		TCGA-HC-8259-01A-11D-2260-08	add784d0-7733-448c-a8b9-53442128d8ac	TCGA-HC-8259-01	TCGA-HC-8259-01		TCGA-HC-8259-01A-11D-2259-01	add784d0-7733-448c-a8b9-53442128d8ac	TCGA-HC-8259-01	TCGA-HC-8259-01	TCGA-HC-8259-01A-11D-2260-08		add784d0-7733-448c-a8b9-53442128d8ac
TCGA-HC-8259-11	0	TCGA-HC-8259-11	924	0	days	TCGA-HC-8259	924	0	days	924	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			50	TCGA-HC-8259-F66035	TCGA-HC-8259		NO		M0	T1c	-18309							0	924		123							Scheduled Follow-up Submission	Complete Remission/Response	2014-10-1	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Left		NO	NO				NO				No		T2a			8259	TUMOR FREE	3	Complete Remission/Response	0.01	NO	R0	Solid Tissue Normal	11	3			NO		YES	NO	HC			Prostate			LIVING	2011		b805e5e4-4d99-46c8-b308-11cac572ac42					b805e5e4-4d99-46c8-b308-11cac572ac42		TCGA-HC-8259-11			b805e5e4-4d99-46c8-b308-11cac572ac42		TCGA-HC-8259-11			b805e5e4-4d99-46c8-b308-11cac572ac42
TCGA-HC-8260-01	0	TCGA-HC-8260-01	686	0	days	TCGA-HC-8260	686	0	days	686	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			43	TCGA-HC-8260-F64387	TCGA-HC-8260	TCGA-HC-8260-01A	NO		M0		-15884							0	686		106							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-29	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	1	NO	YES				NO	9	0		No	N0	T2c	TCGA-HC-8260.12d41624-f0a9-4ba1-aa55-18fea0b733af.pdf		8260	TUMOR FREE	3	Complete Remission/Response	0.01	NO	R1	Primary Tumor	01	4	0.1		NO		YES	NO	HC	Apex		Prostate		A	LIVING	2011	Peripheral Zone	59a3d245-6921-4799-9eb7-1bff6021680f	TCGA-HC-8260-01A-11D-2259-01	TCGA-HC-8260-01A-11D-2261-05		TCGA-HC-8260-01A-11D-2260-08	59a3d245-6921-4799-9eb7-1bff6021680f	TCGA-HC-8260-01	TCGA-HC-8260-01		TCGA-HC-8260-01A-11D-2259-01	59a3d245-6921-4799-9eb7-1bff6021680f	TCGA-HC-8260-01	TCGA-HC-8260-01	TCGA-HC-8260-01A-11D-2260-08	TCGA-HC-8260-01A-11D-2260-08	59a3d245-6921-4799-9eb7-1bff6021680f
TCGA-HC-8260-11	0	TCGA-HC-8260-11	686	0	days	TCGA-HC-8260	686	0	days	686	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			43	TCGA-HC-8260-F64387	TCGA-HC-8260	TCGA-HC-8260-11A	NO		M0		-15884							0	686		106							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-29	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.6	NO	Bilateral	0.9	NO	YES				NO	9	0		No	N0	T2c			8260	TUMOR FREE	3	Complete Remission/Response	0.01	NO	R1	Solid Tissue Normal	11	4	0.3		NO		YES	NO	HC	Apex		Prostate		A	LIVING	2011	Peripheral Zone	094a8a62-d69a-4054-a9d8-120cf7920c39					094a8a62-d69a-4054-a9d8-120cf7920c39		TCGA-HC-8260-11			094a8a62-d69a-4054-a9d8-120cf7920c39		TCGA-HC-8260-11			094a8a62-d69a-4054-a9d8-120cf7920c39
TCGA-HC-8261-01	0	TCGA-HC-8261-01	546	0	days	TCGA-HC-8261	546	0	days	546	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			48	TCGA-HC-8261-F57017	TCGA-HC-8261	TCGA-HC-8261-01A					-17874							0	546									Scheduled Follow-up Submission	Complete Remission/Response	2014-2-28	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.3	NO	Bilateral	0.4	NO	NO				NO				No		T2c	TCGA-HC-8261.66690c59-06ae-4d5e-b862-3be6a11d67fb.pdf		8261	TUMOR FREE	3	Complete Remission/Response		NO	R0	Primary Tumor	01	4	0.2		NO		YES	NO	HC			Prostate		A	LIVING	2011		4a54f172-9435-4e46-8396-405634425db2	TCGA-HC-8261-01A-11D-2259-01	TCGA-HC-8261-01A-11D-2261-05,TCGA-HC-8261-01B-05D-2299-05		TCGA-HC-8261-01A-11D-2260-08	4a54f172-9435-4e46-8396-405634425db2	TCGA-HC-8261-01	TCGA-HC-8261-01		TCGA-HC-8261-01A-11D-2259-01	4a54f172-9435-4e46-8396-405634425db2	TCGA-HC-8261-01	TCGA-HC-8261-01	TCGA-HC-8261-01A-11D-2260-08,TCGA-HC-8261-01B-05D-2298-08	TCGA-HC-8261-01A-11D-2260-08	4a54f172-9435-4e46-8396-405634425db2
TCGA-HC-8262-01	0	TCGA-HC-8262-01	679	0	days	TCGA-HC-8262	679	0	days	679	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57	TCGA-HC-8262-F48770	TCGA-HC-8262		NO				-20946							0	679		112							Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	8	0		No	N0	T2c			8262	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	HC			Prostate			LIVING	2011		b081b1a5-2ab9-401b-a892-83e1d51ade54	TCGA-HC-8262-01A-11D-2259-01	TCGA-HC-8262-01A-11D-2261-05		TCGA-HC-8262-01A-11D-2260-08	b081b1a5-2ab9-401b-a892-83e1d51ade54	TCGA-HC-8262-01	TCGA-HC-8262-01		TCGA-HC-8262-01A-11D-2259-01	b081b1a5-2ab9-401b-a892-83e1d51ade54	TCGA-HC-8262-01	TCGA-HC-8262-01	TCGA-HC-8262-01A-11D-2260-08	TCGA-HC-8262-01A-11D-2260-08	b081b1a5-2ab9-401b-a892-83e1d51ade54
TCGA-HC-8262-11	0	TCGA-HC-8262-11	679	0	days	TCGA-HC-8262	679	0	days	679	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57	TCGA-HC-8262-F48770	TCGA-HC-8262	TCGA-HC-8262-11A	NO				-20946							0	679		112							Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	0.7	NO	YES				NO	8	0		No	N0	T2c			8262	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Solid Tissue Normal	11	4	0.3		NO		YES	NO	HC			Prostate		A	LIVING	2011		4979a47e-0078-40c7-abad-849dfd54263c					4979a47e-0078-40c7-abad-849dfd54263c		TCGA-HC-8262-11			4979a47e-0078-40c7-abad-849dfd54263c		TCGA-HC-8262-11			4979a47e-0078-40c7-abad-849dfd54263c
TCGA-HC-8264-01	0	TCGA-HC-8264-01	48	0	days	TCGA-HC-8264	48	0	days	48	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			60		TCGA-HC-8264	TCGA-HC-8264-01B					-22177							0	48											2013-1-25	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	1.2		YES				NO	2	1		No	N1	T3b	TCGA-HC-8264.147b5116-ae7b-4c43-8e6d-3a0064f28902.pdf		8264	WITH TUMOR	4				R1	Primary Tumor	01	5	0.5				YES	NO	HC			Prostate		B	LIVING	2011		9adad1de-52dd-48a2-b025-bc9081af4ac9	TCGA-HC-8264-01B-11D-2391-01	TCGA-HC-8264-01B-11D-2399-05		TCGA-HC-8264-01B-11D-2395-08	9adad1de-52dd-48a2-b025-bc9081af4ac9	TCGA-HC-8264-01	TCGA-HC-8264-01	3BDBE78B-8F80-44DC-91F0-9763A0A36F29	TCGA-HC-8264-01B-11D-2391-01	9adad1de-52dd-48a2-b025-bc9081af4ac9	TCGA-HC-8264-01	TCGA-HC-8264-01	TCGA-HC-8264-01B-11D-2395-08	TCGA-HC-8264-01B-11D-2395-08	9adad1de-52dd-48a2-b025-bc9081af4ac9
TCGA-HC-8265-01	0	TCGA-HC-8265-01	483	0	days	TCGA-HC-8265	483	0	days	483	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-HC-8265-F48767	TCGA-HC-8265		NO				-24382							0	483		119							Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	8	0		No	N0	T3a			8265	TUMOR FREE	3	Complete Remission/Response	0.1	YES	R1	Primary Tumor	01	5			NO		YES	NO	HC			Prostate			LIVING	2011		cefe4277-778b-42b3-8e05-5df8327f50be	TCGA-HC-8265-01A-11D-2259-01	TCGA-HC-8265-01A-11D-2261-05,TCGA-HC-8265-01B-04D-2299-05		TCGA-HC-8265-01A-11D-2260-08	cefe4277-778b-42b3-8e05-5df8327f50be	TCGA-HC-8265-01	TCGA-HC-8265-01		TCGA-HC-8265-01A-11D-2259-01	cefe4277-778b-42b3-8e05-5df8327f50be	TCGA-HC-8265-01	TCGA-HC-8265-01	TCGA-HC-8265-01B-04D-2298-08,TCGA-HC-8265-01A-11D-2260-08	TCGA-HC-8265-01A-11D-2260-08	cefe4277-778b-42b3-8e05-5df8327f50be
TCGA-HC-8266-01	0	TCGA-HC-8266-01	473	0	days	TCGA-HC-8266	473	0	days	473	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55	TCGA-HC-8266-F66043	TCGA-HC-8266	TCGA-HC-8266-01A			M0		-20280							0	473									Scheduled Follow-up Submission		2014-10-1	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES			0.5	NO	Bilateral	0.8	NO	YES				NO	5	0		No	N0	T3b	TCGA-HC-8266.cb8abdbd-c61d-4ad4-bd8b-a7e9dbc20d2d.pdf		8266	WITH TUMOR	4			NO	R1	Primary Tumor	01	4	0.2		NO		YES	NO	HC			Prostate		A	LIVING	2012		32798ff7-089c-46dc-afc3-1c3f3995ecf9	TCGA-HC-8266-01A-11D-2259-01	TCGA-HC-8266-01A-11D-2261-05		TCGA-HC-8266-01A-11D-2260-08	32798ff7-089c-46dc-afc3-1c3f3995ecf9	TCGA-HC-8266-01	TCGA-HC-8266-01		TCGA-HC-8266-01A-11D-2259-01	32798ff7-089c-46dc-afc3-1c3f3995ecf9	TCGA-HC-8266-01	TCGA-HC-8266-01	TCGA-HC-8266-01A-11D-2260-08	TCGA-HC-8266-01A-11D-2260-08	32798ff7-089c-46dc-afc3-1c3f3995ecf9
TCGA-HC-A48F-01	0	TCGA-HC-A48F-01	680	0	days	TCGA-HC-A48F	680	0	days	680	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			47	TCGA-HC-A48F-F64404	TCGA-HC-A48F			Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-17434	29			30			0	680					YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-8-29	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	10	1		No	N1	T2c			A48F	TUMOR FREE	4	Complete Remission/Response		YES	R1	Primary Tumor	01	4			YES		YES	NO	HC			Prostate			LIVING	2012	Overlapping / Multiple Zones	bc2bbaca-4bd5-4a3d-a93a-ebc1bc9f4d5f	TCGA-HC-A48F-01A-11D-A256-01	TCGA-HC-A48F-01A-11D-A258-05		TCGA-HC-A48F-01A-11D-A257-08	bc2bbaca-4bd5-4a3d-a93a-ebc1bc9f4d5f	TCGA-HC-A48F-01	TCGA-HC-A48F-01		TCGA-HC-A48F-01A-11D-A256-01	bc2bbaca-4bd5-4a3d-a93a-ebc1bc9f4d5f	TCGA-HC-A48F-01	TCGA-HC-A48F-01	TCGA-HC-A48F-01A-11D-A257-08	TCGA-HC-A48F-01A-11D-A257-08	bc2bbaca-4bd5-4a3d-a93a-ebc1bc9f4d5f
TCGA-HC-A4ZV-01	0	TCGA-HC-A4ZV-01	23	0	days	TCGA-HC-A4ZV	23	0	days	23	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			56		TCGA-HC-A4ZV	TCGA-HC-A4ZV-01A				T2c	-20634		79					0	23											2013-3-15	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	80		NO	Bilateral			YES				NO	13	0	false	No	N0	T3b	TCGA-HC-A4ZV.424EBA82-F32C-4387-B919-F7C8F1212232.pdf		A4ZV	WITH TUMOR	5				R1	Primary Tumor	01	4					YES	NO	HC			Prostate		A	LIVING	2012	Overlapping / Multiple Zones	2728c0e3-f8fe-4da4-96ec-885334df4e0f	TCGA-HC-A4ZV-01A-11D-A26L-01	TCGA-HC-A4ZV-01A-11D-A26N-05		TCGA-HC-A4ZV-01A-11D-A26M-08	2728c0e3-f8fe-4da4-96ec-885334df4e0f	TCGA-HC-A4ZV-01	TCGA-HC-A4ZV-01		TCGA-HC-A4ZV-01A-11D-A26L-01	2728c0e3-f8fe-4da4-96ec-885334df4e0f	TCGA-HC-A4ZV-01	TCGA-HC-A4ZV-01	TCGA-HC-A4ZV-01A-11D-A26M-08	TCGA-HC-A4ZV-01A-11D-A26M-08	2728c0e3-f8fe-4da4-96ec-885334df4e0f
TCGA-HC-A631-01	0	TCGA-HC-A631-01	54	0	days	TCGA-HC-A631	54	0	days	54	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			67		TCGA-HC-A631	TCGA-HC-A631-01A		Normal (no evidence of prostate cancer) [cM0]	M0	T2	-24749	25	101		21			0	54					YES	No Evidence of Extraprostatic Extension					2014-4-22	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	40		NO	Bilateral			YES				NO	2	0	false	No	N0	T2c	TCGA-HC-A631.70585F33-CB9E-4365-9CA2-E384BED102DD.pdf		A631	WITH TUMOR	4				R1	Primary Tumor	01	5				3	YES	NO	HC			Prostate		A	LIVING	2012		95086d05-3789-400a-b663-5d9d3a346325	TCGA-HC-A631-01A-11D-A323-01	TCGA-HC-A631-01A-11D-A29T-05		TCGA-HC-A631-01A-11D-A29Q-08	95086d05-3789-400a-b663-5d9d3a346325	TCGA-HC-A631-01	TCGA-HC-A631-01		TCGA-HC-A631-01A-11D-A323-01	95086d05-3789-400a-b663-5d9d3a346325	TCGA-HC-A631-01	TCGA-HC-A631-01	TCGA-HC-A631-01A-11D-A29Q-08	TCGA-HC-A631-01A-11D-A29Q-08	95086d05-3789-400a-b663-5d9d3a346325
TCGA-HC-A632-01	0	TCGA-HC-A632-01	61	0	days	TCGA-HC-A632	61	0	days	61	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			68		TCGA-HC-A632		NO		M0	T1c	-24916							0	61											2013-10-15	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral			YES				NO	5	0		No	N0	T3a			A632	TUMOR FREE	4				R0	Primary Tumor	01	5					YES	NO	HC			Prostate			LIVING	2013		e766089b-b399-4231-ad1a-139c4283a5bd	TCGA-HC-A632-01A-11D-A323-01	TCGA-HC-A632-01A-11D-A29T-05		TCGA-HC-A632-01A-11D-A29Q-08	e766089b-b399-4231-ad1a-139c4283a5bd	TCGA-HC-A632-01	TCGA-HC-A632-01		TCGA-HC-A632-01A-11D-A323-01	e766089b-b399-4231-ad1a-139c4283a5bd	TCGA-HC-A632-01	TCGA-HC-A632-01	TCGA-HC-A632-01A-11D-A29Q-08	TCGA-HC-A632-01A-11D-A29Q-08	e766089b-b399-4231-ad1a-139c4283a5bd
TCGA-HC-A6AL-01	0	TCGA-HC-A6AL-01	67	0	days	TCGA-HC-A6AL	67	0	days	67	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			64		TCGA-HC-A6AL	TCGA-HC-A6AL-01A			M0	T1c	-23618		224		21			0	67					YES	No Evidence of Extraprostatic Extension	NO				2013-9-19	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	50		NO	Bilateral			YES				NO	3	0	false	No	N0	T2c	TCGA-HC-A6AL.2A2BA0EA-C67A-4AA6-948C-019AA6475C06.pdf		A6AL	TUMOR FREE	3				R0	Primary Tumor	01	4					YES	NO	HC			Prostate		A	LIVING	2012		97ce2468-dfb0-41c5-903c-577728feff95	TCGA-HC-A6AL-01A-11D-A30D-01	TCGA-HC-A6AL-01A-11D-A30F-05		TCGA-HC-A6AL-01A-11D-A30E-08	97ce2468-dfb0-41c5-903c-577728feff95	TCGA-HC-A6AL-01	TCGA-HC-A6AL-01		TCGA-HC-A6AL-01A-11D-A30D-01	97ce2468-dfb0-41c5-903c-577728feff95	TCGA-HC-A6AL-01	TCGA-HC-A6AL-01	TCGA-HC-A6AL-01A-11D-A30E-08		97ce2468-dfb0-41c5-903c-577728feff95
TCGA-HC-A6AN-01	0	TCGA-HC-A6AN-01	49	0	days	TCGA-HC-A6AN	49	0	days	49	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			67		TCGA-HC-A6AN	TCGA-HC-A6AN-01A			M0	T1c	-24697		209					0	49											2014-4-22	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	20		NO	Bilateral			YES				NO	1	0	false	No	N0	T3a	TCGA-HC-A6AN.D5C8CC7E-BADE-457C-AC31-CC138C8C794C.pdf		A6AN	WITH TUMOR	4				R1	Primary Tumor	01	3					YES	NO	HC			Prostate		A	LIVING	2012		6af0bf8a-6243-493b-92f5-4ea2604d35cd	TCGA-HC-A6AN-01A-11D-A30D-01	TCGA-HC-A6AN-01A-11D-A30F-05		TCGA-HC-A6AN-01A-11D-A30E-08	6af0bf8a-6243-493b-92f5-4ea2604d35cd	TCGA-HC-A6AN-01	TCGA-HC-A6AN-01		TCGA-HC-A6AN-01A-11D-A30D-01	6af0bf8a-6243-493b-92f5-4ea2604d35cd	TCGA-HC-A6AN-01	TCGA-HC-A6AN-01	TCGA-HC-A6AN-01A-11D-A30E-08		6af0bf8a-6243-493b-92f5-4ea2604d35cd
TCGA-HC-A6AO-01	0	TCGA-HC-A6AO-01	530	0	days	TCGA-HC-A6AO	530	0	days	530	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			52	TCGA-HC-A6AO-F66036	TCGA-HC-A6AO	TCGA-HC-A6AO-01A			M0	T1c	-19298		301					0	530					NO		YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Scheduled Follow-up Submission	Complete Remission/Response	2014-10-1	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	30		NO	Bilateral		NO	NO				NO			false	No		T2c	TCGA-HC-A6AO.37F41695-9D8D-4CA1-9728-6A04AAD76274.pdf		A6AO	TUMOR FREE	4	Complete Remission/Response		NO	R0	Primary Tumor	01	3			NO		YES	NO	HC			Prostate		A	LIVING	2012		9ff2bdcd-1c48-4f81-8644-c302132b2400	TCGA-HC-A6AO-01A-11D-A30D-01	TCGA-HC-A6AO-01A-11D-A30F-05		TCGA-HC-A6AO-01A-11D-A30E-08	9ff2bdcd-1c48-4f81-8644-c302132b2400	TCGA-HC-A6AO-01	TCGA-HC-A6AO-01		TCGA-HC-A6AO-01A-11D-A30D-01	9ff2bdcd-1c48-4f81-8644-c302132b2400	TCGA-HC-A6AO-01	TCGA-HC-A6AO-01	TCGA-HC-A6AO-01A-11D-A30E-08		9ff2bdcd-1c48-4f81-8644-c302132b2400
TCGA-HC-A6AP-01	0	TCGA-HC-A6AP-01	71	0	days	TCGA-HC-A6AP	71	0	days	71	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61		TCGA-HC-A6AP	TCGA-HC-A6AP-01A			M0	T1c	-22318		182		15			0	71					YES	No Evidence of Extraprostatic Extension	NO				2013-9-19	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	40		NO	Bilateral			NO				NO			false	No		T2c	TCGA-HC-A6AP.7271E139-D1C7-4FB1-B148-54DE4A1DF42B.pdf		A6AP		3				RX	Primary Tumor	01	4					YES	NO	HC			Prostate		A	LIVING	2012	Overlapping / Multiple Zones	14b3c94a-781d-4df9-9ee6-a3236d099dc6	TCGA-HC-A6AP-01A-11D-A30D-01	TCGA-HC-A6AP-01A-11D-A30F-05		TCGA-HC-A6AP-01A-11D-A30E-08	14b3c94a-781d-4df9-9ee6-a3236d099dc6	TCGA-HC-A6AP-01	TCGA-HC-A6AP-01		TCGA-HC-A6AP-01A-11D-A30D-01	14b3c94a-781d-4df9-9ee6-a3236d099dc6	TCGA-HC-A6AP-01	TCGA-HC-A6AP-01	TCGA-HC-A6AP-01A-11D-A30E-08		14b3c94a-781d-4df9-9ee6-a3236d099dc6
TCGA-HC-A6AQ-01	0	TCGA-HC-A6AQ-01	106	0	days	TCGA-HC-A6AQ	106	0	days	106	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			60		TCGA-HC-A6AQ			Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22208	15						0	106					NO		NO				2013-9-19	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral			NO				NO				Yes, History of Prior Malignancy		T2c			A6AQ	TUMOR FREE	3				R0	Primary Tumor	01	4					YES	NO	HC			Prostate			LIVING	2012		deeaffd6-c733-4fc1-857e-693a49b73423	TCGA-HC-A6AQ-01A-11D-A30D-01	TCGA-HC-A6AQ-01A-11D-A30F-05		TCGA-HC-A6AQ-01A-11D-A30E-08	deeaffd6-c733-4fc1-857e-693a49b73423	TCGA-HC-A6AQ-01	TCGA-HC-A6AQ-01		TCGA-HC-A6AQ-01A-11D-A30D-01	deeaffd6-c733-4fc1-857e-693a49b73423	TCGA-HC-A6AQ-01	TCGA-HC-A6AQ-01	TCGA-HC-A6AQ-01A-11D-A30E-08		deeaffd6-c733-4fc1-857e-693a49b73423
TCGA-HC-A6AS-01	0	TCGA-HC-A6AS-01	44	0	days	TCGA-HC-A6AS	44	0	days	44	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			70		TCGA-HC-A6AS	TCGA-HC-A6AS-01A		Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-25661	27	127		27			0	44					YES	No Evidence of Extraprostatic Extension	NO				2013-9-19	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	30		NO	Right			YES				NO	5	0	false	No	N0	T2a	TCGA-HC-A6AS.89891821-AF8C-4105-8270-D6FCF714697F.pdf		A6AS	TUMOR FREE	3				R0	Primary Tumor	01	4					YES	NO	HC			Prostate		A	LIVING	2012		9605aa9b-2739-4d98-864d-fcfdb59b9ef5	TCGA-HC-A6AS-01A-11D-A30D-01	TCGA-HC-A6AS-01A-11D-A30F-05		TCGA-HC-A6AS-01A-11D-A30E-08	9605aa9b-2739-4d98-864d-fcfdb59b9ef5	TCGA-HC-A6AS-01	TCGA-HC-A6AS-01		TCGA-HC-A6AS-01A-11D-A30D-01	9605aa9b-2739-4d98-864d-fcfdb59b9ef5	TCGA-HC-A6AS-01	TCGA-HC-A6AS-01	TCGA-HC-A6AS-01A-11D-A30E-08		9605aa9b-2739-4d98-864d-fcfdb59b9ef5
TCGA-HC-A6HX-01	0	TCGA-HC-A6HX-01	38	0	days	TCGA-HC-A6HX	38	0	days	38	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55		TCGA-HC-A6HX	TCGA-HC-A6HX-01A			M0	T1c	-20263		112					0	38											2013-9-19	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	30		NO	Bilateral			YES				NO	4	0	false	No	N0	T2c	TCGA-HC-A6HX.0E22E3BE-B28B-40CC-83F9-9B59593B7187.pdf		A6HX	TUMOR FREE	4				R0	Primary Tumor	01	3				5	YES	NO	HC			Prostate		A	LIVING	2013		95fd9476-083d-41d5-a7dc-a605673b82d3	TCGA-HC-A6HX-01A-11D-A31K-01	TCGA-HC-A6HX-01A-11D-A31M-05		TCGA-HC-A6HX-01A-11D-A31L-08	95fd9476-083d-41d5-a7dc-a605673b82d3	TCGA-HC-A6HX-01	TCGA-HC-A6HX-01		TCGA-HC-A6HX-01A-11D-A31K-01	95fd9476-083d-41d5-a7dc-a605673b82d3	TCGA-HC-A6HX-01	TCGA-HC-A6HX-01	TCGA-HC-A6HX-01A-11D-A31L-08		95fd9476-083d-41d5-a7dc-a605673b82d3
TCGA-HC-A6HY-01	0	TCGA-HC-A6HY-01	134	0	days	TCGA-HC-A6HY	134	0	days	134	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			51		TCGA-HC-A6HY	TCGA-HC-A6HY-01A			M0	T1c	-18779		179		92			0	134					YES	No Evidence of Extraprostatic Extension					2013-9-19	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	50		NO	Bilateral			NO				NO			false	No		T2c	TCGA-HC-A6HY.91DC18E8-EF04-47C0-A77F-632A9DE2BA55.pdf		A6HY	TUMOR FREE	3				R0	Primary Tumor	01	4					YES	NO	HC			Prostate		A	LIVING	2012		027f330a-6206-4fd4-8790-8bb5e0207bc1	TCGA-HC-A6HY-01A-11D-A31K-01	TCGA-HC-A6HY-01A-11D-A31M-05		TCGA-HC-A6HY-01A-11D-A31L-08	027f330a-6206-4fd4-8790-8bb5e0207bc1	TCGA-HC-A6HY-01	TCGA-HC-A6HY-01		TCGA-HC-A6HY-01A-11D-A31K-01	027f330a-6206-4fd4-8790-8bb5e0207bc1	TCGA-HC-A6HY-01	TCGA-HC-A6HY-01	TCGA-HC-A6HY-01A-11D-A31L-08		027f330a-6206-4fd4-8790-8bb5e0207bc1
TCGA-HC-A76W-01	0	TCGA-HC-A76W-01	213	0	days	TCGA-HC-A76W	213	0	days	213	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			73		TCGA-HC-A76W	TCGA-HC-A76W-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2	-26755	62	260					0	213		213			NO		NO				2014-3-28	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	50		NO	Bilateral			YES				NO	4	0	true	Yes, History of Synchronous/Bilateral Malignancy	N0	T3b	TCGA-HC-A76W.C59C0C25-B1FC-45C5-AD7E-0FBA9574656C.pdf		A76W	WITH TUMOR	3		0.01		R1	Primary Tumor	01	4					YES	NO	HC	Apex|Middle|Base		Prostate		A	LIVING	2012		94399af6-33b3-4622-a5b1-d2e446061980	TCGA-HC-A76W-01A-11D-A33S-01	TCGA-HC-A76W-01A-11D-A33U-05		TCGA-HC-A76W-01A-11D-A33T-08	94399af6-33b3-4622-a5b1-d2e446061980	TCGA-HC-A76W-01	TCGA-HC-A76W-01		TCGA-HC-A76W-01A-11D-A33S-01	94399af6-33b3-4622-a5b1-d2e446061980	TCGA-HC-A76W-01	TCGA-HC-A76W-01		TCGA-HC-A76W-01A-11D-A33T-08	94399af6-33b3-4622-a5b1-d2e446061980
TCGA-HC-A76X-01	0	TCGA-HC-A76X-01	150	0	days	TCGA-HC-A76X	150	0	days	150	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			62		TCGA-HC-A76X	TCGA-HC-A76X-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22756	10	149					0	150		150									2014-3-28	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	60		NO	Bilateral			YES				NO	1	0	true	No	N0	T2c	TCGA-HC-A76X.DA72A108-04AA-424B-83EE-714036869E87.pdf		A76X	TUMOR FREE	3		0.01		R0	Primary Tumor	01	4					YES	NO	HC	Apex|Middle|Base		Prostate		A	LIVING	2013		99dd7197-d956-4e4f-aee1-e0362eef2e20	TCGA-HC-A76X-01A-11D-A33S-01	TCGA-HC-A76X-01A-11D-A33U-05		TCGA-HC-A76X-01A-11D-A33T-08	99dd7197-d956-4e4f-aee1-e0362eef2e20	TCGA-HC-A76X-01	TCGA-HC-A76X-01	43111791-46EE-45BD-813B-EF2A5619C40C	TCGA-HC-A76X-01A-11D-A33S-01	99dd7197-d956-4e4f-aee1-e0362eef2e20	TCGA-HC-A76X-01	TCGA-HC-A76X-01		TCGA-HC-A76X-01A-11D-A33T-08	99dd7197-d956-4e4f-aee1-e0362eef2e20
TCGA-HC-A8CY-01	0	TCGA-HC-A8CY-01	290	0	days	TCGA-HC-A8CY			days	290	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63		TCGA-HC-A8CY			Abnormal (not related to prostate cancer)	M0	T1c	-23154	41			41			0	290		290			YES	No Evidence of Extraprostatic Extension	NO				2014-3-28	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral			YES					3	1		No	N1	T3a			A8CY	WITH TUMOR	5		0.9		R1	Primary Tumor	01	4					YES	NO	HC			Prostate			LIVING	2013	Overlapping / Multiple Zones	d6c16450-87c1-4b18-bab5-8cb782fdb99c	TCGA-HC-A8CY-01A-11D-A363-01	TCGA-HC-A8CY-01A-11D-A365-05		TCGA-HC-A8CY-01A-11D-A364-08	d6c16450-87c1-4b18-bab5-8cb782fdb99c	TCGA-HC-A8CY-01	TCGA-HC-A8CY-01		TCGA-HC-A8CY-01A-11D-A363-01	d6c16450-87c1-4b18-bab5-8cb782fdb99c	TCGA-HC-A8CY-01	TCGA-HC-A8CY-01		TCGA-HC-A8CY-01A-11D-A364-08	d6c16450-87c1-4b18-bab5-8cb782fdb99c
TCGA-HC-A8D0-01	0	TCGA-HC-A8D0-01	775	0	days	TCGA-HC-A8D0	775	0	days	775	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61	TCGA-HC-A8D0-F68682	TCGA-HC-A8D0	TCGA-HC-A8D0-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22465	11	517		11	14		0	775		110			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2014-12-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	60		NO	Left		NO	YES				NO	10	0	false	No	N0	T2a	TCGA-HC-A8D0.E29BD9A6-B0F0-42D8-B952-85B71C3D5BC9.pdf		A8D0	TUMOR FREE	3	Complete Remission/Response	0.01	NO	R0	Primary Tumor	01	4			NO		YES	NO	HC	Apex|Middle		Prostate		A	LIVING	2012	Overlapping / Multiple Zones	1dd9dd18-3137-4515-9346-909e772b6ca8	TCGA-HC-A8D0-01A-11D-A363-01	TCGA-HC-A8D0-01A-11D-A365-05		TCGA-HC-A8D0-01A-11D-A364-08	1dd9dd18-3137-4515-9346-909e772b6ca8	TCGA-HC-A8D0-01	TCGA-HC-A8D0-01		TCGA-HC-A8D0-01A-11D-A363-01	1dd9dd18-3137-4515-9346-909e772b6ca8	TCGA-HC-A8D0-01	TCGA-HC-A8D0-01		TCGA-HC-A8D0-01A-11D-A364-08	1dd9dd18-3137-4515-9346-909e772b6ca8
TCGA-HC-A8D1-01	0	TCGA-HC-A8D1-01	573	0	days	TCGA-HC-A8D1	573	0	days	573	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			68	TCGA-HC-A8D1-F68683	TCGA-HC-A8D1		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2	-25137	14						0	573		168			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-12-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	6	0		No	N0	T2c			A8D1	TUMOR FREE	3	Complete Remission/Response	0.01	NO	R0	Primary Tumor	01	4			NO		YES	NO	HC			Prostate			LIVING	2012		f0c1b588-ebe6-4f6c-a013-c36091c8e29c	TCGA-HC-A8D1-01A-11D-A363-01	TCGA-HC-A8D1-01A-11D-A365-05		TCGA-HC-A8D1-01A-11D-A364-08	f0c1b588-ebe6-4f6c-a013-c36091c8e29c	TCGA-HC-A8D1-01	TCGA-HC-A8D1-01		TCGA-HC-A8D1-01A-11D-A363-01	f0c1b588-ebe6-4f6c-a013-c36091c8e29c	TCGA-HC-A8D1-01	TCGA-HC-A8D1-01		TCGA-HC-A8D1-01A-11D-A364-08	f0c1b588-ebe6-4f6c-a013-c36091c8e29c
TCGA-HC-A9TE-01	0	TCGA-HC-A9TE-01	587	0	days	TCGA-HC-A9TE	216	1	days	587	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	YES	64	TCGA-HC-A9TE-F72404	TCGA-HC-A9TE	TCGA-HC-A9TE-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-23543	13	159		16		216	0	587	216	134			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Stable Disease	2015-6-10	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Transurethral resection (TURBT)	50		NO	Bilateral		NO	YES	Other, specify	Biochemical evidence of disease	Biochemical	YES	7	1	false	No	N0	T3b	TCGA-HC-A9TE.BC2B6EED-5BD7-407D-AFAD-47A611F3C62C.pdf		A9TE	WITH TUMOR	5	Partial Remission/Response	0.064	NO	R1	Primary Tumor	01	4			NO	3	YES	NO	HC	Apex|Middle|Base	NO	Prostate		A	LIVING	2013	Overlapping / Multiple Zones	212f9e63-ba39-4765-8522-86833312f8db	TCGA-HC-A9TE-01A-11D-A41J-01	TCGA-HC-A9TE-01A-11D-A41L-05		TCGA-HC-A9TE-01A-11D-A41K-08	212f9e63-ba39-4765-8522-86833312f8db	TCGA-HC-A9TE-01	TCGA-HC-A9TE-01		TCGA-HC-A9TE-01A-11D-A41J-01	212f9e63-ba39-4765-8522-86833312f8db	TCGA-HC-A9TE-01	TCGA-HC-A9TE-01			212f9e63-ba39-4765-8522-86833312f8db
TCGA-HC-A9TH-01	0	TCGA-HC-A9TH-01	844	0	days	TCGA-HC-A9TH	351	1	days	844	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	NO	58	TCGA-HC-A9TH-F72401	TCGA-HC-A9TH	TCGA-HC-A9TH-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1b	-21460	155	320				351	0	844	351	295							Scheduled Follow-up Submission	Progressive Disease	2015-6-10	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Transurethral resection (TURBT)	60		NO	Bilateral		NO	YES	Other, specify	Biochemical evidence of disease	Biochemical	YES	2	0	false	No	N0	T3b	TCGA-HC-A9TH.C2755FC2-E4BD-4997-B2F9-1F1C3A9C28AE.pdf		A9TH	WITH TUMOR	5	Partial Remission/Response	0.38	NO	R1	Primary Tumor	01	4			NO	5	YES	NO	HC	Apex|Middle|Base	NO	Prostate		A	LIVING	2013		3d8c5a1e-618c-4a68-b9d7-d01a86ccf88b	TCGA-HC-A9TH-01A-11D-A41J-01	TCGA-HC-A9TH-01A-11D-A41L-05		TCGA-HC-A9TH-01A-11D-A41K-08	3d8c5a1e-618c-4a68-b9d7-d01a86ccf88b	TCGA-HC-A9TH-01	TCGA-HC-A9TH-01		TCGA-HC-A9TH-01A-11D-A41J-01	3d8c5a1e-618c-4a68-b9d7-d01a86ccf88b	TCGA-HC-A9TH-01	TCGA-HC-A9TH-01			3d8c5a1e-618c-4a68-b9d7-d01a86ccf88b
TCGA-HI-7168-01	0	TCGA-HI-7168-01	3323	0	days	TCGA-HI-7168	2505	1	days	3323	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	NO	62	TCGA-HI-7168-F66322	TCGA-HI-7168	TCGA-HI-7168-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22881	19				19	308	0	3323	2505	2289	1523		NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Progressive Disease	2014-10-10	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.3	NO	YES	Bone	Biochemical evidence of disease		YES	9	0		No	N0	T3b	TCGA-HI-7168.d29af7d7-996d-44a9-a571-878ea0f95403.pdf		7168	WITH TUMOR	4	Progressive Disease	0.3		R0	Primary Tumor	01	5	0.4				NO	YES	HI		YES	Prostate	Distant Metastasis	A	LIVING	2005		5ce29b9f-3b54-45a6-96e1-ddc3494e6141	TCGA-HI-7168-01A-11D-2112-01	TCGA-HI-7168-01A-11D-2116-05		TCGA-HI-7168-01A-11D-2114-08	5ce29b9f-3b54-45a6-96e1-ddc3494e6141	TCGA-HI-7168-01	TCGA-HI-7168-01	3B50FC1B-3EE6-455E-A5ED-DF54202C08F6	TCGA-HI-7168-01A-11D-2112-01	5ce29b9f-3b54-45a6-96e1-ddc3494e6141	TCGA-HI-7168-01	TCGA-HI-7168-01	TCGA-HI-7168-01A-11D-2114-08	TCGA-HI-7168-01A-11D-2114-08	5ce29b9f-3b54-45a6-96e1-ddc3494e6141
TCGA-HI-7169-01	0	TCGA-HI-7169-01	2684	0	days	TCGA-HI-7169	2684	0	days	2684	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55	TCGA-HI-7169-F29015	TCGA-HI-7169	TCGA-HI-7169-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-20133	33						0	2684		1941			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2012-2-21	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	1.3		YES				NO	4	0		No	N0	T3a	TCGA-HI-7169.ed386bc1-82a8-489e-81e0-53a93325a48e.pdf		7169	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R1	Primary Tumor	01	4	0.3		NO		NO	YES	HI	Apex		Prostate		A	LIVING	2006		70a93713-e154-46c8-9360-b873c63f0f05	TCGA-HI-7169-01A-11D-2112-01	TCGA-HI-7169-01A-11D-2116-05		TCGA-HI-7169-01A-11D-2114-08	70a93713-e154-46c8-9360-b873c63f0f05	TCGA-HI-7169-01	TCGA-HI-7169-01	32D75427-C6A9-41CD-BF22-B0866C862AFB	TCGA-HI-7169-01A-11D-2112-01	70a93713-e154-46c8-9360-b873c63f0f05	TCGA-HI-7169-01	TCGA-HI-7169-01	TCGA-HI-7169-01A-11D-2114-08		70a93713-e154-46c8-9360-b873c63f0f05
TCGA-HI-7170-01	0	TCGA-HI-7170-01	2522	0	days	TCGA-HI-7170	2522	0	days	2522	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			58	TCGA-HI-7170-F29013	TCGA-HI-7170	TCGA-HI-7170-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-21199	-96			-92	-78		0	2522		1746			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2012-2-21	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Transurethral resection (TURBT)		0.8	NO	Bilateral	1.3		YES				NO	6	0		No	N0	T2c	TCGA-HI-7170.96f2ece8-246a-43fe-8963-217613c84f0b.pdf		7170	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3	0.4		NO		NO	YES	HI	Apex		Prostate		A	LIVING	2006		f7ab806e-12d3-4dfc-90bf-cc49851cc34b	TCGA-HI-7170-01A-11D-2112-01	TCGA-HI-7170-01A-11D-2116-05		TCGA-HI-7170-01A-11D-2114-08	f7ab806e-12d3-4dfc-90bf-cc49851cc34b	TCGA-HI-7170-01	TCGA-HI-7170-01	9AEB253A-A8C4-449F-979B-74FB466A931E	TCGA-HI-7170-01A-11D-2112-01	f7ab806e-12d3-4dfc-90bf-cc49851cc34b	TCGA-HI-7170-01	TCGA-HI-7170-01	TCGA-HI-7170-01A-11D-2114-08	TCGA-HI-7170-01A-11D-2114-08	f7ab806e-12d3-4dfc-90bf-cc49851cc34b
TCGA-HI-7171-01	1	TCGA-HI-7171-01	1329	1	days	TCGA-HI-7171			days	1329	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	YES	56	TCGA-HI-7171-F29021	TCGA-HI-7171	TCGA-HI-7171-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-20776			1329			218	0			631	543	631	NO		YES	No Evidence of Extraprostatic Extension	Additional New Tumor Event	Progressive Disease	2012-2-22	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		1	NO	Bilateral	1.6		YES		Biochemical evidence of disease		YES	7	0		No	N0	T3b	TCGA-HI-7171.0bdd67bb-5cf4-4972-9ab6-9878c351857f.pdf		7171	WITH TUMOR	5	Stable Disease	0.7	NO	R1	Primary Tumor	01	4	0.3		NO		NO	YES	HI	Apex|Middle|Base		Prostate	Biochemical Recurrence	A	DECEASED	2008		2fbbb35f-15ae-43a1-bf6b-d3da0bbd38d4	TCGA-HI-7171-01A-12D-2112-01	TCGA-HI-7171-01A-12D-2116-05		TCGA-HI-7171-01A-12D-2114-08	2fbbb35f-15ae-43a1-bf6b-d3da0bbd38d4	TCGA-HI-7171-01	TCGA-HI-7171-01	D29A9541-89D3-46EF-A1C7-C01830B931CB	TCGA-HI-7171-01A-12D-2112-01	2fbbb35f-15ae-43a1-bf6b-d3da0bbd38d4	TCGA-HI-7171-01	TCGA-HI-7171-01	TCGA-HI-7171-01A-12D-2114-08	TCGA-HI-7171-01A-12D-2114-08	2fbbb35f-15ae-43a1-bf6b-d3da0bbd38d4
TCGA-J4-8198-01	0	TCGA-J4-8198-01	614	0	days	TCGA-J4-8198	614	0	days	614	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			49	TCGA-J4-8198-F55294	TCGA-J4-8198	TCGA-J4-8198-01A	NO		M0	T1c	-17935							0	614		76							Scheduled Follow-up Submission	Complete Remission/Response	2014-1-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.7	NO	Bilateral	0.8	NO	NO				NO				No		T3b	TCGA-J4-8198.c61b1da1-f0d2-48c9-ac71-5967799def29.pdf		8198	TUMOR FREE	4	Complete Remission/Response	0.1	NO		Primary Tumor	01	3	0.4		NO	5	YES	NO	J4	Apex|Middle|Base		Prostate		A	LIVING	2011		2cb1479d-b88e-42a6-a576-e519c98689ca	TCGA-J4-8198-01A-11D-2259-01	TCGA-J4-8198-01A-11D-2261-05		TCGA-J4-8198-01A-11D-2260-08	2cb1479d-b88e-42a6-a576-e519c98689ca	TCGA-J4-8198-01	TCGA-J4-8198-01	4872992E-43CD-4454-AEFE-31A3339F6687	TCGA-J4-8198-01A-11D-2259-01	2cb1479d-b88e-42a6-a576-e519c98689ca	TCGA-J4-8198-01	TCGA-J4-8198-01	TCGA-J4-8198-01A-11D-2260-08	TCGA-J4-8198-01A-11D-2260-08	2cb1479d-b88e-42a6-a576-e519c98689ca
TCGA-J4-8200-01	0	TCGA-J4-8200-01	1218	0	days	TCGA-J4-8200	1218	0	days	1218	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			47	TCGA-J4-8200-F70849	TCGA-J4-8200	TCGA-J4-8200-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2	-17167	41			41			0	1218		196			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy		0.5	NO	Bilateral	0.7	NO	YES				NO	4	0		No	N0	T2c	TCGA-J4-8200.5E18C318-D20B-4837-850D-34FD96C87EEC.pdf		8200	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4	0.4		NO		YES	NO	J4			Prostate		A	LIVING	2011	Overlapping / Multiple Zones	bcc096bf-c300-4e3d-b616-daee079938e6	TCGA-J4-8200-01A-11D-A323-01	TCGA-J4-8200-01A-11D-A29T-05		TCGA-J4-8200-01A-11D-A29Q-08	bcc096bf-c300-4e3d-b616-daee079938e6	TCGA-J4-8200-01	TCGA-J4-8200-01	1F9E72E0-4F30-43E7-9F49-71B40798BA3C	TCGA-J4-8200-01A-11D-A323-01	bcc096bf-c300-4e3d-b616-daee079938e6	TCGA-J4-8200-01	TCGA-J4-8200-01	TCGA-J4-8200-01A-11D-A29Q-08	TCGA-J4-8200-01A-11D-A29Q-08	bcc096bf-c300-4e3d-b616-daee079938e6
TCGA-J4-A67K-01	0	TCGA-J4-A67K-01	1004	0	days	TCGA-J4-A67K	1004	0	days	1004	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			68	TCGA-J4-A67K-F63849	TCGA-J4-A67K	TCGA-J4-A67K-01A	NO		M0	T2b	-24908		580					0	1004		557							Scheduled Follow-up Submission		2014-8-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	190		NO	Bilateral		NO	NO				NO			true	No		T2c	TCGA-J4-A67K.F8FF8077-8922-4CC8-95DD-4AF68CCC7EEC.pdf		A67K	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3			NO		YES	NO	J4			Prostate		A	LIVING	2011	Peripheral Zone	631b5e57-557b-48d1-a263-5c1b456e73b2	TCGA-J4-A67K-01A-21D-A30D-01	TCGA-J4-A67K-01A-21D-A30F-05		TCGA-J4-A67K-01A-21D-A30E-08	631b5e57-557b-48d1-a263-5c1b456e73b2	TCGA-J4-A67K-01	TCGA-J4-A67K-01	602816C4-4D5A-479F-B8A2-B77FCA6993DF	TCGA-J4-A67K-01A-21D-A30D-01	631b5e57-557b-48d1-a263-5c1b456e73b2	TCGA-J4-A67K-01	TCGA-J4-A67K-01	TCGA-J4-A67K-01A-21D-A30E-08		631b5e57-557b-48d1-a263-5c1b456e73b2
TCGA-J4-A67L-01	0	TCGA-J4-A67L-01	770	0	days	TCGA-J4-A67L	770	0	days	770	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			54	TCGA-J4-A67L-F63850	TCGA-J4-A67L	TCGA-J4-A67L-01A	NO		M0	T2a	-20034		485					0	770		518							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	70		NO	Left		NO	YES				NO	1	0	true	No	N0	T3a	TCGA-J4-A67L.91F854F5-D488-4B25-B59A-6CB59C6357BB.pdf		A67L	TUMOR FREE	3	Complete Remission/Response	.01	NO	R0	Primary Tumor	01	4			NO		YES	NO	J4	Apex|Middle|Base		Prostate		A	LIVING	2011	Peripheral Zone	1636e620-09c8-46c7-bf33-9efeceae7cd4	TCGA-J4-A67L-01A-11D-A30D-01	TCGA-J4-A67L-01A-11D-A30F-05		TCGA-J4-A67L-01A-11D-A30E-08	1636e620-09c8-46c7-bf33-9efeceae7cd4	TCGA-J4-A67L-01	TCGA-J4-A67L-01		TCGA-J4-A67L-01A-11D-A30D-01	1636e620-09c8-46c7-bf33-9efeceae7cd4	TCGA-J4-A67L-01	TCGA-J4-A67L-01	TCGA-J4-A67L-01A-11D-A30E-08		1636e620-09c8-46c7-bf33-9efeceae7cd4
TCGA-J4-A67M-01	0	TCGA-J4-A67M-01	941	0	days	TCGA-J4-A67M	941	0	days	941	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55	TCGA-J4-A67M-F63853	TCGA-J4-A67M	TCGA-J4-A67M-01A	NO		M0	T2a	-20211		482					0	941		482							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	320		NO	Bilateral		NO	YES				NO	6	0	true	No	N0	T3a	TCGA-J4-A67M.590FEE5C-E5FF-4DB2-8A7E-6502E5B9A56B.pdf		A67M	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3			NO		YES	NO	J4	Apex|Middle|Base		Prostate		A	LIVING	2011	Peripheral Zone	2ccc0221-155e-47b1-ace4-6c78bfc5d4a4	TCGA-J4-A67M-01A-11D-A30D-01	TCGA-J4-A67M-01A-11D-A30F-05		TCGA-J4-A67M-01A-11D-A30E-08	2ccc0221-155e-47b1-ace4-6c78bfc5d4a4	TCGA-J4-A67M-01	TCGA-J4-A67M-01	D29C229D-DE77-4076-A5FB-47C4829740BB	TCGA-J4-A67M-01A-11D-A30D-01	2ccc0221-155e-47b1-ace4-6c78bfc5d4a4	TCGA-J4-A67M-01	TCGA-J4-A67M-01	TCGA-J4-A67M-01A-11D-A30E-08		2ccc0221-155e-47b1-ace4-6c78bfc5d4a4
TCGA-J4-A67N-01	0	TCGA-J4-A67N-01	937	0	days	TCGA-J4-A67N	442	1	days	937	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	61	TCGA-J4-A67N-F59131	TCGA-J4-A67N	TCGA-J4-A67N-01A	YES		M0	T2a	-22420		504				442	0	937	442	503	503						Scheduled Follow-up Submission		2014-8-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	420		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	8	0	true	No	N0	T3a	TCGA-J4-A67N.70E5E77E-6B59-40A7-8E87-456EF28AED98.pdf		A67N	WITH TUMOR	3	Complete Remission/Response	0.7	NO	R0	Primary Tumor	01	4			NO		YES	NO	J4	Apex|Middle|Base		Prostate		A	LIVING	2011	Peripheral Zone	0c925aa2-8118-498b-8b5f-17740005df68	TCGA-J4-A67N-01A-11D-A30D-01	TCGA-J4-A67N-01A-11D-A30F-05		TCGA-J4-A67N-01A-11D-A30E-08	0c925aa2-8118-498b-8b5f-17740005df68	TCGA-J4-A67N-01	TCGA-J4-A67N-01	74C0C27D-709E-4C30-88C9-F2B79F1338C3	TCGA-J4-A67N-01A-11D-A30D-01	0c925aa2-8118-498b-8b5f-17740005df68	TCGA-J4-A67N-01	TCGA-J4-A67N-01	TCGA-J4-A67N-01A-11D-A30E-08		0c925aa2-8118-498b-8b5f-17740005df68
TCGA-J4-A67O-01	0	TCGA-J4-A67O-01	839	0	days	TCGA-J4-A67O	839	0	days	839	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			59	TCGA-J4-A67O-F63884	TCGA-J4-A67O	TCGA-J4-A67O-01A	NO		M0	T2a	-21714		392					0	839		490							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	250		NO	Bilateral		NO	YES				NO	2	0	true	No	N0	T2c	TCGA-J4-A67O.BF98B941-3DEB-46EB-803D-4A4AF49F529E.pdf		A67O	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	J4	Apex		Prostate		A	LIVING	2012	Peripheral Zone	e1fd847f-23c7-4baa-a7ff-d0954d855d1a	TCGA-J4-A67O-01A-11D-A30D-01	TCGA-J4-A67O-01A-11D-A30F-05		TCGA-J4-A67O-01A-11D-A30E-08	e1fd847f-23c7-4baa-a7ff-d0954d855d1a	TCGA-J4-A67O-01	TCGA-J4-A67O-01	4BBFB22E-7BBB-404D-9610-C34F9AD3073D	TCGA-J4-A67O-01A-11D-A30D-01	e1fd847f-23c7-4baa-a7ff-d0954d855d1a	TCGA-J4-A67O-01	TCGA-J4-A67O-01	TCGA-J4-A67O-01A-11D-A30E-08		e1fd847f-23c7-4baa-a7ff-d0954d855d1a
TCGA-J4-A67Q-01	0	TCGA-J4-A67Q-01	975	0	days	TCGA-J4-A67Q	975	0	days	975	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			77	TCGA-J4-A67Q-F63912	TCGA-J4-A67Q	TCGA-J4-A67Q-01A	NO		M0	T2b	-28447		584					0	975		616							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-21	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	140		NO	Bilateral		NO	NO				NO			true	No		T2c	TCGA-J4-A67Q.E7702E20-7616-4A88-862B-E860045E9C81.pdf		A67Q	TUMOR FREE	3	Complete Remission/Response	0.1	NO		Primary Tumor	01	3			NO		YES	NO	J4	Apex|Middle		Prostate		A	LIVING	2011	Peripheral Zone	1b57a251-d1ee-4635-b3f8-8109ddbabf7d	TCGA-J4-A67Q-01A-21D-A30D-01	TCGA-J4-A67Q-01A-21D-A30F-05		TCGA-J4-A67Q-01A-21D-A30E-08	1b57a251-d1ee-4635-b3f8-8109ddbabf7d	TCGA-J4-A67Q-01	TCGA-J4-A67Q-01	0A2BE409-A60C-48FA-BD03-84E82385B1E8	TCGA-J4-A67Q-01A-21D-A30D-01	1b57a251-d1ee-4635-b3f8-8109ddbabf7d	TCGA-J4-A67Q-01	TCGA-J4-A67Q-01	TCGA-J4-A67Q-01A-21D-A30E-08		1b57a251-d1ee-4635-b3f8-8109ddbabf7d
TCGA-J4-A67R-01	0	TCGA-J4-A67R-01	910	0	days	TCGA-J4-A67R	910	0	days	910	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			65	TCGA-J4-A67R-F63916	TCGA-J4-A67R	TCGA-J4-A67R-01A	NO		M0	T1c	-23807		440					0	910		454							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-21	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	80		NO	Bilateral		NO	YES				NO	4	0	true	No	N0	T2c	TCGA-J4-A67R.EAFE4CB1-BB7F-4D26-851D-49ECE5A73750.pdf		A67R	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3			NO		YES	NO	J4	Middle|Base		Prostate		A	LIVING	2012	Peripheral Zone	5a96d821-45e8-4d06-89c3-1f951c04375d	TCGA-J4-A67R-01A-21D-A30D-01	TCGA-J4-A67R-01A-21D-A30F-05		TCGA-J4-A67R-01A-21D-A30E-08	5a96d821-45e8-4d06-89c3-1f951c04375d	TCGA-J4-A67R-01	TCGA-J4-A67R-01	040D0D07-1872-426D-AB68-3D598B46AC86	TCGA-J4-A67R-01A-21D-A30D-01	5a96d821-45e8-4d06-89c3-1f951c04375d	TCGA-J4-A67R-01	TCGA-J4-A67R-01	TCGA-J4-A67R-01A-21D-A30E-08		5a96d821-45e8-4d06-89c3-1f951c04375d
TCGA-J4-A67S-01	0	TCGA-J4-A67S-01	833	0	days	TCGA-J4-A67S	708	1	days	833	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	63	TCGA-J4-A67S-F63921	TCGA-J4-A67S	TCGA-J4-A67S-01A	NO		M0	T2b	-23332		427				708	0	833	708	522							Scheduled Follow-up Submission	Progressive Disease	2014-8-21	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	50		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	3	0	true	No	N0	T3a	TCGA-J4-A67S.D5BC3AA7-D957-4291-8A6B-D148AA7CA909.pdf		A67S	WITH TUMOR	3	Complete Remission/Response	0.1	NO	R1	Primary Tumor	01	4			NO		YES	NO	J4	Apex|Middle|Base		Prostate		A	LIVING	2012	Peripheral Zone	0eb9fc91-e56d-496b-9ecf-683a4d4d6fa1	TCGA-J4-A67S-01A-11D-A30D-01	TCGA-J4-A67S-01A-11D-A30F-05		TCGA-J4-A67S-01A-11D-A30E-08	0eb9fc91-e56d-496b-9ecf-683a4d4d6fa1	TCGA-J4-A67S-01	TCGA-J4-A67S-01		TCGA-J4-A67S-01A-11D-A30D-01	0eb9fc91-e56d-496b-9ecf-683a4d4d6fa1	TCGA-J4-A67S-01	TCGA-J4-A67S-01	TCGA-J4-A67S-01A-11D-A30E-08		0eb9fc91-e56d-496b-9ecf-683a4d4d6fa1
TCGA-J4-A67T-01	0	TCGA-J4-A67T-01	183	0	days	TCGA-J4-A67T	183	0	days	183	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63	TCGA-J4-A67T-F63922	TCGA-J4-A67T	TCGA-J4-A67T-01A	NO		M0	T1c	-23211		409					0	183		154							Scheduled Follow-up Submission		2014-8-21	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	490		NO	Bilateral		YES	NO				NO			true	No		T2c	TCGA-J4-A67T.8E3BAF97-3B7F-4B3A-BC88-BACB5A716DFD.pdf		A67T	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	J4	Apex|Middle		Prostate		A	LIVING	2012	Peripheral Zone	d268f4e1-937a-40a8-b058-a87949bedd8b	TCGA-J4-A67T-01A-11D-A30W-01	TCGA-J4-A67T-01A-11D-A30Z-05		TCGA-J4-A67T-01A-11D-A30X-08	d268f4e1-937a-40a8-b058-a87949bedd8b	TCGA-J4-A67T-01	TCGA-J4-A67T-01	0BD80A62-B5B5-40B4-8FC1-DB735D692B75	TCGA-J4-A67T-01A-11D-A30W-01	d268f4e1-937a-40a8-b058-a87949bedd8b	TCGA-J4-A67T-01	TCGA-J4-A67T-01	TCGA-J4-A67T-01A-11D-A30X-08	TCGA-J4-A67T-01A-11D-A30X-08	d268f4e1-937a-40a8-b058-a87949bedd8b
TCGA-J4-A6G1-01	0	TCGA-J4-A6G1-01	769	0	days	TCGA-J4-A6G1	769	0	days	769	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			68	TCGA-J4-A6G1-F63926	TCGA-J4-A6G1		NO		M0	T2b	-24945					34		0	769		178					YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Scheduled Follow-up Submission	Complete Remission/Response	2014-8-21	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	2	0		No	N0	T3a			A6G1	TUMOR FREE	4	Complete Remission/Response	0.1	YES	R0	Primary Tumor	01	4			NO	3	YES	NO	J4			Prostate			LIVING	2012	Peripheral Zone	a9444bb5-5136-4a9a-b734-167ce00dd040	TCGA-J4-A6G1-01A-11D-A30W-01	TCGA-J4-A6G1-01A-11D-A30Z-05		TCGA-J4-A6G1-01A-11D-A30X-08	a9444bb5-5136-4a9a-b734-167ce00dd040	TCGA-J4-A6G1-01	TCGA-J4-A6G1-01		TCGA-J4-A6G1-01A-11D-A30W-01	a9444bb5-5136-4a9a-b734-167ce00dd040	TCGA-J4-A6G1-01	TCGA-J4-A6G1-01	TCGA-J4-A6G1-01A-11D-A30X-08	TCGA-J4-A6G1-01A-11D-A30X-08	a9444bb5-5136-4a9a-b734-167ce00dd040
TCGA-J4-A6G3-01	0	TCGA-J4-A6G3-01	849	0	days	TCGA-J4-A6G3	618	1	days	849	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	NO	57	TCGA-J4-A6G3-F63927	TCGA-J4-A6G3	TCGA-J4-A6G3-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2	-20836	17	479			15	618	0	849	618	528			NO		YES	Extraprostatic Extension Localized (e.g. seminal vesicles)|Extraprostatic Extension (regional lymphadenopathy) [e.g. cN1]	Scheduled Follow-up Submission		2014-8-21	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	80		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	5	0	true	No	N0	T3b	TCGA-J4-A6G3.63F0D5A2-CCAB-48C7-9BD9-F75A699DE1AD.pdf		A6G3	WITH TUMOR	4	Partial Remission/Response	0.4	YES	R1	Primary Tumor	01	4			NO		YES	NO	J4			Prostate		A	LIVING	2012	Peripheral Zone	613b606c-0d1e-49ff-bd2b-30fa17b14fb6	TCGA-J4-A6G3-01A-11D-A30W-01	TCGA-J4-A6G3-01A-11D-A30Z-05		TCGA-J4-A6G3-01A-11D-A30X-08	613b606c-0d1e-49ff-bd2b-30fa17b14fb6	TCGA-J4-A6G3-01	TCGA-J4-A6G3-01		TCGA-J4-A6G3-01A-11D-A30W-01	613b606c-0d1e-49ff-bd2b-30fa17b14fb6	TCGA-J4-A6G3-01	TCGA-J4-A6G3-01	TCGA-J4-A6G3-01A-11D-A30X-08	TCGA-J4-A6G3-01A-11D-A30X-08	613b606c-0d1e-49ff-bd2b-30fa17b14fb6
TCGA-J4-A6M7-01	0	TCGA-J4-A6M7-01	512	0	days	TCGA-J4-A6M7	512	0	days	512	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			53	TCGA-J4-A6M7-F63950	TCGA-J4-A6M7	TCGA-J4-A6M7-01A	NO		M0	T2	-19640		309					0	512		279							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-21	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	220		NO	Bilateral		NO	NO				NO			true	No		T2c	TCGA-J4-A6M7.F717DD9D-074A-4252-9125-C00A3DE587B0.pdf		A6M7	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	J4	Apex|Middle		Prostate		A	LIVING	2012	Peripheral Zone	b6d9a928-0ecb-43c7-b88a-0179e524a7c2	TCGA-J4-A6M7-01A-11D-A31K-01	TCGA-J4-A6M7-01A-11D-A31M-05		TCGA-J4-A6M7-01A-11D-A31L-08	b6d9a928-0ecb-43c7-b88a-0179e524a7c2	TCGA-J4-A6M7-01	TCGA-J4-A6M7-01	883FCEB6-E39B-4FDB-853F-4C2B8CD97044	TCGA-J4-A6M7-01A-11D-A31K-01	b6d9a928-0ecb-43c7-b88a-0179e524a7c2	TCGA-J4-A6M7-01	TCGA-J4-A6M7-01	TCGA-J4-A6M7-01A-11D-A31L-08	TCGA-J4-A6M7-01A-11D-A31L-08	b6d9a928-0ecb-43c7-b88a-0179e524a7c2
TCGA-J4-A83I-01	0	TCGA-J4-A83I-01	685	0	days	TCGA-J4-A83I	685	0	days	685	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63	TCGA-J4-A83I-F70492	TCGA-J4-A83I	TCGA-J4-A83I-01A	NO		M0	T1c	-23240		183					0	685		257							Scheduled Follow-up Submission	Complete Remission/Response	2015-2-25	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	100		NO	Bilateral		NO	YES				NO	2	0	true	No	N0	T3a	TCGA-J4-A83I.E3AFE230-AE22-4120-BC42-7FE78FCB06A2.pdf		A83I	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3			NO		YES	NO	J4	Apex|Middle|Base		Prostate		A	LIVING	2013	Peripheral Zone	4dc2d981-d303-4dd8-8ef5-1d1bcd0e8250	TCGA-J4-A83I-01A-11D-A363-01	TCGA-J4-A83I-01A-11D-A365-05		TCGA-J4-A83I-01A-11D-A364-08	4dc2d981-d303-4dd8-8ef5-1d1bcd0e8250	TCGA-J4-A83I-01	TCGA-J4-A83I-01	026361DD-0522-4172-8613-D328607F914A	TCGA-J4-A83I-01A-11D-A363-01	4dc2d981-d303-4dd8-8ef5-1d1bcd0e8250	TCGA-J4-A83I-01	TCGA-J4-A83I-01		TCGA-J4-A83I-01A-11D-A364-08	4dc2d981-d303-4dd8-8ef5-1d1bcd0e8250
TCGA-J4-A83J-01	0	TCGA-J4-A83J-01	696	0	days	TCGA-J4-A83J	696	0	days	696	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			68	TCGA-J4-A83J-F70133	TCGA-J4-A83J	TCGA-J4-A83J-01A	NO		M0	T1c	-24960		272					0	696		235							Scheduled Follow-up Submission	Complete Remission/Response	2015-1-28	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	210		NO	Bilateral		NO	YES				NO	1	0	true	No	N0	T2c	TCGA-J4-A83J.D3FF2CCF-E6D0-4C8A-9159-F78176E7EE59.pdf		A83J	TUMOR FREE	3	Complete Remission/Response	0.04	NO	R1	Primary Tumor	01	4			NO		YES	NO	J4	Apex|Middle|Base		Prostate		A	LIVING	2013	Peripheral Zone	2bbec916-3c74-45b7-9eab-76022899fe7d	TCGA-J4-A83J-01A-11D-A363-01	TCGA-J4-A83J-01A-11D-A365-05		TCGA-J4-A83J-01A-11D-A364-08	2bbec916-3c74-45b7-9eab-76022899fe7d	TCGA-J4-A83J-01	TCGA-J4-A83J-01	B2AFB3F8-2683-4C92-8227-4A61741F72F0	TCGA-J4-A83J-01A-11D-A363-01	2bbec916-3c74-45b7-9eab-76022899fe7d	TCGA-J4-A83J-01	TCGA-J4-A83J-01			2bbec916-3c74-45b7-9eab-76022899fe7d
TCGA-J4-A83J-11	0	TCGA-J4-A83J-11	696	0	days	TCGA-J4-A83J	696	0	days	696	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			68	TCGA-J4-A83J-F70133	TCGA-J4-A83J	TCGA-J4-A83J-11A	NO		M0	T1c	-24960		272					0	696		235							Scheduled Follow-up Submission	Complete Remission/Response	2015-1-28	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	220		NO	Bilateral		NO	YES				NO	1	0	true	No	N0	T2c			A83J	TUMOR FREE	3	Complete Remission/Response	0.04	NO	R1	Solid Tissue Normal	11	4			NO		YES	NO	J4	Apex|Middle|Base		Prostate		A	LIVING	2013	Peripheral Zone	6c5a212a-4dab-45a5-854d-296f0a6ee7c3					6c5a212a-4dab-45a5-854d-296f0a6ee7c3		TCGA-J4-A83J-11			6c5a212a-4dab-45a5-854d-296f0a6ee7c3		TCGA-J4-A83J-11			6c5a212a-4dab-45a5-854d-296f0a6ee7c3
TCGA-J4-A83K-01	0	TCGA-J4-A83K-01	328	0	days	TCGA-J4-A83K	328	0	days	328	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			52	TCGA-J4-A83K-F63953	TCGA-J4-A83K		NO		M0	T1c	-19299							0	328		205							Scheduled Follow-up Submission	Complete Remission/Response	2014-8-21	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	NO				NO				No		T2c			A83K	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3			NO		YES	NO	J4	Apex|Middle|Base		Prostate			LIVING	2013	Peripheral Zone	c16ddaf4-4bfe-4917-a208-aa5a89beb17e	TCGA-J4-A83K-01A-11D-A34T-01	TCGA-J4-A83K-01A-11D-A34V-05		TCGA-J4-A83K-01A-11D-A34U-08	c16ddaf4-4bfe-4917-a208-aa5a89beb17e	TCGA-J4-A83K-01	TCGA-J4-A83K-01		TCGA-J4-A83K-01A-11D-A34T-01	c16ddaf4-4bfe-4917-a208-aa5a89beb17e	TCGA-J4-A83K-01	TCGA-J4-A83K-01		TCGA-J4-A83K-01A-11D-A34U-08	c16ddaf4-4bfe-4917-a208-aa5a89beb17e
TCGA-J4-A83L-01	0	TCGA-J4-A83L-01	720	0	days	TCGA-J4-A83L	720	0	days	720	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61	TCGA-J4-A83L-F70493	TCGA-J4-A83L	TCGA-J4-A83L-01A	NO		M0	T1c	-22338		218					0	720		316							Scheduled Follow-up Submission	Complete Remission/Response	2015-2-18	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	50		NO	Bilateral		NO	YES				NO	5	0	true	No	N0	T2c	TCGA-J4-A83L.837A4811-0DAF-46F6-9C84-D2BBFFC56AF0.pdf		A83L	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	J4	Apex|Middle|Base		Prostate		A	LIVING	2013	Central Zone	2345f76d-8250-4586-a15a-633ac5abc070	TCGA-J4-A83L-01A-11D-A34T-01	TCGA-J4-A83L-01A-11D-A34V-05		TCGA-J4-A83L-01A-11D-A34U-08	2345f76d-8250-4586-a15a-633ac5abc070	TCGA-J4-A83L-01	TCGA-J4-A83L-01		TCGA-J4-A83L-01A-11D-A34T-01	2345f76d-8250-4586-a15a-633ac5abc070	TCGA-J4-A83L-01	TCGA-J4-A83L-01			2345f76d-8250-4586-a15a-633ac5abc070
TCGA-J4-A83M-01	0	TCGA-J4-A83M-01	543	0	days	TCGA-J4-A83M	521	1	days	543	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	YES	64	TCGA-J4-A83M-F70485	TCGA-J4-A83M	TCGA-J4-A83M-01A	NO		M0	T2c	-23624		412				521	0	543	521	437							Scheduled Follow-up Submission	Partial Remission/Response	2015-2-18	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	40		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	4	0	true	No	N0	T2c	TCGA-J4-A83M.8AA3EBE4-49E8-4D0A-A3A4-B51E41B3AA4F.pdf		A83M		4	Complete Remission/Response	0.2	YES	R1	Primary Tumor	01	3			NO		YES	NO	J4	Apex|Middle		Prostate		A	LIVING	2012	Peripheral Zone	8ab941c0-6e1c-403c-901d-03ac81bbb81f	TCGA-J4-A83M-01A-11D-A34T-01	TCGA-J4-A83M-01A-11D-A34V-05		TCGA-J4-A83M-01A-11D-A34U-08	8ab941c0-6e1c-403c-901d-03ac81bbb81f	TCGA-J4-A83M-01	TCGA-J4-A83M-01		TCGA-J4-A83M-01A-11D-A34T-01	8ab941c0-6e1c-403c-901d-03ac81bbb81f	TCGA-J4-A83M-01	TCGA-J4-A83M-01		TCGA-J4-A83M-01A-11D-A34U-08	8ab941c0-6e1c-403c-901d-03ac81bbb81f
TCGA-J4-A83N-01	0	TCGA-J4-A83N-01	992	0	days	TCGA-J4-A83N	433	1	days	992	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	YES	57	TCGA-J4-A83N-F70169	TCGA-J4-A83N	TCGA-J4-A83N-01A	NO		M0	T1c	-20841		519					0	992	433	530							Scheduled Follow-up Submission	Progressive Disease	2015-1-29	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	240		NO	Bilateral		NO	NO		New Primary Tumor		YES			true	No		T2c	TCGA-J4-A83N.C40A9D7F-BFEC-4C07-A1C3-A34706E39713.pdf		A83N	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO		YES	NO	J4	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones	f01339fa-0c8b-440f-98d2-9f7365e0cc9b	TCGA-J4-A83N-01A-11D-A34T-01	TCGA-J4-A83N-01A-11D-A34V-05		TCGA-J4-A83N-01A-11D-A34U-08	f01339fa-0c8b-440f-98d2-9f7365e0cc9b	TCGA-J4-A83N-01	TCGA-J4-A83N-01	E949D28E-5B2A-4987-8845-B17F5F98BAD5	TCGA-J4-A83N-01A-11D-A34T-01	f01339fa-0c8b-440f-98d2-9f7365e0cc9b	TCGA-J4-A83N-01	TCGA-J4-A83N-01		TCGA-J4-A83N-01A-11D-A34U-08	f01339fa-0c8b-440f-98d2-9f7365e0cc9b
TCGA-J4-AATV-01	0	TCGA-J4-AATV-01	553	0	days	TCGA-J4-AATV	553	0	days	553	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	71	TCGA-J4-AATV-F70902	TCGA-J4-AATV	TCGA-J4-AATV-01A	NO		M0		-25943		151					0	553		358							Scheduled Follow-up Submission	Partial Remission/Response	2015-3-10	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	50		NO	Bilateral		NO	YES				NO	4		true	No	N0	T2c	TCGA-J4-AATV.860F2174-869F-47E4-ABC1-14E4F608669A.pdf		AATV	WITH TUMOR	3	Partial Remission/Response	0	NO	R1	Primary Tumor	01	3			NO		YES	NO	J4			Prostate		A	LIVING	2013		692c9e12-4ebc-43e2-a520-6e22b6b4e8ed	TCGA-J4-AATV-01A-11D-A41J-01	TCGA-J4-AATV-01A-11D-A41L-05		TCGA-J4-AATV-01A-11D-A41K-08	692c9e12-4ebc-43e2-a520-6e22b6b4e8ed	TCGA-J4-AATV-01	TCGA-J4-AATV-01		TCGA-J4-AATV-01A-11D-A41J-01	692c9e12-4ebc-43e2-a520-6e22b6b4e8ed	TCGA-J4-AATV-01	TCGA-J4-AATV-01			692c9e12-4ebc-43e2-a520-6e22b6b4e8ed
TCGA-J4-AATZ-01	0	TCGA-J4-AATZ-01	412	0	days	TCGA-J4-AATZ			days	412	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66		TCGA-J4-AATZ	TCGA-J4-AATZ-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-24226	33	170		23	23	79	0	412		386				No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension			2014-8-14	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	80		NO	Bilateral			YES				YES	4	0	true	No	N0	T3a	TCGA-J4-AATZ.369F71EC-186A-41DA-91F7-B0FD209BEC8F.pdf		AATZ	WITH TUMOR	4	Complete Remission/Response	0	YES	R1	Primary Tumor	01	5			YES		YES	NO	J4	Apex		Prostate		A	LIVING	2013	Peripheral Zone	0f83b483-2bfe-431a-a958-cadf9a19efea	TCGA-J4-AATZ-01A-11D-A41J-01	TCGA-J4-AATZ-01A-11D-A41L-05		TCGA-J4-AATZ-01A-11D-A41K-08	0f83b483-2bfe-431a-a958-cadf9a19efea	TCGA-J4-AATZ-01	TCGA-J4-AATZ-01		TCGA-J4-AATZ-01A-11D-A41J-01	0f83b483-2bfe-431a-a958-cadf9a19efea	TCGA-J4-AATZ-01	TCGA-J4-AATZ-01			0f83b483-2bfe-431a-a958-cadf9a19efea
TCGA-J4-AAU2-01	0	TCGA-J4-AAU2-01	825	0	days	TCGA-J4-AAU2	825	0	days	825	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			59	TCGA-J4-AAU2-F70142	TCGA-J4-AAU2	TCGA-J4-AAU2-01A	NO		M0		-21656		430					0	825		224							Scheduled Follow-up Submission	Complete Remission/Response	2015-1-28	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	70		NO	Bilateral		NO	YES				NO	1	0	true	No	N0	T2c	TCGA-J4-AAU2.D4358B1C-AB27-4B36-ABF9-B4EE2E504493.pdf		AAU2	TUMOR FREE	3	Complete Remission/Response	0	NO	R0	Primary Tumor	01	3			NO		YES	NO	J4			Prostate		A	LIVING	2012		3e70c3e7-e946-46c8-b703-bc531bd1edce	TCGA-J4-AAU2-01A-11D-A41J-01	TCGA-J4-AAU2-01A-11D-A41L-05		TCGA-J4-AAU2-01A-11D-A41K-08	3e70c3e7-e946-46c8-b703-bc531bd1edce	TCGA-J4-AAU2-01	TCGA-J4-AAU2-01		TCGA-J4-AAU2-01A-11D-A41J-01	3e70c3e7-e946-46c8-b703-bc531bd1edce	TCGA-J4-AAU2-01	TCGA-J4-AAU2-01			3e70c3e7-e946-46c8-b703-bc531bd1edce
TCGA-J9-A52B-01	0	TCGA-J9-A52B-01	422	0	days	TCGA-J9-A52B			days	422	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			62		TCGA-J9-A52B		NO	Normal (no evidence of prostate cancer) [cM0]		T3b	-22849	11			11		85	0	422		414			YES	No Evidence of Extraprostatic Extension	NO				2013-3-14	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy				Bilateral			YES				YES	7	0		No	N0	T3b			A52B		5	Complete Remission/Response	0.010	NO	R1	Primary Tumor	01	4			NO		NO	YES	J9	Apex|Middle|Base		Prostate			LIVING	2012	Overlapping / Multiple Zones	b3c06bf7-49a3-48cb-9418-c25f8559b04c	TCGA-J9-A52B-01A-11D-A26L-01	TCGA-J9-A52B-01A-11D-A26N-05		TCGA-J9-A52B-01A-11D-A26M-08	b3c06bf7-49a3-48cb-9418-c25f8559b04c	TCGA-J9-A52B-01	TCGA-J9-A52B-01		TCGA-J9-A52B-01A-11D-A26L-01	b3c06bf7-49a3-48cb-9418-c25f8559b04c	TCGA-J9-A52B-01	TCGA-J9-A52B-01	TCGA-J9-A52B-01A-11D-A26M-08	TCGA-J9-A52B-01A-11D-A26M-08	b3c06bf7-49a3-48cb-9418-c25f8559b04c
TCGA-J9-A52C-01	0	TCGA-J9-A52C-01	178	0	days	TCGA-J9-A52C	178	0	days	178	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57		TCGA-J9-A52C	TCGA-J9-A52C-01A	NO	Normal (no evidence of prostate cancer) [cM0]		T1c	-20966	38	156		62			0	178		178			YES	No Evidence of Extraprostatic Extension	NO				2013-3-14	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy	90		NO	Bilateral			NO				NO			false	No		T3b	TCGA-J9-A52C.CAAC3743-CE39-4A47-8D46-3C4917D469C1.pdf		A52C		4		0.03	NO	R0	Primary Tumor	01	5			NO	3	YES	NO	J9	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones	77d1e365-4ccc-4b1a-aa0d-cda00b246ba4	TCGA-J9-A52C-01A-11D-A26L-01	TCGA-J9-A52C-01A-11D-A26N-05		TCGA-J9-A52C-01A-11D-A26M-08	77d1e365-4ccc-4b1a-aa0d-cda00b246ba4	TCGA-J9-A52C-01	TCGA-J9-A52C-01	F15C57F1-CD77-4883-8DB4-26885DAF5151	TCGA-J9-A52C-01A-11D-A26L-01	77d1e365-4ccc-4b1a-aa0d-cda00b246ba4	TCGA-J9-A52C-01	TCGA-J9-A52C-01	TCGA-J9-A52C-01A-11D-A26M-08		77d1e365-4ccc-4b1a-aa0d-cda00b246ba4
TCGA-J9-A52D-01	0	TCGA-J9-A52D-01	212	0	days	TCGA-J9-A52D	212	0	days	212	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			71		TCGA-J9-A52D		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-26023	-6			21			0	212		146			YES	No Evidence of Extraprostatic Extension	NO				2014-4-9	MALE	9	Prostate Adenocarcinoma, Other Subtype	No	C61	8500/3	C61.9	YES	Core needle biopsy				Bilateral			NO				NO				No		T3a			A52D	TUMOR FREE	4		0.059	NO	R0	Primary Tumor	01	5			NO	3	NO	YES	J9	Apex|Middle		Prostate			LIVING	2012	Transition Zone	f73e06ac-aa61-45be-b666-83279a7fb908		TCGA-J9-A52D-01A-11D-A29T-05		TCGA-J9-A52D-01A-11D-A29Q-08	f73e06ac-aa61-45be-b666-83279a7fb908	TCGA-J9-A52D-01	TCGA-J9-A52D-01			f73e06ac-aa61-45be-b666-83279a7fb908		TCGA-J9-A52D-01	TCGA-J9-A52D-01A-11D-A29Q-08		f73e06ac-aa61-45be-b666-83279a7fb908
TCGA-J9-A52E-01	0	TCGA-J9-A52E-01	323	0	days	TCGA-J9-A52E			days	323	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			65		TCGA-J9-A52E	TCGA-J9-A52E-01A	NO	Normal (no evidence of prostate cancer) [cM0]		T2c	-23741	15	299		12		89	0	323		393			YES	No Evidence of Extraprostatic Extension	NO				2013-3-15	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8550/3	C61.9	YES	Core needle biopsy	100		NO	Bilateral			YES				YES	8	0	false	No	N0	T3b	TCGA-J9-A52E.5154D45B-244F-45B1-BE2F-9C02716B1CB4.pdf		A52E	TUMOR FREE	4	Partial Remission/Response	0.01	NO	R1	Primary Tumor	01	5			NO	3	NO	YES	J9	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones	fc25b041-1fcb-456b-8e55-28b74a32ab91	TCGA-J9-A52E-01A-11D-A26L-01	TCGA-J9-A52E-01A-11D-A26N-05		TCGA-J9-A52E-01A-11D-A26M-08	fc25b041-1fcb-456b-8e55-28b74a32ab91	TCGA-J9-A52E-01	TCGA-J9-A52E-01	5E28457A-C9A5-47D7-A83A-3797436403BF	TCGA-J9-A52E-01A-11D-A26L-01	fc25b041-1fcb-456b-8e55-28b74a32ab91	TCGA-J9-A52E-01	TCGA-J9-A52E-01	TCGA-J9-A52E-01A-11D-A26M-08		fc25b041-1fcb-456b-8e55-28b74a32ab91
TCGA-J9-A8CK-01	0	TCGA-J9-A8CK-01	321	0	days	TCGA-J9-A8CK	321	0	days	321	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66		TCGA-J9-A8CK	TCGA-J9-A8CK-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-24285	8	365		8			0	321		321			YES	No Evidence of Extraprostatic Extension	NO				2015-2-6	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	90		NO	Bilateral			NO				NO			true	No		T3a	TCGA-J9-A8CK.D47D0C55-D871-44F3-A851-BD610FD7BA30.pdf		A8CK	TUMOR FREE	4		0.010	NO	R1	Primary Tumor	01	5			NO	3	YES	NO	J9	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones	ecb89f0a-31a4-428f-b2be-f882d55a146c	TCGA-J9-A8CK-01A-11D-A34T-01	TCGA-J9-A8CK-01A-11D-A34V-05		TCGA-J9-A8CK-01A-11D-A34U-08	ecb89f0a-31a4-428f-b2be-f882d55a146c	TCGA-J9-A8CK-01	TCGA-J9-A8CK-01	F5A95D97-F758-48BA-91DD-121B9D7433C4	TCGA-J9-A8CK-01A-11D-A34T-01	ecb89f0a-31a4-428f-b2be-f882d55a146c	TCGA-J9-A8CK-01	TCGA-J9-A8CK-01		TCGA-J9-A8CK-01A-11D-A34U-08	ecb89f0a-31a4-428f-b2be-f882d55a146c
TCGA-J9-A8CL-01	0	TCGA-J9-A8CL-01	405	0	days	TCGA-J9-A8CL			days	405	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66		TCGA-J9-A8CL	TCGA-J9-A8CL-01A	YES	Equivocal	M0	T3a	-24145	6	278		11		132	0	405		405			YES	No Evidence of Extraprostatic Extension	NO				2015-1-27	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	80		NO	Bilateral			NO				YES			true	No		T3b	TCGA-J9-A8CL.062E0E86-B3E0-4CC0-9BE5-0EBDB81DCB5B.pdf		A8CL	WITH TUMOR	4		12.01		R1	Primary Tumor	01	5				3	YES	NO	J9	Apex|Middle|Base		Prostate		A	LIVING	2013	Overlapping / Multiple Zones	166b8cda-180b-4095-a991-69e79efec904	TCGA-J9-A8CL-01A-11D-A34T-01	TCGA-J9-A8CL-01A-11D-A34V-05		TCGA-J9-A8CL-01A-11D-A34U-08	166b8cda-180b-4095-a991-69e79efec904	TCGA-J9-A8CL-01	TCGA-J9-A8CL-01		TCGA-J9-A8CL-01A-11D-A34T-01	166b8cda-180b-4095-a991-69e79efec904	TCGA-J9-A8CL-01	TCGA-J9-A8CL-01		TCGA-J9-A8CL-01A-11D-A34U-08	166b8cda-180b-4095-a991-69e79efec904
TCGA-J9-A8CM-01	0	TCGA-J9-A8CM-01	463	0	days	TCGA-J9-A8CM			days	463	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66		TCGA-J9-A8CM	TCGA-J9-A8CM-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-24118	14	238				344	0	463		463			NO		NO				2015-2-1	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	230		NO	Bilateral			YES				YES	14	1	true	No	N1	T3b	TCGA-J9-A8CM.7B7CB375-6046-437F-8513-9F713EA6407A.pdf		A8CM	WITH TUMOR	5	Partial Remission/Response	0.55	NO	R1	Primary Tumor	01	4			NO	3	YES	NO	J9	Apex|Middle|Base		Prostate		A	LIVING	2013	Peripheral Zone	304a95c1-2180-4a81-a85a-880427e97d67	TCGA-J9-A8CM-01A-11D-A34T-01	TCGA-J9-A8CM-01A-11D-A34V-05		TCGA-J9-A8CM-01A-11D-A34U-08	304a95c1-2180-4a81-a85a-880427e97d67	TCGA-J9-A8CM-01	TCGA-J9-A8CM-01	2246A3A6-98DE-4B85-903D-54CF8B93BF07	TCGA-J9-A8CM-01A-11D-A34T-01	304a95c1-2180-4a81-a85a-880427e97d67	TCGA-J9-A8CM-01	TCGA-J9-A8CM-01		TCGA-J9-A8CM-01A-11D-A34U-08	304a95c1-2180-4a81-a85a-880427e97d67
TCGA-J9-A8CN-01	0	TCGA-J9-A8CN-01	1237	0	days	TCGA-J9-A8CN	1237	0	days	1237	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			53		TCGA-J9-A8CN	TCGA-J9-A8CN-01A	NO		M0	T1c	-19662		971					0	1237		963			NO		NO				2015-2-1	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	100		NO	Bilateral			NO				NO			true	Yes, History of Prior Malignancy		T3a	TCGA-J9-A8CN.3D3F5AFD-4DA0-43EC-B6B9-D2F16B6206E8.pdf		A8CN	TUMOR FREE	3	Complete Remission/Response	0.03	NO	R1	Primary Tumor	01	3			NO	4	YES	NO	J9	Apex|Middle		Prostate		A	LIVING	2011	Transition Zone	2de65e78-be71-4f41-be55-d9ef61b277c3	TCGA-J9-A8CN-01A-11D-A34T-01	TCGA-J9-A8CN-01A-11D-A34V-05		TCGA-J9-A8CN-01A-11D-A34U-08	2de65e78-be71-4f41-be55-d9ef61b277c3	TCGA-J9-A8CN-01	TCGA-J9-A8CN-01	81362E50-EAA0-46FB-99F3-47F19B774B68	TCGA-J9-A8CN-01A-11D-A34T-01	2de65e78-be71-4f41-be55-d9ef61b277c3	TCGA-J9-A8CN-01	TCGA-J9-A8CN-01		TCGA-J9-A8CN-01A-11D-A34U-08	2de65e78-be71-4f41-be55-d9ef61b277c3
TCGA-J9-A8CP-01	0	TCGA-J9-A8CP-01	386	0	days	TCGA-J9-A8CP	386	0	days	386	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66		TCGA-J9-A8CP	TCGA-J9-A8CP-01A	NO		M0	T2a	-24299		113					0	386		298			NO		NO				2015-2-1	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	90		NO	Bilateral			NO				NO			true	No		T3a	TCGA-J9-A8CP.526E96AC-D8A9-4FED-8D31-05E2427DE513.pdf		A8CP	TUMOR FREE	4	Complete Remission/Response	0.010	NO	R0	Primary Tumor	01	3			NO		YES	NO	J9	Apex|Middle		Prostate		A	LIVING	2013	Overlapping / Multiple Zones	4558d242-2bd6-4272-913f-59c6b8f05d64	TCGA-J9-A8CP-01A-11D-A34T-01	TCGA-J9-A8CP-01A-11D-A34V-05		TCGA-J9-A8CP-01A-11D-A34U-08	4558d242-2bd6-4272-913f-59c6b8f05d64	TCGA-J9-A8CP-01	TCGA-J9-A8CP-01	1111DDF5-715A-4D8E-91CC-403BADF8CE57	TCGA-J9-A8CP-01A-11D-A34T-01	4558d242-2bd6-4272-913f-59c6b8f05d64	TCGA-J9-A8CP-01	TCGA-J9-A8CP-01		TCGA-J9-A8CP-01A-11D-A34U-08	4558d242-2bd6-4272-913f-59c6b8f05d64
TCGA-KC-A4BL-01	0	TCGA-KC-A4BL-01	934	0	days	TCGA-KC-A4BL			days	934	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			65		TCGA-KC-A4BL	TCGA-KC-A4BL-01A	YES	Abnormal (not related to prostate cancer)	M0	T1c	-24081	38	2101		38	66	193	0	934		206			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension			2015-1-23	MALE	7	Prostate Adenocarcinoma Acinar Type	Yes, Pharmaceutical Treatment Prior to Resection	C61	8140/3	C61.9	YES	Core needle biopsy	160		NO	Bilateral			YES				YES	4	0	true	No	N0	T2c	TCGA-KC-A4BL.EEF5303A-D63A-4D2F-A8B6-A78437A583FF.pdf		A4BL	WITH TUMOR	3	Partial Remission/Response	3.15		R0	Primary Tumor	01	4				5	NO	YES	KC	Middle|Base		Prostate		A	LIVING	2006	Peripheral Zone	71160876-7965-4899-a8b2-c549cc25260b	TCGA-KC-A4BL-01A-31D-A256-01	TCGA-KC-A4BL-01A-31D-A258-05		TCGA-KC-A4BL-01A-31D-A257-08	71160876-7965-4899-a8b2-c549cc25260b	TCGA-KC-A4BL-01	TCGA-KC-A4BL-01	B926A73F-7CD8-4B97-8E6C-D24AE1EA5431	TCGA-KC-A4BL-01A-31D-A256-01	71160876-7965-4899-a8b2-c549cc25260b	TCGA-KC-A4BL-01	TCGA-KC-A4BL-01	TCGA-KC-A4BL-01A-31D-A257-08	TCGA-KC-A4BL-01A-31D-A257-08	71160876-7965-4899-a8b2-c549cc25260b
TCGA-KC-A4BN-01	0	TCGA-KC-A4BN-01	1815	0	days	TCGA-KC-A4BN			days	1815	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55		TCGA-KC-A4BN	TCGA-KC-A4BN-01A	NO		M0	T1c	-20392		1246			44		0	1815		529			NO		YES	No Evidence of Extraprostatic Extension			2014-7-22	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	570		NO	Right			YES					6	0	true	No	N0	T2a	TCGA-KC-A4BN.A929648E-54E0-4215-9148-4E1498961697.pdf		A4BN	TUMOR FREE	3	Complete Remission/Response	0	NO	R0	Primary Tumor	01	4			NO		NO	YES	KC	Middle		Prostate		A	LIVING	2009		887b3624-2609-4928-9b17-d6e82cc4baa5	TCGA-KC-A4BN-01A-61D-A256-01	TCGA-KC-A4BN-01A-61D-A258-05		TCGA-KC-A4BN-01A-61D-A257-08	887b3624-2609-4928-9b17-d6e82cc4baa5	TCGA-KC-A4BN-01	TCGA-KC-A4BN-01	16E39B12-7B32-4D64-AFA8-5D55E25536DD	TCGA-KC-A4BN-01A-61D-A256-01	887b3624-2609-4928-9b17-d6e82cc4baa5	TCGA-KC-A4BN-01	TCGA-KC-A4BN-01	TCGA-KC-A4BN-01A-61D-A257-08	TCGA-KC-A4BN-01A-61D-A257-08	887b3624-2609-4928-9b17-d6e82cc4baa5
TCGA-KC-A4BO-01	0	TCGA-KC-A4BO-01	607	0	days	TCGA-KC-A4BO	607	0	days	607	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55		TCGA-KC-A4BO	TCGA-KC-A4BO-01A	NO	Abnormal (not related to prostate cancer)	M0	T1c	-20368	21	742		21	98		0	607		478			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension			2015-1-23	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	590		NO	Bilateral			YES				NO	13	0	true	No	N0	T2c	TCGA-KC-A4BO.C601C012-0EC4-4386-9A9A-3485FD4968E1.pdf		A4BO	TUMOR FREE	3	Complete Remission/Response	0.04	NO	R0	Primary Tumor	01	4			NO	5	NO	YES	KC	Apex|Middle		Prostate		A	LIVING	2010	Peripheral Zone		TCGA-KC-A4BO-01A-61D-A256-01	TCGA-KC-A4BO-01A-61D-A258-05		TCGA-KC-A4BO-01A-61D-A257-08			TCGA-KC-A4BO-01	8DEB3822-4FED-44E2-9D11-4A43EC0C1CA0	TCGA-KC-A4BO-01A-61D-A256-01			TCGA-KC-A4BO-01			
TCGA-KC-A4BR-01	0	TCGA-KC-A4BR-01	1349	0	days	TCGA-KC-A4BR			days	1349	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			75		TCGA-KC-A4BR	TCGA-KC-A4BR-01A	NO	Abnormal (not related to prostate cancer)	M0	T2	-27741	15	1161		-8	90	1022	0	1349		1258			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension			2015-1-23	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	600		NO	Bilateral			YES				YES	11	1	true	No	N1	T3b	TCGA-KC-A4BR.E44796E6-0446-4706-8B8F-A21D417EAB43.pdf		A4BR	WITH TUMOR	4	Complete Remission/Response	0.00	NO	R0	Primary Tumor	01	5			NO		NO	YES	KC	Apex|Middle|Base		Prostate		A	LIVING	2009	Peripheral Zone	47c88c6e-4f26-46bc-8198-06c211f64e00	TCGA-KC-A4BR-01A-32D-A256-01	TCGA-KC-A4BR-01A-32D-A258-05		TCGA-KC-A4BR-01A-32D-A257-08	47c88c6e-4f26-46bc-8198-06c211f64e00	TCGA-KC-A4BR-01	TCGA-KC-A4BR-01	A7B9F799-6958-4860-B828-AE1F4BBB2F24	TCGA-KC-A4BR-01A-32D-A256-01	47c88c6e-4f26-46bc-8198-06c211f64e00	TCGA-KC-A4BR-01	TCGA-KC-A4BR-01	TCGA-KC-A4BR-01A-32D-A257-08	TCGA-KC-A4BR-01A-32D-A257-08	47c88c6e-4f26-46bc-8198-06c211f64e00
TCGA-KC-A4BV-01	0	TCGA-KC-A4BV-01	1328	0	days	TCGA-KC-A4BV			days	1328	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66		TCGA-KC-A4BV	TCGA-KC-A4BV-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T2	-24138	16	943		18	81	1328	0	1328		1328			YES	No Evidence of Extraprostatic Extension	YES	Extraprostatic Extension Localized (e.g. seminal vesicles)			2014-7-22	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	420		NO	Bilateral			YES				YES	10	0	true	No	N0	T3a	TCGA-KC-A4BV.CC0244A3-48CF-4448-A7F1-5DB9EC3B823A.pdf		A4BV	WITH TUMOR	4	Complete Remission/Response	.530	NO	R0	Primary Tumor	01	5			NO	3	NO	YES	KC	Apex|Middle|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones	450b68b9-573f-4921-93b6-8a57ff9a7263	TCGA-KC-A4BV-01A-31D-A26L-01	TCGA-KC-A4BV-01A-31D-A26N-05		TCGA-KC-A4BV-01A-31D-A26M-08	450b68b9-573f-4921-93b6-8a57ff9a7263	TCGA-KC-A4BV-01	TCGA-KC-A4BV-01	539AAD8D-FEAE-4C77-9255-512A7274E7B2	TCGA-KC-A4BV-01A-31D-A26L-01	450b68b9-573f-4921-93b6-8a57ff9a7263	TCGA-KC-A4BV-01	TCGA-KC-A4BV-01	TCGA-KC-A4BV-01A-31D-A26M-08	TCGA-KC-A4BV-01A-31D-A26M-08	450b68b9-573f-4921-93b6-8a57ff9a7263
TCGA-KC-A7F3-01	0	TCGA-KC-A7F3-01	665	0	days	TCGA-KC-A7F3	665	0	days	665	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			67		TCGA-KC-A7F3	TCGA-KC-A7F3-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24676	32	195		32	43		0	665		664			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension			2015-1-23	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	270		NO	Bilateral			YES				NO	19	0	true	No	N0	T2c	TCGA-KC-A7F3.8878BDE3-634E-497C-AC4A-219E2F0B7153.pdf		A7F3	TUMOR FREE	3	Complete Remission/Response	0.00	NO	R0	Primary Tumor	01	4			NO		NO	YES	KC	Apex		Prostate		A	LIVING	2013	Peripheral Zone	689a544a-c116-46f9-ae3c-769e793f21c7	TCGA-KC-A7F3-01A-21D-A33S-01	TCGA-KC-A7F3-01A-21D-A33U-05		TCGA-KC-A7F3-01A-21D-A33T-08	689a544a-c116-46f9-ae3c-769e793f21c7	TCGA-KC-A7F3-01	TCGA-KC-A7F3-01	AB99F4D9-FAEF-486D-B47B-2A3F2B08D25D	TCGA-KC-A7F3-01A-21D-A33S-01	689a544a-c116-46f9-ae3c-769e793f21c7	TCGA-KC-A7F3-01	TCGA-KC-A7F3-01		TCGA-KC-A7F3-01A-21D-A33T-08	689a544a-c116-46f9-ae3c-769e793f21c7
TCGA-KC-A7F5-01	0	TCGA-KC-A7F5-01	91	0	days	TCGA-KC-A7F5	91	0	days	91	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			54		TCGA-KC-A7F5	TCGA-KC-A7F5-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-20015	5	138		5	-56		0	91		91			YES	No Evidence of Extraprostatic Extension	YES	Extraprostatic Extension Localized (e.g. seminal vesicles)			2015-1-25	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	250		NO	Right			YES				NO	16	0	true	No	N0	T2c	TCGA-KC-A7F5.3899F8DA-A4C2-40C3-AE27-227F7992B5EE.pdf		A7F5	TUMOR FREE	4	Complete Remission/Response	0.00	NO	R0	Primary Tumor	01	3			NO	5	NO	YES	KC	Apex|Middle|Base		Prostate		A	LIVING	2013	Peripheral Zone	9e0d5361-7994-48b6-a865-18d430b72239		TCGA-KC-A7F5-01A-11D-A33U-05		TCGA-KC-A7F5-01A-11D-A33T-08	9e0d5361-7994-48b6-a865-18d430b72239	TCGA-KC-A7F5-01	TCGA-KC-A7F5-01	0E20B975-A3A5-4C07-8351-48E6FFB5F18E		9e0d5361-7994-48b6-a865-18d430b72239		TCGA-KC-A7F5-01			9e0d5361-7994-48b6-a865-18d430b72239
TCGA-KC-A7F6-01	0	TCGA-KC-A7F6-01	263	0	days	TCGA-KC-A7F6	263	0	days	263	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63		TCGA-KC-A7F6	TCGA-KC-A7F6-01A	NO	Abnormal (not related to prostate cancer)	M0	T1c	-23367	44	171		44	-121		0	263		193			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension			2015-1-25	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	130		NO	Bilateral			YES				NO	23	0	true	No	N0	T2c	TCGA-KC-A7F6.357EC50A-622F-4757-A044-7E38A12421FE.pdf		A7F6	TUMOR FREE	3	Complete Remission/Response	0.00	NO	R0	Primary Tumor	01	4			NO		NO	YES	KC	Apex|Middle		Prostate		A	LIVING	2013	Peripheral Zone	cea23bbc-1a4a-4498-987b-67728912ae40	TCGA-KC-A7F6-01A-11D-A33S-01	TCGA-KC-A7F6-01A-11D-A33U-05		TCGA-KC-A7F6-01A-11D-A33T-08	cea23bbc-1a4a-4498-987b-67728912ae40	TCGA-KC-A7F6-01	TCGA-KC-A7F6-01	24410A14-5036-4D2E-9C9E-5750E1BBA5D9	TCGA-KC-A7F6-01A-11D-A33S-01	cea23bbc-1a4a-4498-987b-67728912ae40	TCGA-KC-A7F6-01	TCGA-KC-A7F6-01		TCGA-KC-A7F6-01A-11D-A33T-08	cea23bbc-1a4a-4498-987b-67728912ae40
TCGA-KC-A7FA-01	0	TCGA-KC-A7FA-01	598	0	days	TCGA-KC-A7FA	598	0	days	598	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63		TCGA-KC-A7FA	TCGA-KC-A7FA-01A	NO	Abnormal (not related to prostate cancer)	M0	T2c	-23208	70	146		62	40		0	598		161			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension			2015-1-25	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	120		NO	Bilateral			YES				NO	24	0	true	Yes, History of Prior Malignancy	N0	T3a	TCGA-KC-A7FA.CF60F3B8-9AF5-4D51-8E17-BC7940235E96.pdf		A7FA	TUMOR FREE	3	Complete Remission/Response	0.00	NO	R0	Primary Tumor	01	4			NO		NO	YES	KC	Apex|Middle|Base		Prostate		A	LIVING	2013	Peripheral Zone	81ee8dcb-89dd-462e-b5de-2394bc6d522b	TCGA-KC-A7FA-01A-21D-A33S-01	TCGA-KC-A7FA-01A-21D-A33U-05		TCGA-KC-A7FA-01A-21D-A33T-08	81ee8dcb-89dd-462e-b5de-2394bc6d522b	TCGA-KC-A7FA-01	TCGA-KC-A7FA-01	A15A3A98-2810-4154-A9EF-E5B43349BF39	TCGA-KC-A7FA-01A-21D-A33S-01	81ee8dcb-89dd-462e-b5de-2394bc6d522b	TCGA-KC-A7FA-01	TCGA-KC-A7FA-01		TCGA-KC-A7FA-01A-21D-A33T-08	81ee8dcb-89dd-462e-b5de-2394bc6d522b
TCGA-KC-A7FD-01	0	TCGA-KC-A7FD-01	270	0	days	TCGA-KC-A7FD	270	0	days	270	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			62		TCGA-KC-A7FD	TCGA-KC-A7FD-01A	NO		M0	T1c	-22745		157		29	45		0	270		144			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension			2015-1-25	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	130		NO	Bilateral			YES				NO	16	0	true	No	N0	T3a	TCGA-KC-A7FD.15E27E53-1EF7-495A-A000-F10108E653C2.pdf		A7FD	TUMOR FREE	3	Complete Remission/Response	0.00	NO	R0	Primary Tumor	01	4			NO		NO	YES	KC	Apex|Middle|Base		Prostate		A	LIVING	2013	Peripheral Zone	1d913abe-aadd-498f-9b1d-7d3746ae315c	TCGA-KC-A7FD-01A-11D-A33S-01	TCGA-KC-A7FD-01A-11D-A33U-05		TCGA-KC-A7FD-01A-11D-A33T-08	1d913abe-aadd-498f-9b1d-7d3746ae315c	TCGA-KC-A7FD-01	TCGA-KC-A7FD-01	9C753A44-DC06-4AC0-B7C1-39B987B0428A	TCGA-KC-A7FD-01A-11D-A33S-01	1d913abe-aadd-498f-9b1d-7d3746ae315c	TCGA-KC-A7FD-01	TCGA-KC-A7FD-01		TCGA-KC-A7FD-01A-11D-A33T-08	1d913abe-aadd-498f-9b1d-7d3746ae315c
TCGA-KC-A7FE-01	0	TCGA-KC-A7FE-01	352	0	days	TCGA-KC-A7FE	352	0	days	352	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			62		TCGA-KC-A7FE	TCGA-KC-A7FE-01A	NO	Abnormal (not related to prostate cancer)	M0	T1c	-22718	76	212		76	53		0	352		185			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension			2015-1-25	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	120		NO	Bilateral			YES				NO	2	0	true	No	N0	T2c	TCGA-KC-A7FE.715B093C-7832-46EA-AC95-01406A90D529.pdf		A7FE	TUMOR FREE	3	Complete Remission/Response	0.00	NO	R1	Primary Tumor	01	4			NO		NO	YES	KC	Apex|Middle		Prostate		A	LIVING	2013	Peripheral Zone	17607f39-23c6-4eee-8aa4-ed705284ff4e	TCGA-KC-A7FE-01A-12D-A33S-01	TCGA-KC-A7FE-01A-12D-A33U-05		TCGA-KC-A7FE-01A-12D-A33T-08	17607f39-23c6-4eee-8aa4-ed705284ff4e	TCGA-KC-A7FE-01	TCGA-KC-A7FE-01	E470C35A-7E13-42A7-9225-78A56D6B1D94	TCGA-KC-A7FE-01A-12D-A33S-01	17607f39-23c6-4eee-8aa4-ed705284ff4e	TCGA-KC-A7FE-01	TCGA-KC-A7FE-01		TCGA-KC-A7FE-01A-12D-A33T-08	17607f39-23c6-4eee-8aa4-ed705284ff4e
TCGA-KK-A59V-01	0	TCGA-KK-A59V-01	3440	0	days	TCGA-KK-A59V	3440	0	days	3440	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			64	TCGA-KK-A59V-F70432	TCGA-KK-A59V	TCGA-KK-A59V-01A	NO		M0	T3a	-23483		2742					0	3440		2500			NO		NO		Scheduled Follow-up Submission		2015-2-13	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	190		NO	Bilateral		NO	YES				NO	9	0	true	No	N0	T3b	TCGA-KK-A59V.0A977EFF-C276-46CB-9187-92F504C7B535.pdf		A59V	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	5			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2005	Peripheral Zone	d8012229-3666-4380-9d2a-2beaca772242	TCGA-KK-A59V-01A-11D-A323-01	TCGA-KK-A59V-01A-11D-A29T-05		TCGA-KK-A59V-01A-11D-A29Q-08	d8012229-3666-4380-9d2a-2beaca772242	TCGA-KK-A59V-01	TCGA-KK-A59V-01	9591CEAE-DBE0-4E1F-BEB7-22EA6579225C	TCGA-KK-A59V-01A-11D-A323-01	d8012229-3666-4380-9d2a-2beaca772242	TCGA-KK-A59V-01	TCGA-KK-A59V-01	TCGA-KK-A59V-01A-11D-A29Q-08		d8012229-3666-4380-9d2a-2beaca772242
TCGA-KK-A59X-01	0	TCGA-KK-A59X-01	2535	0	days	TCGA-KK-A59X	2233	1	days	2535	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	NO	55	TCGA-KK-A59X-F70433	TCGA-KK-A59X	TCGA-KK-A59X-01A		Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-20416	12	1731		12			0	2535	2233				YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission		2015-2-23	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	170		NO	Bilateral		NO	YES	Other, specify	Locoregional Recurrence	Bladder	YES	14	2	true	No	N1	T3b	TCGA-KK-A59X.64BB13A6-1071-4C2A-937C-17ACC07ADF75.pdf		A59X	WITH TUMOR	5			YES	R1	Primary Tumor	01	4			NO		NO	YES	KK	Apex|Middle|Base	YES	Prostate	Distant Metastasis	A	LIVING	2008	Peripheral Zone	efbbd41e-6911-49d5-9d54-cc95e0c81415	TCGA-KK-A59X-01A-11D-A323-01	TCGA-KK-A59X-01A-11D-A29T-05		TCGA-KK-A59X-01A-11D-A29Q-08	efbbd41e-6911-49d5-9d54-cc95e0c81415	TCGA-KK-A59X-01	TCGA-KK-A59X-01	B8B5E05A-7239-4D32-A975-0409DF415833	TCGA-KK-A59X-01A-11D-A323-01	efbbd41e-6911-49d5-9d54-cc95e0c81415	TCGA-KK-A59X-01	TCGA-KK-A59X-01	TCGA-KK-A59X-01A-11D-A29Q-08	TCGA-KK-A59X-01A-11D-A29Q-08	efbbd41e-6911-49d5-9d54-cc95e0c81415
TCGA-KK-A59Y-01	0	TCGA-KK-A59Y-01	1968	0	days	TCGA-KK-A59Y	1968	0	days	1968	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			56	TCGA-KK-A59Y-F70436	TCGA-KK-A59Y	TCGA-KK-A59Y-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-20768	13	1158		13			0	1968		1359			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-2-16	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	110		NO	Bilateral		NO	YES				NO	4	2	true	No	N1	T3a	TCGA-KK-A59Y.324E4C8E-1F95-4DA6-9D1F-97E6087BA2C7.pdf		A59Y	TUMOR FREE	4	Complete Remission/Response	0.1	YES	RX	Primary Tumor	01	5			YES		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2009	Peripheral Zone	08a5e204-0002-4148-8b87-bbb9b490e825	TCGA-KK-A59Y-01A-11D-A26L-01	TCGA-KK-A59Y-01A-11D-A26N-05		TCGA-KK-A59Y-01A-11D-A26M-08	08a5e204-0002-4148-8b87-bbb9b490e825	TCGA-KK-A59Y-01	TCGA-KK-A59Y-01	70D842F6-C7CA-4E6A-BB98-0FDC991785D7	TCGA-KK-A59Y-01A-11D-A26L-01	08a5e204-0002-4148-8b87-bbb9b490e825	TCGA-KK-A59Y-01	TCGA-KK-A59Y-01	TCGA-KK-A59Y-01A-11D-A26M-08	TCGA-KK-A59Y-01A-11D-A26M-08	08a5e204-0002-4148-8b87-bbb9b490e825
TCGA-KK-A59Z-01	0	TCGA-KK-A59Z-01	2628	0	days	TCGA-KK-A59Z	2628	0	days	2628	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-KK-A59Z-F70443	TCGA-KK-A59Z	TCGA-KK-A59Z-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-24306	24	1985		20			0	2628		849			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission		2015-2-16	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	260		NO	Bilateral		NO	YES				NO	2	0	true	No	N0	T2c	TCGA-KK-A59Z.DDF6F24F-4406-49EE-9EE0-7129D8544677.pdf		A59Z	TUMOR FREE	4		0.1	NO	R0	Primary Tumor	01	3			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2007	Peripheral Zone	bbc5dea9-50e1-44b7-9d43-82896b9229b5	TCGA-KK-A59Z-01A-12D-A26L-01	TCGA-KK-A59Z-01A-12D-A26N-05		TCGA-KK-A59Z-01A-12D-A26M-08	bbc5dea9-50e1-44b7-9d43-82896b9229b5	TCGA-KK-A59Z-01	TCGA-KK-A59Z-01	8FA1DEF1-8C24-4B15-8875-30538F7E9E91	TCGA-KK-A59Z-01A-12D-A26L-01	bbc5dea9-50e1-44b7-9d43-82896b9229b5	TCGA-KK-A59Z-01	TCGA-KK-A59Z-01	TCGA-KK-A59Z-01A-12D-A26M-08	TCGA-KK-A59Z-01A-12D-A26M-08	bbc5dea9-50e1-44b7-9d43-82896b9229b5
TCGA-KK-A5A1-01	1	TCGA-KK-A5A1-01	2469	1	days	TCGA-KK-A5A1			days	2469	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			72	TCGA-KK-A5A1-F70560	TCGA-KK-A5A1	TCGA-KK-A5A1-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-26415	57	3586	2469	14			0	2364		420			YES		NO		Scheduled Follow-up Submission		2015-2-25	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	90		NO	Bilateral		NO	YES				YES	3	0	true	No	N0	T3b	TCGA-KK-A5A1.DF56D103-963E-4C23-9DB8-1333AFF418CE.pdf		A5A1		4	Partial Remission/Response	0.1	NO	R1	Primary Tumor	01	5		Medical Record	NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	DECEASED	2003	Overlapping / Multiple Zones	acd9261f-37cf-44ca-86c4-e42d88d86b6c		TCGA-KK-A5A1-01A-11D-A29T-05		TCGA-KK-A5A1-01A-11D-A29Q-08	acd9261f-37cf-44ca-86c4-e42d88d86b6c	TCGA-KK-A5A1-01	TCGA-KK-A5A1-01	B87F9B41-6DAF-42E6-A00F-92DCE6D801F7		acd9261f-37cf-44ca-86c4-e42d88d86b6c		TCGA-KK-A5A1-01	TCGA-KK-A5A1-01A-11D-A29Q-08		acd9261f-37cf-44ca-86c4-e42d88d86b6c
TCGA-KK-A6DY-01	0	TCGA-KK-A6DY-01	4295	0	days	TCGA-KK-A6DY	4295	0	days	4295	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			50	TCGA-KK-A6DY-F70446	TCGA-KK-A6DY		NO		M0	T1c	-18420							0	4295		903			NO		NO		Scheduled Follow-up Submission		2015-2-16	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	12	0		No	N0	T2c			A6DY	WITH TUMOR	3		0.1	NO	R1	Primary Tumor	01	4			NO		NO	YES	KK	Apex|Middle|Base		Prostate			LIVING	2002	Peripheral Zone	bf46c30c-14fa-4e2a-a013-4e84f24eb63b	TCGA-KK-A6DY-01A-12D-A30W-01	TCGA-KK-A6DY-01A-12D-A30Z-05		TCGA-KK-A6DY-01A-12D-A30X-08	bf46c30c-14fa-4e2a-a013-4e84f24eb63b	TCGA-KK-A6DY-01	TCGA-KK-A6DY-01		TCGA-KK-A6DY-01A-12D-A30W-01	bf46c30c-14fa-4e2a-a013-4e84f24eb63b	TCGA-KK-A6DY-01	TCGA-KK-A6DY-01	TCGA-KK-A6DY-01A-12D-A30X-08	TCGA-KK-A6DY-01A-12D-A30X-08	bf46c30c-14fa-4e2a-a013-4e84f24eb63b
TCGA-KK-A6E0-01	0	TCGA-KK-A6E0-01	1483	0	days	TCGA-KK-A6E0	1483	0	days	1483	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			59	TCGA-KK-A6E0-F70468	TCGA-KK-A6E0	TCGA-KK-A6E0-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-21700	11	859				941	0	1483		941			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-2-17	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	140		NO	Right		NO	YES				NO	9	0	true	No	N0	T3a	TCGA-KK-A6E0.41BD5E57-29AE-41C8-96D7-2832C726E83B.pdf		A6E0	TUMOR FREE	4	Complete Remission/Response	0.3	YES	R0	Primary Tumor	01	5			YES		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2011	Peripheral Zone	12c2e11c-8ba3-4cce-8c28-c005edc4e4cc	TCGA-KK-A6E0-01A-11D-A30W-01	TCGA-KK-A6E0-01A-11D-A30Z-05		TCGA-KK-A6E0-01A-11D-A30X-08	12c2e11c-8ba3-4cce-8c28-c005edc4e4cc	TCGA-KK-A6E0-01	TCGA-KK-A6E0-01	A94B48BB-03D7-46D8-9969-4B9000A3B779	TCGA-KK-A6E0-01A-11D-A30W-01	12c2e11c-8ba3-4cce-8c28-c005edc4e4cc	TCGA-KK-A6E0-01	TCGA-KK-A6E0-01	TCGA-KK-A6E0-01A-11D-A30X-08	TCGA-KK-A6E0-01A-11D-A30X-08	12c2e11c-8ba3-4cce-8c28-c005edc4e4cc
TCGA-KK-A6E1-01	0	TCGA-KK-A6E1-01	2198	0	days	TCGA-KK-A6E1	2198	0	days	2198	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57	TCGA-KK-A6E1-F70479	TCGA-KK-A6E1	TCGA-KK-A6E1-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-21063	-24	1598		-24			0	2198		356			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission		2015-2-18	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	250		NO	Bilateral		NO	YES				NO	24	5	true	No	N1	T3b	TCGA-KK-A6E1.E8264E2D-E4BB-40BB-9305-18DDD777D664.pdf		A6E1	TUMOR FREE	4	Complete Remission/Response	0.1	YES	RX	Primary Tumor	01	5			YES		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2008	Overlapping / Multiple Zones	b38350db-b102-4a38-9edb-0089ca95840b	TCGA-KK-A6E1-01A-11D-A30W-01	TCGA-KK-A6E1-01A-11D-A30Z-05		TCGA-KK-A6E1-01A-11D-A30X-08	b38350db-b102-4a38-9edb-0089ca95840b	TCGA-KK-A6E1-01	TCGA-KK-A6E1-01	C09F01D2-47DA-4F3F-BC19-D8582CC49A19	TCGA-KK-A6E1-01A-11D-A30W-01	b38350db-b102-4a38-9edb-0089ca95840b	TCGA-KK-A6E1-01	TCGA-KK-A6E1-01	TCGA-KK-A6E1-01A-11D-A30X-08	TCGA-KK-A6E1-01A-11D-A30X-08	b38350db-b102-4a38-9edb-0089ca95840b
TCGA-KK-A6E2-01	0	TCGA-KK-A6E2-01	5024	0	days	TCGA-KK-A6E2	5024	0	days	5024	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			54	TCGA-KK-A6E2-F70481	TCGA-KK-A6E2	TCGA-KK-A6E2-01A	NO		M0	T2a	-19974		4724					0	5024		438			NO		NO		Scheduled Follow-up Submission		2015-2-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	290		NO	Bilateral		NO	YES				NO	5	0	true	No	N0	T2c	TCGA-KK-A6E2.84DBE486-DFA5-4FBC-BA8F-E10CC0247645.pdf		A6E2	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2000	Transition Zone	79d5f928-67b2-4db0-b018-a52889200dd3	TCGA-KK-A6E2-01A-11D-A30W-01	TCGA-KK-A6E2-01A-11D-A30Z-05		TCGA-KK-A6E2-01A-11D-A30X-08	79d5f928-67b2-4db0-b018-a52889200dd3	TCGA-KK-A6E2-01	TCGA-KK-A6E2-01	25BF06AA-FAB2-4F89-82C0-02F34E3A37B0	TCGA-KK-A6E2-01A-11D-A30W-01	79d5f928-67b2-4db0-b018-a52889200dd3	TCGA-KK-A6E2-01	TCGA-KK-A6E2-01	TCGA-KK-A6E2-01A-11D-A30X-08	TCGA-KK-A6E2-01A-11D-A30X-08	79d5f928-67b2-4db0-b018-a52889200dd3
TCGA-KK-A6E3-01	0	TCGA-KK-A6E3-01	2056	0	days	TCGA-KK-A6E3	2056	0	days	2056	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			56		TCGA-KK-A6E3	TCGA-KK-A6E3-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-20547	10	3355					0	2056		1065			NO		NO				2014-3-27	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	140		NO	Bilateral			YES				NO	3	0	true	No	N0	T2c	TCGA-KK-A6E3.4796F9C1-49BD-411E-9D9B-D95001D76F53.pdf		A6E3	TUMOR FREE	3		0.1	NO	R0	Primary Tumor	01	4			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2004	Transition Zone	40126675-87b4-4f49-8e55-2cf42bb536eb	TCGA-KK-A6E3-01A-21D-A30D-01	TCGA-KK-A6E3-01A-21D-A30F-05		TCGA-KK-A6E3-01A-21D-A30E-08	40126675-87b4-4f49-8e55-2cf42bb536eb	TCGA-KK-A6E3-01	TCGA-KK-A6E3-01	E9D6E375-6D3B-411F-899B-F37954C61755	TCGA-KK-A6E3-01A-21D-A30D-01	40126675-87b4-4f49-8e55-2cf42bb536eb	TCGA-KK-A6E3-01	TCGA-KK-A6E3-01	TCGA-KK-A6E3-01A-21D-A30E-08		40126675-87b4-4f49-8e55-2cf42bb536eb
TCGA-KK-A6E4-01	1	TCGA-KK-A6E4-01	3502	1	days	TCGA-KK-A6E4	3502	0	days	3502	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			69	TCGA-KK-A6E4-F70483	TCGA-KK-A6E4	TCGA-KK-A6E4-01A	NO		M0	T1c	-25338		3094	3502				0	2753		890			NO		NO		Scheduled Follow-up Submission		2015-2-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	190		NO	Right		NO	YES				NO	4	0	true	No	N0	T2b	TCGA-KK-A6E4.D4A30E0D-4829-4B4E-863A-DF2ACED85BE8.pdf		A6E4	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4		Medical Record	NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	DECEASED	2004	Peripheral Zone	5793ef8d-17da-49a6-a606-9ce76c0a7a2a	TCGA-KK-A6E4-01A-11D-A30D-01	TCGA-KK-A6E4-01A-11D-A30F-05		TCGA-KK-A6E4-01A-11D-A30E-08	5793ef8d-17da-49a6-a606-9ce76c0a7a2a	TCGA-KK-A6E4-01	TCGA-KK-A6E4-01	BAAC61A0-2FB1-49F5-BA68-C00EFDA0A519	TCGA-KK-A6E4-01A-11D-A30D-01	5793ef8d-17da-49a6-a606-9ce76c0a7a2a	TCGA-KK-A6E4-01	TCGA-KK-A6E4-01	TCGA-KK-A6E4-01A-11D-A30E-08		5793ef8d-17da-49a6-a606-9ce76c0a7a2a
TCGA-KK-A6E5-01	0	TCGA-KK-A6E5-01	2073	0	days	TCGA-KK-A6E5	2073	0	days	2073	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63	TCGA-KK-A6E5-F70484	TCGA-KK-A6E5		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-23144	-19			-19			0	2073		1496			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-2-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	27	0		No	N0	T3b			A6E5	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3			NO		NO	YES	KK	Apex|Middle|Base		Prostate			LIVING	2009	Peripheral Zone	a9e18d77-7074-49d6-b686-fa7d3463d156	TCGA-KK-A6E5-01A-11D-A30W-01	TCGA-KK-A6E5-01A-11D-A30Z-05		TCGA-KK-A6E5-01A-11D-A30X-08	a9e18d77-7074-49d6-b686-fa7d3463d156	TCGA-KK-A6E5-01	TCGA-KK-A6E5-01		TCGA-KK-A6E5-01A-11D-A30W-01	a9e18d77-7074-49d6-b686-fa7d3463d156	TCGA-KK-A6E5-01	TCGA-KK-A6E5-01	TCGA-KK-A6E5-01A-11D-A30X-08	TCGA-KK-A6E5-01A-11D-A30X-08	a9e18d77-7074-49d6-b686-fa7d3463d156
TCGA-KK-A6E6-01	0	TCGA-KK-A6E6-01	3447	0	days	TCGA-KK-A6E6	3447	0	days	3447	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			69		TCGA-KK-A6E6	TCGA-KK-A6E6-01A	NO		M0	T2b	-25320		3813					0	3447		3447			NO		NO				2014-3-27	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	50		NO	Bilateral			YES				NO	5	0	true	No	N0	T3a	TCGA-KK-A6E6.C67B882A-02B1-4511-B55C-87A33FC3E73E.pdf		A6E6	TUMOR FREE	4		0.1	NO	R0	Primary Tumor	01	5			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2002	Peripheral Zone	79922276-6e00-4f17-851f-554f52f71520	TCGA-KK-A6E6-01A-11D-A30W-01	TCGA-KK-A6E6-01A-11D-A30Z-05		TCGA-KK-A6E6-01A-11D-A30X-08	79922276-6e00-4f17-851f-554f52f71520	TCGA-KK-A6E6-01			TCGA-KK-A6E6-01A-11D-A30W-01	79922276-6e00-4f17-851f-554f52f71520	TCGA-KK-A6E6-01		TCGA-KK-A6E6-01A-11D-A30X-08	TCGA-KK-A6E6-01A-11D-A30X-08	79922276-6e00-4f17-851f-554f52f71520
TCGA-KK-A6E7-01	0	TCGA-KK-A6E7-01	2760	0	days	TCGA-KK-A6E7	925	1	days	2760	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	46	TCGA-KK-A6E7-F70486	TCGA-KK-A6E7	TCGA-KK-A6E7-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-17074	-46	2151		-45	8	925	0	2760	925	1847			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension|Equivocal	Scheduled Follow-up Submission		2015-2-24	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	40		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	11	1	true	No	N1	T3a	TCGA-KK-A6E7.8173D1A9-5564-4824-AFD6-2097B90F4008.pdf		A6E7	WITH TUMOR	5	Partial Remission/Response	0.1	NO	R1	Primary Tumor	01	4			NO		NO	YES	KK	Apex|Middle		Prostate		A	LIVING	2007	Transition Zone	025caa8f-3290-488b-b7d0-aacf769a53e4	TCGA-KK-A6E7-01A-11D-A31K-01	TCGA-KK-A6E7-01A-11D-A31M-05		TCGA-KK-A6E7-01A-11D-A31L-08	025caa8f-3290-488b-b7d0-aacf769a53e4	TCGA-KK-A6E7-01	TCGA-KK-A6E7-01		TCGA-KK-A6E7-01A-11D-A31K-01	025caa8f-3290-488b-b7d0-aacf769a53e4	TCGA-KK-A6E7-01	TCGA-KK-A6E7-01	TCGA-KK-A6E7-01A-11D-A31L-08		025caa8f-3290-488b-b7d0-aacf769a53e4
TCGA-KK-A6E8-01	0	TCGA-KK-A6E8-01	1770	0	days	TCGA-KK-A6E8	1770	0	days	1770	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			68		TCGA-KK-A6E8	TCGA-KK-A6E8-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-25026	97	2128			104		0	1770		1769			NO		YES	No Evidence of Extraprostatic Extension			2014-3-27	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	120		NO	Bilateral			YES				NO	14	0	true	No	N0	T2c	TCGA-KK-A6E8.3716A52E-E0B7-4FE0-AC2B-07F2F3A0D6AD.pdf		A6E8	TUMOR FREE	4		0.1	NO	RX	Primary Tumor	01	5			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2007	Transition Zone	246b4ac3-ceec-41c2-bab9-ed88baf668ae	TCGA-KK-A6E8-01A-11D-A31K-01	TCGA-KK-A6E8-01A-11D-A31M-05		TCGA-KK-A6E8-01A-11D-A31L-08	246b4ac3-ceec-41c2-bab9-ed88baf668ae	TCGA-KK-A6E8-01	TCGA-KK-A6E8-01	97219DA1-B3A3-4DD9-99AC-2C016445BA33	TCGA-KK-A6E8-01A-11D-A31K-01	246b4ac3-ceec-41c2-bab9-ed88baf668ae	TCGA-KK-A6E8-01	TCGA-KK-A6E8-01	TCGA-KK-A6E8-01A-11D-A31L-08		246b4ac3-ceec-41c2-bab9-ed88baf668ae
TCGA-KK-A7AP-01	0	TCGA-KK-A7AP-01	196	0	days	TCGA-KK-A7AP			days	196	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55		TCGA-KK-A7AP	TCGA-KK-A7AP-01A		Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-20403	175	1130					0	196					NO		NO				2014-6-6	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	160		NO	Right			YES					15	2	true	Yes, History of Prior Malignancy	N1	T3b	TCGA-KK-A7AP.5B2E970F-CF58-4A8E-90FD-A1AA16C95142.pdf		A7AP		4				R1	Primary Tumor	01	5					NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones	9a4b7216-886c-4247-bcf3-22abc9d10835	TCGA-KK-A7AP-01A-12D-A33S-01	TCGA-KK-A7AP-01A-12D-A33U-05		TCGA-KK-A7AP-01A-12D-A33T-08	9a4b7216-886c-4247-bcf3-22abc9d10835	TCGA-KK-A7AP-01	TCGA-KK-A7AP-01	B3C464FD-9E3F-4667-A0E9-E0DC47D65764	TCGA-KK-A7AP-01A-12D-A33S-01	9a4b7216-886c-4247-bcf3-22abc9d10835	TCGA-KK-A7AP-01	TCGA-KK-A7AP-01		TCGA-KK-A7AP-01A-12D-A33T-08	9a4b7216-886c-4247-bcf3-22abc9d10835
TCGA-KK-A7AQ-01	0	TCGA-KK-A7AQ-01	1610	0	days	TCGA-KK-A7AQ	1610	0	days	1610	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			62	TCGA-KK-A7AQ-F70490	TCGA-KK-A7AQ		NO		M0	T2a	-22731					38	1217	0	1610		1385					YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2015-2-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	11	0		No	N0	T2c			A7AQ	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3			NO	5	NO	YES	KK	Apex|Middle		Prostate			LIVING	2010	Peripheral Zone	b87af222-7056-4704-80c6-6766b8826767	TCGA-KK-A7AQ-01A-11D-A33S-01	TCGA-KK-A7AQ-01A-11D-A33U-05		TCGA-KK-A7AQ-01A-11D-A33T-08	b87af222-7056-4704-80c6-6766b8826767	TCGA-KK-A7AQ-01	TCGA-KK-A7AQ-01		TCGA-KK-A7AQ-01A-11D-A33S-01	b87af222-7056-4704-80c6-6766b8826767	TCGA-KK-A7AQ-01	TCGA-KK-A7AQ-01			b87af222-7056-4704-80c6-6766b8826767
TCGA-KK-A7AU-01	0	TCGA-KK-A7AU-01	1775	0	days	TCGA-KK-A7AU	1775	0	days	1775	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63	TCGA-KK-A7AU-F70505	TCGA-KK-A7AU	TCGA-KK-A7AU-01A	NO		M0	T2b	-23118		1266			123	207	0	1775		1621			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2015-2-24	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	120		NO	Bilateral		NO	YES				NO	11	3	true	No	N1	T3b	TCGA-KK-A7AU.4BA7AC63-6B00-44E3-9545-6A4836912B1E.pdf		A7AU	TUMOR FREE	4	Progressive Disease	0.0	NO	R1	Primary Tumor	01	5			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2010	Peripheral Zone	eb344d08-f396-47b1-b832-dc0eb5d4abfb	TCGA-KK-A7AU-01A-11D-A32A-01	TCGA-KK-A7AU-01A-11D-A32C-05		TCGA-KK-A7AU-01A-11D-A32B-08	eb344d08-f396-47b1-b832-dc0eb5d4abfb	TCGA-KK-A7AU-01	TCGA-KK-A7AU-01	294C495A-6213-4318-9EF8-8F5D005BE309	TCGA-KK-A7AU-01A-11D-A32A-01	eb344d08-f396-47b1-b832-dc0eb5d4abfb	TCGA-KK-A7AU-01	TCGA-KK-A7AU-01		TCGA-KK-A7AU-01A-11D-A32B-08	eb344d08-f396-47b1-b832-dc0eb5d4abfb
TCGA-KK-A7AV-01	0	TCGA-KK-A7AV-01	822	0	days	TCGA-KK-A7AV	822	0	days	822	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			58	TCGA-KK-A7AV-F70507	TCGA-KK-A7AV	TCGA-KK-A7AV-01A	NO		M0	T1c	-21192		587			48		0	822		822			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2015-2-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	60		NO	Bilateral		NO	YES				NO	23	0	true	No	N0	T2c	TCGA-KK-A7AV.7C653DC8-83CE-42D9-A3D5-FA06CAFFF8EE.pdf		A7AV	TUMOR FREE	3	Complete Remission/Response	0.1	NO	RX	Primary Tumor	01	4			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2012	Peripheral Zone	2b18be96-7a63-4bd7-b937-db23d45dd36c	TCGA-KK-A7AV-01A-11D-A32A-01	TCGA-KK-A7AV-01A-11D-A32C-05		TCGA-KK-A7AV-01A-11D-A32B-08	2b18be96-7a63-4bd7-b937-db23d45dd36c	TCGA-KK-A7AV-01	TCGA-KK-A7AV-01		TCGA-KK-A7AV-01A-11D-A32A-01	2b18be96-7a63-4bd7-b937-db23d45dd36c	TCGA-KK-A7AV-01	TCGA-KK-A7AV-01		TCGA-KK-A7AV-01A-11D-A32B-08	2b18be96-7a63-4bd7-b937-db23d45dd36c
TCGA-KK-A7AW-01	0	TCGA-KK-A7AW-01	1054	0	days	TCGA-KK-A7AW			days	1054	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57		TCGA-KK-A7AW	TCGA-KK-A7AW-01A	YES		M0	T2a	-20869		983		11		204	0	1054		204			YES		NO				2014-8-19	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	60		NO	Right			YES					9	1	true	No	N1	T3a	TCGA-KK-A7AW.B5E8DF63-7C54-4D45-93ED-5C80075C63A5.pdf		A7AW	TUMOR FREE	4		0.8		R0	Primary Tumor	01	3					NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2010	Peripheral Zone	4f9b77fa-f087-44c3-a8f2-aeec410bfc9c	TCGA-KK-A7AW-01A-11D-A32A-01	TCGA-KK-A7AW-01A-11D-A32C-05		TCGA-KK-A7AW-01A-11D-A32B-08	4f9b77fa-f087-44c3-a8f2-aeec410bfc9c	TCGA-KK-A7AW-01	TCGA-KK-A7AW-01		TCGA-KK-A7AW-01A-11D-A32A-01	4f9b77fa-f087-44c3-a8f2-aeec410bfc9c	TCGA-KK-A7AW-01	TCGA-KK-A7AW-01			4f9b77fa-f087-44c3-a8f2-aeec410bfc9c
TCGA-KK-A7AY-01	0	TCGA-KK-A7AY-01	1754	0	days	TCGA-KK-A7AY	1754	0	days	1754	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			60	TCGA-KK-A7AY-F70514	TCGA-KK-A7AY	TCGA-KK-A7AY-01A	NO		M0	T2a	-22220		1246				1124	0	1754		1572			NO		NO		Scheduled Follow-up Submission	Stable Disease	2015-2-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	110		NO	Bilateral		NO	YES				NO	8	0	true	No	N0	T2c	TCGA-KK-A7AY.BA64AA42-00AD-4DAD-ABE7-BDDC253B9B45.pdf		A7AY	TUMOR FREE	4	Complete Remission/Response	0.2	NO	R0	Primary Tumor	01	3			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2010	Peripheral Zone	0fecf92d-9c02-4da8-aadd-c8105b99698b	TCGA-KK-A7AY-01A-11D-A33S-01	TCGA-KK-A7AY-01A-11D-A33U-05		TCGA-KK-A7AY-01A-11D-A33T-08	0fecf92d-9c02-4da8-aadd-c8105b99698b	TCGA-KK-A7AY-01	TCGA-KK-A7AY-01		TCGA-KK-A7AY-01A-11D-A33S-01	0fecf92d-9c02-4da8-aadd-c8105b99698b	TCGA-KK-A7AY-01	TCGA-KK-A7AY-01			0fecf92d-9c02-4da8-aadd-c8105b99698b
TCGA-KK-A7AZ-01	0	TCGA-KK-A7AZ-01	1519	0	days	TCGA-KK-A7AZ			days	1519	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			56	TCGA-KK-A7AZ-F70515	TCGA-KK-A7AZ	TCGA-KK-A7AZ-01A				T2b	-20507		1045			141		0	1519					NO		YES	Equivocal	Scheduled Follow-up Submission		2015-2-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	200		NO	Right		NO	YES					14	0	true	No	N0	T3a	TCGA-KK-A7AZ.5DEA3530-6618-4A73-94C7-F23DA06DA52C.pdf		A7AZ		4				R0	Primary Tumor	01	3					NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2010	Peripheral Zone	4d8fe8a9-7bf2-4c95-8aae-f43baeab5826	TCGA-KK-A7AZ-01A-12D-A32A-01	TCGA-KK-A7AZ-01A-12D-A32C-05		TCGA-KK-A7AZ-01A-12D-A32B-08	4d8fe8a9-7bf2-4c95-8aae-f43baeab5826	TCGA-KK-A7AZ-01		10053A5A-9749-41FA-BD4F-3EA396C1F1D5	TCGA-KK-A7AZ-01A-12D-A32A-01	4d8fe8a9-7bf2-4c95-8aae-f43baeab5826	TCGA-KK-A7AZ-01				4d8fe8a9-7bf2-4c95-8aae-f43baeab5826
TCGA-KK-A7B0-01	0	TCGA-KK-A7B0-01	1329	0	days	TCGA-KK-A7B0	1329	0	days	1329	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			67	TCGA-KK-A7B0-F70516	TCGA-KK-A7B0	TCGA-KK-A7B0-01A	NO		M0	T2b	-24756		783				606	0	1329		999			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-2-24	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	150		NO	Bilateral		NO	YES				NO	17	0	true	No	N0	T3b	TCGA-KK-A7B0.A6F717F0-66D2-4AEB-88F6-1A95D26489BC.pdf		A7B0	TUMOR FREE	4	Stable Disease	0.1	NO	R0	Primary Tumor	01	5			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2011	Overlapping / Multiple Zones	13d2199f-d552-4ea3-9d7c-c2d1fb01d7a7	TCGA-KK-A7B0-01A-11D-A32A-01	TCGA-KK-A7B0-01A-11D-A32C-05		TCGA-KK-A7B0-01A-11D-A32B-08	13d2199f-d552-4ea3-9d7c-c2d1fb01d7a7	TCGA-KK-A7B0-01	TCGA-KK-A7B0-01	021977C3-C439-419A-B3DF-AAE39EAC4CA2	TCGA-KK-A7B0-01A-11D-A32A-01	13d2199f-d552-4ea3-9d7c-c2d1fb01d7a7	TCGA-KK-A7B0-01	TCGA-KK-A7B0-01			13d2199f-d552-4ea3-9d7c-c2d1fb01d7a7
TCGA-KK-A7B1-01	0	TCGA-KK-A7B1-01	1063	0	days	TCGA-KK-A7B1			days	1063	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			65	TCGA-KK-A7B1-F70517	TCGA-KK-A7B1	TCGA-KK-A7B1-01A	NO		M0	T1c	-23803		839			52		0	1063		179			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission		2015-2-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	110		NO	Bilateral		NO	YES					21	0	true	No	N0	T3a	TCGA-KK-A7B1.F7802347-53BA-44B9-ACFE-7A10A014822B.pdf		A7B1		4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2011	Peripheral Zone	9bf3daf6-37b4-4dea-92e9-6ed6e54f69f6	TCGA-KK-A7B1-01A-11D-A32A-01	TCGA-KK-A7B1-01A-11D-A32C-05		TCGA-KK-A7B1-01A-11D-A32B-08	9bf3daf6-37b4-4dea-92e9-6ed6e54f69f6	TCGA-KK-A7B1-01	TCGA-KK-A7B1-01	5F2ABD6D-5C1F-480B-A75B-4748C9E42AE7	TCGA-KK-A7B1-01A-11D-A32A-01	9bf3daf6-37b4-4dea-92e9-6ed6e54f69f6	TCGA-KK-A7B1-01	TCGA-KK-A7B1-01		TCGA-KK-A7B1-01A-11D-A32B-08	9bf3daf6-37b4-4dea-92e9-6ed6e54f69f6
TCGA-KK-A7B2-01	0	TCGA-KK-A7B2-01	1099	0	days	TCGA-KK-A7B2	692	1	days	1099	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	68	TCGA-KK-A7B2-F70518	TCGA-KK-A7B2	TCGA-KK-A7B2-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24845	58	554		58		692	0	1099	692	845			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Stable Disease	2015-2-24	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	130		NO	Left		NO	YES		Biochemical evidence of disease		YES	13	1	true	No	N1	T3a	TCGA-KK-A7B2.9A37DFF6-CDD7-40DD-A6A6-3966BC4E275A.pdf		A7B2	WITH TUMOR	4	Stable Disease	0.3	NO	R0	Primary Tumor	01	5			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones	9d5f0b9f-ff36-4a80-8472-412d0ec803c5	TCGA-KK-A7B2-01A-12D-A32A-01	TCGA-KK-A7B2-01A-12D-A32C-05		TCGA-KK-A7B2-01A-12D-A32B-08	9d5f0b9f-ff36-4a80-8472-412d0ec803c5	TCGA-KK-A7B2-01	TCGA-KK-A7B2-01	EAFA78AE-262F-4BCC-BDFA-051C9DDA0F8E	TCGA-KK-A7B2-01A-12D-A32A-01	9d5f0b9f-ff36-4a80-8472-412d0ec803c5	TCGA-KK-A7B2-01	TCGA-KK-A7B2-01			9d5f0b9f-ff36-4a80-8472-412d0ec803c5
TCGA-KK-A7B3-01	0	TCGA-KK-A7B3-01	899	0	days	TCGA-KK-A7B3	294	1	days	899	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO		62	TCGA-KK-A7B3-F70519	TCGA-KK-A7B3	TCGA-KK-A7B3-01A	NO		M0	T3a	-22830		486			112	294	0	899	294	637			NO		YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Scheduled Follow-up Submission	Complete Remission/Response	2015-2-24	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	220		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	17	0	true	Yes, History of Prior Malignancy	N0	T3b	TCGA-KK-A7B3.45C687C3-52B9-4035-B916-777128B9AAE0.pdf		A7B3	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	5			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2012	Peripheral Zone	f3b04f74-8565-45f4-8a14-c0400c954ac4	TCGA-KK-A7B3-01A-11D-A33S-01	TCGA-KK-A7B3-01A-11D-A33U-05		TCGA-KK-A7B3-01A-11D-A33T-08	f3b04f74-8565-45f4-8a14-c0400c954ac4	TCGA-KK-A7B3-01	TCGA-KK-A7B3-01	E8F9ABEF-B961-4190-A287-607F24C58972	TCGA-KK-A7B3-01A-11D-A33S-01	f3b04f74-8565-45f4-8a14-c0400c954ac4	TCGA-KK-A7B3-01	TCGA-KK-A7B3-01		TCGA-KK-A7B3-01A-11D-A33T-08	f3b04f74-8565-45f4-8a14-c0400c954ac4
TCGA-KK-A7B4-01	0	TCGA-KK-A7B4-01	987	0	days	TCGA-KK-A7B4	963	1	days	987	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	64	TCGA-KK-A7B4-F70523	TCGA-KK-A7B4	TCGA-KK-A7B4-01A	YES	Equivocal	M0	T3b	-23644	29	434			29	637	0	987	963	637			NO		YES	Equivocal	Scheduled Follow-up Submission	Progressive Disease	2015-2-24	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	160		NO	Bilateral		NO	YES	Bone	Locoregional Recurrence		YES	20	8	true	Yes, History of Prior Malignancy	N1	T3b	TCGA-KK-A7B4.19CE314A-B253-4F6F-9D77-37B33CFC6F2E.pdf		A7B4	WITH TUMOR	4	Stable Disease	0.6	NO	R1	Primary Tumor	01	5			YES		NO	YES	KK	Apex|Middle|Base	YES	Prostate	Distant Metastasis	A	LIVING	2012	Overlapping / Multiple Zones	dce52b98-298c-4980-ba8b-3791b6528d4c	TCGA-KK-A7B4-01A-11D-A32A-01	TCGA-KK-A7B4-01A-11D-A32C-05		TCGA-KK-A7B4-01A-11D-A32B-08	dce52b98-298c-4980-ba8b-3791b6528d4c	TCGA-KK-A7B4-01	TCGA-KK-A7B4-01	5F026779-6B16-48A6-B59A-8478CCD3ED24	TCGA-KK-A7B4-01A-11D-A32A-01	dce52b98-298c-4980-ba8b-3791b6528d4c	TCGA-KK-A7B4-01	TCGA-KK-A7B4-01		TCGA-KK-A7B4-01A-11D-A32B-08	dce52b98-298c-4980-ba8b-3791b6528d4c
TCGA-KK-A8I4-01	0	TCGA-KK-A8I4-01	2259	0	days	TCGA-KK-A8I4	2162	1	days	2259	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	NO	64	TCGA-KK-A8I4-F70491	TCGA-KK-A8I4	TCGA-KK-A8I4-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-23706	70	1798			70	2162	0	2259	2162	1964			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission		2015-2-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	120		NO	Left		NO	YES		Biochemical evidence of disease		YES	15	1	true	No	N1	T3b	TCGA-KK-A8I4.633E280A-24F4-49FF-95B8-DDA5F447480E.pdf		A8I4	WITH TUMOR	4	Progressive Disease	0.2	NO	R0	Primary Tumor	01	3			NO	5	NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2008	Peripheral Zone	b4d87462-1fc4-4ee4-b905-c2919ebceb33	TCGA-KK-A8I4-01A-11D-A363-01	TCGA-KK-A8I4-01A-11D-A365-05		TCGA-KK-A8I4-01A-11D-A364-08	b4d87462-1fc4-4ee4-b905-c2919ebceb33	TCGA-KK-A8I4-01	TCGA-KK-A8I4-01	07EC66DD-ACFD-471B-B7D2-C15742CB2D03	TCGA-KK-A8I4-01A-11D-A363-01	b4d87462-1fc4-4ee4-b905-c2919ebceb33	TCGA-KK-A8I4-01	TCGA-KK-A8I4-01		TCGA-KK-A8I4-01A-11D-A364-08	b4d87462-1fc4-4ee4-b905-c2919ebceb33
TCGA-KK-A8I5-01	0	TCGA-KK-A8I5-01	3096	0	days	TCGA-KK-A8I5	3096	0	days	3096	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55	TCGA-KK-A8I5-F70513	TCGA-KK-A8I5	TCGA-KK-A8I5-01A	NO		M0	T2a	-20337		2717					0	3096		1979			NO		NO		Scheduled Follow-up Submission		2015-2-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	130		NO	Right		NO	YES				NO	6		true	No	N0	T2b	TCGA-KK-A8I5.CF19D931-B8BE-4978-8C08-081744230305.pdf		A8I5	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2006	Peripheral Zone	1afe5497-bd6d-45b9-816d-52e7fb20ea4e	TCGA-KK-A8I5-01A-11D-A363-01	TCGA-KK-A8I5-01A-11D-A365-05		TCGA-KK-A8I5-01A-11D-A364-08	1afe5497-bd6d-45b9-816d-52e7fb20ea4e	TCGA-KK-A8I5-01	TCGA-KK-A8I5-01	5EEB5789-0D53-4ECE-9924-918EDE7B89D5	TCGA-KK-A8I5-01A-11D-A363-01	1afe5497-bd6d-45b9-816d-52e7fb20ea4e	TCGA-KK-A8I5-01	TCGA-KK-A8I5-01		TCGA-KK-A8I5-01A-11D-A364-08	1afe5497-bd6d-45b9-816d-52e7fb20ea4e
TCGA-KK-A8I6-01	0	TCGA-KK-A8I6-01	668	0	days	TCGA-KK-A8I6	668	0	days	668	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			58		TCGA-KK-A8I6	TCGA-KK-A8I6-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-21499	-14	808		-13	17		0	668		668			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension			2014-8-18	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	170		NO	Bilateral			YES				NO	23	0	true	No	N0	T3a	TCGA-KK-A8I6.11107580-AAF3-4CE8-AC75-8636CE8C515E.pdf		A8I6	TUMOR FREE	4	Complete Remission/Response	0.2	NO	R0	Primary Tumor	01	3			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2011	Peripheral Zone	0b02de77-8d04-4be6-87db-0f0506ee5e54	TCGA-KK-A8I6-01A-11D-A363-01	TCGA-KK-A8I6-01A-11D-A365-05		TCGA-KK-A8I6-01A-11D-A364-08	0b02de77-8d04-4be6-87db-0f0506ee5e54	TCGA-KK-A8I6-01	TCGA-KK-A8I6-01	EA1C6B94-A29F-478B-8416-BB5106EDCB57	TCGA-KK-A8I6-01A-11D-A363-01	0b02de77-8d04-4be6-87db-0f0506ee5e54	TCGA-KK-A8I6-01	TCGA-KK-A8I6-01		TCGA-KK-A8I6-01A-11D-A364-08	0b02de77-8d04-4be6-87db-0f0506ee5e54
TCGA-KK-A8I7-01	0	TCGA-KK-A8I7-01	2002	0	days	TCGA-KK-A8I7	1756	1	days	2002	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	NO	55	TCGA-KK-A8I7-F70524	TCGA-KK-A8I7	TCGA-KK-A8I7-01A	NO		M0	T2c	-20256		1634		24		1088	0	2002	1756	1877	1756		YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-2-24	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	150		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	9	0	true	No	N0	T3b	TCGA-KK-A8I7.70BA9BA3-05E5-4B40-9D6A-BBECCAAADD81.pdf		A8I7	TUMOR FREE	4	Progressive Disease	0.1	NO	R1	Primary Tumor	01	5			NO		NO	YES	KK	Apex|Middle|Base	YES	Prostate	Biochemical Recurrence	A	LIVING	2009	Peripheral Zone	6086c6f1-e184-4a3e-935d-3addef5ecc2c	TCGA-KK-A8I7-01A-21D-A363-01	TCGA-KK-A8I7-01A-21D-A365-05		TCGA-KK-A8I7-01A-21D-A364-08	6086c6f1-e184-4a3e-935d-3addef5ecc2c	TCGA-KK-A8I7-01	TCGA-KK-A8I7-01	9FBC8B7D-6DEA-40F3-860E-97AD2E34A9D8	TCGA-KK-A8I7-01A-21D-A363-01	6086c6f1-e184-4a3e-935d-3addef5ecc2c	TCGA-KK-A8I7-01	TCGA-KK-A8I7-01			6086c6f1-e184-4a3e-935d-3addef5ecc2c
TCGA-KK-A8I8-01	0	TCGA-KK-A8I8-01	967	0	days	TCGA-KK-A8I8	967	0	days	967	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			69	TCGA-KK-A8I8-F70526	TCGA-KK-A8I8	TCGA-KK-A8I8-01A	NO		M0	T2a	-25546		535			31		0	967		757			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2015-2-24	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	110		NO	Bilateral		NO	YES				NO	27		true	No	N0	T3b	TCGA-KK-A8I8.EA62695C-65BD-4E4A-BB9D-0D1CC5B90636.pdf		A8I8	TUMOR FREE	4	Complete Remission/Response	0.1	YES	R1	Primary Tumor	01	5			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2012	Peripheral Zone	532e3276-07d4-4e86-a955-4f474bc8ae36	TCGA-KK-A8I8-01A-11D-A363-01	TCGA-KK-A8I8-01A-11D-A365-05		TCGA-KK-A8I8-01A-11D-A364-08	532e3276-07d4-4e86-a955-4f474bc8ae36	TCGA-KK-A8I8-01	TCGA-KK-A8I8-01	0EECAF91-E4FB-4BA9-B556-C995CE9DD3E3	TCGA-KK-A8I8-01A-11D-A363-01	532e3276-07d4-4e86-a955-4f474bc8ae36	TCGA-KK-A8I8-01	TCGA-KK-A8I8-01		TCGA-KK-A8I8-01A-11D-A364-08	532e3276-07d4-4e86-a955-4f474bc8ae36
TCGA-KK-A8I9-01	0	TCGA-KK-A8I9-01	1001	0	days	TCGA-KK-A8I9	940	1	days	1001	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	61	TCGA-KK-A8I9-F70527	TCGA-KK-A8I9	TCGA-KK-A8I9-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-22295	0	528		-3	0	940	0	1001	940	721			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Stable Disease	2015-2-24	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	50		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	14		true	No	N0	T3a	TCGA-KK-A8I9.D086A0A1-E06A-4B7E-B158-A5D04BCE06E1.pdf		A8I9	WITH TUMOR	4	Complete Remission/Response	0.1	YES	RX	Primary Tumor	01	4			YES		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2012	Peripheral Zone	239d5e7e-5fb5-4df3-ae6b-a5a06ee296ae	TCGA-KK-A8I9-01A-11D-A363-01	TCGA-KK-A8I9-01A-11D-A365-05		TCGA-KK-A8I9-01A-11D-A364-08	239d5e7e-5fb5-4df3-ae6b-a5a06ee296ae	TCGA-KK-A8I9-01	TCGA-KK-A8I9-01		TCGA-KK-A8I9-01A-11D-A363-01	239d5e7e-5fb5-4df3-ae6b-a5a06ee296ae	TCGA-KK-A8I9-01	TCGA-KK-A8I9-01		TCGA-KK-A8I9-01A-11D-A364-08	239d5e7e-5fb5-4df3-ae6b-a5a06ee296ae
TCGA-KK-A8IA-01	0	TCGA-KK-A8IA-01	1931	0	days	TCGA-KK-A8IA	1931	0	days	1931	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			69	TCGA-KK-A8IA-F70528	TCGA-KK-A8IA	TCGA-KK-A8IA-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T3b	-25284	26	1665		26			0	1931		1383			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission		2015-2-24	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	230		NO	Bilateral		NO	YES				NO	19	3	true	No	N1	T3b	TCGA-KK-A8IA.641BD2CD-8B57-49BB-A2E1-9EB78097B4D6.pdf		A8IA		4		0.1	NO	RX	Primary Tumor	01	5			YES		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2009	Peripheral Zone	fbf9c35e-9b03-4c5e-a065-0265ae35a409	TCGA-KK-A8IA-01A-11D-A363-01	TCGA-KK-A8IA-01A-11D-A365-05		TCGA-KK-A8IA-01A-11D-A364-08	fbf9c35e-9b03-4c5e-a065-0265ae35a409	TCGA-KK-A8IA-01	TCGA-KK-A8IA-01	C8238611-9006-49FE-ADFB-D1167916A28B	TCGA-KK-A8IA-01A-11D-A363-01	fbf9c35e-9b03-4c5e-a065-0265ae35a409	TCGA-KK-A8IA-01	TCGA-KK-A8IA-01		TCGA-KK-A8IA-01A-11D-A364-08	fbf9c35e-9b03-4c5e-a065-0265ae35a409
TCGA-KK-A8IB-01	0	TCGA-KK-A8IB-01	83	0	days	TCGA-KK-A8IB			days	83	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			65		TCGA-KK-A8IB	TCGA-KK-A8IB-01A			M0	T2a	-24041		338					0	83					NO		NO				2014-8-19	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	360		NO	Bilateral			YES					21		true	Yes, History of Prior Malignancy	N0	T3a	TCGA-KK-A8IB.B9FBCA1B-CAEB-48A1-87B8-C873AC07FD8B.pdf		A8IB		4				R0	Primary Tumor	01	5					NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2012	Peripheral Zone	02fea7d7-d604-41c2-9506-a62824140df4	TCGA-KK-A8IB-01A-11D-A363-01	TCGA-KK-A8IB-01A-11D-A365-05		TCGA-KK-A8IB-01A-11D-A364-08	02fea7d7-d604-41c2-9506-a62824140df4	TCGA-KK-A8IB-01	TCGA-KK-A8IB-01	A8E140A3-8006-48CA-9C0F-E202F9AE1B4D	TCGA-KK-A8IB-01A-11D-A363-01	02fea7d7-d604-41c2-9506-a62824140df4	TCGA-KK-A8IB-01	TCGA-KK-A8IB-01		TCGA-KK-A8IB-01A-11D-A364-08	02fea7d7-d604-41c2-9506-a62824140df4
TCGA-KK-A8IC-01	0	TCGA-KK-A8IC-01	2051	0	days	TCGA-KK-A8IC	1060	1	days	2051	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	NO	54	TCGA-KK-A8IC-F64008	TCGA-KK-A8IC	TCGA-KK-A8IC-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-19902	7	1784		6		1060	0	2051	1060	2047	2019		YES	No Evidence of Extraprostatic Extension	NO		Additional New Tumor Event	Stable Disease	2014-8-25	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	140		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	38		true	No	N0	T3b	TCGA-KK-A8IC.D11CB264-3D9E-49ED-85AA-57E4A26A5ED1.pdf		A8IC	WITH TUMOR	4	Progressive Disease	0.9	NO	R0	Primary Tumor	01	5			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2008	Peripheral Zone	8ae687ed-f9b2-41fc-88d7-e977fef25582	TCGA-KK-A8IC-01A-11D-A363-01	TCGA-KK-A8IC-01A-11D-A365-05		TCGA-KK-A8IC-01A-11D-A364-08	8ae687ed-f9b2-41fc-88d7-e977fef25582	TCGA-KK-A8IC-01	TCGA-KK-A8IC-01	6718AED6-8EDA-4AEC-8C7D-07BC69E6B132	TCGA-KK-A8IC-01A-11D-A363-01	8ae687ed-f9b2-41fc-88d7-e977fef25582	TCGA-KK-A8IC-01	TCGA-KK-A8IC-01		TCGA-KK-A8IC-01A-11D-A364-08	8ae687ed-f9b2-41fc-88d7-e977fef25582
TCGA-KK-A8ID-01	0	TCGA-KK-A8ID-01	2107	0	days	TCGA-KK-A8ID	2107	0	days	2107	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			70	TCGA-KK-A8ID-F70529	TCGA-KK-A8ID	TCGA-KK-A8ID-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-25851	43	1717		-5			0	2107		1924			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-2-24	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	160		NO	Bilateral		NO	YES				NO	19	2	true	No	N1	T3b	TCGA-KK-A8ID.51303D5A-8963-4A4E-8A30-8EB0CA6D9437.pdf		A8ID	TUMOR FREE	5	Complete Remission/Response	0.1	NO	R1	Primary Tumor	01	4			YES		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2009	Overlapping / Multiple Zones	dc0bcf42-993d-4119-b91e-399a639c1480	TCGA-KK-A8ID-01A-11D-A363-01	TCGA-KK-A8ID-01A-11D-A365-05		TCGA-KK-A8ID-01A-11D-A364-08	dc0bcf42-993d-4119-b91e-399a639c1480	TCGA-KK-A8ID-01	TCGA-KK-A8ID-01	6E2ED8C2-EA96-47D4-9F6E-125D5D6686D0	TCGA-KK-A8ID-01A-11D-A363-01	dc0bcf42-993d-4119-b91e-399a639c1480	TCGA-KK-A8ID-01	TCGA-KK-A8ID-01		TCGA-KK-A8ID-01A-11D-A364-08	dc0bcf42-993d-4119-b91e-399a639c1480
TCGA-KK-A8IF-01	0	TCGA-KK-A8IF-01	804	0	days	TCGA-KK-A8IF			days	804	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57		TCGA-KK-A8IF	TCGA-KK-A8IF-01A	YES		M0	T2a	-20888		2351			522	648	0	804		788			NO		YES	No Evidence of Extraprostatic Extension			2014-8-18	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	160		NO	Bilateral			YES				YES	33		true	No	N0	T3a	TCGA-KK-A8IF.BF56F683-5D52-4154-B9D4-1B6D2608C5AA.pdf		A8IF	WITH TUMOR	4		0.7		R0	Primary Tumor	01	3					NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2007	Transition Zone	8744dea9-5e21-47b0-9327-8177526d9d31	TCGA-KK-A8IF-01A-11D-A363-01	TCGA-KK-A8IF-01A-11D-A365-05		TCGA-KK-A8IF-01A-11D-A364-08	8744dea9-5e21-47b0-9327-8177526d9d31	TCGA-KK-A8IF-01	TCGA-KK-A8IF-01	0FF387D4-AB6A-425A-8256-1237F7FC0F2F	TCGA-KK-A8IF-01A-11D-A363-01	8744dea9-5e21-47b0-9327-8177526d9d31	TCGA-KK-A8IF-01	TCGA-KK-A8IF-01		TCGA-KK-A8IF-01A-11D-A364-08	8744dea9-5e21-47b0-9327-8177526d9d31
TCGA-KK-A8IG-01	0	TCGA-KK-A8IG-01	2505	0	days	TCGA-KK-A8IG	2505	0	days	2505	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55	TCGA-KK-A8IG-F70530	TCGA-KK-A8IG	TCGA-KK-A8IG-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-20266	63	2057		63			0	2505		2211			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-2-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	60		NO	Bilateral		NO	YES				NO	19		true	No	N0	T3a	TCGA-KK-A8IG.D1F786EC-03F5-458B-99AC-3B89EFFF2297.pdf		A8IG	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R1	Primary Tumor	01	3			NO		NO	YES	KK	Apex|Middle		Prostate		A	LIVING	2008	Transition Zone	95c350df-1871-430a-9c08-f3d88e2edcaf	TCGA-KK-A8IG-01A-11D-A363-01	TCGA-KK-A8IG-01A-11D-A365-05		TCGA-KK-A8IG-01A-11D-A364-08	95c350df-1871-430a-9c08-f3d88e2edcaf	TCGA-KK-A8IG-01	TCGA-KK-A8IG-01		TCGA-KK-A8IG-01A-11D-A363-01	95c350df-1871-430a-9c08-f3d88e2edcaf	TCGA-KK-A8IG-01	TCGA-KK-A8IG-01		TCGA-KK-A8IG-01A-11D-A364-08	95c350df-1871-430a-9c08-f3d88e2edcaf
TCGA-KK-A8IH-01	0	TCGA-KK-A8IH-01	2013	0	days	TCGA-KK-A8IH	2013	0	days	2013	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			50	TCGA-KK-A8IH-F70531	TCGA-KK-A8IH	TCGA-KK-A8IH-01A	NO		M0	T2b	-18560		1631					0	2013		1634			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-2-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	170		NO	Bilateral		NO	YES				NO	10		true	No	N0	T3a	TCGA-KK-A8IH.E2FC2177-CB74-4E23-B24D-68F4ECEA57C2.pdf		A8IH	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3			NO	5	NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2009	Peripheral Zone	994566a7-664e-4b9b-9320-126940c14b6b	TCGA-KK-A8IH-01A-11D-A363-01	TCGA-KK-A8IH-01A-11D-A365-05		TCGA-KK-A8IH-01A-11D-A364-08	994566a7-664e-4b9b-9320-126940c14b6b	TCGA-KK-A8IH-01	TCGA-KK-A8IH-01	9755CEAB-EF49-4F43-9710-C1BC7820B893	TCGA-KK-A8IH-01A-11D-A363-01	994566a7-664e-4b9b-9320-126940c14b6b	TCGA-KK-A8IH-01	TCGA-KK-A8IH-01		TCGA-KK-A8IH-01A-11D-A364-08	994566a7-664e-4b9b-9320-126940c14b6b
TCGA-KK-A8II-01	1	TCGA-KK-A8II-01	3467	1	days	TCGA-KK-A8II	1854	1	days	3467	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	NO	61	TCGA-KK-A8II-F68762	TCGA-KK-A8II	TCGA-KK-A8II-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-22460	-28	3293	3467	11		626	0		1854	2891			YES	No Evidence of Extraprostatic Extension	NO		Additional New Tumor Event	Progressive Disease	2014-12-16	MALE	9	Prostate Adenocarcinoma, Other Subtype	No	C61	8500/3	C61.9	YES	Core needle biopsy	240		NO	Bilateral		NO	YES	Bone	Biochemical evidence of disease		YES	19		true	No	N0	T3a	TCGA-KK-A8II.0C940BA1-22F7-412D-AD58-84B950157601.pdf		A8II	WITH TUMOR	4	Complete Remission/Response	39.8	NO	R0	Primary Tumor	01	5		Medical Record	NO		NO	YES	KK	Apex|Middle|Base	YES	Prostate	Distant Metastasis	A	DECEASED	2004	Peripheral Zone	d5cb344a-fec2-4370-88ef-4837ae8573dc	TCGA-KK-A8II-01A-11D-A363-01	TCGA-KK-A8II-01A-11D-A365-05		TCGA-KK-A8II-01A-11D-A364-08	d5cb344a-fec2-4370-88ef-4837ae8573dc	TCGA-KK-A8II-01	TCGA-KK-A8II-01	7DE10C16-6E56-4BE0-BB42-B651B2DF2C24	TCGA-KK-A8II-01A-11D-A363-01	d5cb344a-fec2-4370-88ef-4837ae8573dc	TCGA-KK-A8II-01	TCGA-KK-A8II-01		TCGA-KK-A8II-01A-11D-A364-08	d5cb344a-fec2-4370-88ef-4837ae8573dc
TCGA-KK-A8IJ-01	0	TCGA-KK-A8IJ-01	1559	0	days	TCGA-KK-A8IJ			days	1559	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			59		TCGA-KK-A8IJ	TCGA-KK-A8IJ-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-21793	42	1749		42			0	1559		167			YES	No Evidence of Extraprostatic Extension	NO				2014-8-19	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	240		NO	Bilateral			YES				YES	34	1	true	No	N1	T3b	TCGA-KK-A8IJ.F224443D-410F-4F1E-9CA0-04A652985616.pdf		A8IJ		4		0.1		R0	Primary Tumor	01	3				5	NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2009	Peripheral Zone	a8f619f1-c92e-4e7b-99f9-d25984935cde	TCGA-KK-A8IJ-01A-11D-A34T-01	TCGA-KK-A8IJ-01A-11D-A34V-05		TCGA-KK-A8IJ-01A-11D-A34U-08	a8f619f1-c92e-4e7b-99f9-d25984935cde	TCGA-KK-A8IJ-01	TCGA-KK-A8IJ-01	8D73AAEA-C409-4438-8682-99786DF345D5	TCGA-KK-A8IJ-01A-11D-A34T-01	a8f619f1-c92e-4e7b-99f9-d25984935cde	TCGA-KK-A8IJ-01	TCGA-KK-A8IJ-01		TCGA-KK-A8IJ-01A-11D-A34U-08	a8f619f1-c92e-4e7b-99f9-d25984935cde
TCGA-KK-A8IK-01	0	TCGA-KK-A8IK-01	2052	0	days	TCGA-KK-A8IK	2052	0	days	2052	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			56	TCGA-KK-A8IK-F70532	TCGA-KK-A8IK	TCGA-KK-A8IK-01A	NO	Abnormal (not related to prostate cancer)	M0	T1c	-20594	-69	1759		-69			0	2052					YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission		2015-2-24	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	80		NO	Bilateral		NO	YES				NO	6		true	No	N0	T2c	TCGA-KK-A8IK.CBFE7CBE-890E-4749-9566-0CE41A93D69D.pdf		A8IK	TUMOR FREE	4	Complete Remission/Response	0.0	NO	R0	Primary Tumor	01	5			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2008	Peripheral Zone	2d669bc4-fb4b-4db9-b6a3-f54dde950056	TCGA-KK-A8IK-01A-11D-A363-01	TCGA-KK-A8IK-01A-11D-A365-05		TCGA-KK-A8IK-01A-11D-A364-08	2d669bc4-fb4b-4db9-b6a3-f54dde950056	TCGA-KK-A8IK-01	TCGA-KK-A8IK-01		TCGA-KK-A8IK-01A-11D-A363-01	2d669bc4-fb4b-4db9-b6a3-f54dde950056	TCGA-KK-A8IK-01	TCGA-KK-A8IK-01		TCGA-KK-A8IK-01A-11D-A364-08	2d669bc4-fb4b-4db9-b6a3-f54dde950056
TCGA-KK-A8IL-01	1	TCGA-KK-A8IL-01	628	1	days	TCGA-KK-A8IL			days	628	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			65		TCGA-KK-A8IL	TCGA-KK-A8IL-01A	NO		M0	T1c	-23849		1420	628	7	87		0			144			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension			2014-8-19	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	60		NO	Bilateral			YES					08	01	true	No	N1	T3b	TCGA-KK-A8IL.9F54DC02-35C0-4D0E-A1D8-63F820CF72C4.pdf		A8IL		4		0.1		R1	Primary Tumor	01	5		Medical Record			NO	YES	KK	Apex|Middle|Base		Prostate		A	DECEASED	2009	Peripheral Zone	0e2cfe4b-18fe-47f6-b357-a43f97a9b531	TCGA-KK-A8IL-01A-11D-A363-01	TCGA-KK-A8IL-01A-11D-A365-05		TCGA-KK-A8IL-01A-11D-A364-08	0e2cfe4b-18fe-47f6-b357-a43f97a9b531	TCGA-KK-A8IL-01	TCGA-KK-A8IL-01		TCGA-KK-A8IL-01A-11D-A363-01	0e2cfe4b-18fe-47f6-b357-a43f97a9b531	TCGA-KK-A8IL-01	TCGA-KK-A8IL-01		TCGA-KK-A8IL-01A-11D-A364-08	0e2cfe4b-18fe-47f6-b357-a43f97a9b531
TCGA-KK-A8IM-01	0	TCGA-KK-A8IM-01	1915	0	days	TCGA-KK-A8IM	1915	0	days	1915	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55	TCGA-KK-A8IM-F70533	TCGA-KK-A8IM	TCGA-KK-A8IM-01A	NO		M0	T2a	-20425		1466					0	1915		1438			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-2-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	60		NO	Bilateral		NO	YES				NO	5		true	No	N0	T2c	TCGA-KK-A8IM.C0D3148F-A371-4983-9E62-DA5446385173.pdf		A8IM	TUMOR FREE	4	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	3			NO		NO	YES	KK	Apex|Middle|Base		Prostate		A	LIVING	2009	Peripheral Zone	6d249571-1535-4db3-9860-a56a02941200	TCGA-KK-A8IM-01A-11D-A363-01	TCGA-KK-A8IM-01A-11D-A365-05		TCGA-KK-A8IM-01A-11D-A364-08	6d249571-1535-4db3-9860-a56a02941200	TCGA-KK-A8IM-01	TCGA-KK-A8IM-01		TCGA-KK-A8IM-01A-11D-A363-01	6d249571-1535-4db3-9860-a56a02941200	TCGA-KK-A8IM-01	TCGA-KK-A8IM-01			6d249571-1535-4db3-9860-a56a02941200
TCGA-M7-A71Y-01	0	TCGA-M7-A71Y-01	493	0	days	TCGA-M7-A71Y	493	0	days	493	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55	TCGA-M7-A71Y-F61811	TCGA-M7-A71Y	TCGA-M7-A71Y-01A	NO			T1c	-20357		183					0	493		158			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-7-7	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	140		NO	Bilateral		NO	NO				NO			false	No		T2c	TCGA-M7-A71Y.569825C5-98D3-4A52-AD1D-2859F8F54A34.pdf		A71Y	TUMOR FREE	3	Complete Remission/Response		NO	R0	Primary Tumor	01	4			NO		YES	NO	M7	Apex|Middle|Base		Prostate		A	LIVING	2013	Overlapping / Multiple Zones	a3f81069-d0a9-49af-bd22-24c6142241b6	TCGA-M7-A71Y-01A-22D-A32A-01	TCGA-M7-A71Y-01A-22D-A32C-05		TCGA-M7-A71Y-01A-22D-A32B-08	a3f81069-d0a9-49af-bd22-24c6142241b6	TCGA-M7-A71Y-01		693F8FB0-76DB-4A04-A20A-0C73077ED9A6	TCGA-M7-A71Y-01A-22D-A32A-01	a3f81069-d0a9-49af-bd22-24c6142241b6	TCGA-M7-A71Y-01			TCGA-M7-A71Y-01A-22D-A32B-08	a3f81069-d0a9-49af-bd22-24c6142241b6
TCGA-M7-A71Z-01	0	TCGA-M7-A71Z-01	643	0	days	TCGA-M7-A71Z	643	0	days	643	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			62	TCGA-M7-A71Z-F68775	TCGA-M7-A71Z	TCGA-M7-A71Z-01A	NO			T2a	-22785		136					0	643		209			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-12-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	160		NO	Right		NO	YES				NO	9	0	false	No	N0	T3a	TCGA-M7-A71Z.5F9BC119-B8E9-4C05-8A34-AA8E79C490B6.pdf		A71Z	TUMOR FREE	4	Complete Remission/Response		NO	R0	Primary Tumor	01	3			NO		YES	NO	M7	Apex|Base		Prostate		A	LIVING	2013	Overlapping / Multiple Zones	f64c8677-da87-4543-b53c-4de28d86fff1	TCGA-M7-A71Z-01A-12D-A32A-01	TCGA-M7-A71Z-01A-12D-A32C-05		TCGA-M7-A71Z-01A-12D-A32B-08	f64c8677-da87-4543-b53c-4de28d86fff1	TCGA-M7-A71Z-01	TCGA-M7-A71Z-01	C3F52FA3-A05B-48C0-B7A0-82B463A0CCEB	TCGA-M7-A71Z-01A-12D-A32A-01	f64c8677-da87-4543-b53c-4de28d86fff1	TCGA-M7-A71Z-01	TCGA-M7-A71Z-01			f64c8677-da87-4543-b53c-4de28d86fff1
TCGA-M7-A720-01	0	TCGA-M7-A720-01	384	0	days	TCGA-M7-A720	384	0	days	384	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			53	TCGA-M7-A720-F70038	TCGA-M7-A720	TCGA-M7-A720-01A	NO			T1c	-19642		190					0	384		302			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-1-26	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	130		NO	Bilateral		YES	NO				NO			false	No		T2c	TCGA-M7-A720.65D5D425-D41A-4E98-AA86-119F3BE1D3CE.pdf		A720	TUMOR FREE	3	Complete Remission/Response		NO	R0	Primary Tumor	01	3			NO		YES	NO	M7	Middle|Base		Prostate		A	LIVING	2013	Peripheral Zone	0c18423b-7a7e-440d-96a7-ec3815aa411c	TCGA-M7-A720-01A-12D-A32A-01	TCGA-M7-A720-01A-12D-A32C-05		TCGA-M7-A720-01A-12D-A32B-08	0c18423b-7a7e-440d-96a7-ec3815aa411c	TCGA-M7-A720-01	TCGA-M7-A720-01	EBE5ED85-FD4C-431A-9BE7-B88BF2582708	TCGA-M7-A720-01A-12D-A32A-01	0c18423b-7a7e-440d-96a7-ec3815aa411c	TCGA-M7-A720-01	TCGA-M7-A720-01		TCGA-M7-A720-01A-12D-A32B-08	0c18423b-7a7e-440d-96a7-ec3815aa411c
TCGA-M7-A721-01	0	TCGA-M7-A721-01	400	0	days	TCGA-M7-A721	400	0	days	400	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			70	TCGA-M7-A721-F61812	TCGA-M7-A721	TCGA-M7-A721-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-25585	-8	276			-8		0	400		162			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission		2014-7-7	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	120		NO	Bilateral		YES	NO				NO			false	No		T2c	TCGA-M7-A721.357FE07A-B561-44BF-B59B-811F77C1F634.pdf		A721	TUMOR FREE	3	Complete Remission/Response		NO	R1	Primary Tumor	01	4			NO		YES	NO	M7	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones	b490a174-95fa-4681-be76-e1690fb17131	TCGA-M7-A721-01A-12D-A32A-01	TCGA-M7-A721-01A-12D-A32C-05		TCGA-M7-A721-01A-12D-A32B-08	b490a174-95fa-4681-be76-e1690fb17131	TCGA-M7-A721-01	TCGA-M7-A721-01	7416D676-6F14-4971-A20B-EB2C5E1FFF69	TCGA-M7-A721-01A-12D-A32A-01	b490a174-95fa-4681-be76-e1690fb17131	TCGA-M7-A721-01	TCGA-M7-A721-01		TCGA-M7-A721-01A-12D-A32B-08	b490a174-95fa-4681-be76-e1690fb17131
TCGA-M7-A722-01	0	TCGA-M7-A722-01	1060	0	days	TCGA-M7-A722			days	1060	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			65	TCGA-M7-A722-F71084	TCGA-M7-A722	TCGA-M7-A722-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-23880	3	577		3		559	0	1060		559			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-3-17	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	190		NO	Bilateral		NO	YES				YES	4	0	false	No	N0	T3a	TCGA-M7-A722.4D0EE4BC-69EC-45D2-8739-24E1FE1A526A.pdf		A722	TUMOR FREE	4	Partial Remission/Response		NO	R1	Primary Tumor	01	4			NO	3	YES	NO	M7			Prostate		A	LIVING	2011	Overlapping / Multiple Zones	ed257c43-c4be-42c9-8968-82bb9c0b8ce2	TCGA-M7-A722-01A-12D-A363-01	TCGA-M7-A722-01A-12D-A365-05		TCGA-M7-A722-01A-12D-A364-08	ed257c43-c4be-42c9-8968-82bb9c0b8ce2	TCGA-M7-A722-01	TCGA-M7-A722-01	51538E59-F215-414E-B126-F5AC77501A97	TCGA-M7-A722-01A-12D-A363-01	ed257c43-c4be-42c9-8968-82bb9c0b8ce2	TCGA-M7-A722-01	TCGA-M7-A722-01			ed257c43-c4be-42c9-8968-82bb9c0b8ce2
TCGA-M7-A723-01	0	TCGA-M7-A723-01	763	0	days	TCGA-M7-A723	763	0	days	763	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			54	TCGA-M7-A723-F61813	TCGA-M7-A723	TCGA-M7-A723-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-20064	8	442		11			0	763		62			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-7-7	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	150		NO	Bilateral		NO	YES				NO	17	1	false	No	N1	T3b	TCGA-M7-A723.8F42420C-A513-4A6A-A89F-B5C9303FBF59.pdf		A723	TUMOR FREE	4	Complete Remission/Response	0.1	YES	R1	Primary Tumor	01	3			YES	5	YES	NO	M7	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones	d139f13a-72aa-4bd8-bee2-c60c6bb016f2	TCGA-M7-A723-01A-12D-A32A-01	TCGA-M7-A723-01A-12D-A32C-05		TCGA-M7-A723-01A-12D-A32B-08	d139f13a-72aa-4bd8-bee2-c60c6bb016f2	TCGA-M7-A723-01	TCGA-M7-A723-01	6368E005-1260-485C-B019-1F2C82B5715E	TCGA-M7-A723-01A-12D-A32A-01	d139f13a-72aa-4bd8-bee2-c60c6bb016f2	TCGA-M7-A723-01	TCGA-M7-A723-01			d139f13a-72aa-4bd8-bee2-c60c6bb016f2
TCGA-M7-A724-01	0	TCGA-M7-A724-01	889	0	days	TCGA-M7-A724			days	889	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			64	TCGA-M7-A724-F70042	TCGA-M7-A724	TCGA-M7-A724-01A	NO	Abnormal (not related to prostate cancer)	M0	T1c	-23595	11	351		35			0	889		483			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-1-26	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	160		NO	Right		NO	YES				YES	7	0	false	No	N0	T3a	TCGA-M7-A724.AF3AE21A-2D5F-4769-B438-C42415A47330.pdf		A724	WITH TUMOR	4	Progressive Disease		NO	R1	Primary Tumor	01	4			NO		YES	NO	M7	Apex|Base		Prostate		A	LIVING	2012	Peripheral Zone	8a3c4f20-3714-4dfd-9fb2-e7bae0c73432	TCGA-M7-A724-01A-12D-A32A-01	TCGA-M7-A724-01A-12D-A32C-05		TCGA-M7-A724-01A-12D-A32B-08	8a3c4f20-3714-4dfd-9fb2-e7bae0c73432	TCGA-M7-A724-01	TCGA-M7-A724-01	10D64418-9272-47C7-B03F-A58D2AB83E6A	TCGA-M7-A724-01A-12D-A32A-01	8a3c4f20-3714-4dfd-9fb2-e7bae0c73432	TCGA-M7-A724-01	TCGA-M7-A724-01			8a3c4f20-3714-4dfd-9fb2-e7bae0c73432
TCGA-M7-A725-01	0	TCGA-M7-A725-01	573	0	days	TCGA-M7-A725	573	0	days	573	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			56	TCGA-M7-A725-F61814	TCGA-M7-A725	TCGA-M7-A725-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-20474	16	240		16			0	573		96			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission		2014-7-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	110		NO	Bilateral		NO	YES				NO	11	0	false	No	N0	T3b	TCGA-M7-A725.5885079D-F3C7-44DB-9BA1-60DCA1C9919C.pdf		A725	TUMOR FREE	4	Complete Remission/Response		NO	R1	Primary Tumor	01	3			NO	5	YES	NO	M7	Apex|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones	2faac3f0-67e2-433a-ad56-c43e794c7fee	TCGA-M7-A725-01A-12D-A32A-01	TCGA-M7-A725-01A-12D-A32C-05		TCGA-M7-A725-01A-12D-A32B-08	2faac3f0-67e2-433a-ad56-c43e794c7fee	TCGA-M7-A725-01	TCGA-M7-A725-01	6911F17B-F9E6-45FC-8BB3-9ED3C8BEA353	TCGA-M7-A725-01A-12D-A32A-01	2faac3f0-67e2-433a-ad56-c43e794c7fee	TCGA-M7-A725-01	TCGA-M7-A725-01		TCGA-M7-A725-01A-12D-A32B-08	2faac3f0-67e2-433a-ad56-c43e794c7fee
TCGA-MG-AAMC-01	0	TCGA-MG-AAMC-01	173	0	days	TCGA-MG-AAMC	173	0	days	173	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			59	TCGA-MG-AAMC-F68686	TCGA-MG-AAMC	TCGA-MG-AAMC-01A	NO		M0	T1c	-21846		278					0	173		54							Scheduled Follow-up Submission		2015-1-9	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	40		NO			YES					NO			true	No	N0	T3a	TCGA-MG-AAMC.CBC765C1-9191-4A40-979F-CF2434B10CAB.pdf		AAMC	TUMOR FREE	4	Complete Remission/Response	.01	NO	R0	Primary Tumor	01	5			NO	3	NO	YES	MG			Prostate		A	LIVING	2013		1747f562-8e96-47e6-96ab-26f34d54b4bd	TCGA-MG-AAMC-01A-11D-A41J-01	TCGA-MG-AAMC-01A-11D-A41L-05		TCGA-MG-AAMC-01A-11D-A41K-08	1747f562-8e96-47e6-96ab-26f34d54b4bd	TCGA-MG-AAMC-01	TCGA-MG-AAMC-01		TCGA-MG-AAMC-01A-11D-A41J-01	1747f562-8e96-47e6-96ab-26f34d54b4bd	TCGA-MG-AAMC-01	TCGA-MG-AAMC-01			1747f562-8e96-47e6-96ab-26f34d54b4bd
TCGA-QU-A6IL-01	0	TCGA-QU-A6IL-01	97	0	days	TCGA-QU-A6IL	97	0	days	97	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			64	TCGA-QU-A6IL-F66982	TCGA-QU-A6IL	TCGA-QU-A6IL-01A	NO		M0	T2a	-23710		4048					0	97		91								Complete Remission/Response	2014-10-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy			NO	Bilateral		YES	YES				NO	4	0	true	No	N0	T2c	TCGA-QU-A6IL.EF13AC98-FA7C-442C-A6A4-A5E7ECB2596D.pdf		A6IL	TUMOR FREE	3	Complete Remission/Response	0.2	NO	R0	Primary Tumor	01	4			NO		NO	YES	QU	Apex|Middle|Base		Prostate		A	LIVING	2002		788e9097-8705-44e4-a7c7-7fbb75f7f9e2	TCGA-QU-A6IL-01A-11D-A31K-01	TCGA-QU-A6IL-01A-11D-A31M-05		TCGA-QU-A6IL-01A-11D-A31L-08	788e9097-8705-44e4-a7c7-7fbb75f7f9e2	TCGA-QU-A6IL-01	TCGA-QU-A6IL-01		TCGA-QU-A6IL-01A-11D-A31K-01	788e9097-8705-44e4-a7c7-7fbb75f7f9e2	TCGA-QU-A6IL-01	TCGA-QU-A6IL-01	TCGA-QU-A6IL-01A-11D-A31L-08		788e9097-8705-44e4-a7c7-7fbb75f7f9e2
TCGA-QU-A6IM-01	0	TCGA-QU-A6IM-01	1247	0	days	TCGA-QU-A6IM	1247	0	days	1247	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			59	TCGA-QU-A6IM-F66983	TCGA-QU-A6IM	TCGA-QU-A6IM-01A	NO	Equivocal	M0	T2b	-21792	35	3796		50	35		0	1247		896			YES	Equivocal	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2014-10-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	40		NO	Left		YES	YES				NO	2	0	true	Yes, History of Prior Malignancy	N0	T2a	TCGA-QU-A6IM.6999B5F3-AC5C-4447-9590-548F103039C3.pdf		A6IM	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO		NO	YES	QU	Apex|Middle		Prostate		A	LIVING	2003		9fe289f4-0f5f-4d72-935c-4fb3f44fa91a	TCGA-QU-A6IM-01A-11D-A31K-01	TCGA-QU-A6IM-01A-11D-A31M-05		TCGA-QU-A6IM-01A-11D-A31L-08	9fe289f4-0f5f-4d72-935c-4fb3f44fa91a	TCGA-QU-A6IM-01	TCGA-QU-A6IM-01		TCGA-QU-A6IM-01A-11D-A31K-01	9fe289f4-0f5f-4d72-935c-4fb3f44fa91a	TCGA-QU-A6IM-01	TCGA-QU-A6IM-01	TCGA-QU-A6IM-01A-11D-A31L-08		9fe289f4-0f5f-4d72-935c-4fb3f44fa91a
TCGA-QU-A6IN-01	0	TCGA-QU-A6IN-01	4264	0	days	TCGA-QU-A6IN	4264	0	days	4264	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61	TCGA-QU-A6IN-F66984	TCGA-QU-A6IN	TCGA-QU-A6IN-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22286	21	3789			43		0	4264		3428			NO		YES		Scheduled Follow-up Submission	Complete Remission/Response	2014-10-31	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	110		NO	Bilateral		NO	YES				NO	15	0	true	No	N0	T2c	TCGA-QU-A6IN.11063611-DCFF-427E-89A9-25961C79DF07.pdf		A6IN	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	4			NO	5	NO	YES	QU	Apex|Middle|Base		Prostate		A	LIVING	2003		3447e7c9-5d79-4cc0-9e00-6c8552565597	TCGA-QU-A6IN-01A-11D-A31K-01	TCGA-QU-A6IN-01A-11D-A31M-05		TCGA-QU-A6IN-01A-11D-A31L-08	3447e7c9-5d79-4cc0-9e00-6c8552565597	TCGA-QU-A6IN-01	TCGA-QU-A6IN-01	9964CB21-71EF-4A39-AEC3-EE674BA4372A	TCGA-QU-A6IN-01A-11D-A31K-01	3447e7c9-5d79-4cc0-9e00-6c8552565597	TCGA-QU-A6IN-01	TCGA-QU-A6IN-01	TCGA-QU-A6IN-01A-11D-A31L-08		3447e7c9-5d79-4cc0-9e00-6c8552565597
TCGA-QU-A6IO-01	0	TCGA-QU-A6IO-01	3716	0	days	TCGA-QU-A6IO	3716	0	days	3716	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			53	TCGA-QU-A6IO-F66985	TCGA-QU-A6IO		NO		M0	T1c	-19564							0	3716		1436			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-10-31	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	2	0		No	N0	T2c			A6IO	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R1	Primary Tumor	01	3			NO		NO	YES	QU	Apex|Middle|Base		Prostate			LIVING	2003		f974f0e8-cbca-4d1f-a435-937f945ea3dc	TCGA-QU-A6IO-01A-11D-A31K-01	TCGA-QU-A6IO-01A-11D-A31M-05		TCGA-QU-A6IO-01A-11D-A31L-08	f974f0e8-cbca-4d1f-a435-937f945ea3dc	TCGA-QU-A6IO-01	TCGA-QU-A6IO-01		TCGA-QU-A6IO-01A-11D-A31K-01	f974f0e8-cbca-4d1f-a435-937f945ea3dc	TCGA-QU-A6IO-01	TCGA-QU-A6IO-01	TCGA-QU-A6IO-01A-11D-A31L-08		f974f0e8-cbca-4d1f-a435-937f945ea3dc
TCGA-QU-A6IP-01	0	TCGA-QU-A6IP-01	2620	0	days	TCGA-QU-A6IP	2620	0	days	2620	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-QU-A6IP-F66986	TCGA-QU-A6IP	TCGA-QU-A6IP-01A	NO		M0	T2a	-24212		3118					0	2620		2620			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-10-31	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	140		NO	Right		YES	YES				NO	2	0	true	No	N0	T2a	TCGA-QU-A6IP.D1E73097-6F07-4B1E-8914-074FA037CB85.pdf		A6IP	TUMOR FREE	3	Complete Remission/Response	0	NO	R0	Primary Tumor	01	3			NO		NO	YES	QU	Middle|Base		Prostate		A	LIVING	2004		8adec7c9-1c95-419b-9876-a3f9d068d392	TCGA-QU-A6IP-01A-11D-A31K-01	TCGA-QU-A6IP-01A-11D-A31M-05		TCGA-QU-A6IP-01A-11D-A31L-08	8adec7c9-1c95-419b-9876-a3f9d068d392	TCGA-QU-A6IP-01	TCGA-QU-A6IP-01	EB984C4C-CF89-438A-81FC-096B5871D2AC	TCGA-QU-A6IP-01A-11D-A31K-01	8adec7c9-1c95-419b-9876-a3f9d068d392	TCGA-QU-A6IP-01	TCGA-QU-A6IP-01	TCGA-QU-A6IP-01A-11D-A31L-08	TCGA-QU-A6IP-01A-11D-A31L-08	8adec7c9-1c95-419b-9876-a3f9d068d392
TCGA-SU-A7E7-01	0	TCGA-SU-A7E7-01	551	0	days	TCGA-SU-A7E7	551	0	days	551	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	60	TCGA-SU-A7E7-F64938	TCGA-SU-A7E7	TCGA-SU-A7E7-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-22185	6	165		-10			0	551		426			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-16	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	300		NO	Right		NO	YES				NO	9	0	true	No	N0	T2b	TCGA-SU-A7E7.120AA6E7-735D-442E-99AA-4EFE93C365F6.pdf		A7E7	TUMOR FREE	5	Complete Remission/Response	0.01	NO	R0	Primary Tumor	01	3			NO		YES	NO	SU	Base		Prostate		A	LIVING	2013	Peripheral Zone	041bbea8-d1fe-4f96-be85-67a95e651044	TCGA-SU-A7E7-01A-22D-A33S-01	TCGA-SU-A7E7-01A-22D-A33U-05		TCGA-SU-A7E7-01A-22D-A33T-08	041bbea8-d1fe-4f96-be85-67a95e651044	TCGA-SU-A7E7-01	TCGA-SU-A7E7-01	BDF1C6D7-456C-4997-916C-9B23F232A664	TCGA-SU-A7E7-01A-22D-A33S-01	041bbea8-d1fe-4f96-be85-67a95e651044	TCGA-SU-A7E7-01	TCGA-SU-A7E7-01		TCGA-SU-A7E7-01A-22D-A33T-08	041bbea8-d1fe-4f96-be85-67a95e651044
TCGA-TK-A8OK-01	0	TCGA-TK-A8OK-01	27	0	days	TCGA-TK-A8OK	27	0	days	27	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			73	TCGA-TK-A8OK-F58472	TCGA-TK-A8OK	TCGA-TK-A8OK-01A			M0		-26976		202					0	27									Scheduled Follow-up Submission		2014-11-11	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	620		NO	Right		YES					NO			false	No			TCGA-TK-A8OK.887947BA-A888-40C4-8582-EE89E678EC04.pdf		A8OK	TUMOR FREE	3			NO		Primary Tumor	01	4			NO		YES	NO	TK			Prostate		A	LIVING	2013	Overlapping / Multiple Zones	244e1006-d5b9-46cb-8478-8a4591fdb6be	TCGA-TK-A8OK-01A-22D-A363-01	TCGA-TK-A8OK-01A-22D-A365-05		TCGA-TK-A8OK-01A-22D-A364-08	244e1006-d5b9-46cb-8478-8a4591fdb6be	TCGA-TK-A8OK-01	TCGA-TK-A8OK-01	48E215F9-D144-4253-9EF0-103F29FFC37A	TCGA-TK-A8OK-01A-22D-A363-01	244e1006-d5b9-46cb-8478-8a4591fdb6be	TCGA-TK-A8OK-01	TCGA-TK-A8OK-01		TCGA-TK-A8OK-01A-22D-A364-08	244e1006-d5b9-46cb-8478-8a4591fdb6be
TCGA-TP-A8TT-01	0	TCGA-TP-A8TT-01	526	0	days	TCGA-TP-A8TT	526	0	days	526	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate		YES	64	TCGA-TP-A8TT-F60866	TCGA-TP-A8TT	TCGA-TP-A8TT-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-23476	23	265		15			0	526		237			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-15	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	440		NO	Left		NO	YES				NO	11	0	true	No	N0	T3a	TCGA-TP-A8TT.35E5E09D-8872-4BCC-99DC-876A3CCF9761.pdf		A8TT		4	Partial Remission/Response	0.024	YES	R0	Primary Tumor	01	3			NO		YES	NO	TP	Apex|Middle|Base		Prostate		A	LIVING	2013	Peripheral Zone	f5204ae5-1d85-41ec-b9c2-c48c310c5710	TCGA-TP-A8TT-01A-12D-A41J-01	TCGA-TP-A8TT-01A-12D-A41L-05		TCGA-TP-A8TT-01A-12D-A41K-08	f5204ae5-1d85-41ec-b9c2-c48c310c5710	TCGA-TP-A8TT-01	TCGA-TP-A8TT-01	91676E09-874E-4641-A572-E0C8CCDEA92B	TCGA-TP-A8TT-01A-12D-A41J-01	f5204ae5-1d85-41ec-b9c2-c48c310c5710	TCGA-TP-A8TT-01	TCGA-TP-A8TT-01			f5204ae5-1d85-41ec-b9c2-c48c310c5710
TCGA-TP-A8TV-01	0	TCGA-TP-A8TV-01	610	0	days	TCGA-TP-A8TV	610	0	days	610	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			62	TCGA-TP-A8TV-F70511	TCGA-TP-A8TV	TCGA-TP-A8TV-01A	NO		M0	T1c	-22872		194					0	610		249			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-2-19	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	300		NO	Bilateral		NO	YES				NO	4	0	true	No	N0	T2c	TCGA-TP-A8TV.5B38DF20-A6AF-4CD7-9322-36D4823C7A3E.pdf		A8TV	TUMOR FREE	4	Complete Remission/Response	0.019	YES	R1	Primary Tumor	01	3			NO	5	YES	NO	TP	Apex|Middle|Base		Prostate		A	LIVING	2013	Overlapping / Multiple Zones	ae3426f1-be88-4bf6-8ff4-3c7b7d6a804f	TCGA-TP-A8TV-01A-11D-A41J-01	TCGA-TP-A8TV-01A-11D-A41L-05		TCGA-TP-A8TV-01A-11D-A41K-08	ae3426f1-be88-4bf6-8ff4-3c7b7d6a804f	TCGA-TP-A8TV-01	TCGA-TP-A8TV-01	5180CC69-E884-45CD-BAFB-4E64897AD807	TCGA-TP-A8TV-01A-11D-A41J-01	ae3426f1-be88-4bf6-8ff4-3c7b7d6a804f	TCGA-TP-A8TV-01	TCGA-TP-A8TV-01			ae3426f1-be88-4bf6-8ff4-3c7b7d6a804f
TCGA-V1-A8MF-01	0	TCGA-V1-A8MF-01	1449	0	days	TCGA-V1-A8MF	1449	0	days	1449	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			65	TCGA-V1-A8MF-F69431	TCGA-V1-A8MF	TCGA-V1-A8MF-01A	NO		M0	T2c	-24090								1449		1218			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-1-9	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	130		NO	Bilateral		NO	YES				NO	8	0	true	No	N0	T3a	TCGA-V1-A8MF.C2A32E46-BB93-43E6-BF3A-995745161434.pdf		A8MF		3	Complete Remission/Response	0.14	NO	R1	Primary Tumor	01	3			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone	c84acacb-d7ab-481e-8462-94693fdf5980	TCGA-V1-A8MF-01A-11D-A363-01	TCGA-V1-A8MF-01A-11D-A365-05		TCGA-V1-A8MF-01A-11D-A364-08	c84acacb-d7ab-481e-8462-94693fdf5980	TCGA-V1-A8MF-01	TCGA-V1-A8MF-01	78954B24-3805-4FCB-8F89-11BA10F942BA	TCGA-V1-A8MF-01A-11D-A363-01	c84acacb-d7ab-481e-8462-94693fdf5980	TCGA-V1-A8MF-01	TCGA-V1-A8MF-01		TCGA-V1-A8MF-01A-11D-A364-08	c84acacb-d7ab-481e-8462-94693fdf5980
TCGA-V1-A8MG-01	0	TCGA-V1-A8MG-01	857	0	days	TCGA-V1-A8MG	857	0	days	857	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			53	TCGA-V1-A8MG-F69432	TCGA-V1-A8MG		NO		M0	T2c	-19710								857		583			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-1-9	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	NO				NO				No		T3b			A8MG		3	Complete Remission/Response	0.03	NO	R1	Primary Tumor	01	4			NO		NO	YES	V1	Apex		Prostate			LIVING		Peripheral Zone	b1c64c55-b558-44b3-b617-a84d6b493d82	TCGA-V1-A8MG-01A-11D-A363-01	TCGA-V1-A8MG-01A-11D-A365-05		TCGA-V1-A8MG-01A-11D-A364-08	b1c64c55-b558-44b3-b617-a84d6b493d82	TCGA-V1-A8MG-01	TCGA-V1-A8MG-01		TCGA-V1-A8MG-01A-11D-A363-01	b1c64c55-b558-44b3-b617-a84d6b493d82	TCGA-V1-A8MG-01	TCGA-V1-A8MG-01		TCGA-V1-A8MG-01A-11D-A364-08	b1c64c55-b558-44b3-b617-a84d6b493d82
TCGA-V1-A8MJ-01	0	TCGA-V1-A8MJ-01	1791	0	days	TCGA-V1-A8MJ			days	1791	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	YES	58	TCGA-V1-A8MJ-F69461	TCGA-V1-A8MJ	TCGA-V1-A8MJ-01A	NO		M0	T2a	-21535						428		1791		1230			NO		NO		Scheduled Follow-up Submission	Partial Remission/Response	2015-1-9	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	70		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	16	1	true	No	N1	T3a	TCGA-V1-A8MJ.5BF9CF4D-B724-4FFD-A336-ECE60FC80E0D.pdf		A8MJ		3	Progressive Disease	0.015	NO	R0	Primary Tumor	01	4			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone	98662e95-24f7-41c7-a3f4-50ce203fa9a4	TCGA-V1-A8MJ-01A-11D-A363-01	TCGA-V1-A8MJ-01A-11D-A365-05		TCGA-V1-A8MJ-01A-11D-A364-08	98662e95-24f7-41c7-a3f4-50ce203fa9a4	TCGA-V1-A8MJ-01	TCGA-V1-A8MJ-01	F9FA02A5-1B22-4CD3-A3E3-C41BA3BCC61C	TCGA-V1-A8MJ-01A-11D-A363-01	98662e95-24f7-41c7-a3f4-50ce203fa9a4	TCGA-V1-A8MJ-01	TCGA-V1-A8MJ-01		TCGA-V1-A8MJ-01A-11D-A364-08	98662e95-24f7-41c7-a3f4-50ce203fa9a4
TCGA-V1-A8MK-01	0	TCGA-V1-A8MK-01	508	0	days	TCGA-V1-A8MK	508	0	days	508	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			41	TCGA-V1-A8MK-F69460	TCGA-V1-A8MK		YES		M0	T2a	-15330								508		-1			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-1-9	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	NO				NO				No	N0	T2c			A8MK		3	Complete Remission/Response	0.83	NO	R0	Primary Tumor	01	3			NO		NO	YES	V1	Apex		Prostate			LIVING		Peripheral Zone	c7a98315-43bb-4917-90c9-93f9caf47fdc	TCGA-V1-A8MK-01A-11D-A363-01	TCGA-V1-A8MK-01A-11D-A365-05		TCGA-V1-A8MK-01A-11D-A364-08	c7a98315-43bb-4917-90c9-93f9caf47fdc	TCGA-V1-A8MK-01	TCGA-V1-A8MK-01		TCGA-V1-A8MK-01A-11D-A363-01	c7a98315-43bb-4917-90c9-93f9caf47fdc	TCGA-V1-A8MK-01	TCGA-V1-A8MK-01			c7a98315-43bb-4917-90c9-93f9caf47fdc
TCGA-V1-A8ML-01	0	TCGA-V1-A8ML-01	448	0	days	TCGA-V1-A8ML	448	0	days	448	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63	TCGA-V1-A8ML-F69415	TCGA-V1-A8ML	TCGA-V1-A8ML-01A	NO		M0	T2b	-23360								448		448			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-1-9	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	10		NO	Bilateral		NO	YES				NO	12	0	true	No	N0	T2c	TCGA-V1-A8ML.4C4405A3-FC07-4155-8C5A-2693E34F347B.pdf		A8ML		3	Complete Remission/Response	0.01	NO	R0	Primary Tumor	01	4			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone	4866c074-094a-4432-8d23-825fd698eeda	TCGA-V1-A8ML-01A-11D-A376-01	TCGA-V1-A8ML-01A-11D-A378-05		TCGA-V1-A8ML-01A-11D-A377-08	4866c074-094a-4432-8d23-825fd698eeda	TCGA-V1-A8ML-01	TCGA-V1-A8ML-01		TCGA-V1-A8ML-01A-11D-A376-01	4866c074-094a-4432-8d23-825fd698eeda	TCGA-V1-A8ML-01	TCGA-V1-A8ML-01		TCGA-V1-A8ML-01A-11D-A377-08	4866c074-094a-4432-8d23-825fd698eeda
TCGA-V1-A8MM-01	0	TCGA-V1-A8MM-01	1195	0	days	TCGA-V1-A8MM			days	1195	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	YES	60	TCGA-V1-A8MM-F69416	TCGA-V1-A8MM	TCGA-V1-A8MM-01A	YES		M0	T2b	-22265						990		1195		990			NO		NO		Scheduled Follow-up Submission	Partial Remission/Response	2015-1-9	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	90		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	10	0	true	No	N0	T3a	TCGA-V1-A8MM.2FBA596B-858D-4043-BDCF-CCE582A74D67.pdf		A8MM		4	Progressive Disease	0.37	NO	R0	Primary Tumor	01	3			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone	0386cc4d-0318-4293-a22e-869c3b34fa63	TCGA-V1-A8MM-01A-11D-A376-01	TCGA-V1-A8MM-01A-11D-A378-05		TCGA-V1-A8MM-01A-11D-A377-08	0386cc4d-0318-4293-a22e-869c3b34fa63	TCGA-V1-A8MM-01	TCGA-V1-A8MM-01		TCGA-V1-A8MM-01A-11D-A376-01	0386cc4d-0318-4293-a22e-869c3b34fa63	TCGA-V1-A8MM-01	TCGA-V1-A8MM-01			0386cc4d-0318-4293-a22e-869c3b34fa63
TCGA-V1-A8MU-01	0	TCGA-V1-A8MU-01	1876	0	days	TCGA-V1-A8MU			days	1876	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	YES	56	TCGA-V1-A8MU-F69444	TCGA-V1-A8MU	TCGA-V1-A8MU-01A	NO		M0	T2b	-20805				87		192		1876		1384			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Partial Remission/Response	2015-1-9	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	160		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	15	1	true	No	N1	T3a	TCGA-V1-A8MU.8E072738-2D8E-4254-B1DE-A8008C614B7F.pdf		A8MU		3	Progressive Disease	0.015	NO	R1	Primary Tumor	01	4			YES		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone	823142ae-3165-44fd-bdd8-b54acef6897f	TCGA-V1-A8MU-01A-11D-A376-01	TCGA-V1-A8MU-01A-11D-A378-05		TCGA-V1-A8MU-01A-11D-A377-08	823142ae-3165-44fd-bdd8-b54acef6897f	TCGA-V1-A8MU-01	TCGA-V1-A8MU-01	F8BA1C00-8A41-4A7D-86EF-1A96CE49DD97	TCGA-V1-A8MU-01A-11D-A376-01	823142ae-3165-44fd-bdd8-b54acef6897f	TCGA-V1-A8MU-01	TCGA-V1-A8MU-01		TCGA-V1-A8MU-01A-11D-A377-08	823142ae-3165-44fd-bdd8-b54acef6897f
TCGA-V1-A8WL-01	0	TCGA-V1-A8WL-01	1948	0	days	TCGA-V1-A8WL	1948	0	days	1948	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			64	TCGA-V1-A8WL-F69417	TCGA-V1-A8WL	TCGA-V1-A8WL-01A	NO		M0	T1c	-23725								1948		1175			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-1-9	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	90		NO	Bilateral		NO	YES				NO	4	0	true	No	N0	T3a	TCGA-V1-A8WL.6E301400-1200-40F7-8249-AD310C44A212.pdf		A8WL		3	Complete Remission/Response	0.015	NO	R0	Primary Tumor	01	4			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone	bd8e46c1-5b67-407e-a6fb-67017488a923	TCGA-V1-A8WL-01A-11D-A376-01	TCGA-V1-A8WL-01A-11D-A378-05		TCGA-V1-A8WL-01A-11D-A377-08	bd8e46c1-5b67-407e-a6fb-67017488a923	TCGA-V1-A8WL-01	TCGA-V1-A8WL-01	5ABADB84-AB1D-46E4-9878-16013D54EF24	TCGA-V1-A8WL-01A-11D-A376-01	bd8e46c1-5b67-407e-a6fb-67017488a923	TCGA-V1-A8WL-01	TCGA-V1-A8WL-01		TCGA-V1-A8WL-01A-11D-A377-08	bd8e46c1-5b67-407e-a6fb-67017488a923
TCGA-V1-A8WN-01	0	TCGA-V1-A8WN-01	924	0	days	TCGA-V1-A8WN	924	0	days	924	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			47	TCGA-V1-A8WN-F69450	TCGA-V1-A8WN	TCGA-V1-A8WN-01A	NO		M0	T2a	-17520								924		463			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-1-9	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	30		NO	Bilateral		NO	NO				NO			true	No		T2c	TCGA-V1-A8WN.F25C1C00-CDFE-4ABD-A920-857AFEA691A5.pdf		A8WN		3	Complete Remission/Response	0.02	NO	R0	Primary Tumor	01	3			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone	15b039c0-f334-4221-b438-c859bb46cc26	TCGA-V1-A8WN-01A-11D-A376-01	TCGA-V1-A8WN-01A-11D-A378-05		TCGA-V1-A8WN-01A-11D-A377-08	15b039c0-f334-4221-b438-c859bb46cc26	TCGA-V1-A8WN-01	TCGA-V1-A8WN-01		TCGA-V1-A8WN-01A-11D-A376-01	15b039c0-f334-4221-b438-c859bb46cc26	TCGA-V1-A8WN-01	TCGA-V1-A8WN-01		TCGA-V1-A8WN-01A-11D-A377-08	15b039c0-f334-4221-b438-c859bb46cc26
TCGA-V1-A8WS-01	0	TCGA-V1-A8WS-01	474	0	days	TCGA-V1-A8WS			days	474	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	YES	56	TCGA-V1-A8WS-F69434	TCGA-V1-A8WS	TCGA-V1-A8WS-01A	NO		M0	T1c	-20805								474		474			NO		NO		Scheduled Follow-up Submission	Partial Remission/Response	2015-1-9	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	30		NO	Bilateral		NO	NO		Biochemical evidence of disease		YES			true	No		T3b	TCGA-V1-A8WS.0BD9565E-DBBB-428D-BF6D-2B31F0E5DDC5.pdf		A8WS		3	Progressive Disease	0.09	NO	R0	Primary Tumor	01	3			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone	0514988e-85d3-4ce1-a860-39bd5ac19660	TCGA-V1-A8WS-01A-11D-A376-01	TCGA-V1-A8WS-01A-11D-A378-05		TCGA-V1-A8WS-01A-11D-A377-08	0514988e-85d3-4ce1-a860-39bd5ac19660	TCGA-V1-A8WS-01	TCGA-V1-A8WS-01		TCGA-V1-A8WS-01A-11D-A376-01	0514988e-85d3-4ce1-a860-39bd5ac19660	TCGA-V1-A8WS-01	TCGA-V1-A8WS-01		TCGA-V1-A8WS-01A-11D-A377-08	0514988e-85d3-4ce1-a860-39bd5ac19660
TCGA-V1-A8WV-01	0	TCGA-V1-A8WV-01	686	0	days	TCGA-V1-A8WV	686	0	days	686	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			52	TCGA-V1-A8WV-F69419	TCGA-V1-A8WV		NO		M0	T2a	-19345				95				686		686			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-1-9	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	10	1		No	N1	T3b			A8WV		4	Complete Remission/Response	0.01	NO	R0	Primary Tumor	01	5			YES		NO	YES	V1	Middle		Prostate			LIVING		Peripheral Zone	bfb7a272-3b86-4d5d-a3df-6aea8fd3b66b	TCGA-V1-A8WV-01A-11D-A376-01	TCGA-V1-A8WV-01A-11D-A378-05		TCGA-V1-A8WV-01A-11D-A377-08	bfb7a272-3b86-4d5d-a3df-6aea8fd3b66b	TCGA-V1-A8WV-01	TCGA-V1-A8WV-01		TCGA-V1-A8WV-01A-11D-A376-01	bfb7a272-3b86-4d5d-a3df-6aea8fd3b66b	TCGA-V1-A8WV-01	TCGA-V1-A8WV-01		TCGA-V1-A8WV-01A-11D-A377-08	bfb7a272-3b86-4d5d-a3df-6aea8fd3b66b
TCGA-V1-A8WW-01	0	TCGA-V1-A8WW-01	1078	0	days	TCGA-V1-A8WW			days	1078	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	YES	59	TCGA-V1-A8WW-F69466	TCGA-V1-A8WW	TCGA-V1-A8WW-01A	NO		M0	T2b	-21900					709	58		1078		695			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Partial Remission/Response	2015-1-9	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	50		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	20	1	true	No	N1	T3b	TCGA-V1-A8WW.36FBC30B-6566-4C5F-BE51-D267B4F856B3.pdf		A8WW		4	Progressive Disease	0.015	NO	R0	Primary Tumor	01	5			YES		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone	213f0f94-d682-462b-bbb3-bd8ce9f0ffff	TCGA-V1-A8WW-01A-11D-A376-01	TCGA-V1-A8WW-01A-11D-A378-05		TCGA-V1-A8WW-01A-11D-A377-08	213f0f94-d682-462b-bbb3-bd8ce9f0ffff	TCGA-V1-A8WW-01	TCGA-V1-A8WW-01		TCGA-V1-A8WW-01A-11D-A376-01	213f0f94-d682-462b-bbb3-bd8ce9f0ffff	TCGA-V1-A8WW-01	TCGA-V1-A8WW-01		TCGA-V1-A8WW-01A-11D-A377-08	213f0f94-d682-462b-bbb3-bd8ce9f0ffff
TCGA-V1-A8X3-01	0	TCGA-V1-A8X3-01	202	0	days	TCGA-V1-A8X3	202	0	days	202	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			51	TCGA-V1-A8X3-F69469	TCGA-V1-A8X3	TCGA-V1-A8X3-01A	NO		M0	T1c	-18980								202		202			NO		NO		Scheduled Follow-up Submission		2015-1-9	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	170		NO	Bilateral		NO	YES				NO	18	0	true	No	N0	T2c	TCGA-V1-A8X3.267C0EAB-ECC4-44BC-89C9-8C54F3B22A6E.pdf		A8X3		3	Complete Remission/Response	0.03	NO	R1	Primary Tumor	01	4			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone	560a04b3-0738-4a27-ad0f-c6a5a091c869	TCGA-V1-A8X3-01A-11D-A376-01	TCGA-V1-A8X3-01A-11D-A378-05		TCGA-V1-A8X3-01A-11D-A377-08	560a04b3-0738-4a27-ad0f-c6a5a091c869	TCGA-V1-A8X3-01	TCGA-V1-A8X3-01	3540A732-C76A-4951-AA6D-EFC400F6A272	TCGA-V1-A8X3-01A-11D-A376-01	560a04b3-0738-4a27-ad0f-c6a5a091c869	TCGA-V1-A8X3-01	TCGA-V1-A8X3-01		TCGA-V1-A8X3-01A-11D-A377-08	560a04b3-0738-4a27-ad0f-c6a5a091c869
TCGA-V1-A9O5-01	0	TCGA-V1-A9O5-01	1932	0	days	TCGA-V1-A9O5			days	1932	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	64	TCGA-V1-A9O5-F69449	TCGA-V1-A9O5	TCGA-V1-A9O5-01A	YES		M0	T2b	-23725				25		124		1932		1776			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-1-9	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	230		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	20	6	true	No	N1	T4	TCGA-V1-A9O5.4C94E826-144A-4879-99A3-E3B1655D4066.pdf		A9O5		5	Complete Remission/Response	3.26	YES	R1	Primary Tumor	01	4			YES		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone	ac245ce7-dd49-4b6e-8692-6cf440e99b89	TCGA-V1-A9O5-01A-11D-A41J-01	TCGA-V1-A9O5-01A-11D-A41L-05		TCGA-V1-A9O5-01A-11D-A41K-08	ac245ce7-dd49-4b6e-8692-6cf440e99b89	TCGA-V1-A9O5-01	TCGA-V1-A9O5-01	1DB43799-AB1A-4C07-8E9B-D04B154FEAC6	TCGA-V1-A9O5-01A-11D-A41J-01	ac245ce7-dd49-4b6e-8692-6cf440e99b89	TCGA-V1-A9O5-01	TCGA-V1-A9O5-01			ac245ce7-dd49-4b6e-8692-6cf440e99b89
TCGA-V1-A9O5-06	0	TCGA-V1-A9O5-06	1932	0	days	TCGA-V1-A9O5			days	1932	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	64	TCGA-V1-A9O5-F69449	TCGA-V1-A9O5		YES		M0	T2b	-23725				25		124		1932		1776			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-1-9	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES		Biochemical evidence of disease		YES	20	6		No	N1	T4			A9O5		5	Complete Remission/Response	3.26	YES	R1	Metastatic	06	4			YES		NO	YES	V1	Apex		Prostate			LIVING		Peripheral Zone	b23ad2ad-d6d2-4e5a-96d7-424cd506a180		TCGA-V1-A9O5-06A-11D-A41L-05		TCGA-V1-A9O5-06A-11D-A41K-08	b23ad2ad-d6d2-4e5a-96d7-424cd506a180		TCGA-V1-A9O5-06			b23ad2ad-d6d2-4e5a-96d7-424cd506a180		TCGA-V1-A9O5-06			b23ad2ad-d6d2-4e5a-96d7-424cd506a180
TCGA-V1-A9O7-01	0	TCGA-V1-A9O7-01	2499	0	days	TCGA-V1-A9O7			days	2499	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	NO	60	TCGA-V1-A9O7-F69451	TCGA-V1-A9O7	TCGA-V1-A9O7-01A	YES		M0	T2b	-22265					45	819		2499		2425			NO		YES		Scheduled Follow-up Submission	Partial Remission/Response	2015-1-9	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	710		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	15	0	true	No	N0	T3a	TCGA-V1-A9O7.0D2327CA-DE0A-4B74-BD53-6370ED222B96.pdf		A9O7		5	Progressive Disease	9.69	YES	R1	Primary Tumor	01	4			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone	66e392a4-c4fb-43a7-bba1-6a940967158f	TCGA-V1-A9O7-01A-21D-A41J-01	TCGA-V1-A9O7-01A-21D-A41L-05		TCGA-V1-A9O7-01A-21D-A41K-08	66e392a4-c4fb-43a7-bba1-6a940967158f	TCGA-V1-A9O7-01	TCGA-V1-A9O7-01		TCGA-V1-A9O7-01A-21D-A41J-01	66e392a4-c4fb-43a7-bba1-6a940967158f	TCGA-V1-A9O7-01	TCGA-V1-A9O7-01			66e392a4-c4fb-43a7-bba1-6a940967158f
TCGA-V1-A9O9-01	0	TCGA-V1-A9O9-01	2870	0	days	TCGA-V1-A9O9	2870	0	days	2870	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			56	TCGA-V1-A9O9-F69445	TCGA-V1-A9O9		YES		M0		-20805								2870		-53			NO		NO		Scheduled Follow-up Submission		2015-1-9	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	12	0		No	N0	T3b			A9O9		3	Complete Remission/Response	5.04	NO	R0	Primary Tumor	01	5			NO		NO	YES	V1	Apex		Prostate			LIVING		Peripheral Zone	dda7df91-6e67-46d3-bfdc-d5bde725f44c	TCGA-V1-A9O9-01A-11D-A41J-01	TCGA-V1-A9O9-01A-11D-A41L-05		TCGA-V1-A9O9-01A-11D-A41K-08	dda7df91-6e67-46d3-bfdc-d5bde725f44c	TCGA-V1-A9O9-01	TCGA-V1-A9O9-01		TCGA-V1-A9O9-01A-11D-A41J-01	dda7df91-6e67-46d3-bfdc-d5bde725f44c	TCGA-V1-A9O9-01	TCGA-V1-A9O9-01			dda7df91-6e67-46d3-bfdc-d5bde725f44c
TCGA-V1-A9OA-01	0	TCGA-V1-A9OA-01	636	0	days	TCGA-V1-A9OA	636	0	days	636	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61	TCGA-V1-A9OA-F69441	TCGA-V1-A9OA	TCGA-V1-A9OA-01A	NO		M0	T2c	-22630					27			636		510			NO		YES		Scheduled Follow-up Submission	Complete Remission/Response	2015-1-9	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	10		NO	Bilateral		NO	YES				NO	8	1	true	No	N1	T3b	TCGA-V1-A9OA.F8BC91E0-7D98-40B2-B99E-570564C3ECD2.pdf		A9OA		4	Complete Remission/Response	0.01	YES	R0	Primary Tumor	01	5			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone	434c7cb8-d131-46e0-a068-5345b5a77fff	TCGA-V1-A9OA-01A-11D-A41J-01	TCGA-V1-A9OA-01A-11D-A41L-05		TCGA-V1-A9OA-01A-11D-A41K-08	434c7cb8-d131-46e0-a068-5345b5a77fff	TCGA-V1-A9OA-01	TCGA-V1-A9OA-01		TCGA-V1-A9OA-01A-11D-A41J-01	434c7cb8-d131-46e0-a068-5345b5a77fff	TCGA-V1-A9OA-01	TCGA-V1-A9OA-01			434c7cb8-d131-46e0-a068-5345b5a77fff
TCGA-V1-A9OF-01	0	TCGA-V1-A9OF-01	1184	0	days	TCGA-V1-A9OF	1184	0	days	1184	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			49	TCGA-V1-A9OF-F69400	TCGA-V1-A9OF		NO		M0	T1c	-18250								1184		1184			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-1-9	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	NO				NO				No		T2c			A9OF		3	Complete Remission/Response	0.01	NO	R1	Primary Tumor	01	3			NO		NO	YES	V1	Apex		Prostate			LIVING		Peripheral Zone	e6f9cecd-b130-441d-9073-cf1df303e2ab	TCGA-V1-A9OF-01A-11D-A41J-01	TCGA-V1-A9OF-01A-11D-A41L-05		TCGA-V1-A9OF-01A-11D-A41K-08	e6f9cecd-b130-441d-9073-cf1df303e2ab	TCGA-V1-A9OF-01	TCGA-V1-A9OF-01		TCGA-V1-A9OF-01A-11D-A41J-01	e6f9cecd-b130-441d-9073-cf1df303e2ab	TCGA-V1-A9OF-01	TCGA-V1-A9OF-01			e6f9cecd-b130-441d-9073-cf1df303e2ab
TCGA-V1-A9OH-01	0	TCGA-V1-A9OH-01	2403	0	days	TCGA-V1-A9OH	2403	0	days	2403	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63	TCGA-V1-A9OH-F69402	TCGA-V1-A9OH	TCGA-V1-A9OH-01A	NO		M0	T1c	-23360								2403		1253			NO		NO		Scheduled Follow-up Submission		2015-1-9	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	70		NO	Right		NO	NO				NO			true	No		T2b	TCGA-V1-A9OH.8B30DB97-6EB7-42EF-8A12-C9B1F1B5251B.pdf		A9OH		4	Complete Remission/Response	0.01	NO	R0	Primary Tumor	01	4			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone	4d83df74-09cf-4590-a15a-c5c583cbb639	TCGA-V1-A9OH-01A-11D-A41J-01	TCGA-V1-A9OH-01A-11D-A41L-05		TCGA-V1-A9OH-01A-11D-A41K-08	4d83df74-09cf-4590-a15a-c5c583cbb639	TCGA-V1-A9OH-01	TCGA-V1-A9OH-01	3817849E-67B9-46C9-BC3E-F4A80888AE6F	TCGA-V1-A9OH-01A-11D-A41J-01	4d83df74-09cf-4590-a15a-c5c583cbb639	TCGA-V1-A9OH-01	TCGA-V1-A9OH-01			4d83df74-09cf-4590-a15a-c5c583cbb639
TCGA-V1-A9OL-01	0	TCGA-V1-A9OL-01	1913	0	days	TCGA-V1-A9OL			days	1913	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	65	TCGA-V1-A9OL-F69471	TCGA-V1-A9OL	TCGA-V1-A9OL-01A	NO		M0	T2	-24090				19		105		1913		559			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-1-9	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	190		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	9	0	true	No	N0	T3b	TCGA-V1-A9OL.E63E681C-8E25-4C1E-8C37-9EAA2697088B.pdf		A9OL		5	Complete Remission/Response	0.01	NO	R0	Primary Tumor	01	4			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone	e312e528-bed2-4067-a562-1c27dd93d540	TCGA-V1-A9OL-01A-11D-A41J-01	TCGA-V1-A9OL-01A-11D-A41L-05		TCGA-V1-A9OL-01A-11D-A41K-08	e312e528-bed2-4067-a562-1c27dd93d540	TCGA-V1-A9OL-01	TCGA-V1-A9OL-01	94DF3591-19A5-4C63-AC53-CA572B353AB9	TCGA-V1-A9OL-01A-11D-A41J-01	e312e528-bed2-4067-a562-1c27dd93d540	TCGA-V1-A9OL-01	TCGA-V1-A9OL-01			e312e528-bed2-4067-a562-1c27dd93d540
TCGA-V1-A9OQ-01	0	TCGA-V1-A9OQ-01	371	0	days	TCGA-V1-A9OQ	371	0	days	371	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			67	TCGA-V1-A9OQ-F69411	TCGA-V1-A9OQ	TCGA-V1-A9OQ-01A	NO		M0	T1c	-24820								371		371			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-1-9	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	60		NO	Bilateral		NO	NO				NO	0		true	No		T3a	TCGA-V1-A9OQ.8EA3FE2C-7C76-41F8-AEC4-A89C5DD2FF7B.pdf		A9OQ		3	Complete Remission/Response	0.01	NO	R1	Primary Tumor	01	3			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone	46993591-8ffa-4e54-ba85-d013a7c190c9	TCGA-V1-A9OQ-01A-11D-A41J-01	TCGA-V1-A9OQ-01A-11D-A41L-05		TCGA-V1-A9OQ-01A-11D-A41K-08	46993591-8ffa-4e54-ba85-d013a7c190c9	TCGA-V1-A9OQ-01	TCGA-V1-A9OQ-01	C6475EDA-2126-4F7A-B0C9-C8A46C3E7EE2	TCGA-V1-A9OQ-01A-11D-A41J-01	46993591-8ffa-4e54-ba85-d013a7c190c9	TCGA-V1-A9OQ-01	TCGA-V1-A9OQ-01			46993591-8ffa-4e54-ba85-d013a7c190c9
TCGA-V1-A9OT-01	0	TCGA-V1-A9OT-01	476	0	days	TCGA-V1-A9OT			days	476	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	61	TCGA-V1-A9OT-F69439	TCGA-V1-A9OT	TCGA-V1-A9OT-01A	YES		M0	T1c	-22630						292		476		349			NO		NO		Scheduled Follow-up Submission	Partial Remission/Response	2015-1-9	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	220		NO	Bilateral		NO	NO		Biochemical evidence of disease		YES			true	No		T2c	TCGA-V1-A9OT.40B928AE-1977-4077-9F44-282E85273EF2.pdf		A9OT		3	Progressive Disease	0.01	NO	R1	Primary Tumor	01	3			NO		NO	YES	V1	Middle		Prostate		A	LIVING		Peripheral Zone	d2f9c79e-127a-4e53-869d-3ff6b2baf0aa	TCGA-V1-A9OT-01A-11D-A41J-01	TCGA-V1-A9OT-01A-11D-A41L-05		TCGA-V1-A9OT-01A-11D-A41K-08	d2f9c79e-127a-4e53-869d-3ff6b2baf0aa	TCGA-V1-A9OT-01	TCGA-V1-A9OT-01	5017EF3A-7AAF-4338-80B0-FD189F273829	TCGA-V1-A9OT-01A-11D-A41J-01	d2f9c79e-127a-4e53-869d-3ff6b2baf0aa	TCGA-V1-A9OT-01	TCGA-V1-A9OT-01			d2f9c79e-127a-4e53-869d-3ff6b2baf0aa
TCGA-V1-A9OX-01	0	TCGA-V1-A9OX-01	1134	0	days	TCGA-V1-A9OX	1134	0	days	1134	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			56	TCGA-V1-A9OX-F69435	TCGA-V1-A9OX	TCGA-V1-A9OX-01A	NO		M0		-20805								1134		256			NO		NO		Scheduled Follow-up Submission		2015-1-9	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	150		NO	Bilateral		NO	YES				NO	8	0	true	No	N0	T2c	TCGA-V1-A9OX.4D42611A-3A08-4A1A-A033-13E810FCCA3E.pdf		A9OX		3	Partial Remission/Response	0.04	NO	R0	Primary Tumor	01	5			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone	af080299-4f21-42bb-8477-8d7414cdaf9f	TCGA-V1-A9OX-01A-11D-A41J-01	TCGA-V1-A9OX-01A-11D-A41L-05		TCGA-V1-A9OX-01A-11D-A41K-08	af080299-4f21-42bb-8477-8d7414cdaf9f	TCGA-V1-A9OX-01	TCGA-V1-A9OX-01	76DA618F-A968-4E6B-8F60-DFBB6013FAC0	TCGA-V1-A9OX-01A-11D-A41J-01	af080299-4f21-42bb-8477-8d7414cdaf9f	TCGA-V1-A9OX-01	TCGA-V1-A9OX-01			af080299-4f21-42bb-8477-8d7414cdaf9f
TCGA-V1-A9OY-01	0	TCGA-V1-A9OY-01	1067	0	days	TCGA-V1-A9OY	1067	0	days	1067	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57	TCGA-V1-A9OY-F69409	TCGA-V1-A9OY	TCGA-V1-A9OY-01A	NO		M0	T2	-21170								1067		170			NO		NO		Scheduled Follow-up Submission		2015-1-9	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	70		NO	Bilateral		NO	YES				NO	13	1	true	No	N1	T3a	TCGA-V1-A9OY.93F584C1-F62C-4DA6-B2C8-755DBED9CE18.pdf		A9OY		4	Complete Remission/Response	0.099	NO	R1	Primary Tumor	01	3			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone	35900b9c-bc5c-49cc-acb4-410305e8ab64	TCGA-V1-A9OY-01A-11D-A41J-01	TCGA-V1-A9OY-01A-11D-A41L-05		TCGA-V1-A9OY-01A-11D-A41K-08	35900b9c-bc5c-49cc-acb4-410305e8ab64	TCGA-V1-A9OY-01	TCGA-V1-A9OY-01	AE40B37F-924C-44F4-8E4A-532A18958CEC	TCGA-V1-A9OY-01A-11D-A41J-01	35900b9c-bc5c-49cc-acb4-410305e8ab64	TCGA-V1-A9OY-01	TCGA-V1-A9OY-01			35900b9c-bc5c-49cc-acb4-410305e8ab64
TCGA-V1-A9Z7-01	0	TCGA-V1-A9Z7-01	874	0	days	TCGA-V1-A9Z7			days	874	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			54	TCGA-V1-A9Z7-F70268	TCGA-V1-A9Z7	TCGA-V1-A9Z7-01A	YES		M0	T2	-20075				50				874		-75			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission		2015-2-2	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	310		NO	Bilateral		NO	YES				YES	10	0	true	No	N0	T3b	TCGA-V1-A9Z7.E50B8F61-E948-417F-A5B6-2C087A8D2B01.pdf		A9Z7		5	Complete Remission/Response	28.1	NO	R0	Primary Tumor	01	4			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone	fa901a09-cc13-402a-aba6-f93f4242c3d1	TCGA-V1-A9Z7-01A-11D-A41J-01	TCGA-V1-A9Z7-01A-11D-A41L-05		TCGA-V1-A9Z7-01A-11D-A41K-08	fa901a09-cc13-402a-aba6-f93f4242c3d1	TCGA-V1-A9Z7-01	TCGA-V1-A9Z7-01	9F6D9542-4CDB-46DD-9494-BB3B71CB63E8	TCGA-V1-A9Z7-01A-11D-A41J-01	fa901a09-cc13-402a-aba6-f93f4242c3d1	TCGA-V1-A9Z7-01	TCGA-V1-A9Z7-01			fa901a09-cc13-402a-aba6-f93f4242c3d1
TCGA-V1-A9Z8-01	0	TCGA-V1-A9Z8-01	827	0	days	TCGA-V1-A9Z8	827	0	days	827	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			59	TCGA-V1-A9Z8-F70269	TCGA-V1-A9Z8	TCGA-V1-A9Z8-01A	NO		M0		-21900								827		181			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-2-2	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	120		NO	Bilateral		NO	YES				NO	18	0	true	No	N0	T3b	TCGA-V1-A9Z8.3C543195-4F88-4FA4-A397-EDF375FCE61A.pdf		A9Z8	TUMOR FREE	5	Complete Remission/Response	0.01	NO	R1	Primary Tumor	01	4			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone	6eb18bd6-15f9-42fb-a8d0-91c7fb0342ff	TCGA-V1-A9Z8-01A-11D-A41J-01	TCGA-V1-A9Z8-01A-11D-A41L-05		TCGA-V1-A9Z8-01A-11D-A41K-08	6eb18bd6-15f9-42fb-a8d0-91c7fb0342ff	TCGA-V1-A9Z8-01	TCGA-V1-A9Z8-01	473F88C1-4380-4A99-90EF-0D70B0C40EF7	TCGA-V1-A9Z8-01A-11D-A41J-01	6eb18bd6-15f9-42fb-a8d0-91c7fb0342ff	TCGA-V1-A9Z8-01	TCGA-V1-A9Z8-01			6eb18bd6-15f9-42fb-a8d0-91c7fb0342ff
TCGA-V1-A9Z9-01	0	TCGA-V1-A9Z9-01	540	0	days	TCGA-V1-A9Z9	540	0	days	540	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63	TCGA-V1-A9Z9-F70270	TCGA-V1-A9Z9	TCGA-V1-A9Z9-01A	NO		M0	T1c	-23360					9			540		291			NO		YES		Scheduled Follow-up Submission	Complete Remission/Response	2015-2-2	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	140		NO	Bilateral		NO	YES				NO	29	0	true	No	N0	T2c	TCGA-V1-A9Z9.9D297084-0545-4D51-8D14-15754BAAB18B.pdf		A9Z9	TUMOR FREE	4	Complete Remission/Response	0.015	NO	R0	Primary Tumor	01	5			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone	7c626639-ebbc-472b-8ad0-239068f6d4e8	TCGA-V1-A9Z9-01A-21D-A41J-01	TCGA-V1-A9Z9-01A-21D-A41L-05		TCGA-V1-A9Z9-01A-21D-A41K-08	7c626639-ebbc-472b-8ad0-239068f6d4e8	TCGA-V1-A9Z9-01	TCGA-V1-A9Z9-01	BAB09201-DEA3-4C9C-97FC-91E001E10254	TCGA-V1-A9Z9-01A-21D-A41J-01	7c626639-ebbc-472b-8ad0-239068f6d4e8	TCGA-V1-A9Z9-01	TCGA-V1-A9Z9-01			7c626639-ebbc-472b-8ad0-239068f6d4e8
TCGA-V1-A9ZG-01	0	TCGA-V1-A9ZG-01	1517	0	days	TCGA-V1-A9ZG	1517	0	days	1517	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			64	TCGA-V1-A9ZG-F70257	TCGA-V1-A9ZG	TCGA-V1-A9ZG-01A	NO		M0	T1c	-23725								1517		893			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-2-2	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	330		NO	Bilateral		NO	YES				NO	5	0	true	No	N0	T2c	TCGA-V1-A9ZG.D7B1ABAE-1A72-496C-B11F-469F65B37347.pdf		A9ZG	TUMOR FREE	4	Complete Remission/Response	0.015	NO	R0	Primary Tumor	01	5			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone	e8f34083-66fe-43d4-9860-77427c481dcd	TCGA-V1-A9ZG-01A-11D-A41J-01	TCGA-V1-A9ZG-01A-11D-A41L-05		TCGA-V1-A9ZG-01A-11D-A41K-08	e8f34083-66fe-43d4-9860-77427c481dcd	TCGA-V1-A9ZG-01	TCGA-V1-A9ZG-01	316629DF-AFA4-4256-B0B6-55EFAAFDA60B	TCGA-V1-A9ZG-01A-11D-A41J-01	e8f34083-66fe-43d4-9860-77427c481dcd	TCGA-V1-A9ZG-01	TCGA-V1-A9ZG-01			e8f34083-66fe-43d4-9860-77427c481dcd
TCGA-V1-A9ZI-01	0	TCGA-V1-A9ZI-01	1640	0	days	TCGA-V1-A9ZI			days	1640	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	68	TCGA-V1-A9ZI-F70259	TCGA-V1-A9ZI	TCGA-V1-A9ZI-01A	YES		M0		-25185				40		86		1640		86			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission		2015-2-2	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	120		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	10	0	true	No	N0	T3b	TCGA-V1-A9ZI.7C3EC6A6-C005-4877-A6C8-C3174709A3FF.pdf		A9ZI		4	Progressive Disease	3.11	NO	R0	Primary Tumor	01	5			NO		NO	YES	V1	Middle		Prostate		A	LIVING		Peripheral Zone	01234d47-e213-401f-b4fe-f33b15bcec7d	TCGA-V1-A9ZI-01A-11D-A41J-01	TCGA-V1-A9ZI-01A-11D-A41L-05		TCGA-V1-A9ZI-01A-11D-A41K-08	01234d47-e213-401f-b4fe-f33b15bcec7d	TCGA-V1-A9ZI-01	TCGA-V1-A9ZI-01	7D500092-40AE-4624-8467-F75EB75FF82A	TCGA-V1-A9ZI-01A-11D-A41J-01	01234d47-e213-401f-b4fe-f33b15bcec7d	TCGA-V1-A9ZI-01	TCGA-V1-A9ZI-01			01234d47-e213-401f-b4fe-f33b15bcec7d
TCGA-V1-A9ZK-01	0	TCGA-V1-A9ZK-01	1383	0	days	TCGA-V1-A9ZK	1383	0	days	1383	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			68	TCGA-V1-A9ZK-F70261	TCGA-V1-A9ZK	TCGA-V1-A9ZK-01A	NO		M0	T2a	-25185								1383		1049			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-2-2	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8490/3	C61.9	YES	Core needle biopsy	50		NO	Left		NO	YES				NO	6	0	true	No	N0	T3b	TCGA-V1-A9ZK.9AD0F7C3-9DEB-427C-B8A3-007B874AB12A.pdf		A9ZK	TUMOR FREE	4	Complete Remission/Response	0.01	NO	R0	Primary Tumor	01	4			NO		NO	YES	V1	Middle		Prostate		A	LIVING		Peripheral Zone	4c0ca123-3b83-4a25-aa0f-fe1a593ea969	TCGA-V1-A9ZK-01A-11D-A41J-01	TCGA-V1-A9ZK-01A-11D-A41L-05		TCGA-V1-A9ZK-01A-11D-A41K-08	4c0ca123-3b83-4a25-aa0f-fe1a593ea969	TCGA-V1-A9ZK-01	TCGA-V1-A9ZK-01		TCGA-V1-A9ZK-01A-11D-A41J-01	4c0ca123-3b83-4a25-aa0f-fe1a593ea969	TCGA-V1-A9ZK-01	TCGA-V1-A9ZK-01			4c0ca123-3b83-4a25-aa0f-fe1a593ea969
TCGA-V1-A9ZR-01	0	TCGA-V1-A9ZR-01	1361	0	days	TCGA-V1-A9ZR			days	1361	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			68	TCGA-V1-A9ZR-F70265	TCGA-V1-A9ZR	TCGA-V1-A9ZR-01A	YES		M0	T2c	-25185				78				1361		54			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2015-2-2	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	430		NO	Bilateral		NO	YES				YES	7		true	No	N0	T4	TCGA-V1-A9ZR.DB23EC5B-D86A-4B32-8C52-E91CAD4B7695.pdf		A9ZR	TUMOR FREE	4	Complete Remission/Response	1.44	NO	R1	Primary Tumor	01	4			NO		NO	YES	V1	Apex		Prostate		A	LIVING		Peripheral Zone	7d74ec0f-631d-463c-820e-ce796cb3b798	TCGA-V1-A9ZR-01A-11D-A41J-01	TCGA-V1-A9ZR-01A-11D-A41L-05		TCGA-V1-A9ZR-01A-11D-A41K-08	7d74ec0f-631d-463c-820e-ce796cb3b798	TCGA-V1-A9ZR-01	TCGA-V1-A9ZR-01	1684AD7E-7035-4E50-A2FD-17DCDD78559F	TCGA-V1-A9ZR-01A-11D-A41J-01	7d74ec0f-631d-463c-820e-ce796cb3b798	TCGA-V1-A9ZR-01	TCGA-V1-A9ZR-01			7d74ec0f-631d-463c-820e-ce796cb3b798
TCGA-VN-A88I-01	0	TCGA-VN-A88I-01	269	0	days	TCGA-VN-A88I	269	0	days	269	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			59	TCGA-VN-A88I-F62589	TCGA-VN-A88I	TCGA-VN-A88I-01A	NO	Abnormal (not related to prostate cancer)	M0	T1c	-21576	9	730			-1		0	269		269			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission		2014-7-21	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	260		NO	Bilateral		YES	YES				NO	11	0	true	No	N0	T3a	TCGA-VN-A88I.571D4E0A-97DF-4B78-8F78-81DF0C040941.pdf		A88I	WITH TUMOR	4	Partial Remission/Response	0.16		R0	Primary Tumor	01	4				5	NO	YES	VN	Apex|Middle|Base		Prostate		A	LIVING	2011	Overlapping / Multiple Zones	625d2894-bb92-450a-af72-013d81df221d	TCGA-VN-A88I-01A-11D-A34T-01	TCGA-VN-A88I-01A-11D-A34V-05		TCGA-VN-A88I-01A-11D-A34U-08	625d2894-bb92-450a-af72-013d81df221d	TCGA-VN-A88I-01	TCGA-VN-A88I-01	EB376578-4795-483E-AAC2-C3F268EA8434	TCGA-VN-A88I-01A-11D-A34T-01	625d2894-bb92-450a-af72-013d81df221d	TCGA-VN-A88I-01	TCGA-VN-A88I-01		TCGA-VN-A88I-01A-11D-A34U-08	625d2894-bb92-450a-af72-013d81df221d
TCGA-VN-A88K-01	0	TCGA-VN-A88K-01	776	0	days	TCGA-VN-A88K	776	0	days	776	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			58	TCGA-VN-A88K-F62590	TCGA-VN-A88K	TCGA-VN-A88K-01A	NO	Equivocal	M0	T1c	-21524	24	870		24	-48		0	776		776			YES	No Evidence of Extraprostatic Extension	YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Scheduled Follow-up Submission	Complete Remission/Response	2014-12-22	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	300		NO	Bilateral		YES	YES				NO	37	15	true	No	N1	T3a	TCGA-VN-A88K.C990DBAF-40D6-4D19-8345-62495C3959A0.pdf		A88K		4	Complete Remission/Response	0	NO	R0	Primary Tumor	01	4			YES	5	NO	YES	VN	Apex|Middle|Base		Prostate		A	LIVING	2011	Overlapping / Multiple Zones	f7aad847-52aa-4dc8-8ea5-6f1a4f47e2aa	TCGA-VN-A88K-01A-11D-A34T-01	TCGA-VN-A88K-01A-11D-A34V-05		TCGA-VN-A88K-01A-11D-A34U-08	f7aad847-52aa-4dc8-8ea5-6f1a4f47e2aa	TCGA-VN-A88K-01	TCGA-VN-A88K-01	01B32A9B-FA8B-4F15-AD86-DDA939C3EDFC	TCGA-VN-A88K-01A-11D-A34T-01	f7aad847-52aa-4dc8-8ea5-6f1a4f47e2aa	TCGA-VN-A88K-01	TCGA-VN-A88K-01		TCGA-VN-A88K-01A-11D-A34U-08	f7aad847-52aa-4dc8-8ea5-6f1a4f47e2aa
TCGA-VN-A88L-01	0	TCGA-VN-A88L-01	746	0	days	TCGA-VN-A88L	746	0	days	746	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			54	TCGA-VN-A88L-F65022	TCGA-VN-A88L	TCGA-VN-A88L-01A	NO		M0	T1c	-20026		367			79		0	746		394			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2014-12-22	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	130		NO	Bilateral		NO	YES				NO	18	0	true	No	N0	T2c	TCGA-VN-A88L.7247904D-2E8C-49B5-8D35-A6CE0D9687DE.pdf		A88L	TUMOR FREE	3	Complete Remission/Response	0	NO	R0	Primary Tumor	01	4			NO		NO	YES	VN	Middle|Base		Prostate		A	LIVING	2012		6f4d55e9-37fc-40c3-92d0-5bdabc063447	TCGA-VN-A88L-01A-11D-A34T-01	TCGA-VN-A88L-01A-11D-A34V-05		TCGA-VN-A88L-01A-11D-A34U-08	6f4d55e9-37fc-40c3-92d0-5bdabc063447	TCGA-VN-A88L-01	TCGA-VN-A88L-01	9DC21531-0542-4563-BD6C-3FDD509335D9	TCGA-VN-A88L-01A-11D-A34T-01	6f4d55e9-37fc-40c3-92d0-5bdabc063447	TCGA-VN-A88L-01	TCGA-VN-A88L-01		TCGA-VN-A88L-01A-11D-A34U-08	6f4d55e9-37fc-40c3-92d0-5bdabc063447
TCGA-VN-A88M-01	0	TCGA-VN-A88M-01	189	0	days	TCGA-VN-A88M	189	0	days	189	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55	TCGA-VN-A88M-F62591	TCGA-VN-A88M				M0	T1c	-20157					128		0	189					NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission		2014-12-22	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral		YES	YES				NO	13	0		No	N0	T2c			A88M	TUMOR FREE	3	Complete Remission/Response		NO	R0	Primary Tumor	01	4			NO		NO	YES	VN	Middle		Prostate			LIVING	2013		aa86654d-003d-4190-b2bc-f4b40f77474f	TCGA-VN-A88M-01A-11D-A34T-01	TCGA-VN-A88M-01A-11D-A34V-05		TCGA-VN-A88M-01A-11D-A34U-08	aa86654d-003d-4190-b2bc-f4b40f77474f	TCGA-VN-A88M-01	TCGA-VN-A88M-01		TCGA-VN-A88M-01A-11D-A34T-01	aa86654d-003d-4190-b2bc-f4b40f77474f	TCGA-VN-A88M-01	TCGA-VN-A88M-01			aa86654d-003d-4190-b2bc-f4b40f77474f
TCGA-VN-A88N-01	0	TCGA-VN-A88N-01	766	0	days	TCGA-VN-A88N	766	0	days	766	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			62	TCGA-VN-A88N-F72543	TCGA-VN-A88N	TCGA-VN-A88N-01A	NO	Equivocal	M0	T1c	-22695	98	156		98	-117		0	766		176			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission		2015-7-13	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	50		NO	Bilateral		NO	YES				NO	50	0	true	No	N0	T2c	TCGA-VN-A88N.CB3E6129-CCCC-4EEB-88CD-63DE78D8F163.pdf		A88N	TUMOR FREE	4	Complete Remission/Response	0	NO	R0	Primary Tumor	01	3			NO		NO	YES	VN	Apex|Middle|Base		Prostate		A	LIVING	2013	Overlapping / Multiple Zones	7dae2f3c-56cb-425a-8d7f-7113e1cfc72e	TCGA-VN-A88N-01A-11D-A363-01	TCGA-VN-A88N-01A-11D-A365-05		TCGA-VN-A88N-01A-11D-A364-08	7dae2f3c-56cb-425a-8d7f-7113e1cfc72e	TCGA-VN-A88N-01	TCGA-VN-A88N-01		TCGA-VN-A88N-01A-11D-A363-01	7dae2f3c-56cb-425a-8d7f-7113e1cfc72e	TCGA-VN-A88N-01	TCGA-VN-A88N-01		TCGA-VN-A88N-01A-11D-A364-08	7dae2f3c-56cb-425a-8d7f-7113e1cfc72e
TCGA-VN-A88O-01	0	TCGA-VN-A88O-01	481	0	days	TCGA-VN-A88O	481	0	days	481	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			49	TCGA-VN-A88O-F72128	TCGA-VN-A88O	TCGA-VN-A88O-01A	NO		M0	T1c	-17945		426			70		0	481		376			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission		2015-4-17	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	60		NO	Bilateral		YES	YES				NO	34	0	true	No	N0	T2c	TCGA-VN-A88O.E47DAF10-187B-4909-A0C5-D96231A5893F.pdf		A88O	TUMOR FREE	3	Complete Remission/Response	0	NO	R0	Primary Tumor	01	4			NO	4	NO	YES	VN	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones	621b5b13-6568-41fa-9e42-3992fa05dd1f	TCGA-VN-A88O-01A-11D-A34T-01	TCGA-VN-A88O-01A-11D-A34V-05		TCGA-VN-A88O-01A-11D-A34U-08	621b5b13-6568-41fa-9e42-3992fa05dd1f	TCGA-VN-A88O-01	TCGA-VN-A88O-01		TCGA-VN-A88O-01A-11D-A34T-01	621b5b13-6568-41fa-9e42-3992fa05dd1f	TCGA-VN-A88O-01	TCGA-VN-A88O-01		TCGA-VN-A88O-01A-11D-A34U-08	621b5b13-6568-41fa-9e42-3992fa05dd1f
TCGA-VN-A88P-01	0	TCGA-VN-A88P-01	1260	0	days	TCGA-VN-A88P	1260	0	days	1260	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			60	TCGA-VN-A88P-F69078	TCGA-VN-A88P	TCGA-VN-A88P-01A	NO	Abnormal (not related to prostate cancer)	M0	T1c	-21916	839	911		839	805		0	1260		917			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2014-12-29	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	140		NO	Bilateral		NO	YES				NO	65	0	true	No	N0	T2c	TCGA-VN-A88P.9C83DFB8-B75A-40D1-B791-BE52B52BBDA6.pdf		A88P	TUMOR FREE	3	Complete Remission/Response	0	NO	R0	Primary Tumor	01	4			NO		NO	YES	VN	Base		Prostate		A	LIVING	2011	Overlapping / Multiple Zones	e6310fd5-418f-4315-8c0a-78b05a95c214	TCGA-VN-A88P-01A-11D-A34T-01	TCGA-VN-A88P-01A-11D-A34V-05		TCGA-VN-A88P-01A-11D-A34U-08	e6310fd5-418f-4315-8c0a-78b05a95c214	TCGA-VN-A88P-01	TCGA-VN-A88P-01	F1C836D5-1E39-43AC-A0C8-800C4964E8C2	TCGA-VN-A88P-01A-11D-A34T-01	e6310fd5-418f-4315-8c0a-78b05a95c214	TCGA-VN-A88P-01	TCGA-VN-A88P-01		TCGA-VN-A88P-01A-11D-A34U-08	e6310fd5-418f-4315-8c0a-78b05a95c214
TCGA-VN-A88Q-01	0	TCGA-VN-A88Q-01	1366	0	days	TCGA-VN-A88Q	1366	0	days	1366	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			60	TCGA-VN-A88Q-F68875	TCGA-VN-A88Q		NO	Abnormal (not related to prostate cancer)	M0	T2a	-22087	929				796		0	1366		1000			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2014-12-22	MALE	8	Prostate Adenocarcinoma, Other Subtype	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	12	0		No	N0	T2c			A88Q	TUMOR FREE	4	Complete Remission/Response	0	NO	R0	Primary Tumor	01	4			NO		NO	YES	VN	Apex		Prostate			LIVING	2010	Overlapping / Multiple Zones	c44359a0-d7c7-45bc-80e7-5139d4a77234	TCGA-VN-A88Q-01A-11D-A34T-01	TCGA-VN-A88Q-01A-11D-A34V-05		TCGA-VN-A88Q-01A-11D-A34U-08	c44359a0-d7c7-45bc-80e7-5139d4a77234	TCGA-VN-A88Q-01	TCGA-VN-A88Q-01		TCGA-VN-A88Q-01A-11D-A34T-01	c44359a0-d7c7-45bc-80e7-5139d4a77234	TCGA-VN-A88Q-01	TCGA-VN-A88Q-01		TCGA-VN-A88Q-01A-11D-A34U-08	c44359a0-d7c7-45bc-80e7-5139d4a77234
TCGA-VN-A88R-01	0	TCGA-VN-A88R-01	784	0	days	TCGA-VN-A88R	512	1	days	784	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	NO	53	TCGA-VN-A88R-F69083	TCGA-VN-A88R	TCGA-VN-A88R-01A	NO	Abnormal (not related to prostate cancer)	M0	T1c	-19513	316	402		316	207	512	0	784	512	459			YES	Equivocal	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission		2014-12-29	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	40		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	34	0	true	No	N0	T2c	TCGA-VN-A88R.6DDC4292-91C9-49A7-B34D-578ECA0A7F56.pdf		A88R		4	Partial Remission/Response	0.15	NO	R0	Primary Tumor	01	4			NO		NO	YES	VN	Apex|Middle|Base		Prostate		A	LIVING	2012		7e0203fd-e55d-4d05-9877-6b502250ffc3	TCGA-VN-A88R-01A-11D-A363-01	TCGA-VN-A88R-01A-11D-A365-05		TCGA-VN-A88R-01A-11D-A364-08	7e0203fd-e55d-4d05-9877-6b502250ffc3	TCGA-VN-A88R-01	TCGA-VN-A88R-01		TCGA-VN-A88R-01A-11D-A363-01	7e0203fd-e55d-4d05-9877-6b502250ffc3	TCGA-VN-A88R-01	TCGA-VN-A88R-01		TCGA-VN-A88R-01A-11D-A364-08	7e0203fd-e55d-4d05-9877-6b502250ffc3
TCGA-VN-A943-01	0	TCGA-VN-A943-01	496	0	days	TCGA-VN-A943	496	0	days	496	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			71	TCGA-VN-A943-F69100	TCGA-VN-A943		NO		M0	T1c	-26162					-17		0	496		132			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2014-12-29	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	10	0		No	N0	T2c			A943	TUMOR FREE	4	Complete Remission/Response	0.01	NO	R0	Primary Tumor	01	4			NO		NO	YES	VN	Apex|Middle|Base		Prostate			LIVING	2013	Overlapping / Multiple Zones	c83c8992-5d92-4c1e-a59d-cf890ecb9bb4	TCGA-VN-A943-01A-11D-A41J-01	TCGA-VN-A943-01A-11D-A41L-05		TCGA-VN-A943-01A-11D-A41K-08	c83c8992-5d92-4c1e-a59d-cf890ecb9bb4	TCGA-VN-A943-01	TCGA-VN-A943-01		TCGA-VN-A943-01A-11D-A41J-01	c83c8992-5d92-4c1e-a59d-cf890ecb9bb4	TCGA-VN-A943-01	TCGA-VN-A943-01			c83c8992-5d92-4c1e-a59d-cf890ecb9bb4
TCGA-VP-A872-01	0	TCGA-VP-A872-01	3631	0	days	TCGA-VP-A872	3631	0	days	3631	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			60	TCGA-VP-A872-F64422	TCGA-VP-A872		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2	-22098	8						0	3631		3253			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-2	MALE	8	Prostate Adenocarcinoma, Other Subtype	No	C61	8500/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	12	0		No	N0	T3a			A872	TUMOR FREE	5	Complete Remission/Response	0.01	NO	R0	Primary Tumor	01	3			NO	4	NO	YES	VP	Apex|Base		Prostate			LIVING	2005	Overlapping / Multiple Zones	f8fba04c-cd45-4f85-8b75-dcf5426b7637	TCGA-VP-A872-01A-11D-A34T-01	TCGA-VP-A872-01A-11D-A34V-05		TCGA-VP-A872-01A-11D-A34U-08	f8fba04c-cd45-4f85-8b75-dcf5426b7637	TCGA-VP-A872-01	TCGA-VP-A872-01		TCGA-VP-A872-01A-11D-A34T-01	f8fba04c-cd45-4f85-8b75-dcf5426b7637	TCGA-VP-A872-01	TCGA-VP-A872-01		TCGA-VP-A872-01A-11D-A34U-08	f8fba04c-cd45-4f85-8b75-dcf5426b7637
TCGA-VP-A875-01	0	TCGA-VP-A875-01	2309	0	days	TCGA-VP-A875	2309	0	days	2309	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			67	TCGA-VP-A875-F64433	TCGA-VP-A875	TCGA-VP-A875-01A	NO	Abnormal (not related to prostate cancer)	M0	T2a	-24742	15	3124		15			0	2309		867			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-2	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	280		NO	Bilateral		YES	YES				NO	4	0	true	No	N0	T3a	TCGA-VP-A875.2CF80467-58E9-4A65-94D5-08401BE6ACB5.pdf		A875	TUMOR FREE	3	Complete Remission/Response	0.01	NO	R0	Primary Tumor	01	4			NO		NO	YES	VP	Apex|Base		Prostate		A	LIVING	2005	Overlapping / Multiple Zones	c47f8609-65d3-4cca-b599-58add67672c7	TCGA-VP-A875-01A-31D-A34T-01	TCGA-VP-A875-01A-31D-A34V-05		TCGA-VP-A875-01A-31D-A34U-08	c47f8609-65d3-4cca-b599-58add67672c7	TCGA-VP-A875-01	TCGA-VP-A875-01	077ECEE0-AF3D-4F34-8D82-E058B953C53F	TCGA-VP-A875-01A-31D-A34T-01	c47f8609-65d3-4cca-b599-58add67672c7	TCGA-VP-A875-01	TCGA-VP-A875-01		TCGA-VP-A875-01A-31D-A34U-08	c47f8609-65d3-4cca-b599-58add67672c7
TCGA-VP-A876-01	0	TCGA-VP-A876-01	3333	0	days	TCGA-VP-A876	3333	0	days	3333	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			46	TCGA-VP-A876-F64436	TCGA-VP-A876	TCGA-VP-A876-01A	NO	Normal (no evidence of prostate cancer) [cM0]		T1c	-16934	13	3054		13			0	3333		2576			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-2	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	20		NO	Bilateral		NO	YES				NO	12	0	true	No	N0	T2c	TCGA-VP-A876.A10667AF-8A71-492D-B71C-95160DE9EEE6.pdf		A876	TUMOR FREE	3	Complete Remission/Response	0.1	NO	R0	Primary Tumor	01	5			NO		NO	YES	VP	Apex|Base		Prostate		A	LIVING	2005	Overlapping / Multiple Zones	2099f0da-0318-4b94-a418-d6e6cf65454b	TCGA-VP-A876-01A-11D-A34T-01	TCGA-VP-A876-01A-11D-A34V-05		TCGA-VP-A876-01A-11D-A34U-08	2099f0da-0318-4b94-a418-d6e6cf65454b	TCGA-VP-A876-01	TCGA-VP-A876-01		TCGA-VP-A876-01A-11D-A34T-01	2099f0da-0318-4b94-a418-d6e6cf65454b	TCGA-VP-A876-01	TCGA-VP-A876-01		TCGA-VP-A876-01A-11D-A34U-08	2099f0da-0318-4b94-a418-d6e6cf65454b
TCGA-VP-A878-01	0	TCGA-VP-A878-01	3130	0	days	TCGA-VP-A878	2354	1	days	3130	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	NO	58	TCGA-VP-A878-F64439	TCGA-VP-A878	TCGA-VP-A878-01A	NO	Normal (no evidence of prostate cancer) [cM0]		T1c	-21402	35	2725		44		1843	0	3130	2354	2704	1934	2011	YES	Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1]	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-2	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	220		NO	Bilateral		NO	YES	Bone	Distant Metastasis		YES	3	1	true	No	N1	T2c	TCGA-VP-A878.635464F3-6A6B-4574-8413-058651AB4068.pdf		A878	WITH TUMOR	4	Partial Remission/Response	0.1	NO	R1	Primary Tumor	01	5			NO		NO	YES	VP	Apex|Base	NO	Prostate		A	LIVING	2006	Overlapping / Multiple Zones	2405edaf-b4cc-4292-92a3-8b890ffaa70f	TCGA-VP-A878-01A-31D-A34T-01	TCGA-VP-A878-01A-31D-A34V-05		TCGA-VP-A878-01A-31D-A34U-08	2405edaf-b4cc-4292-92a3-8b890ffaa70f	TCGA-VP-A878-01	TCGA-VP-A878-01	5A467EBB-657B-4B94-8901-424E02563537	TCGA-VP-A878-01A-31D-A34T-01	2405edaf-b4cc-4292-92a3-8b890ffaa70f	TCGA-VP-A878-01	TCGA-VP-A878-01		TCGA-VP-A878-01A-31D-A34U-08	2405edaf-b4cc-4292-92a3-8b890ffaa70f
TCGA-VP-A879-01	1	TCGA-VP-A879-01	728	1	days	TCGA-VP-A879	728	0	days	728	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			70	TCGA-VP-A879-F64442	TCGA-VP-A879	TCGA-VP-A879-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-25799	8	2578	728	8			0			688			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-2	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	110		NO	Right		NO	YES				NO	2	0	true	No	N0	T2b	TCGA-VP-A879.526F7E5C-B681-46B7-B118-10AB3F2DD30E.pdf		A879	TUMOR FREE	4	Complete Remission/Response	0.01	NO	R0	Primary Tumor	01	5		Medical Record	NO		NO	YES	VP	Apex|Base		Prostate		A	DECEASED	2006	Overlapping / Multiple Zones	1cba2729-ee83-44a3-a21a-ad5359a2bbe3	TCGA-VP-A879-01A-11D-A34T-01	TCGA-VP-A879-01A-11D-A34V-05		TCGA-VP-A879-01A-11D-A34U-08	1cba2729-ee83-44a3-a21a-ad5359a2bbe3	TCGA-VP-A879-01	TCGA-VP-A879-01		TCGA-VP-A879-01A-11D-A34T-01	1cba2729-ee83-44a3-a21a-ad5359a2bbe3	TCGA-VP-A879-01	TCGA-VP-A879-01		TCGA-VP-A879-01A-11D-A34U-08	1cba2729-ee83-44a3-a21a-ad5359a2bbe3
TCGA-VP-A87B-01	0	TCGA-VP-A87B-01	2722	0	days	TCGA-VP-A87B	2473	1	days	2722	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	NO	63	TCGA-VP-A87B-F64449	TCGA-VP-A87B		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-23271						2310	0	2722	2473	2309	2459		YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-3	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Right		NO	YES	Lung	New Primary Tumor		YES	2	0		No	N0	T2b			A87B	WITH TUMOR	4	Progressive Disease	3.37	YES	R0	Primary Tumor	01	4			NO	3	NO	YES	VP	Apex|Base	NO	Prostate			LIVING	2007	Overlapping / Multiple Zones	a899dca6-deb0-49f8-8c8b-2854b108de5a	TCGA-VP-A87B-01A-11D-A34T-01	TCGA-VP-A87B-01A-11D-A34V-05		TCGA-VP-A87B-01A-11D-A34U-08	a899dca6-deb0-49f8-8c8b-2854b108de5a	TCGA-VP-A87B-01	TCGA-VP-A87B-01		TCGA-VP-A87B-01A-11D-A34T-01	a899dca6-deb0-49f8-8c8b-2854b108de5a	TCGA-VP-A87B-01	TCGA-VP-A87B-01		TCGA-VP-A87B-01A-11D-A34U-08	a899dca6-deb0-49f8-8c8b-2854b108de5a
TCGA-VP-A87C-01	0	TCGA-VP-A87C-01	1690	0	days	TCGA-VP-A87C	1690	0	days	1690	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			67	TCGA-VP-A87C-F64470	TCGA-VP-A87C		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24608	14			14			0	1690		1690			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral		YES	YES				NO	12	0		No	N0	T2c			A87C	TUMOR FREE	4	Complete Remission/Response	0.5	NO	R0	Primary Tumor	01	3			NO		NO	YES	VP	Apex|Base		Prostate			LIVING	2007	Overlapping / Multiple Zones	e6e404f0-3317-496c-b4f8-555408a3dfd6	TCGA-VP-A87C-01A-11D-A34T-01	TCGA-VP-A87C-01A-11D-A34V-05		TCGA-VP-A87C-01A-11D-A34U-08	e6e404f0-3317-496c-b4f8-555408a3dfd6	TCGA-VP-A87C-01	TCGA-VP-A87C-01		TCGA-VP-A87C-01A-11D-A34T-01	e6e404f0-3317-496c-b4f8-555408a3dfd6	TCGA-VP-A87C-01	TCGA-VP-A87C-01		TCGA-VP-A87C-01A-11D-A34U-08	e6e404f0-3317-496c-b4f8-555408a3dfd6
TCGA-VP-A87D-01	0	TCGA-VP-A87D-01	1853	0	days	TCGA-VP-A87D	1853	0	days	1853	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			54	TCGA-VP-A87D-F64469	TCGA-VP-A87D		YES	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-19818	14				12	1194	0	1853		1853			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2014-9-3	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral		YES	YES				NO	12	3		No	N1	T3a			A87D	TUMOR FREE	4	Complete Remission/Response	0.2	NO	R0	Primary Tumor	01	5			YES		NO	YES	VP	Apex|Base		Prostate			LIVING	2007	Overlapping / Multiple Zones	ca36f013-1f5d-41f4-85a5-2b8a149a5cfa	TCGA-VP-A87D-01A-11D-A34T-01	TCGA-VP-A87D-01A-11D-A34V-05		TCGA-VP-A87D-01A-11D-A34U-08	ca36f013-1f5d-41f4-85a5-2b8a149a5cfa	TCGA-VP-A87D-01	TCGA-VP-A87D-01		TCGA-VP-A87D-01A-11D-A34T-01	ca36f013-1f5d-41f4-85a5-2b8a149a5cfa	TCGA-VP-A87D-01	TCGA-VP-A87D-01		TCGA-VP-A87D-01A-11D-A34U-08	ca36f013-1f5d-41f4-85a5-2b8a149a5cfa
TCGA-VP-A87E-01	0	TCGA-VP-A87E-01	2037	0	days	TCGA-VP-A87E	2037	0	days	2037	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			59	TCGA-VP-A87E-F64474	TCGA-VP-A87E	TCGA-VP-A87E-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-21811	15	2059		15			0	2037		2037			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-3	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	220		NO	Bilateral		YES	YES				NO	12	0	true	No	N0	T2c	TCGA-VP-A87E.6B46F895-B5CD-40B8-8962-AA8DF2505446.pdf		A87E	TUMOR FREE	3	Complete Remission/Response	0.11	NO	R0	Primary Tumor	01	3			NO		NO	YES	VP	Apex|Base		Prostate		A	LIVING	2008	Overlapping / Multiple Zones	ecbb33ff-c485-485f-a169-6bb7c1c84baf	TCGA-VP-A87E-01A-31D-A34T-01	TCGA-VP-A87E-01A-31D-A34V-05		TCGA-VP-A87E-01A-31D-A34U-08	ecbb33ff-c485-485f-a169-6bb7c1c84baf	TCGA-VP-A87E-01	TCGA-VP-A87E-01	8175BE77-BA0B-4FB2-A6AA-6DF5A8D0C04B	TCGA-VP-A87E-01A-31D-A34T-01	ecbb33ff-c485-485f-a169-6bb7c1c84baf	TCGA-VP-A87E-01	TCGA-VP-A87E-01		TCGA-VP-A87E-01A-31D-A34U-08	ecbb33ff-c485-485f-a169-6bb7c1c84baf
TCGA-VP-A87H-01	0	TCGA-VP-A87H-01	663	0	days	TCGA-VP-A87H	663	0	days	663	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			76	TCGA-VP-A87H-F64478	TCGA-VP-A87H	TCGA-VP-A87H-01A	NO		M0	T2	-28060		1714		24			0	663		663			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-3	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	50		NO	Bilateral		YES	YES				NO	16	0	true	No	N0	T3b	TCGA-VP-A87H.B2B58670-AE26-43A0-8D3C-AAF354958727.pdf		A87H	TUMOR FREE	4	Complete Remission/Response	0.01	NO	R2	Primary Tumor	01	5			NO		NO	YES	VP	Apex|Base		Prostate		A	LIVING	2009	Overlapping / Multiple Zones	3aba16f9-47fe-419a-92d3-c73049adce2b	TCGA-VP-A87H-01A-11D-A34T-01	TCGA-VP-A87H-01A-11D-A34V-05		TCGA-VP-A87H-01A-11D-A34U-08	3aba16f9-47fe-419a-92d3-c73049adce2b	TCGA-VP-A87H-01	TCGA-VP-A87H-01		TCGA-VP-A87H-01A-11D-A34T-01	3aba16f9-47fe-419a-92d3-c73049adce2b	TCGA-VP-A87H-01	TCGA-VP-A87H-01		TCGA-VP-A87H-01A-11D-A34U-08	3aba16f9-47fe-419a-92d3-c73049adce2b
TCGA-VP-A87J-01	0	TCGA-VP-A87J-01	1774	0	days	TCGA-VP-A87J	1774	0	days	1774	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			56	TCGA-VP-A87J-F64485	TCGA-VP-A87J	TCGA-VP-A87J-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-20792	11	1379		13			0	1774		1296			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	130		NO	Bilateral		NO	YES				NO	11	1	true	No	N1	T3a	TCGA-VP-A87J.03F4F8F1-ACE1-4391-85AC-A10B2F56CDD0.pdf		A87J	TUMOR FREE	3	Complete Remission/Response	0.13	NO	R2	Primary Tumor	01	4			NO		NO	YES	VP	Apex|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones	eecb9837-09fc-4e99-93d3-d3686c9783da	TCGA-VP-A87J-01A-11D-A34T-01	TCGA-VP-A87J-01A-11D-A34V-05		TCGA-VP-A87J-01A-11D-A34U-08	eecb9837-09fc-4e99-93d3-d3686c9783da	TCGA-VP-A87J-01	TCGA-VP-A87J-01	30BCCEFD-980E-43C1-B9BB-243B1FCE44C3	TCGA-VP-A87J-01A-11D-A34T-01	eecb9837-09fc-4e99-93d3-d3686c9783da	TCGA-VP-A87J-01	TCGA-VP-A87J-01		TCGA-VP-A87J-01A-11D-A34U-08	eecb9837-09fc-4e99-93d3-d3686c9783da
TCGA-VP-A87K-01	0	TCGA-VP-A87K-01	1306	0	days	TCGA-VP-A87K	697	1	days	1306	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	YES	63	TCGA-VP-A87K-F64502	TCGA-VP-A87K	TCGA-VP-A87K-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-23030	13	1112		13		467	0	1306	697	655	533	655	YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-3	MALE	8	Prostate Adenocarcinoma, Other Subtype	No	C61	8500/3	C61.9	YES	Core needle biopsy	130		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	12	0	true	No	N0	T3b	TCGA-VP-A87K.6B2C5B8F-61B5-4D8B-A091-B28066A1629A.pdf		A87K	TUMOR FREE	4	Complete Remission/Response	0.3	NO	R1	Primary Tumor	01	4			NO		NO	YES	VP	Apex|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones	1a9b6614-f2fd-4a0f-9586-a8b7d339c7ca	TCGA-VP-A87K-01A-11D-A34T-01	TCGA-VP-A87K-01A-11D-A34V-05		TCGA-VP-A87K-01A-11D-A34U-08	1a9b6614-f2fd-4a0f-9586-a8b7d339c7ca	TCGA-VP-A87K-01	TCGA-VP-A87K-01	ACBE85E8-D46E-4C20-B7D4-D48BC8E3B5AA	TCGA-VP-A87K-01A-11D-A34T-01	1a9b6614-f2fd-4a0f-9586-a8b7d339c7ca	TCGA-VP-A87K-01	TCGA-VP-A87K-01		TCGA-VP-A87K-01A-11D-A34U-08	1a9b6614-f2fd-4a0f-9586-a8b7d339c7ca
TCGA-VP-AA1N-01	0	TCGA-VP-AA1N-01	1365	0	days	TCGA-VP-AA1N	1365	0	days	1365	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			70	TCGA-VP-AA1N-F64506	TCGA-VP-AA1N	TCGA-VP-AA1N-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-25781	17	2112		17			0	1365		542			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-9-3	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	250		NO	Bilateral		YES	YES				NO	5	0	true	No	N0	T3a	TCGA-VP-AA1N.B76B30C1-F87D-494B-A95A-3F9E511ED3B1.pdf		AA1N	TUMOR FREE	5	Complete Remission/Response	0.01	YES	R1	Primary Tumor	01	4			NO		NO	YES	VP	Apex|Base		Prostate		A	LIVING	2008	Overlapping / Multiple Zones	81f85c7b-5262-466b-b4fb-a4fe9febfe0a	TCGA-VP-AA1N-01A-31D-A41J-01	TCGA-VP-AA1N-01A-31D-A41L-05		TCGA-VP-AA1N-01A-31D-A41K-08	81f85c7b-5262-466b-b4fb-a4fe9febfe0a	TCGA-VP-AA1N-01	TCGA-VP-AA1N-01	5FEE1D08-009A-4CAA-801E-0EF953031332	TCGA-VP-AA1N-01A-31D-A41J-01	81f85c7b-5262-466b-b4fb-a4fe9febfe0a	TCGA-VP-AA1N-01	TCGA-VP-AA1N-01			81f85c7b-5262-466b-b4fb-a4fe9febfe0a
TCGA-WW-A8ZI-01	0	TCGA-WW-A8ZI-01	449	0	days	TCGA-WW-A8ZI	449	0	days	449	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			70	TCGA-WW-A8ZI-F67645	TCGA-WW-A8ZI	TCGA-WW-A8ZI-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-25593	13	135		20			0	449		176			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-7	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	170		NO	Bilateral		NO	YES				NO	4	0	true	No	N0	T2c	TCGA-WW-A8ZI.91350D32-096F-4839-ABE4-6AC4354E7B68.pdf		A8ZI	TUMOR FREE	4	Complete Remission/Response	0	NO	R0	Primary Tumor	01	4			NO		YES	NO	WW	Apex		Prostate		A	LIVING	2013		effc8583-559f-4e01-bd93-11b39d95a290	TCGA-WW-A8ZI-01A-11D-A376-01	TCGA-WW-A8ZI-01A-11D-A378-05		TCGA-WW-A8ZI-01A-11D-A377-08	effc8583-559f-4e01-bd93-11b39d95a290	TCGA-WW-A8ZI-01	TCGA-WW-A8ZI-01	A3E7C63B-AF98-4A27-9FB2-DB59FAB8B814	TCGA-WW-A8ZI-01A-11D-A376-01	effc8583-559f-4e01-bd93-11b39d95a290	TCGA-WW-A8ZI-01	TCGA-WW-A8ZI-01		TCGA-WW-A8ZI-01A-11D-A377-08	effc8583-559f-4e01-bd93-11b39d95a290
TCGA-X4-A8KQ-01	0	TCGA-X4-A8KQ-01	1383	0	days	TCGA-X4-A8KQ			days	1383	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			65	TCGA-X4-A8KQ-F67716	TCGA-X4-A8KQ	TCGA-X4-A8KQ-01A	NO		M0	T1c	-23999		1078				883	0	1383		963			NO		NO		Scheduled Follow-up Submission	Stable Disease	2014-11-10	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	250		NO	Right		NO	YES		Biochemical evidence of disease		YES	3	0	true	No	N0	T3b	TCGA-X4-A8KQ.978B4E1F-FDA4-41FA-8341-ED6E851168A6.pdf		A8KQ	WITH TUMOR	4	Progressive Disease	.25	YES	RX	Primary Tumor	01	5			YES		NO	YES	X4			Prostate		A	LIVING	2010	Peripheral Zone	cff667cc-724f-4f8a-96c0-cdd6512805a2	TCGA-X4-A8KQ-01A-12D-A363-01	TCGA-X4-A8KQ-01A-12D-A365-05		TCGA-X4-A8KQ-01A-12D-A364-08	cff667cc-724f-4f8a-96c0-cdd6512805a2	TCGA-X4-A8KQ-01	TCGA-X4-A8KQ-01	C1BE9473-E561-4DCF-8238-4EF36DFAC1BB	TCGA-X4-A8KQ-01A-12D-A363-01	cff667cc-724f-4f8a-96c0-cdd6512805a2	TCGA-X4-A8KQ-01	TCGA-X4-A8KQ-01			cff667cc-724f-4f8a-96c0-cdd6512805a2
TCGA-X4-A8KS-01	0	TCGA-X4-A8KS-01	979	0	days	TCGA-X4-A8KS	979	0	days	979	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61	TCGA-X4-A8KS-F67714	TCGA-X4-A8KS	TCGA-X4-A8KS-01A	NO		M0	T2c	-22571		735					0	979		797			NO		NO		Scheduled Follow-up Submission	Partial Remission/Response	2014-11-10	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	160		NO	Bilateral		NO	NO				NO			true	No		T2c	TCGA-X4-A8KS.30844429-3F9C-4AD0-8A23-64012532347C.pdf		A8KS	TUMOR FREE	3	Partial Remission/Response	.01	NO	RX	Primary Tumor	01	4			NO		NO	YES	X4			Prostate		A	LIVING	2011	Peripheral Zone	984a3498-4b0b-4242-9fd3-640175da22ec	TCGA-X4-A8KS-01A-12D-A363-01	TCGA-X4-A8KS-01A-12D-A365-05		TCGA-X4-A8KS-01A-12D-A364-08	984a3498-4b0b-4242-9fd3-640175da22ec	TCGA-X4-A8KS-01	TCGA-X4-A8KS-01		TCGA-X4-A8KS-01A-12D-A363-01	984a3498-4b0b-4242-9fd3-640175da22ec	TCGA-X4-A8KS-01	TCGA-X4-A8KS-01			984a3498-4b0b-4242-9fd3-640175da22ec
TCGA-XA-A8JR-01	0	TCGA-XA-A8JR-01	376	0	days	TCGA-XA-A8JR	376	0	days	376	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			68	TCGA-XA-A8JR-F69794	TCGA-XA-A8JR	TCGA-XA-A8JR-01A	NO		M0		-25090		223					0	376		69							Scheduled Follow-up Submission		2015-1-20	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	110		NO	Bilateral		NO	YES				NO	7	0	true	No	N0	T2c	TCGA-XA-A8JR.587379B6-9AF9-471D-834C-668555ABC32A.pdf		A8JR	TUMOR FREE	4	Complete Remission/Response	0	NO	R2	Primary Tumor	01	3			NO	5	YES	NO	XA			Prostate		A	LIVING	2013		419e456e-40fc-4bc7-8b9f-c54d9935b7e2	TCGA-XA-A8JR-01A-11D-A363-01	TCGA-XA-A8JR-01A-11D-A365-05		TCGA-XA-A8JR-01A-11D-A364-08	419e456e-40fc-4bc7-8b9f-c54d9935b7e2	TCGA-XA-A8JR-01	TCGA-XA-A8JR-01	B774F7F2-5B17-4FC0-8A84-815EF5D03067	TCGA-XA-A8JR-01A-11D-A363-01	419e456e-40fc-4bc7-8b9f-c54d9935b7e2	TCGA-XA-A8JR-01	TCGA-XA-A8JR-01		TCGA-XA-A8JR-01A-11D-A364-08	419e456e-40fc-4bc7-8b9f-c54d9935b7e2
TCGA-XJ-A83F-01	0	TCGA-XJ-A83F-01	1127	0	days	TCGA-XJ-A83F	1127	0	days	1127	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			67	TCGA-XJ-A83F-F57164	TCGA-XJ-A83F		NO											0	1127		762			NO		NO		Scheduled Follow-up Submission		2014-10-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Transurethral resection (TURBT)				Right		NO	YES				NO	7	0		No	N0	T3a			A83F	TUMOR FREE	3	Complete Remission/Response	0.01	NO	RX	Primary Tumor	01	4			NO		NO	YES	XJ	Middle|Base		Prostate			LIVING	2011	Peripheral Zone	ef59f19f-f7c0-4cf3-b686-a0cd09a996b3	TCGA-XJ-A83F-01A-11D-A34T-01	TCGA-XJ-A83F-01A-11D-A34V-05		TCGA-XJ-A83F-01A-11D-A34U-08	ef59f19f-f7c0-4cf3-b686-a0cd09a996b3	TCGA-XJ-A83F-01	TCGA-XJ-A83F-01		TCGA-XJ-A83F-01A-11D-A34T-01	ef59f19f-f7c0-4cf3-b686-a0cd09a996b3	TCGA-XJ-A83F-01	TCGA-XJ-A83F-01			ef59f19f-f7c0-4cf3-b686-a0cd09a996b3
TCGA-XJ-A83G-01	0	TCGA-XJ-A83G-01	1461	0	days	TCGA-XJ-A83G	1461	0	days	1461	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			51	TCGA-XJ-A83G-F56698	TCGA-XJ-A83G	TCGA-XJ-A83G-01A	NO			T1c			1114					0	1461		1126			NO				Scheduled Follow-up Submission	Complete Remission/Response	2014-10-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	40		NO	Bilateral		NO	YES				NO	4	0	false	No	N0	T3b	TCGA-XJ-A83G.F5DB0EA7-336E-4A5E-9BFD-3291A5DB4D3D.pdf		A83G	TUMOR FREE	4	Complete Remission/Response	0.01	NO		Primary Tumor	01	3			NO	5	NO	YES	XJ	Apex|Middle		Prostate		A	LIVING	2010	Peripheral Zone	585bed4d-5d57-4308-ab8e-7a0f97e48153	TCGA-XJ-A83G-01A-11D-A34T-01	TCGA-XJ-A83G-01A-11D-A34V-05		TCGA-XJ-A83G-01A-11D-A34U-08	585bed4d-5d57-4308-ab8e-7a0f97e48153	TCGA-XJ-A83G-01	TCGA-XJ-A83G-01		TCGA-XJ-A83G-01A-11D-A34T-01	585bed4d-5d57-4308-ab8e-7a0f97e48153	TCGA-XJ-A83G-01	TCGA-XJ-A83G-01		TCGA-XJ-A83G-01A-11D-A34U-08	585bed4d-5d57-4308-ab8e-7a0f97e48153
TCGA-XJ-A83H-01		TCGA-XJ-A83H-01			days	TCGA-XJ-A83H			days		days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57	TCGA-XJ-A83H-F66192	TCGA-XJ-A83H	TCGA-XJ-A83H-01A	NO		M0	T2a			2241					0	0		1280			NO		NO		Scheduled Follow-up Submission		2014-10-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	40		NO	Bilateral		YES	NO				NO			false	No		T2c	TCGA-XJ-A83H.B4E981CF-B54B-422D-9FD4-E867FAB1FAA8.pdf		A83H		3	Partial Remission/Response	0.03	NO	R0	Primary Tumor	01	4			NO		NO	YES	XJ	Middle|Base		Prostate		A	LIVING	2007	Peripheral Zone	617f26fb-18d8-44dc-8ced-bf3a32428fc9	TCGA-XJ-A83H-01A-11D-A34T-01	TCGA-XJ-A83H-01A-11D-A34V-05		TCGA-XJ-A83H-01A-11D-A34U-08	617f26fb-18d8-44dc-8ced-bf3a32428fc9	TCGA-XJ-A83H-01	TCGA-XJ-A83H-01		TCGA-XJ-A83H-01A-11D-A34T-01	617f26fb-18d8-44dc-8ced-bf3a32428fc9	TCGA-XJ-A83H-01	TCGA-XJ-A83H-01		TCGA-XJ-A83H-01A-11D-A34U-08	617f26fb-18d8-44dc-8ced-bf3a32428fc9
TCGA-XJ-A9DI-01	0	TCGA-XJ-A9DI-01	1461	0	days	TCGA-XJ-A9DI	1461	0	days	1461	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			62	TCGA-XJ-A9DI-F66555	TCGA-XJ-A9DI	TCGA-XJ-A9DI-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b		-61	1443					0	1461		1461			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-10-20	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	20		NO			NO	YES				NO	5	0	false	No	N0	T3b	TCGA-XJ-A9DI.8D5547ED-4864-4CE1-87D0-2FE7621B9B7C.pdf		A9DI	TUMOR FREE	5	Complete Remission/Response	0.10	YES	R0	Primary Tumor	01	4			YES		NO	YES	XJ	Base		Prostate		A	LIVING	2009	Peripheral Zone	4eaaf094-c0d8-476e-ba5b-7d9861c1dd5b	TCGA-XJ-A9DI-01A-11D-A376-01	TCGA-XJ-A9DI-01A-11D-A378-05		TCGA-XJ-A9DI-01A-11D-A377-08	4eaaf094-c0d8-476e-ba5b-7d9861c1dd5b	TCGA-XJ-A9DI-01	TCGA-XJ-A9DI-01		TCGA-XJ-A9DI-01A-11D-A376-01	4eaaf094-c0d8-476e-ba5b-7d9861c1dd5b	TCGA-XJ-A9DI-01	TCGA-XJ-A9DI-01		TCGA-XJ-A9DI-01A-11D-A377-08	4eaaf094-c0d8-476e-ba5b-7d9861c1dd5b
TCGA-XJ-A9DK-01	0	TCGA-XJ-A9DK-01	275	0	days	TCGA-XJ-A9DK	275	0	days	275	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63	TCGA-XJ-A9DK-F66561	TCGA-XJ-A9DK		NO		M0	T1c								0	275		275			NO		NO		Scheduled Follow-up Submission		2014-10-20	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Right		YES	NO				NO				No		T2c			A9DK	TUMOR FREE	4	Complete Remission/Response	0.10	NO	R0	Primary Tumor	01	4			NO		NO	YES	XJ	Apex		Prostate			LIVING	2007	Peripheral Zone	f4024393-b3f0-43b4-916e-4e92cb95c084	TCGA-XJ-A9DK-01A-11D-A376-01	TCGA-XJ-A9DK-01A-11D-A378-05		TCGA-XJ-A9DK-01A-11D-A377-08	f4024393-b3f0-43b4-916e-4e92cb95c084	TCGA-XJ-A9DK-01	TCGA-XJ-A9DK-01		TCGA-XJ-A9DK-01A-11D-A376-01	f4024393-b3f0-43b4-916e-4e92cb95c084	TCGA-XJ-A9DK-01	TCGA-XJ-A9DK-01		TCGA-XJ-A9DK-01A-11D-A377-08	f4024393-b3f0-43b4-916e-4e92cb95c084
TCGA-XJ-A9DQ-01	0	TCGA-XJ-A9DQ-01	91	0	days	TCGA-XJ-A9DQ	91	0	days	91	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			48	TCGA-XJ-A9DQ-F66562	TCGA-XJ-A9DQ	TCGA-XJ-A9DQ-01A	NO		M0	T1c			2265					0	91					NO		NO		Scheduled Follow-up Submission		2014-10-20	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	20		NO	Right		YES	NO				NO			false	No		T2a	TCGA-XJ-A9DQ.CAD1C3A1-9EF6-4253-AEEB-C6D80A07C8E7.pdf		A9DQ		3			NO	R0	Primary Tumor	01	3			NO		NO	YES	XJ	Apex|Base		Prostate		A	LIVING	2007	Peripheral Zone	8a7c238f-3e35-4156-b84d-44a95f8653bc	TCGA-XJ-A9DQ-01A-11D-A376-01	TCGA-XJ-A9DQ-01A-11D-A378-05		TCGA-XJ-A9DQ-01A-11D-A377-08	8a7c238f-3e35-4156-b84d-44a95f8653bc	TCGA-XJ-A9DQ-01	TCGA-XJ-A9DQ-01		TCGA-XJ-A9DQ-01A-11D-A376-01	8a7c238f-3e35-4156-b84d-44a95f8653bc	TCGA-XJ-A9DQ-01	TCGA-XJ-A9DQ-01			8a7c238f-3e35-4156-b84d-44a95f8653bc
TCGA-XJ-A9DX-01	0	TCGA-XJ-A9DX-01	973	0	days	TCGA-XJ-A9DX			days	973	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	YES	51	TCGA-XJ-A9DX-F66568	TCGA-XJ-A9DX	TCGA-XJ-A9DX-01A	NO		M1c	T1c			651				151	0	973		790			NO		NO		Scheduled Follow-up Submission	Partial Remission/Response	2014-10-20	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	40		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	22	2	false	No	N1	T3b	TCGA-XJ-A9DX.FB120749-2C3B-4760-82F2-73C630BF0346.pdf		A9DX	TUMOR FREE	5	Partial Remission/Response	0.05		R1	Primary Tumor	01	4					NO	YES	XJ	Base		Prostate		A	LIVING	2012	Peripheral Zone	66635f8c-2731-4231-9b71-f68f7d5f8072	TCGA-XJ-A9DX-01A-11D-A376-01	TCGA-XJ-A9DX-01A-11D-A378-05		TCGA-XJ-A9DX-01A-11D-A377-08	66635f8c-2731-4231-9b71-f68f7d5f8072	TCGA-XJ-A9DX-01	TCGA-XJ-A9DX-01		TCGA-XJ-A9DX-01A-11D-A376-01	66635f8c-2731-4231-9b71-f68f7d5f8072	TCGA-XJ-A9DX-01	TCGA-XJ-A9DX-01			66635f8c-2731-4231-9b71-f68f7d5f8072
TCGA-XK-AAIR-01	0	TCGA-XK-AAIR-01	972	0	days	TCGA-XK-AAIR	972	0	days	972	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			75	TCGA-XK-AAIR-F68320	TCGA-XK-AAIR		NO		M0	T1c	-27703							0	972		953			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-14	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	10	0		No	N0	T2c			AAIR	TUMOR FREE	4	Complete Remission/Response	0.09	NO	R0	Primary Tumor	01	4			NO		NO	YES	XK	Apex|Middle		Prostate			LIVING	2011		daca8915-ce62-4c6b-a268-c23de4aed85e	TCGA-XK-AAIR-01A-11D-A41J-01	TCGA-XK-AAIR-01A-11D-A41L-05		TCGA-XK-AAIR-01A-11D-A41K-08	daca8915-ce62-4c6b-a268-c23de4aed85e	TCGA-XK-AAIR-01	TCGA-XK-AAIR-01		TCGA-XK-AAIR-01A-11D-A41J-01	daca8915-ce62-4c6b-a268-c23de4aed85e	TCGA-XK-AAIR-01	TCGA-XK-AAIR-01			daca8915-ce62-4c6b-a268-c23de4aed85e
TCGA-XK-AAIV-01	0	TCGA-XK-AAIV-01	1133	0	days	TCGA-XK-AAIV	1133	0	days	1133	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63	TCGA-XK-AAIV-F66999	TCGA-XK-AAIV	TCGA-XK-AAIV-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-23325	16	898		20	42		0	1133		85			YES	No Evidence of Extraprostatic Extension	YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Scheduled Follow-up Submission	Complete Remission/Response	2014-10-29	MALE	10	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	70		NO	Bilateral		NO	YES				NO	18	2	true	No	N1	T3b	TCGA-XK-AAIV.84F5F45E-FE71-407C-A892-996B8A6CC0B6.pdf		AAIV	TUMOR FREE	5	Complete Remission/Response	0.32	YES	R1	Primary Tumor	01	5			YES		NO	YES	XK	Apex|Middle|Base		Prostate		A	LIVING	2011		822773fd-5a37-49ea-8064-c20738ecc24a	TCGA-XK-AAIV-01A-11D-A41J-01	TCGA-XK-AAIV-01A-11D-A41L-05		TCGA-XK-AAIV-01A-11D-A41K-08	822773fd-5a37-49ea-8064-c20738ecc24a	TCGA-XK-AAIV-01	TCGA-XK-AAIV-01		TCGA-XK-AAIV-01A-11D-A41J-01	822773fd-5a37-49ea-8064-c20738ecc24a	TCGA-XK-AAIV-01	TCGA-XK-AAIV-01			822773fd-5a37-49ea-8064-c20738ecc24a
TCGA-XK-AAIW-01	0	TCGA-XK-AAIW-01	1218	0	days	TCGA-XK-AAIW	1218	0	days	1218	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			78	TCGA-XK-AAIW-F67892	TCGA-XK-AAIW	TCGA-XK-AAIW-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-28721	7	884		7			0	1218		769			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	90		NO	Bilateral		NO	YES				NO	7	0	true	No	N0	T3b	TCGA-XK-AAIW.A6E4263E-CFAA-4704-B143-095BA0E8DABF.pdf		AAIW	TUMOR FREE	5	Complete Remission/Response	0.09	NO	R1	Primary Tumor	01	4			NO		NO	YES	XK	Middle|Base		Prostate		A	LIVING	2011		7f94c422-c322-46d8-be7a-eab05ea534af	TCGA-XK-AAIW-01A-11D-A41J-01	TCGA-XK-AAIW-01A-11D-A41L-05		TCGA-XK-AAIW-01A-11D-A41K-08	7f94c422-c322-46d8-be7a-eab05ea534af	TCGA-XK-AAIW-01	TCGA-XK-AAIW-01		TCGA-XK-AAIW-01A-11D-A41J-01	7f94c422-c322-46d8-be7a-eab05ea534af	TCGA-XK-AAIW-01	TCGA-XK-AAIW-01			7f94c422-c322-46d8-be7a-eab05ea534af
TCGA-XK-AAJ3-01	0	TCGA-XK-AAJ3-01	1262	0	days	TCGA-XK-AAJ3	1262	0	days	1262	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			56	TCGA-XK-AAJ3-F66870	TCGA-XK-AAJ3	TCGA-XK-AAJ3-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-20604	13	1185		6			0	1262		863			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission		2014-10-24	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	20		NO	Bilateral		NO	YES				NO	6	0	true	Yes, History of Prior Malignancy	N0	T3a	TCGA-XK-AAJ3.6DAD48EB-0C26-4417-A2C1-57332165EEF2.pdf		AAJ3	TUMOR FREE	4	Complete Remission/Response	0.09	NO	R0	Primary Tumor	01	4			NO		NO	YES	XK	Apex|Middle|Base		Prostate		A	LIVING	2010		81674433-89de-4024-aadc-fd8fede17699	TCGA-XK-AAJ3-01A-11D-A41J-01	TCGA-XK-AAJ3-01A-11D-A41L-05		TCGA-XK-AAJ3-01A-11D-A41K-08	81674433-89de-4024-aadc-fd8fede17699	TCGA-XK-AAJ3-01			TCGA-XK-AAJ3-01A-11D-A41J-01	81674433-89de-4024-aadc-fd8fede17699	TCGA-XK-AAJ3-01				81674433-89de-4024-aadc-fd8fede17699
TCGA-XK-AAJA-01	0	TCGA-XK-AAJA-01	930	0	days	TCGA-XK-AAJA	930	0	days	930	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			62		TCGA-XK-AAJA		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-22771	15						0	930		712			NO		NO				2014-5-12	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral			YES				NO	7	0		No	N0	T3a			AAJA		4	Complete Remission/Response	0.09	NO	R0	Primary Tumor	01	3			NO		NO	YES	XK	Apex|Middle|Base		Prostate			LIVING	2010		ec7657a0-88da-482a-90d1-1fd03578e11b	TCGA-XK-AAJA-01A-11D-A41J-01	TCGA-XK-AAJA-01A-11D-A41L-05		TCGA-XK-AAJA-01A-11D-A41K-08	ec7657a0-88da-482a-90d1-1fd03578e11b	TCGA-XK-AAJA-01	TCGA-XK-AAJA-01		TCGA-XK-AAJA-01A-11D-A41J-01	ec7657a0-88da-482a-90d1-1fd03578e11b	TCGA-XK-AAJA-01	TCGA-XK-AAJA-01			ec7657a0-88da-482a-90d1-1fd03578e11b
TCGA-XK-AAJP-01	0	TCGA-XK-AAJP-01	1259	0	days	TCGA-XK-AAJP	1259	0	days	1259	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-XK-AAJP-F66882	TCGA-XK-AAJP		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-24320	18				18		0	1259		889			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Complete Remission/Response	2014-10-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Left		NO	YES				NO	6	0		No	N0	T3a			AAJP	TUMOR FREE	4	Complete Remission/Response	0.09	NO	R0	Primary Tumor	01	3			NO		NO	YES	XK	Middle|Base		Prostate			LIVING	2011	Peripheral Zone	b426dd0e-446d-4738-a608-beaa368920bf	TCGA-XK-AAJP-01A-11D-A41J-01	TCGA-XK-AAJP-01A-11D-A41L-05		TCGA-XK-AAJP-01A-11D-A41K-08	b426dd0e-446d-4738-a608-beaa368920bf	TCGA-XK-AAJP-01	TCGA-XK-AAJP-01		TCGA-XK-AAJP-01A-11D-A41J-01	b426dd0e-446d-4738-a608-beaa368920bf	TCGA-XK-AAJP-01	TCGA-XK-AAJP-01			b426dd0e-446d-4738-a608-beaa368920bf
TCGA-XK-AAJR-01	0	TCGA-XK-AAJR-01	1124	0	days	TCGA-XK-AAJR	1124	0	days	1124	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61	TCGA-XK-AAJR-F67901	TCGA-XK-AAJR	TCGA-XK-AAJR-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22643	12	776		10		131	0	1124		753			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-12	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	10		NO	Bilateral		NO	YES				NO	8	0	true	No	N0	T3a	TCGA-XK-AAJR.2FB129E0-B651-4F2F-96DA-B2CCECD4F432.pdf		AAJR	TUMOR FREE	4	Complete Remission/Response	0.09	NO	R0	Primary Tumor	01	3			NO	5	NO	YES	XK	Apex|Middle|Base		Prostate		A	LIVING	2011		15850809-45e4-400d-89c0-20d313f699cb	TCGA-XK-AAJR-01A-11D-A41J-01	TCGA-XK-AAJR-01A-11D-A41L-05		TCGA-XK-AAJR-01A-11D-A41K-08	15850809-45e4-400d-89c0-20d313f699cb	TCGA-XK-AAJR-01	TCGA-XK-AAJR-01		TCGA-XK-AAJR-01A-11D-A41J-01	15850809-45e4-400d-89c0-20d313f699cb	TCGA-XK-AAJR-01	TCGA-XK-AAJR-01			15850809-45e4-400d-89c0-20d313f699cb
TCGA-XK-AAJT-01	0	TCGA-XK-AAJT-01	1434	0	days	TCGA-XK-AAJT	1434	0	days	1434	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			75	TCGA-XK-AAJT-F66883	TCGA-XK-AAJT	TCGA-XK-AAJT-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-27428	19	1135		14			0	1434		566			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-10-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	10		NO	Bilateral		NO	YES				NO	4	0	true	No	N0	T3a	TCGA-XK-AAJT.7596C336-6BF6-4188-9C8B-90C0EC840911.pdf		AAJT	TUMOR FREE	4	Partial Remission/Response	0.09	NO	R1	Primary Tumor	01	3			NO	5	NO	YES	XK	Base		Prostate		A	LIVING	2010	Peripheral Zone	4caa2b59-1435-4e64-9cf5-1658b3e9c147	TCGA-XK-AAJT-01A-11D-A41J-01	TCGA-XK-AAJT-01A-11D-A41L-05		TCGA-XK-AAJT-01A-11D-A41K-08	4caa2b59-1435-4e64-9cf5-1658b3e9c147	TCGA-XK-AAJT-01	TCGA-XK-AAJT-01		TCGA-XK-AAJT-01A-11D-A41J-01	4caa2b59-1435-4e64-9cf5-1658b3e9c147	TCGA-XK-AAJT-01	TCGA-XK-AAJT-01			4caa2b59-1435-4e64-9cf5-1658b3e9c147
TCGA-XK-AAJU-01	0	TCGA-XK-AAJU-01	1576	0	days	TCGA-XK-AAJU	1576	0	days	1576	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			65	TCGA-XK-AAJU-F66884	TCGA-XK-AAJU	TCGA-XK-AAJU-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-23958	9	1276					0	1576		1206			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-10-24	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	130		NO	Bilateral		NO	YES				NO	5	0	true	No	N0	T2c	TCGA-XK-AAJU.08C5834B-E57D-4182-86DE-4B83314D6799.pdf		AAJU	TUMOR FREE	4	Complete Remission/Response	0.09	NO	R0	Primary Tumor	01	3			NO		NO	YES	XK	Apex|Middle|Base		Prostate		A	LIVING	2010		45f7bba9-5bf4-4b9c-b749-996e4b8d5582	TCGA-XK-AAJU-01A-11D-A41J-01	TCGA-XK-AAJU-01A-11D-A41L-05		TCGA-XK-AAJU-01A-11D-A41K-08	45f7bba9-5bf4-4b9c-b749-996e4b8d5582	TCGA-XK-AAJU-01	TCGA-XK-AAJU-01		TCGA-XK-AAJU-01A-11D-A41J-01	45f7bba9-5bf4-4b9c-b749-996e4b8d5582	TCGA-XK-AAJU-01	TCGA-XK-AAJU-01			45f7bba9-5bf4-4b9c-b749-996e4b8d5582
TCGA-XK-AAK1-01	0	TCGA-XK-AAK1-01	979	0	days	TCGA-XK-AAK1	979	0	days	979	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			62	TCGA-XK-AAK1-F68316	TCGA-XK-AAK1		NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-22965	-2						0	979		614			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-14	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	6	0		Yes, History of Prior Malignancy	N0	T2c			AAK1	TUMOR FREE	4	Complete Remission/Response	0.09	NO	R0	Primary Tumor	01	3			NO		NO	YES	XK	Apex|Middle|Base		Prostate			LIVING	2012		ec4f5770-275f-494f-af91-b82e62f19f1a	TCGA-XK-AAK1-01A-11D-A41J-01	TCGA-XK-AAK1-01A-11D-A41L-05		TCGA-XK-AAK1-01A-11D-A41K-08	ec4f5770-275f-494f-af91-b82e62f19f1a	TCGA-XK-AAK1-01			TCGA-XK-AAK1-01A-11D-A41J-01	ec4f5770-275f-494f-af91-b82e62f19f1a	TCGA-XK-AAK1-01				ec4f5770-275f-494f-af91-b82e62f19f1a
TCGA-XQ-A8TA-01	1	TCGA-XQ-A8TA-01	146	1	days	TCGA-XQ-A8TA	146	0	days	146	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			59	TCGA-XQ-A8TA-F69992	TCGA-XQ-A8TA		YES	Prostate Cancer Metastases Present [cM1b]	M1b	T3a	-21889			146		-10		0			62			YES	Distant Metastasis [e.g. cM1]	YES	Distant Metastasis [e.g. cM1]	Scheduled Follow-up Submission	Progressive Disease	2015-1-26	MALE	10	Prostate Adenocarcinoma Acinar Type	Yes, Pharmaceutical Treatment Prior to Resection	C61	8140/3	C61.9	YES	Transurethral resection (TURBT)				Bilateral		NO					NO				No				Prostate Cancer	A8TA	WITH TUMOR	5	Progressive Disease	323.0	NO		Primary Tumor	01	5		Medical Record	YES				XQ		YES	Prostate	Distant Metastasis		DECEASED	2012	Peripheral Zone	ae50d91a-35e2-4b18-8089-b18844a63b5e	TCGA-XQ-A8TA-01A-11D-A363-01	TCGA-XQ-A8TA-01A-11D-A365-05		TCGA-XQ-A8TA-01A-11D-A364-08	ae50d91a-35e2-4b18-8089-b18844a63b5e	TCGA-XQ-A8TA-01	TCGA-XQ-A8TA-01		TCGA-XQ-A8TA-01A-11D-A363-01	ae50d91a-35e2-4b18-8089-b18844a63b5e	TCGA-XQ-A8TA-01	TCGA-XQ-A8TA-01		TCGA-XQ-A8TA-01A-11D-A364-08	ae50d91a-35e2-4b18-8089-b18844a63b5e
TCGA-XQ-A8TB-01	0	TCGA-XQ-A8TB-01	770	0	days	TCGA-XQ-A8TB	770	0	days	770	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			67	TCGA-XQ-A8TB-F69995	TCGA-XQ-A8TB		NO	Abnormal (not related to prostate cancer)	M0	T2a	-24623	-24						0	770		674			NO		NO			Complete Remission/Response	2015-1-26	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES				NO	4	0		No	N0	T3b			A8TB	TUMOR FREE	4	Complete Remission/Response	0.0	YES	R1	Primary Tumor	01	5			NO				XQ	Apex|Middle|Base		Prostate			LIVING	2012	Peripheral Zone	ad733fd8-9c1f-4552-88de-3bc50ec1a9ac	TCGA-XQ-A8TB-01A-11D-A363-01	TCGA-XQ-A8TB-01A-11D-A365-05		TCGA-XQ-A8TB-01A-11D-A364-08	ad733fd8-9c1f-4552-88de-3bc50ec1a9ac	TCGA-XQ-A8TB-01	TCGA-XQ-A8TB-01		TCGA-XQ-A8TB-01A-11D-A363-01	ad733fd8-9c1f-4552-88de-3bc50ec1a9ac	TCGA-XQ-A8TB-01	TCGA-XQ-A8TB-01		TCGA-XQ-A8TB-01A-11D-A364-08	ad733fd8-9c1f-4552-88de-3bc50ec1a9ac
TCGA-Y6-A8TL-01	0	TCGA-Y6-A8TL-01	992	0	days	TCGA-Y6-A8TL	992	0	days	992	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			65	TCGA-Y6-A8TL-F68020	TCGA-Y6-A8TL	TCGA-Y6-A8TL-01A	NO			T2a	-23776		677		328			0	992		775			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-13	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	370		NO	Right		NO	YES				NO	5	0	true	No	N0	T3a	TCGA-Y6-A8TL.8DE4AB1E-913E-4763-81EE-272430E5CC4A.pdf		A8TL	TUMOR FREE	3		0	NO	R0	Primary Tumor	01	3			NO		NO	YES	Y6	Apex		Prostate		A	LIVING	2012	Peripheral Zone	baeaec83-29cf-4fcd-b6b4-6054510d9d86	TCGA-Y6-A8TL-01A-21D-A376-01	TCGA-Y6-A8TL-01A-21D-A378-05		TCGA-Y6-A8TL-01A-21D-A377-08	baeaec83-29cf-4fcd-b6b4-6054510d9d86	TCGA-Y6-A8TL-01	TCGA-Y6-A8TL-01	316A3F78-1775-436F-94F1-F0031123CEAE	TCGA-Y6-A8TL-01A-21D-A376-01	baeaec83-29cf-4fcd-b6b4-6054510d9d86	TCGA-Y6-A8TL-01	TCGA-Y6-A8TL-01		TCGA-Y6-A8TL-01A-21D-A377-08	baeaec83-29cf-4fcd-b6b4-6054510d9d86
TCGA-Y6-A9XI-01	0	TCGA-Y6-A9XI-01	526	0	days	TCGA-Y6-A9XI	526	0	days	526	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			72	TCGA-Y6-A9XI-F68012	TCGA-Y6-A9XI	TCGA-Y6-A9XI-01A	NO				-26471		413					0	526		519			NO		NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-12-1	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	210		NO	Bilateral		NO	YES				NO	4	0	true	No	N0	[Discrepancy]	TCGA-Y6-A9XI.FA6B58B3-B9C2-437D-9041-B0179F1386ED.pdf		A9XI	TUMOR FREE	4	Complete Remission/Response	0.06	NO	R1	Primary Tumor	01	4			NO		NO	YES	Y6	Apex		Prostate		A	LIVING	2012	Peripheral Zone	20e1a03e-b18b-41ed-aaf4-95a5aefb4fbf	TCGA-Y6-A9XI-01A-11D-A41J-01	TCGA-Y6-A9XI-01A-11D-A41L-05		TCGA-Y6-A9XI-01A-11D-A41K-08	20e1a03e-b18b-41ed-aaf4-95a5aefb4fbf	TCGA-Y6-A9XI-01	TCGA-Y6-A9XI-01	BC7C4D91-B5A0-4C7F-81BC-A23494859232	TCGA-Y6-A9XI-01A-11D-A41J-01	20e1a03e-b18b-41ed-aaf4-95a5aefb4fbf	TCGA-Y6-A9XI-01	TCGA-Y6-A9XI-01			20e1a03e-b18b-41ed-aaf4-95a5aefb4fbf
TCGA-YJ-A8SW-01	0	TCGA-YJ-A8SW-01	148	0	days	TCGA-YJ-A8SW			days	148	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			67		TCGA-YJ-A8SW	TCGA-YJ-A8SW-01A	YES			T1c			2051				148	0	148		148									2014-5-13	MALE	9	Prostate Adenocarcinoma, Other Subtype	No	C61.9	8480/3	C61.9	YES	Core needle biopsy	1000		NO	Right			YES					2	0	true	No	N0	T3b	TCGA-YJ-A8SW.33D6587B-0289-49B5-9D16-497B6C17EFD9.pdf		A8SW		5		0.38		R1	Primary Tumor	01	4					NO	YES	YJ			Prostate		A	LIVING	2008		6fc325bf-9627-45d7-9081-28df74e79bdb	TCGA-YJ-A8SW-01A-11D-A376-01	TCGA-YJ-A8SW-01A-11D-A378-05		TCGA-YJ-A8SW-01A-11D-A377-08	6fc325bf-9627-45d7-9081-28df74e79bdb	TCGA-YJ-A8SW-01	TCGA-YJ-A8SW-01	64E65412-50A3-43A1-8853-E0BFC8D5DB06	TCGA-YJ-A8SW-01A-11D-A376-01	6fc325bf-9627-45d7-9081-28df74e79bdb	TCGA-YJ-A8SW-01	TCGA-YJ-A8SW-01		TCGA-YJ-A8SW-01A-11D-A377-08	6fc325bf-9627-45d7-9081-28df74e79bdb
TCGA-YL-A8HJ-01	0	TCGA-YL-A8HJ-01	1611	0	days	TCGA-YL-A8HJ	1611	0	days	1611	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			58	TCGA-YL-A8HJ-F67253	TCGA-YL-A8HJ	TCGA-YL-A8HJ-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-21416	54	1653		-34			0	1611		1589			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-3	MALE	9	Prostate Adenocarcinoma, Other Subtype	No	C61	8140/3	C61.9	YES	Core needle biopsy	370		NO	Bilateral		NO	NO				NO			true	No		T3b	TCGA-YL-A8HJ.A4B8AFC5-774E-4FB2-8191-735949EC3E42.pdf		A8HJ	TUMOR FREE	4	Complete Remission/Response	0.03	YES	R0	Primary Tumor	01	5			YES	3	NO	YES	YL	Apex|Middle|Base		Prostate		A	LIVING	2009	Overlapping / Multiple Zones	de7d6e8a-7408-4011-be1a-52e3cc9fa61b	TCGA-YL-A8HJ-01A-11D-A363-01	TCGA-YL-A8HJ-01A-11D-A365-05		TCGA-YL-A8HJ-01A-11D-A364-08	de7d6e8a-7408-4011-be1a-52e3cc9fa61b	TCGA-YL-A8HJ-01	TCGA-YL-A8HJ-01	760FF949-8735-411A-B53C-371FDA18CB60	TCGA-YL-A8HJ-01A-11D-A363-01	de7d6e8a-7408-4011-be1a-52e3cc9fa61b	TCGA-YL-A8HJ-01	TCGA-YL-A8HJ-01		TCGA-YL-A8HJ-01A-11D-A364-08	de7d6e8a-7408-4011-be1a-52e3cc9fa61b
TCGA-YL-A8HK-01	0	TCGA-YL-A8HK-01	1491	0	days	TCGA-YL-A8HK	1376	1	days	1491	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			59	TCGA-YL-A8HK-F56601	TCGA-YL-A8HK	TCGA-YL-A8HK-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0		-21850	27	1477		195		1376	0	1491	1376	1491			YES	No Evidence of Extraprostatic Extension	NO		Additional New Tumor Event		2014-3-13	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	140		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	1	0	true	No	N0	T3b	TCGA-YL-A8HK.AB7217AC-ABF7-4704-9413-9298DDE688EE.pdf		A8HK	WITH TUMOR	4	Complete Remission/Response	1.0	YES	R1	Primary Tumor	01	5			YES		NO	YES	YL	Apex|Middle|Base		Prostate		A	LIVING	2009	Overlapping / Multiple Zones	8697017a-b4d9-4f19-8887-168e80124ebd	TCGA-YL-A8HK-01A-11D-A363-01	TCGA-YL-A8HK-01A-11D-A365-05		TCGA-YL-A8HK-01A-11D-A364-08	8697017a-b4d9-4f19-8887-168e80124ebd	TCGA-YL-A8HK-01	TCGA-YL-A8HK-01	B61841FE-2C11-4DC3-9426-E1029351F7C0	TCGA-YL-A8HK-01A-11D-A363-01	8697017a-b4d9-4f19-8887-168e80124ebd	TCGA-YL-A8HK-01	TCGA-YL-A8HK-01		TCGA-YL-A8HK-01A-11D-A364-08	8697017a-b4d9-4f19-8887-168e80124ebd
TCGA-YL-A8HL-01	0	TCGA-YL-A8HL-01	1565	0	days	TCGA-YL-A8HL	1565	0	days	1565	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			58	TCGA-YL-A8HL-F67258	TCGA-YL-A8HL	TCGA-YL-A8HL-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-21249	25	1387		27			0	1565		1173			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Stable Disease	2014-11-3	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	170		NO	Bilateral		NO	YES				NO	8	2	true	No	N1	T3b	TCGA-YL-A8HL.0C91388C-CCC6-4BBD-B13A-E543A8FC2E5F.pdf		A8HL		4	Stable Disease	0.03	YES	R1	Primary Tumor	01	5			YES		NO	YES	YL	Apex|Middle|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones	c291389a-1dfd-4eef-9542-7269a8bd797a	TCGA-YL-A8HL-01A-11D-A363-01	TCGA-YL-A8HL-01A-11D-A365-05		TCGA-YL-A8HL-01A-11D-A364-08	c291389a-1dfd-4eef-9542-7269a8bd797a	TCGA-YL-A8HL-01	TCGA-YL-A8HL-01	9C580829-CF49-4346-9F40-B94334C0C2B0	TCGA-YL-A8HL-01A-11D-A363-01	c291389a-1dfd-4eef-9542-7269a8bd797a	TCGA-YL-A8HL-01	TCGA-YL-A8HL-01		TCGA-YL-A8HL-01A-11D-A364-08	c291389a-1dfd-4eef-9542-7269a8bd797a
TCGA-YL-A8HM-01	0	TCGA-YL-A8HM-01	1482	0	days	TCGA-YL-A8HM	1473	1	days	1482	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-YL-A8HM-F67260	TCGA-YL-A8HM	TCGA-YL-A8HM-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-24121	26	1323				1473	0	1482	1473	1124			NO		NO		Additional New Tumor Event		2014-11-3	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	160		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	10	0	true	No	N0	T3b	TCGA-YL-A8HM.4CDB8D1D-D1F1-4A78-A0C0-CA56CBC0689C.pdf		A8HM	WITH TUMOR	4	Complete Remission/Response	0.03	YES	R0	Primary Tumor	01	5			YES		NO	YES	YL	Apex|Middle|Base	YES	Prostate	Biochemical Recurrence	A	LIVING	2010	Overlapping / Multiple Zones	49e0744c-4f4c-4cac-bc4e-2a11f1cf6a45	TCGA-YL-A8HM-01A-11D-A363-01	TCGA-YL-A8HM-01A-11D-A365-05		TCGA-YL-A8HM-01A-11D-A364-08	49e0744c-4f4c-4cac-bc4e-2a11f1cf6a45	TCGA-YL-A8HM-01	TCGA-YL-A8HM-01	C2CF4E4E-85B5-42C6-AF19-AB61018CD23C	TCGA-YL-A8HM-01A-11D-A363-01	49e0744c-4f4c-4cac-bc4e-2a11f1cf6a45	TCGA-YL-A8HM-01	TCGA-YL-A8HM-01		TCGA-YL-A8HM-01A-11D-A364-08	49e0744c-4f4c-4cac-bc4e-2a11f1cf6a45
TCGA-YL-A8HO-01	0	TCGA-YL-A8HO-01	2304	0	days	TCGA-YL-A8HO	1068	1	days	2304	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	YES	67	TCGA-YL-A8HO-F67262	TCGA-YL-A8HO	TCGA-YL-A8HO-01A	NO	Abnormal (not related to prostate cancer)	M0		-24509	62	2100		117		1068	0	2304	1068	2168			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Stable Disease	2014-11-3	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	330		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	18	0	true	No	N0	T3a	TCGA-YL-A8HO.3C690B20-F9EC-456D-B397-928E39B3FFE2.pdf		A8HO	WITH TUMOR	4	Stable Disease	0.01	NO	R1	Primary Tumor	01	3			NO	5	NO	YES	YL	Middle|Base		Prostate		A	LIVING	2008	Overlapping / Multiple Zones	35e62a79-9fa0-4ff9-a8c3-d163817d7f08	TCGA-YL-A8HO-01A-11D-A363-01	TCGA-YL-A8HO-01A-11D-A365-05		TCGA-YL-A8HO-01A-11D-A364-08	35e62a79-9fa0-4ff9-a8c3-d163817d7f08	TCGA-YL-A8HO-01	TCGA-YL-A8HO-01	FF75F68F-2BCF-4801-A541-FCA9EAB9EEA4	TCGA-YL-A8HO-01A-11D-A363-01	35e62a79-9fa0-4ff9-a8c3-d163817d7f08	TCGA-YL-A8HO-01	TCGA-YL-A8HO-01		TCGA-YL-A8HO-01A-11D-A364-08	35e62a79-9fa0-4ff9-a8c3-d163817d7f08
TCGA-YL-A8S8-01	0	TCGA-YL-A8S8-01	1890	0	days	TCGA-YL-A8S8	679	1	days	1890	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	YES	68	TCGA-YL-A8S8-F58862	TCGA-YL-A8S8	TCGA-YL-A8S8-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0		-25119	18	2146		28		679	0	1890	679	1890			YES	No Evidence of Extraprostatic Extension	NO		Additional New Tumor Event	Progressive Disease	2014-4-25	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	130		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	10	0	true	No	N0	T3a	TCGA-YL-A8S8.6D4A3078-4C6B-4E94-B859-CCA473B09CF9.pdf		A8S8	WITH TUMOR	4	Stable Disease	1.36	NO	R1	Primary Tumor	01	5			NO		NO	YES	YL	Apex|Middle|Base		Prostate		A	LIVING	2008	Overlapping / Multiple Zones	8a1e40cc-f9be-4df4-9958-53c97d7fd794	TCGA-YL-A8S8-01A-11D-A376-01	TCGA-YL-A8S8-01A-11D-A378-05		TCGA-YL-A8S8-01A-11D-A377-08	8a1e40cc-f9be-4df4-9958-53c97d7fd794	TCGA-YL-A8S8-01	TCGA-YL-A8S8-01	4F6FED0C-A461-4100-8C47-9A3C2A35F49B	TCGA-YL-A8S8-01A-11D-A376-01	8a1e40cc-f9be-4df4-9958-53c97d7fd794	TCGA-YL-A8S8-01	TCGA-YL-A8S8-01		TCGA-YL-A8S8-01A-11D-A377-08	8a1e40cc-f9be-4df4-9958-53c97d7fd794
TCGA-YL-A8S9-01	0	TCGA-YL-A8S9-01	1842	0	days	TCGA-YL-A8S9	1006	1	days	1842	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	YES	63	TCGA-YL-A8S9-F58868	TCGA-YL-A8S9	TCGA-YL-A8S9-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-23204	20	1891					0	1842	1006	1839			NO		NO		Additional New Tumor Event	Complete Remission/Response	2014-4-25	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	110		NO	Bilateral		NO	YES		Locoregional Recurrence		YES	5	0	true	No	N0	T3a	TCGA-YL-A8S9.7E33F018-6494-413F-A68D-AC4013916756.pdf		A8S9		4	Stable Disease	0.03	NO	R1	Primary Tumor	01	5			NO	3	NO	YES	YL	Apex|Middle		Prostate		A	LIVING	2008	Overlapping / Multiple Zones	ada9616f-c9d1-46cd-bccc-29d2e4e0d1ea	TCGA-YL-A8S9-01A-11D-A376-01	TCGA-YL-A8S9-01A-11D-A378-05		TCGA-YL-A8S9-01A-11D-A377-08	ada9616f-c9d1-46cd-bccc-29d2e4e0d1ea	TCGA-YL-A8S9-01	TCGA-YL-A8S9-01	63BEAF58-7656-4FE0-9DF3-E6A28DF3B6DF	TCGA-YL-A8S9-01A-11D-A376-01	ada9616f-c9d1-46cd-bccc-29d2e4e0d1ea	TCGA-YL-A8S9-01	TCGA-YL-A8S9-01		TCGA-YL-A8S9-01A-11D-A377-08	ada9616f-c9d1-46cd-bccc-29d2e4e0d1ea
TCGA-YL-A8SA-01	0	TCGA-YL-A8SA-01	512	0	days	TCGA-YL-A8SA	512	0	days	512	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			69	TCGA-YL-A8SA-F67565	TCGA-YL-A8SA	TCGA-YL-A8SA-01A	NO		M0	T2b	-25340		1465					0	512		467			NO		NO		Scheduled Follow-up Submission		2014-11-6	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	200		NO	Bilateral		YES	YES				NO	9	0	true	No	N0	T3b	TCGA-YL-A8SA.F837EF53-FF44-4F51-8764-27B00168B113.pdf		A8SA		4	Stable Disease	0.06	YES	R1	Primary Tumor	01	4			NO	5	NO	YES	YL	Apex|Middle|Base		Prostate		A	LIVING	2009	Overlapping / Multiple Zones	42b3e255-38df-41f7-a4b8-77510d467dd2	TCGA-YL-A8SA-01A-21D-A376-01	TCGA-YL-A8SA-01A-21D-A378-05		TCGA-YL-A8SA-01A-21D-A377-08	42b3e255-38df-41f7-a4b8-77510d467dd2	TCGA-YL-A8SA-01	TCGA-YL-A8SA-01	B73AC452-1030-4998-80D4-95AE09266783	TCGA-YL-A8SA-01A-21D-A376-01	42b3e255-38df-41f7-a4b8-77510d467dd2	TCGA-YL-A8SA-01	TCGA-YL-A8SA-01		TCGA-YL-A8SA-01A-21D-A377-08	42b3e255-38df-41f7-a4b8-77510d467dd2
TCGA-YL-A8SB-01	0	TCGA-YL-A8SB-01	1719	0	days	TCGA-YL-A8SB	1384	1	days	1719	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	NO	62	TCGA-YL-A8SB-F67264	TCGA-YL-A8SB		NO	Normal (no evidence of prostate cancer) [cM0]	M0		-22991	27			52		1384	0	1719	1384	1384			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission		2014-11-3	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral		NO	YES		Biochemical evidence of disease		YES	3	0		No	N0	T3a			A8SB	WITH TUMOR	4	Stable Disease	0.23	YES	R1	Primary Tumor	01	5			YES		NO	YES	YL	Apex|Middle|Base	YES	Prostate	Biochemical Recurrence		LIVING	2010	Overlapping / Multiple Zones	d593d47e-581a-4da3-bb3a-648b2bfb4cae	TCGA-YL-A8SB-01A-31D-A376-01	TCGA-YL-A8SB-01A-31D-A378-05		TCGA-YL-A8SB-01A-31D-A377-08	d593d47e-581a-4da3-bb3a-648b2bfb4cae	TCGA-YL-A8SB-01	TCGA-YL-A8SB-01		TCGA-YL-A8SB-01A-31D-A376-01	d593d47e-581a-4da3-bb3a-648b2bfb4cae	TCGA-YL-A8SB-01	TCGA-YL-A8SB-01		TCGA-YL-A8SB-01A-31D-A377-08	d593d47e-581a-4da3-bb3a-648b2bfb4cae
TCGA-YL-A8SC-01	0	TCGA-YL-A8SC-01	1261	0	days	TCGA-YL-A8SC	152	1	days	1261	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-YL-A8SC-F58906	TCGA-YL-A8SC	TCGA-YL-A8SC-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-24206	40	1387		47		152	0	1261	152	1261			YES	No Evidence of Extraprostatic Extension	NO		Additional New Tumor Event	Partial Remission/Response	2014-4-27	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	100		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	6	0	true	No	N0	T3a	TCGA-YL-A8SC.557F4A89-87FC-44FA-9460-F8D1BCA759AE.pdf		A8SC	WITH TUMOR	4	Partial Remission/Response	0.65	NO	R1	Primary Tumor	01	5			YES		NO	YES	YL	Apex|Middle|Base	YES	Prostate	Biochemical Recurrence	A	LIVING	2010	Overlapping / Multiple Zones	cc9dfa83-d316-4455-bd08-967fb33a54ff	TCGA-YL-A8SC-01A-11D-A376-01	TCGA-YL-A8SC-01A-11D-A378-05		TCGA-YL-A8SC-01A-11D-A377-08	cc9dfa83-d316-4455-bd08-967fb33a54ff	TCGA-YL-A8SC-01	TCGA-YL-A8SC-01	5B646A8D-2B8F-42CC-B54B-2E5D1DAB2B51	TCGA-YL-A8SC-01A-11D-A376-01	cc9dfa83-d316-4455-bd08-967fb33a54ff	TCGA-YL-A8SC-01	TCGA-YL-A8SC-01		TCGA-YL-A8SC-01A-11D-A377-08	cc9dfa83-d316-4455-bd08-967fb33a54ff
TCGA-YL-A8SF-01	0	TCGA-YL-A8SF-01	1373	0	days	TCGA-YL-A8SF	1373	0	days	1373	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			62	TCGA-YL-A8SF-F67270	TCGA-YL-A8SF	TCGA-YL-A8SF-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-22844	29	1271		22			0	1373		1247			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Stable Disease	2014-11-3	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	520		NO	Bilateral		NO	YES				NO	2	0	true	No	N0	T3b	TCGA-YL-A8SF.9E568211-305B-4F23-8B31-59D80E0EE174.pdf		A8SF		4	Stable Disease	0.01	NO	R1	Primary Tumor	01	4			NO	5	NO	YES	YL	Apex|Middle|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones	bac074d2-4e5b-4450-baee-749fc4a93c7a	TCGA-YL-A8SF-01A-11D-A376-01	TCGA-YL-A8SF-01A-11D-A378-05		TCGA-YL-A8SF-01A-11D-A377-08	bac074d2-4e5b-4450-baee-749fc4a93c7a	TCGA-YL-A8SF-01	TCGA-YL-A8SF-01	E9B96DB5-B4B4-443D-9745-33D8779C2A5A	TCGA-YL-A8SF-01A-11D-A376-01	bac074d2-4e5b-4450-baee-749fc4a93c7a	TCGA-YL-A8SF-01	TCGA-YL-A8SF-01		TCGA-YL-A8SF-01A-11D-A377-08	bac074d2-4e5b-4450-baee-749fc4a93c7a
TCGA-YL-A8SH-01	1	TCGA-YL-A8SH-01	875	1	days	TCGA-YL-A8SH	875	0	days	875	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			69		TCGA-YL-A8SH	TCGA-YL-A8SH-01B	NO		M0		-25395		1481	875				0			617			NO		NO				2014-4-25	MALE	7	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	510		NO	Bilateral			YES				NO	21	0	true	No	N0	T3a	TCGA-YL-A8SH.62FF9B6A-9C3E-4E29-9D57-10CC2025C5B7.pdf	Other, non-malignant disease	A8SH	TUMOR FREE	4	Complete Remission/Response	0.06	NO	R0	Primary Tumor	01	3		Death Certificate	NO		NO	YES	YL	Apex|Middle|Base		Prostate		B	DECEASED	2009	Overlapping / Multiple Zones	905e6c11-d8d7-40a3-a933-f450c544714e	TCGA-YL-A8SH-01B-11D-A376-01	TCGA-YL-A8SH-01B-11D-A378-05		TCGA-YL-A8SH-01B-11D-A377-08	905e6c11-d8d7-40a3-a933-f450c544714e	TCGA-YL-A8SH-01	TCGA-YL-A8SH-01	3F15A275-B61C-4E93-8ECF-B41F9867B3DC	TCGA-YL-A8SH-01B-11D-A376-01	905e6c11-d8d7-40a3-a933-f450c544714e	TCGA-YL-A8SH-01	TCGA-YL-A8SH-01		TCGA-YL-A8SH-01B-11D-A377-08	905e6c11-d8d7-40a3-a933-f450c544714e
TCGA-YL-A8SI-01	0	TCGA-YL-A8SI-01	1614	0	days	TCGA-YL-A8SI	1423	1	days	1614	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	YES	69	TCGA-YL-A8SI-F67703	TCGA-YL-A8SI	TCGA-YL-A8SI-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-25292	47	1345		62		1423	0	1614	1423	1441			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-10	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	390		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	15	0	true	No	N0	T3a	TCGA-YL-A8SI.30B3AC4A-A7B0-4257-BFEB-15AD2F66ADAE.pdf		A8SI	TUMOR FREE	4	Complete Remission/Response	0.48	NO	R0	Primary Tumor	01	5			NO		NO	YES	YL	Apex|Middle|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones	968c1021-d6c1-4e0e-8417-43b78a6bdf6d	TCGA-YL-A8SI-01A-11D-A41J-01	TCGA-YL-A8SI-01A-11D-A41L-05		TCGA-YL-A8SI-01A-11D-A41K-08	968c1021-d6c1-4e0e-8417-43b78a6bdf6d	TCGA-YL-A8SI-01	TCGA-YL-A8SI-01	1B7F9946-3F8D-4B06-A2E0-2DF917E6DA05	TCGA-YL-A8SI-01A-11D-A41J-01	968c1021-d6c1-4e0e-8417-43b78a6bdf6d	TCGA-YL-A8SI-01	TCGA-YL-A8SI-01			968c1021-d6c1-4e0e-8417-43b78a6bdf6d
TCGA-YL-A8SJ-01	0	TCGA-YL-A8SJ-01	1395	0	days	TCGA-YL-A8SJ	752	1	days	1395	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	YES	60	TCGA-YL-A8SJ-F58899	TCGA-YL-A8SJ	TCGA-YL-A8SJ-01B	YES		M0		-21916		1306				752	0	1395	752	1426			NO		NO		Additional New Tumor Event	Partial Remission/Response	2014-4-25	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	460		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	29	0	true	No	N0	T3b	TCGA-YL-A8SJ.86F65B00-7E83-4013-85E8-A4AE42686ACF.pdf		A8SJ	WITH TUMOR	4	Complete Remission/Response	0.24	NO	R0	Primary Tumor	01	5			NO		NO	YES	YL	Middle|Base		Prostate		B	LIVING	2010	Overlapping / Multiple Zones	146b24ab-44b3-4b64-80c2-7ced0f829501	TCGA-YL-A8SJ-01B-11D-A376-01	TCGA-YL-A8SJ-01B-11D-A378-05		TCGA-YL-A8SJ-01B-11D-A377-08	146b24ab-44b3-4b64-80c2-7ced0f829501	TCGA-YL-A8SJ-01	TCGA-YL-A8SJ-01	97C40C9F-600A-42BC-8163-A7AE095DCB85	TCGA-YL-A8SJ-01B-11D-A376-01	146b24ab-44b3-4b64-80c2-7ced0f829501	TCGA-YL-A8SJ-01	TCGA-YL-A8SJ-01		TCGA-YL-A8SJ-01B-11D-A377-08	146b24ab-44b3-4b64-80c2-7ced0f829501
TCGA-YL-A8SK-01	0	TCGA-YL-A8SK-01	1408	0	days	TCGA-YL-A8SK	1408	0	days	1408	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			67	TCGA-YL-A8SK-F67551	TCGA-YL-A8SK	TCGA-YL-A8SK-01B	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-24759	38	1208					0	1408		924			NO		NO		Scheduled Follow-up Submission	Stable Disease	2014-11-6	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	410		NO	Bilateral		NO	YES				NO	20	4	true	No	N1	T3b	TCGA-YL-A8SK.F332F5AD-A0BE-455D-9523-13BDF275DB2A.pdf		A8SK		4	Stable Disease	0.03	YES	R1	Primary Tumor	01	5			YES		NO	YES	YL	Apex|Middle|Base		Prostate		B	LIVING	2010	Overlapping / Multiple Zones	530578d1-044b-4423-bd9c-ae80a2d7fda1	TCGA-YL-A8SK-01B-21D-A376-01	TCGA-YL-A8SK-01B-21D-A378-05		TCGA-YL-A8SK-01B-21D-A377-08	530578d1-044b-4423-bd9c-ae80a2d7fda1	TCGA-YL-A8SK-01	TCGA-YL-A8SK-01	EAFB0B83-81C8-4243-9CB4-E1D7EDB895DF	TCGA-YL-A8SK-01B-21D-A376-01	530578d1-044b-4423-bd9c-ae80a2d7fda1	TCGA-YL-A8SK-01	TCGA-YL-A8SK-01		TCGA-YL-A8SK-01B-21D-A377-08	530578d1-044b-4423-bd9c-ae80a2d7fda1
TCGA-YL-A8SL-01	0	TCGA-YL-A8SL-01	987	0	days	TCGA-YL-A8SL	987	0	days	987	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			74	TCGA-YL-A8SL-F67548	TCGA-YL-A8SL	TCGA-YL-A8SL-01B	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-27033	41	835		43			0	987		623			YES	Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1]	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-6	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	760		NO	Bilateral		NO	YES				NO	19	3	true	No	N1	T3b	TCGA-YL-A8SL.561D6EB5-1E61-4134-B6F6-96B1B9A27163.pdf		A8SL	TUMOR FREE	4	Complete Remission/Response	0	NO	R0	Primary Tumor	01	4			YES	3	NO	YES	YL	Apex|Middle|Base		Prostate		B	LIVING	2011	Overlapping / Multiple Zones	20f7a673-eb82-4bfc-a757-096b2fc3f98b	TCGA-YL-A8SL-01B-21D-A376-01	TCGA-YL-A8SL-01B-21D-A378-05		TCGA-YL-A8SL-01B-21D-A377-08	20f7a673-eb82-4bfc-a757-096b2fc3f98b	TCGA-YL-A8SL-01	TCGA-YL-A8SL-01	CEBD0D90-99F5-44B4-A778-DEA5C97562CD	TCGA-YL-A8SL-01B-21D-A376-01	20f7a673-eb82-4bfc-a757-096b2fc3f98b	TCGA-YL-A8SL-01	TCGA-YL-A8SL-01		TCGA-YL-A8SL-01B-21D-A377-08	20f7a673-eb82-4bfc-a757-096b2fc3f98b
TCGA-YL-A8SO-01	0	TCGA-YL-A8SO-01	3479	0	days	TCGA-YL-A8SO	3479	0	days	3479	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			64	TCGA-YL-A8SO-F67275	TCGA-YL-A8SO	TCGA-YL-A8SO-01B	NO		M0	T1a	-23584		3329					0	3479		3247							Scheduled Follow-up Submission	Stable Disease	2014-11-3	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Transurethral resection (TURBT)	1270		NO	Bilateral		NO	NO				NO			true	No		T3a	TCGA-YL-A8SO.3B555422-C4AD-4FCC-A241-34D33F0DE82B.pdf		A8SO		4	Stable Disease	0	NO	R1	Primary Tumor	01	5			YES		NO	YES	YL	Apex|Middle		Prostate		B	LIVING	2004	Overlapping / Multiple Zones	7471bd76-b32f-41a3-bf95-8752745a7e70	TCGA-YL-A8SO-01B-31D-A376-01	TCGA-YL-A8SO-01B-31D-A378-05		TCGA-YL-A8SO-01B-31D-A377-08	7471bd76-b32f-41a3-bf95-8752745a7e70	TCGA-YL-A8SO-01	TCGA-YL-A8SO-01		TCGA-YL-A8SO-01B-31D-A376-01	7471bd76-b32f-41a3-bf95-8752745a7e70	TCGA-YL-A8SO-01	TCGA-YL-A8SO-01		TCGA-YL-A8SO-01B-31D-A377-08	7471bd76-b32f-41a3-bf95-8752745a7e70
TCGA-YL-A8SP-01	0	TCGA-YL-A8SP-01	2366	0	days	TCGA-YL-A8SP	2366	0	days	2366	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			58	TCGA-YL-A8SP-F67706	TCGA-YL-A8SP	TCGA-YL-A8SP-01B	NO		M0	T2a	-21455		2125					0	2366		2155							Scheduled Follow-up Submission	Progressive Disease	2014-11-10	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	1680		NO	Bilateral		NO	NO				NO			true	No		T3b	TCGA-YL-A8SP.C2465F7D-3F73-4DB5-BD34-370978480408.pdf		A8SP	WITH TUMOR	4	Stable Disease	0.38	NO	R1	Primary Tumor	01	5			YES	3	NO	YES	YL	Apex|Middle|Base		Prostate		B	LIVING	2008	Overlapping / Multiple Zones	2974a881-8198-4c55-89b9-822b8f8c94b0	TCGA-YL-A8SP-01B-11D-A376-01	TCGA-YL-A8SP-01B-11D-A378-05		TCGA-YL-A8SP-01B-11D-A377-08	2974a881-8198-4c55-89b9-822b8f8c94b0	TCGA-YL-A8SP-01	TCGA-YL-A8SP-01	6310206D-974B-4AE4-BC59-E327773DB9C7	TCGA-YL-A8SP-01B-11D-A376-01	2974a881-8198-4c55-89b9-822b8f8c94b0	TCGA-YL-A8SP-01	TCGA-YL-A8SP-01		TCGA-YL-A8SP-01B-11D-A377-08	2974a881-8198-4c55-89b9-822b8f8c94b0
TCGA-YL-A8SQ-01	0	TCGA-YL-A8SQ-01	2083	0	days	TCGA-YL-A8SQ	329	1	days	2083	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	NO	61	TCGA-YL-A8SQ-F67567	TCGA-YL-A8SQ	TCGA-YL-A8SQ-01B	YES	Normal (no evidence of prostate cancer) [cM0]	M0		-22482	19	1898				329	0	2083	329	1943	1445		NO		NO		Scheduled Follow-up Submission	Stable Disease	2014-11-6	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	2630		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	5	0	true	No	N0	T3b	TCGA-YL-A8SQ.A714B71D-3E37-4C89-908B-1C1F0AA49DEA.pdf		A8SQ	WITH TUMOR	4	Stable Disease	1.1	NO	R1	Primary Tumor	01	5			NO	3	NO	YES	YL	Apex|Middle|Base		Prostate		B	LIVING	2008	Overlapping / Multiple Zones	8da55b3d-99f9-4ab4-8ee3-35bafb8d624f	TCGA-YL-A8SQ-01B-11D-A376-01	TCGA-YL-A8SQ-01B-11D-A378-05		TCGA-YL-A8SQ-01B-11D-A377-08	8da55b3d-99f9-4ab4-8ee3-35bafb8d624f	TCGA-YL-A8SQ-01	TCGA-YL-A8SQ-01	8C212508-7CF5-4305-AD25-80C5A92E9D5C	TCGA-YL-A8SQ-01B-11D-A376-01	8da55b3d-99f9-4ab4-8ee3-35bafb8d624f	TCGA-YL-A8SQ-01	TCGA-YL-A8SQ-01		TCGA-YL-A8SQ-01B-11D-A377-08	8da55b3d-99f9-4ab4-8ee3-35bafb8d624f
TCGA-YL-A8SR-01	0	TCGA-YL-A8SR-01	273	0	days	TCGA-YL-A8SR	273	0	days	273	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			64	TCGA-YL-A8SR-F67281	TCGA-YL-A8SR	TCGA-YL-A8SR-01B	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-23488	-1060	884		-1062			0	273		222			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission		2014-11-7	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	560		NO	Bilateral		YES	YES				NO	6	0	true	No	N0	T3a	TCGA-YL-A8SR.0E86A40B-1A40-494F-B3CC-603E2F96A03D.pdf		A8SR		4	Stable Disease	0.06	NO	R1	Primary Tumor	01	5			NO	3	NO	YES	YL	Apex|Middle|Base		Prostate		B	LIVING	2011	Overlapping / Multiple Zones	c3d6c3bb-8882-4033-855e-f164c03799cd	TCGA-YL-A8SR-01B-11D-A376-01	TCGA-YL-A8SR-01B-11D-A378-05		TCGA-YL-A8SR-01B-11D-A377-08	c3d6c3bb-8882-4033-855e-f164c03799cd	TCGA-YL-A8SR-01	TCGA-YL-A8SR-01	64900762-5159-4109-AA38-60CBD80422E6	TCGA-YL-A8SR-01B-11D-A376-01	c3d6c3bb-8882-4033-855e-f164c03799cd	TCGA-YL-A8SR-01	TCGA-YL-A8SR-01		TCGA-YL-A8SR-01B-11D-A377-08	c3d6c3bb-8882-4033-855e-f164c03799cd
TCGA-YL-A9WH-01	0	TCGA-YL-A9WH-01	427	0	days	TCGA-YL-A9WH	427	0	days	427	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			67	TCGA-YL-A9WH-F67282	TCGA-YL-A9WH		NO	Normal (no evidence of prostate cancer) [cM0]	M0		-24755	55						0	427		349			NO		NO		Scheduled Follow-up Submission	Stable Disease	2014-11-3	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy				Bilateral		YES	YES				NO	2	1		No	N1	T3b			A9WH		4	Stable Disease	0.03	YES	R1	Primary Tumor	01	5			YES		NO	YES	YL	Apex|Middle|Base		Prostate			LIVING	2011	Overlapping / Multiple Zones	abef0f85-b339-476f-bc5b-faded3ad6cf7	TCGA-YL-A9WH-01A-11D-A376-01	TCGA-YL-A9WH-01A-11D-A378-05		TCGA-YL-A9WH-01A-11D-A377-08	abef0f85-b339-476f-bc5b-faded3ad6cf7	TCGA-YL-A9WH-01	TCGA-YL-A9WH-01		TCGA-YL-A9WH-01A-11D-A376-01	abef0f85-b339-476f-bc5b-faded3ad6cf7	TCGA-YL-A9WH-01	TCGA-YL-A9WH-01		TCGA-YL-A9WH-01A-11D-A377-08	abef0f85-b339-476f-bc5b-faded3ad6cf7
TCGA-YL-A9WI-01	0	TCGA-YL-A9WI-01	1623	0	days	TCGA-YL-A9WI	1623	0	days	1623	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			63	TCGA-YL-A9WI-F67552	TCGA-YL-A9WI	TCGA-YL-A9WI-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0		-23184	93	1325		99			0	1623		1259			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Stable Disease	2014-11-6	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	680		NO	Bilateral		NO	YES				NO	15	1	true	No	N1	T3a	TCGA-YL-A9WI.746DB832-C507-4FD6-8B8A-09E6268BACC9.pdf		A9WI	TUMOR FREE	4	Stable Disease	0.03	NO	R0	Primary Tumor	01	5			NO		NO	YES	YL	Apex|Middle|Base		Prostate		A	LIVING	2010	Overlapping / Multiple Zones	2bb8de70-7555-4409-b667-c11b1fb716b5	TCGA-YL-A9WI-01A-11D-A376-01	TCGA-YL-A9WI-01A-11D-A378-05		TCGA-YL-A9WI-01A-11D-A377-08	2bb8de70-7555-4409-b667-c11b1fb716b5	TCGA-YL-A9WI-01	TCGA-YL-A9WI-01	38EDCB63-EA73-4A8D-A381-055C55747815	TCGA-YL-A9WI-01A-11D-A376-01	2bb8de70-7555-4409-b667-c11b1fb716b5	TCGA-YL-A9WI-01	TCGA-YL-A9WI-01		TCGA-YL-A9WI-01A-11D-A377-08	2bb8de70-7555-4409-b667-c11b1fb716b5
TCGA-YL-A9WJ-01	1	TCGA-YL-A9WJ-01	1855	1	days	TCGA-YL-A9WJ	1476	1	days	1855	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			47	TCGA-YL-A9WJ-F58534	TCGA-YL-A9WJ	TCGA-YL-A9WJ-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T4	-17322	19	2017	1855	21	51	76	0		1476	838			YES	No Evidence of Extraprostatic Extension	YES	Extraprostatic Extension Localized (e.g. seminal vesicles)			2014-4-14	MALE	8	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	360		NO	Bilateral		NO	YES	Other, specify	Distant Metastasis	Neck	YES	10	1	true	No	N1	T3b	TCGA-YL-A9WJ.EC025153-CB9C-4683-82B4-985AAA9E80AC.pdf	Prostate Cancer	A9WJ	WITH TUMOR	4	Partial Remission/Response	3.1	YES	R1	Primary Tumor	01	4		Medical Record		3	NO	YES	YL	Apex|Middle		Prostate		A	DECEASED	2008	Overlapping / Multiple Zones	79169be4-6386-4c36-9330-c56b6c9e6ebd	TCGA-YL-A9WJ-01A-11D-A376-01	TCGA-YL-A9WJ-01A-11D-A378-05		TCGA-YL-A9WJ-01A-11D-A377-08	79169be4-6386-4c36-9330-c56b6c9e6ebd	TCGA-YL-A9WJ-01	TCGA-YL-A9WJ-01	7E6633B5-FAEF-4ACE-A7EF-93EF26F436AC	TCGA-YL-A9WJ-01A-11D-A376-01	79169be4-6386-4c36-9330-c56b6c9e6ebd	TCGA-YL-A9WJ-01	TCGA-YL-A9WJ-01		TCGA-YL-A9WJ-01A-11D-A377-08	79169be4-6386-4c36-9330-c56b6c9e6ebd
TCGA-YL-A9WK-01	0	TCGA-YL-A9WK-01	2136	0	days	TCGA-YL-A9WK	1009	1	days	2136	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	YES	NO	63	TCGA-YL-A9WK-F67283	TCGA-YL-A9WK	TCGA-YL-A9WK-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-23272	329	1865				1009	0	2136	1009	1871	1687		NO		NO		Scheduled Follow-up Submission	Partial Remission/Response	2014-11-3	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	2085		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	1	0	true	No	N0	T3b	TCGA-YL-A9WK.B963A02D-0AE8-494C-A522-376AFABA374A.pdf		A9WK	WITH TUMOR	4	Stable Disease	15.6	NO	R1	Primary Tumor	01	5			YES		NO	YES	YL	Middle	YES	Prostate	Biochemical Recurrence	A	LIVING	2008	Overlapping / Multiple Zones	0da1e08f-d489-4579-a1ac-5cd79072ce9a	TCGA-YL-A9WK-01A-11D-A376-01	TCGA-YL-A9WK-01A-11D-A378-05		TCGA-YL-A9WK-01A-11D-A377-08	0da1e08f-d489-4579-a1ac-5cd79072ce9a	TCGA-YL-A9WK-01	TCGA-YL-A9WK-01	1D1D50EC-9802-4AE7-AEE9-6CDAE1506547	TCGA-YL-A9WK-01A-11D-A376-01	0da1e08f-d489-4579-a1ac-5cd79072ce9a	TCGA-YL-A9WK-01	TCGA-YL-A9WK-01			0da1e08f-d489-4579-a1ac-5cd79072ce9a
TCGA-YL-A9WL-01	0	TCGA-YL-A9WL-01	740	0	days	TCGA-YL-A9WL	740	1	days	740	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			59	TCGA-YL-A9WL-F58511	TCGA-YL-A9WL	TCGA-YL-A9WL-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-21626	28	755		39		740	0	740	740	740			YES	No Evidence of Extraprostatic Extension	NO		Additional New Tumor Event		2014-4-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	1300		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	15	0	true	No	N0	T3a	TCGA-YL-A9WL.F309E64F-E31C-478A-9F2B-B33AAD6BE37A.pdf		A9WL	WITH TUMOR	4	Complete Remission/Response	6.4	YES	R0	Primary Tumor	01	5			YES	3	NO	YES	YL	Apex|Middle|Base		Prostate		A	LIVING	2011	Overlapping / Multiple Zones	a63b38f7-5d53-4556-a7dc-4e6c3f75ec9b	TCGA-YL-A9WL-01A-11D-A41J-01	TCGA-YL-A9WL-01A-11D-A41L-05		TCGA-YL-A9WL-01A-11D-A41K-08	a63b38f7-5d53-4556-a7dc-4e6c3f75ec9b	TCGA-YL-A9WL-01	TCGA-YL-A9WL-01	B7FFE92B-1509-46A8-9BA7-DA462D3EF08E	TCGA-YL-A9WL-01A-11D-A41J-01	a63b38f7-5d53-4556-a7dc-4e6c3f75ec9b	TCGA-YL-A9WL-01	TCGA-YL-A9WL-01			a63b38f7-5d53-4556-a7dc-4e6c3f75ec9b
TCGA-YL-A9WX-01	0	TCGA-YL-A9WX-01	1518	0	days	TCGA-YL-A9WX	1506	1	days	1518	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			68	TCGA-YL-A9WX-F58515	TCGA-YL-A9WX	TCGA-YL-A9WX-01A	YES	Abnormal (not related to prostate cancer)	M0	T3a	-25008	34	1520		37	41	1506	0	1518	1506	1610			YES	No Evidence of Extraprostatic Extension	YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Additional New Tumor Event		2014-4-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	960		NO	Bilateral		NO	YES		Biochemical evidence of disease		YES	11	1	true	No	N1	T3b	TCGA-YL-A9WX.F7A04AAE-D1E0-4842-82AD-64F2813454F2.pdf		A9WX	WITH TUMOR	4	Complete Remission/Response	0.76	NO	R1	Primary Tumor	01	5			NO	3	NO	YES	YL	Middle		Prostate		A	LIVING	2009	Overlapping / Multiple Zones	31f4a718-276b-4bf1-a61b-b6d946a91c32	TCGA-YL-A9WX-01A-21D-A41J-01	TCGA-YL-A9WX-01A-21D-A41L-05		TCGA-YL-A9WX-01A-21D-A41K-08	31f4a718-276b-4bf1-a61b-b6d946a91c32	TCGA-YL-A9WX-01	TCGA-YL-A9WX-01	0CBC8995-ED23-4D97-93C5-7BA497715BFB	TCGA-YL-A9WX-01A-21D-A41J-01	31f4a718-276b-4bf1-a61b-b6d946a91c32	TCGA-YL-A9WX-01	TCGA-YL-A9WX-01			31f4a718-276b-4bf1-a61b-b6d946a91c32
TCGA-YL-A9WY-01	0	TCGA-YL-A9WY-01	1098	0	days	TCGA-YL-A9WY	975	1	days	1098	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57	TCGA-YL-A9WY-F67290	TCGA-YL-A9WY	TCGA-YL-A9WY-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-21164	50	785			62	765	0	1098	975	765			NO		YES	Extraprostatic Extension Localized (e.g. seminal vesicles)|Extraprostatic Extension (regional lymphadenopathy) [e.g. cN1]	Scheduled Follow-up Submission		2014-11-3	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	970		NO	Bilateral		NO	YES	Bone	Distant Metastasis		YES	19	11	true	No	N1	T3b	TCGA-YL-A9WY.50396173-9B31-42A1-81BC-9D2B5905E54A.pdf		A9WY	WITH TUMOR	5	Stable Disease	1.8	NO	R1	Primary Tumor	01	4			YES		NO	YES	YL	Apex|Middle|Base	YES	Prostate	Distant Metastasis	A	LIVING	2011	Overlapping / Multiple Zones	93dcc430-967c-4410-97ec-c3c814d9b826	TCGA-YL-A9WY-01A-11D-A41J-01	TCGA-YL-A9WY-01A-11D-A41L-05		TCGA-YL-A9WY-01A-11D-A41K-08	93dcc430-967c-4410-97ec-c3c814d9b826	TCGA-YL-A9WY-01	TCGA-YL-A9WY-01	D3C6C2E4-ABDF-4657-9911-F58B6B1BC7D7	TCGA-YL-A9WY-01A-11D-A41J-01	93dcc430-967c-4410-97ec-c3c814d9b826	TCGA-YL-A9WY-01	TCGA-YL-A9WY-01			93dcc430-967c-4410-97ec-c3c814d9b826
TCGA-ZG-A8QW-01	0	TCGA-ZG-A8QW-01	94	0	days	TCGA-ZG-A8QW	94	0	days	94	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			72	TCGA-ZG-A8QW-F67802	TCGA-ZG-A8QW	TCGA-ZG-A8QW-01A		Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-26632	8	156			43		0	94					NO		YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Scheduled Follow-up Submission	Stable Disease	2014-11-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	270		NO	Bilateral		NO	YES				NO	13	1	true	No	N1	T3b	TCGA-ZG-A8QW.6883BDF0-68B9-4D35-8A55-025C98AD2FCA.pdf		A8QW	TUMOR FREE	4	Progressive Disease		NO	R0	Primary Tumor	01	5			NO		NO	YES	ZG	Middle		Prostate		A	LIVING	2013	Overlapping / Multiple Zones	b3079945-f405-4810-b7cc-efa81b3b46ad	TCGA-ZG-A8QW-01A-11D-A376-01	TCGA-ZG-A8QW-01A-11D-A378-05		TCGA-ZG-A8QW-01A-11D-A377-08	b3079945-f405-4810-b7cc-efa81b3b46ad	TCGA-ZG-A8QW-01	TCGA-ZG-A8QW-01	69C5F470-7A6C-4C78-A6FF-3169267C2E61	TCGA-ZG-A8QW-01A-11D-A376-01	b3079945-f405-4810-b7cc-efa81b3b46ad	TCGA-ZG-A8QW-01	TCGA-ZG-A8QW-01		TCGA-ZG-A8QW-01A-11D-A377-08	b3079945-f405-4810-b7cc-efa81b3b46ad
TCGA-ZG-A8QX-01	0	TCGA-ZG-A8QX-01	442	0	days	TCGA-ZG-A8QX	442	0	days	442	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			56	TCGA-ZG-A8QX-F67804	TCGA-ZG-A8QX	TCGA-ZG-A8QX-01A			M0	T1c	-20683		167					0	442					NO		NO		Scheduled Follow-up Submission	Stable Disease	2014-11-12	MALE	6	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	210		NO	Bilateral		NO	YES				NO	18	0	true	No	N0	T2c	TCGA-ZG-A8QX.153CAD0D-4566-4BC2-B33D-FF1B44BA8E2B.pdf		A8QX	TUMOR FREE	3	Stable Disease		NO	R0	Primary Tumor	01	3			NO		NO	YES	ZG	Middle		Prostate		A	LIVING	2013	Overlapping / Multiple Zones	1727eb06-107a-4b21-97d7-20cabf1826ac	TCGA-ZG-A8QX-01A-11D-A376-01	TCGA-ZG-A8QX-01A-11D-A378-05		TCGA-ZG-A8QX-01A-11D-A377-08	1727eb06-107a-4b21-97d7-20cabf1826ac	TCGA-ZG-A8QX-01	TCGA-ZG-A8QX-01	62766243-996D-41B4-8268-5B0ECF3BD2E1	TCGA-ZG-A8QX-01A-11D-A376-01	1727eb06-107a-4b21-97d7-20cabf1826ac	TCGA-ZG-A8QX-01	TCGA-ZG-A8QX-01		TCGA-ZG-A8QX-01A-11D-A377-08	1727eb06-107a-4b21-97d7-20cabf1826ac
TCGA-ZG-A8QY-01	0	TCGA-ZG-A8QY-01	404	0	days	TCGA-ZG-A8QY	404	0	days	404	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			67	TCGA-ZG-A8QY-F67806	TCGA-ZG-A8QY	TCGA-ZG-A8QY-01A		Normal (no evidence of prostate cancer) [cM0]	M0	T2c	-24731	5	250			5		0	404					NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Stable Disease	2014-11-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	160		NO	Bilateral		NO	YES				NO	14	1	true	No	N1	T3b	TCGA-ZG-A8QY.4A09ACD5-F433-4F49-A47A-8DC4D5807E7A.pdf		A8QY	WITH TUMOR	5	Stable Disease		NO	RX	Primary Tumor	01	4			NO	3	NO	YES	ZG	Base		Prostate		A	LIVING	2013	Overlapping / Multiple Zones	bd991045-7c0f-404b-b9e6-63086f9c816f	TCGA-ZG-A8QY-01A-11D-A376-01	TCGA-ZG-A8QY-01A-11D-A378-05		TCGA-ZG-A8QY-01A-11D-A377-08	bd991045-7c0f-404b-b9e6-63086f9c816f	TCGA-ZG-A8QY-01	TCGA-ZG-A8QY-01	A8BBB1CC-9ABF-4560-AB3A-5AC05EA2B195	TCGA-ZG-A8QY-01A-11D-A376-01	bd991045-7c0f-404b-b9e6-63086f9c816f	TCGA-ZG-A8QY-01	TCGA-ZG-A8QY-01		TCGA-ZG-A8QY-01A-11D-A377-08	bd991045-7c0f-404b-b9e6-63086f9c816f
TCGA-ZG-A8QZ-01	0	TCGA-ZG-A8QZ-01	308	0	days	TCGA-ZG-A8QZ	308	0	days	308	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			65	TCGA-ZG-A8QZ-F67807	TCGA-ZG-A8QZ	TCGA-ZG-A8QZ-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-23980	12	322		42			0	308		239			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Stable Disease	2014-11-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	110		NO	Bilateral		NO	YES				NO	8	1	true	No	N1	T3b	TCGA-ZG-A8QZ.930A234B-9B7E-4F2C-905C-AF4CCB5570CB.pdf		A8QZ	TUMOR FREE	4	Stable Disease	0.01	YES	R1	Primary Tumor	01	5			YES	3	NO	YES	ZG	Middle		Prostate		A	LIVING	2013	Overlapping / Multiple Zones	8d4a6058-e687-4bb7-afdc-e9936fdc49b1	TCGA-ZG-A8QZ-01A-11D-A376-01	TCGA-ZG-A8QZ-01A-11D-A378-05		TCGA-ZG-A8QZ-01A-11D-A377-08	8d4a6058-e687-4bb7-afdc-e9936fdc49b1	TCGA-ZG-A8QZ-01	TCGA-ZG-A8QZ-01	372C0BA9-E7D1-4121-9B3E-57EF147FBC27	TCGA-ZG-A8QZ-01A-11D-A376-01	8d4a6058-e687-4bb7-afdc-e9936fdc49b1	TCGA-ZG-A8QZ-01	TCGA-ZG-A8QZ-01		TCGA-ZG-A8QZ-01A-11D-A377-08	8d4a6058-e687-4bb7-afdc-e9936fdc49b1
TCGA-ZG-A9KY-01	0	TCGA-ZG-A9KY-01	130	0	days	TCGA-ZG-A9KY	130	0	days	130	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			73	TCGA-ZG-A9KY-F67809	TCGA-ZG-A9KY	TCGA-ZG-A9KY-01A		Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-27000	14	112		14			0	130					YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Stable Disease	2014-11-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	120		NO	Bilateral		NO	YES				NO	16	2	true	No	N1	T4	TCGA-ZG-A9KY.2E48E905-FCAF-4A5F-A2E0-600276051562.pdf		A9KY		5	Stable Disease		NO	R1	Primary Tumor	01	4			NO		NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2013	Overlapping / Multiple Zones	8083711c-418c-49d4-9717-0e494b50103e	TCGA-ZG-A9KY-01A-11D-A41J-01	TCGA-ZG-A9KY-01A-11D-A41L-05		TCGA-ZG-A9KY-01A-11D-A41K-08	8083711c-418c-49d4-9717-0e494b50103e	TCGA-ZG-A9KY-01	TCGA-ZG-A9KY-01	61934BAA-E8B2-4A8F-8CC9-FB7E9CE948A7	TCGA-ZG-A9KY-01A-11D-A41J-01	8083711c-418c-49d4-9717-0e494b50103e	TCGA-ZG-A9KY-01	TCGA-ZG-A9KY-01			8083711c-418c-49d4-9717-0e494b50103e
TCGA-ZG-A9L0-01	0	TCGA-ZG-A9L0-01	355	0	days	TCGA-ZG-A9L0	355	0	days	355	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			71	TCGA-ZG-A9L0-F67810	TCGA-ZG-A9L0	TCGA-ZG-A9L0-01A		Normal (no evidence of prostate cancer) [cM0]	M0		-26055	-16	152		-119			0	355					YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Stable Disease	2014-11-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	420		NO	Bilateral		NO	YES				NO	20	7	true	No	N1	T3b	TCGA-ZG-A9L0.F5D6CACB-458D-4C16-972E-EF6848DEC4D8.pdf		A9L0	TUMOR FREE	5	Stable Disease		NO	R1	Primary Tumor	01	4			NO	3	NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2013	Overlapping / Multiple Zones	02fc78ec-68ae-4326-8df1-4f69850b5edd	TCGA-ZG-A9L0-01A-11D-A41J-01	TCGA-ZG-A9L0-01A-11D-A41L-05		TCGA-ZG-A9L0-01A-11D-A41K-08	02fc78ec-68ae-4326-8df1-4f69850b5edd	TCGA-ZG-A9L0-01	TCGA-ZG-A9L0-01	B7665C69-C511-4B00-B4CB-4569CFF2586A	TCGA-ZG-A9L0-01A-11D-A41J-01	02fc78ec-68ae-4326-8df1-4f69850b5edd	TCGA-ZG-A9L0-01	TCGA-ZG-A9L0-01			02fc78ec-68ae-4326-8df1-4f69850b5edd
TCGA-ZG-A9L1-01	0	TCGA-ZG-A9L1-01	1302	0	days	TCGA-ZG-A9L1	1302	0	days	1302	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-ZG-A9L1-F67811	TCGA-ZG-A9L1	TCGA-ZG-A9L1-01A	NO		M0	T1c	-24214		1246					0	1302		1147							Scheduled Follow-up Submission	Stable Disease	2014-11-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	750		NO	Bilateral		NO	YES				NO	7	1	true	No	N1	T3b	TCGA-ZG-A9L1.1F620B81-F034-4F28-8DE0-6B19D181D24F.pdf		A9L1	WITH TUMOR	4	Progressive Disease	0.07	YES	R1	Primary Tumor	01	5			NO		NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2010	Peripheral Zone	adda35fc-181d-4a0c-9afe-f2bdd83ab087	TCGA-ZG-A9L1-01A-11D-A41J-01	TCGA-ZG-A9L1-01A-11D-A41L-05		TCGA-ZG-A9L1-01A-11D-A41K-08	adda35fc-181d-4a0c-9afe-f2bdd83ab087	TCGA-ZG-A9L1-01	TCGA-ZG-A9L1-01	18D1E7A6-D33C-472A-A504-F8E0B978B262	TCGA-ZG-A9L1-01A-11D-A41J-01	adda35fc-181d-4a0c-9afe-f2bdd83ab087	TCGA-ZG-A9L1-01	TCGA-ZG-A9L1-01			adda35fc-181d-4a0c-9afe-f2bdd83ab087
TCGA-ZG-A9L2-01	0	TCGA-ZG-A9L2-01	1154	0	days	TCGA-ZG-A9L2	1154	0	days	1154	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			70	TCGA-ZG-A9L2-F67812	TCGA-ZG-A9L2	TCGA-ZG-A9L2-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-25573	6	1056				180	0	1154		1137			NO		NO		Scheduled Follow-up Submission	Stable Disease	2014-11-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	390		NO			NO	YES				NO	14	0	true	No	N0	T3b	TCGA-ZG-A9L2.CA9BA514-709C-48BA-B620-48BFBBA35493.pdf		A9L2	WITH TUMOR	4	Stable Disease	0.01	NO	R1	Primary Tumor	01	5			NO	3	NO	YES	ZG			Prostate		A	LIVING	2011	Peripheral Zone	08fc16b8-f635-4e11-9ee7-afc7e3ea084c	TCGA-ZG-A9L2-01A-31D-A41J-01	TCGA-ZG-A9L2-01A-31D-A41L-05		TCGA-ZG-A9L2-01A-31D-A41K-08	08fc16b8-f635-4e11-9ee7-afc7e3ea084c	TCGA-ZG-A9L2-01	TCGA-ZG-A9L2-01		TCGA-ZG-A9L2-01A-31D-A41J-01	08fc16b8-f635-4e11-9ee7-afc7e3ea084c	TCGA-ZG-A9L2-01	TCGA-ZG-A9L2-01			08fc16b8-f635-4e11-9ee7-afc7e3ea084c
TCGA-ZG-A9L4-01	0	TCGA-ZG-A9L4-01	1108	0	days	TCGA-ZG-A9L4	1108	0	days	1108	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			61	TCGA-ZG-A9L4-F67814	TCGA-ZG-A9L4	TCGA-ZG-A9L4-01A	NO		M0	T1c	-22388		986					0	1108		1108							Scheduled Follow-up Submission	Stable Disease	2014-11-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	170		NO	Bilateral		NO	YES				NO	10	0	true	No	N0	T3b	TCGA-ZG-A9L4.BC344956-732B-4A0A-9493-299442B05CD1.pdf		A9L4		5	Stable Disease	0.03	NO	R1	Primary Tumor	01	4			NO	3	NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2011	Overlapping / Multiple Zones	52371577-673b-43b9-ae0b-5dd12bd2dc32	TCGA-ZG-A9L4-01A-11D-A41J-01	TCGA-ZG-A9L4-01A-11D-A41L-05		TCGA-ZG-A9L4-01A-11D-A41K-08	52371577-673b-43b9-ae0b-5dd12bd2dc32	TCGA-ZG-A9L4-01	TCGA-ZG-A9L4-01	F849CCAA-6DC7-499B-84BF-1DDCBC739068	TCGA-ZG-A9L4-01A-11D-A41J-01	52371577-673b-43b9-ae0b-5dd12bd2dc32	TCGA-ZG-A9L4-01	TCGA-ZG-A9L4-01			52371577-673b-43b9-ae0b-5dd12bd2dc32
TCGA-ZG-A9L5-01	0	TCGA-ZG-A9L5-01	908	0	days	TCGA-ZG-A9L5	908	0	days	908	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			58	TCGA-ZG-A9L5-F67815	TCGA-ZG-A9L5	TCGA-ZG-A9L5-01A	NO		M0	T2a	-21293		953		11			0	908					YES	Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1]	NO		Scheduled Follow-up Submission	Stable Disease	2014-11-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	460		NO	Bilateral		NO	YES				NO	3	1	true	No	N1	T4	TCGA-ZG-A9L5.FE097411-281D-4804-BAB4-D732A95EC689.pdf		A9L5	WITH TUMOR	5	Progressive Disease		NO	R1	Primary Tumor	01	4			YES	3	NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2011	Overlapping / Multiple Zones	8778e5a4-d61f-4fe0-a917-1f8036f85907	TCGA-ZG-A9L5-01A-12D-A41J-01	TCGA-ZG-A9L5-01A-12D-A41L-05		TCGA-ZG-A9L5-01A-12D-A41K-08	8778e5a4-d61f-4fe0-a917-1f8036f85907	TCGA-ZG-A9L5-01	TCGA-ZG-A9L5-01	8D0E8768-C83B-46BC-8ED9-CFAC222887BC	TCGA-ZG-A9L5-01A-12D-A41J-01	8778e5a4-d61f-4fe0-a917-1f8036f85907	TCGA-ZG-A9L5-01	TCGA-ZG-A9L5-01			8778e5a4-d61f-4fe0-a917-1f8036f85907
TCGA-ZG-A9L6-01	0	TCGA-ZG-A9L6-01	687	0	days	TCGA-ZG-A9L6	687	0	days	687	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate	NO	NO	64	TCGA-ZG-A9L6-F67817	TCGA-ZG-A9L6	TCGA-ZG-A9L6-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-23681	13	733		13		664	0	687		664			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Stable Disease	2014-11-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	520		NO	Bilateral		NO	YES				NO	25	0	true	No	N0	T3b	TCGA-ZG-A9L6.1EAD6485-88D7-467C-8E00-335B3D7056B7.pdf		A9L6	WITH TUMOR	5	Partial Remission/Response	0.36	NO	R1	Primary Tumor	01	4			NO	3	NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2011	Overlapping / Multiple Zones	6cd409f7-0933-4fa5-a998-735eadfb30ab	TCGA-ZG-A9L6-01A-11D-A41J-01	TCGA-ZG-A9L6-01A-11D-A41L-05		TCGA-ZG-A9L6-01A-11D-A41K-08	6cd409f7-0933-4fa5-a998-735eadfb30ab	TCGA-ZG-A9L6-01	TCGA-ZG-A9L6-01	19BE2718-6344-4281-B3E6-A6972613DCE5	TCGA-ZG-A9L6-01A-11D-A41J-01	6cd409f7-0933-4fa5-a998-735eadfb30ab	TCGA-ZG-A9L6-01	TCGA-ZG-A9L6-01			6cd409f7-0933-4fa5-a998-735eadfb30ab
TCGA-ZG-A9L9-01	0	TCGA-ZG-A9L9-01	617	0	days	TCGA-ZG-A9L9	617	0	days	617	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			60	TCGA-ZG-A9L9-F67816	TCGA-ZG-A9L9	TCGA-ZG-A9L9-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-22108	-4	665			0	51	0	617					NO		YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Scheduled Follow-up Submission	Stable Disease	2014-11-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	270		NO	Bilateral		NO	YES				NO	15	3	true	No	N1	T3b	TCGA-ZG-A9L9.89DB264B-7026-4A51-BF05-A0629F25CFF6.pdf		A9L9	WITH TUMOR	4	Progressive Disease		YES	R1	Primary Tumor	01	5			NO		NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones	2718ed2d-63b0-4699-b23d-dacb86e6c926	TCGA-ZG-A9L9-01A-11D-A41J-01	TCGA-ZG-A9L9-01A-11D-A41L-05		TCGA-ZG-A9L9-01A-11D-A41K-08	2718ed2d-63b0-4699-b23d-dacb86e6c926	TCGA-ZG-A9L9-01	TCGA-ZG-A9L9-01	532C9277-1271-4C8A-8DB1-F27D23774854	TCGA-ZG-A9L9-01A-11D-A41J-01	2718ed2d-63b0-4699-b23d-dacb86e6c926	TCGA-ZG-A9L9-01	TCGA-ZG-A9L9-01			2718ed2d-63b0-4699-b23d-dacb86e6c926
TCGA-ZG-A9LB-01	0	TCGA-ZG-A9LB-01	583	0	days	TCGA-ZG-A9LB	583	0	days	583	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			72	TCGA-ZG-A9LB-F67821	TCGA-ZG-A9LB	TCGA-ZG-A9LB-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-26447	21	629		31			0	583		485			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Stable Disease	2014-11-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	380		NO	Right		NO	YES				NO	9	0	true	No	N0	T3b	TCGA-ZG-A9LB.224AC4AB-11CC-4832-90FD-937C3C7B4C8E.pdf		A9LB	WITH TUMOR	5	Partial Remission/Response	0.02	NO	R1	Primary Tumor	01	4			NO		NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones	5eef1fb4-f7a7-4e33-bb83-5f589f9a4642	TCGA-ZG-A9LB-01A-11D-A41J-01	TCGA-ZG-A9LB-01A-11D-A41L-05		TCGA-ZG-A9LB-01A-11D-A41K-08	5eef1fb4-f7a7-4e33-bb83-5f589f9a4642	TCGA-ZG-A9LB-01	TCGA-ZG-A9LB-01	FBD53A68-B330-46D3-99B3-A780B80CFDCC	TCGA-ZG-A9LB-01A-11D-A41J-01	5eef1fb4-f7a7-4e33-bb83-5f589f9a4642	TCGA-ZG-A9LB-01	TCGA-ZG-A9LB-01			5eef1fb4-f7a7-4e33-bb83-5f589f9a4642
TCGA-ZG-A9LM-01	0	TCGA-ZG-A9LM-01	378	0	days	TCGA-ZG-A9LM	378	0	days	378	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			72	TCGA-ZG-A9LM-F67938	TCGA-ZG-A9LM	TCGA-ZG-A9LM-01A	NO		M0	T2b	-26377		251		14			0	378		121			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-13	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	170		NO	Right		NO	YES				NO	11	2	true	No	N1	T3a	TCGA-ZG-A9LM.C66F9B46-7652-4BB9-B554-B9AB372EC7BC.pdf		A9LM	TUMOR FREE	4	Complete Remission/Response	0.0	NO	R0	Primary Tumor	01	5			NO	3	NO	YES	ZG	Middle|Base		Prostate		A	LIVING	2013	Peripheral Zone	a79de49e-9b1c-4512-b6ed-df4a858c4875	TCGA-ZG-A9LM-01A-11D-A41J-01	TCGA-ZG-A9LM-01A-11D-A41L-05		TCGA-ZG-A9LM-01A-11D-A41K-08	a79de49e-9b1c-4512-b6ed-df4a858c4875	TCGA-ZG-A9LM-01	TCGA-ZG-A9LM-01	DA03B6A0-2B3C-4D85-9C7B-C1B8411A478D	TCGA-ZG-A9LM-01A-11D-A41J-01	a79de49e-9b1c-4512-b6ed-df4a858c4875	TCGA-ZG-A9LM-01	TCGA-ZG-A9LM-01			a79de49e-9b1c-4512-b6ed-df4a858c4875
TCGA-ZG-A9LN-01	0	TCGA-ZG-A9LN-01	115	0	days	TCGA-ZG-A9LN	115	0	days	115	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			57	TCGA-ZG-A9LN-F67937	TCGA-ZG-A9LN	TCGA-ZG-A9LN-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-21050	3	76		9	7		0	115		90			YES	No Evidence of Extraprostatic Extension	YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Stable Disease	2014-11-13	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	60		NO	Bilateral		NO	YES				NO	10	6	true	No	N1	T3b	TCGA-ZG-A9LN.3B5E5429-7D1E-4AD2-8329-DC784D412393.pdf		A9LN	WITH TUMOR	5	Partial Remission/Response	7.42	NO	R1	Primary Tumor	01	4			YES		NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2013	Overlapping / Multiple Zones	60e9a97e-8cf7-465c-9a31-7c0b714fbf95	TCGA-ZG-A9LN-01A-11D-A41J-01	TCGA-ZG-A9LN-01A-11D-A41L-05		TCGA-ZG-A9LN-01A-11D-A41K-08	60e9a97e-8cf7-465c-9a31-7c0b714fbf95	TCGA-ZG-A9LN-01	TCGA-ZG-A9LN-01		TCGA-ZG-A9LN-01A-11D-A41J-01	60e9a97e-8cf7-465c-9a31-7c0b714fbf95	TCGA-ZG-A9LN-01	TCGA-ZG-A9LN-01			60e9a97e-8cf7-465c-9a31-7c0b714fbf95
TCGA-ZG-A9LS-01	0	TCGA-ZG-A9LS-01	516	0	days	TCGA-ZG-A9LS	516	0	days	516	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			64	TCGA-ZG-A9LS-F67932	TCGA-ZG-A9LS	TCGA-ZG-A9LS-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-23540	16	215		16			0	516		147			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-13	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	190		NO	Bilateral		NO	YES				NO	47	3	true	No	N1	T3b	TCGA-ZG-A9LS.C08F26E6-5CC1-42FC-9533-D4199A5CE8B4.pdf		A9LS	TUMOR FREE	5	Complete Remission/Response	0.03	YES	R1	Primary Tumor	01	4			NO		NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2013	Central Zone	580772bc-57d8-4be2-ad7f-e4d0a8d754a4	TCGA-ZG-A9LS-01A-12D-A41J-01	TCGA-ZG-A9LS-01A-12D-A41L-05		TCGA-ZG-A9LS-01A-12D-A41K-08	580772bc-57d8-4be2-ad7f-e4d0a8d754a4	TCGA-ZG-A9LS-01	TCGA-ZG-A9LS-01	30B90749-1BE3-4C06-8506-A180B5AA129B	TCGA-ZG-A9LS-01A-12D-A41J-01	580772bc-57d8-4be2-ad7f-e4d0a8d754a4	TCGA-ZG-A9LS-01	TCGA-ZG-A9LS-01			580772bc-57d8-4be2-ad7f-e4d0a8d754a4
TCGA-ZG-A9LU-01	0	TCGA-ZG-A9LU-01	579	0	days	TCGA-ZG-A9LU	579	0	days	579	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			67	TCGA-ZG-A9LU-F67851	TCGA-ZG-A9LU	TCGA-ZG-A9LU-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-24742	37	617			40		0	579		549			NO		YES	No Evidence of Extraprostatic Extension	Scheduled Follow-up Submission	Stable Disease	2014-11-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	380		NO	Bilateral		NO	YES				NO	7	0	true	No	N0	T3a	TCGA-ZG-A9LU.DC8CC307-723F-4E7F-AD59-4936BFA55789.pdf		A9LU	WITH TUMOR	5	Partial Remission/Response	0.70	YES	R1	Primary Tumor	01	4			NO		NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones	39c01e87-6cb4-47f5-9ecd-be16781ef1f2	TCGA-ZG-A9LU-01A-11D-A41J-01	TCGA-ZG-A9LU-01A-11D-A41L-05		TCGA-ZG-A9LU-01A-11D-A41K-08	39c01e87-6cb4-47f5-9ecd-be16781ef1f2	TCGA-ZG-A9LU-01	TCGA-ZG-A9LU-01	A0185263-3366-42BD-AD0F-2B61EC64B0FB	TCGA-ZG-A9LU-01A-11D-A41J-01	39c01e87-6cb4-47f5-9ecd-be16781ef1f2	TCGA-ZG-A9LU-01	TCGA-ZG-A9LU-01			39c01e87-6cb4-47f5-9ecd-be16781ef1f2
TCGA-ZG-A9LY-01	0	TCGA-ZG-A9LY-01	370	0	days	TCGA-ZG-A9LY	370	0	days	370	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			60	TCGA-ZG-A9LY-F67845	TCGA-ZG-A9LY	TCGA-ZG-A9LY-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2b	-21942	20	404		12			0	370		288			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Complete Remission/Response	2014-11-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	100		NO	Bilateral		NO	YES				NO	11	1	true	No	N1	T3b	TCGA-ZG-A9LY.E4B3E97A-9587-47C2-BE35-C67B268CA133.pdf		A9LY	TUMOR FREE	4	Complete Remission/Response	0.01	YES	R1	Primary Tumor	01	5			NO	3	NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones	c672c2b4-da56-4584-9126-4d59b5cecc1b	TCGA-ZG-A9LY-01A-11D-A41J-01	TCGA-ZG-A9LY-01A-11D-A41L-05		TCGA-ZG-A9LY-01A-11D-A41K-08	c672c2b4-da56-4584-9126-4d59b5cecc1b	TCGA-ZG-A9LY-01	TCGA-ZG-A9LY-01	97F5F5F2-5652-47F1-8108-A8DFDE7819CB	TCGA-ZG-A9LY-01A-11D-A41J-01	c672c2b4-da56-4584-9126-4d59b5cecc1b	TCGA-ZG-A9LY-01	TCGA-ZG-A9LY-01			c672c2b4-da56-4584-9126-4d59b5cecc1b
TCGA-ZG-A9LZ-01	0	TCGA-ZG-A9LZ-01	692	0	days	TCGA-ZG-A9LZ	692	0	days	692	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			66	TCGA-ZG-A9LZ-F67847	TCGA-ZG-A9LZ	TCGA-ZG-A9LZ-01A	YES	Normal (no evidence of prostate cancer) [cM0]	M0	T3a	-24132	-15	817		-9		310	0	692		692			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Stable Disease	2014-11-12	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	170		NO	Bilateral		NO	YES				NO	5	0	true	No	N0	T3b	TCGA-ZG-A9LZ.D8F34923-C864-4CCC-9012-E74DE7A483CE.pdf		A9LZ	WITH TUMOR	4	Partial Remission/Response	2.19	YES	R1	Primary Tumor	01	5			NO	3	NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2011	Overlapping / Multiple Zones	0e33492b-b79a-42cc-8820-f077875a9384	TCGA-ZG-A9LZ-01A-11D-A41J-01	TCGA-ZG-A9LZ-01A-11D-A41L-05		TCGA-ZG-A9LZ-01A-11D-A41K-08	0e33492b-b79a-42cc-8820-f077875a9384	TCGA-ZG-A9LZ-01	TCGA-ZG-A9LZ-01	CB1BEFDC-A7BC-4989-A390-F8C000D8652E	TCGA-ZG-A9LZ-01A-11D-A41J-01	0e33492b-b79a-42cc-8820-f077875a9384	TCGA-ZG-A9LZ-01	TCGA-ZG-A9LZ-01			0e33492b-b79a-42cc-8820-f077875a9384
TCGA-ZG-A9M4-01	0	TCGA-ZG-A9M4-01	547	0	days	TCGA-ZG-A9M4	547	0	days	547	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			65	TCGA-ZG-A9M4-F67945	TCGA-ZG-A9M4	TCGA-ZG-A9M4-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-24030	21	509		22			0	547		218			YES	Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1]	NO		Scheduled Follow-up Submission	Stable Disease	2014-11-13	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	150		NO	Bilateral		NO	YES				NO	18	1	true	No	N1	T3b	TCGA-ZG-A9M4.86764ADF-5B8B-4989-99AA-595616A115A4.pdf		A9M4	WITH TUMOR	5	Partial Remission/Response	0.95	NO	R1	Primary Tumor	01	4			NO		NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2012	Overlapping / Multiple Zones	9c1dbf62-a42a-4a60-84bb-98715d9a4b60	TCGA-ZG-A9M4-01A-11D-A41J-01	TCGA-ZG-A9M4-01A-11D-A41L-05		TCGA-ZG-A9M4-01A-11D-A41K-08	9c1dbf62-a42a-4a60-84bb-98715d9a4b60	TCGA-ZG-A9M4-01	TCGA-ZG-A9M4-01	691D3F9B-5F1D-4D41-B54E-ECC3D69DB7C2	TCGA-ZG-A9M4-01A-11D-A41J-01	9c1dbf62-a42a-4a60-84bb-98715d9a4b60	TCGA-ZG-A9M4-01	TCGA-ZG-A9M4-01			9c1dbf62-a42a-4a60-84bb-98715d9a4b60
TCGA-ZG-A9MC-01	0	TCGA-ZG-A9MC-01	455	0	days	TCGA-ZG-A9MC	455	0	days	455	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			69	TCGA-ZG-A9MC-F67960	TCGA-ZG-A9MC	TCGA-ZG-A9MC-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-25477	3	434			0		0	455		427			NO		YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Scheduled Follow-up Submission	Stable Disease	2014-11-13	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	230		NO	Bilateral		NO	YES				NO	14	2	true	No	N1	T3b	TCGA-ZG-A9MC.1B48B5AE-27A9-4D79-923C-14AF6DE4B4E0.pdf		A9MC	WITH TUMOR	5	Partial Remission/Response	31.85	YES	R1	Primary Tumor	01	4			NO	3	NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2012	Peripheral Zone	d992a3c1-fe30-4d15-a4e6-4e250e834da2	TCGA-ZG-A9MC-01A-31D-A41J-01	TCGA-ZG-A9MC-01A-31D-A41L-05		TCGA-ZG-A9MC-01A-31D-A41K-08	d992a3c1-fe30-4d15-a4e6-4e250e834da2	TCGA-ZG-A9MC-01	TCGA-ZG-A9MC-01	70BAE419-1B3E-4245-831B-D8B87E9F019C	TCGA-ZG-A9MC-01A-31D-A41J-01	d992a3c1-fe30-4d15-a4e6-4e250e834da2	TCGA-ZG-A9MC-01	TCGA-ZG-A9MC-01			d992a3c1-fe30-4d15-a4e6-4e250e834da2
TCGA-ZG-A9N3-01	0	TCGA-ZG-A9N3-01	349	0	days	TCGA-ZG-A9N3	349	0	days	349	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			73	TCGA-ZG-A9N3-F68209	TCGA-ZG-A9N3	TCGA-ZG-A9N3-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-26902	7	69			7		0	349		244			NO		YES	Extraprostatic Extension Localized (e.g. seminal vesicles)	Scheduled Follow-up Submission	Stable Disease	2014-11-14	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	210		NO	Bilateral		NO	YES				NO	30	1	true	No	N1	T3b	TCGA-ZG-A9N3.C97CA9D4-71F2-4068-9959-BF8F7829189C.pdf		A9N3	WITH TUMOR	5	Partial Remission/Response	0.1	NO	R1	Primary Tumor	01	4			YES	3	NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2013	Overlapping / Multiple Zones	2ee45f38-cb92-4e91-acea-e454a13f59d9	TCGA-ZG-A9N3-01A-11D-A41J-01	TCGA-ZG-A9N3-01A-11D-A41L-05		TCGA-ZG-A9N3-01A-11D-A41K-08	2ee45f38-cb92-4e91-acea-e454a13f59d9	TCGA-ZG-A9N3-01	TCGA-ZG-A9N3-01	BC0DA73E-2A1F-4853-8AD0-FB8649A7FD48	TCGA-ZG-A9N3-01A-11D-A41J-01	2ee45f38-cb92-4e91-acea-e454a13f59d9	TCGA-ZG-A9N3-01	TCGA-ZG-A9N3-01			2ee45f38-cb92-4e91-acea-e454a13f59d9
TCGA-ZG-A9ND-01	0	TCGA-ZG-A9ND-01	410	0	days	TCGA-ZG-A9ND	410	0	days	410	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			55	TCGA-ZG-A9ND-F68219	TCGA-ZG-A9ND	TCGA-ZG-A9ND-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T1c	-20428	7	283		10			0	410		184			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission	Stable Disease	2014-11-14	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	80		NO	Bilateral		NO	YES				NO	8	0	true	No	N0	T3a	TCGA-ZG-A9ND.89122E71-1246-44A5-9D44-4F95284EB02E.pdf		A9ND	TUMOR FREE	5	Complete Remission/Response	0.08	NO	R0	Primary Tumor	01	4			NO	3	NO	YES	ZG	Apex|Middle		Prostate		A	LIVING	2013	Overlapping / Multiple Zones	35a82435-e313-4206-b328-b2b1db736aef	TCGA-ZG-A9ND-01A-11D-A41J-01	TCGA-ZG-A9ND-01A-11D-A41L-05		TCGA-ZG-A9ND-01A-11D-A41K-08	35a82435-e313-4206-b328-b2b1db736aef	TCGA-ZG-A9ND-01	TCGA-ZG-A9ND-01		TCGA-ZG-A9ND-01A-11D-A41J-01	35a82435-e313-4206-b328-b2b1db736aef	TCGA-ZG-A9ND-01	TCGA-ZG-A9ND-01			35a82435-e313-4206-b328-b2b1db736aef
TCGA-ZG-A9NI-01	0	TCGA-ZG-A9NI-01	132	0	days	TCGA-ZG-A9NI	132	0	days	132	days	TCGA Prostate Cancer (PRAD)	prostate adenocarcinoma	Prostate			73	TCGA-ZG-A9NI-F67955	TCGA-ZG-A9NI	TCGA-ZG-A9NI-01A	NO	Normal (no evidence of prostate cancer) [cM0]	M0	T2a	-26697	22	139		22			0	132		99			YES	No Evidence of Extraprostatic Extension	NO		Scheduled Follow-up Submission		2014-11-13	MALE	9	Prostate Adenocarcinoma Acinar Type	No	C61	8140/3	C61.9	YES	Core needle biopsy	160		NO	Bilateral		NO	YES				NO	21	0	true	No	N0	T3b	TCGA-ZG-A9NI.70DD94DF-13D1-40FC-A52B-43E2229563E3.pdf		A9NI	TUMOR FREE	5	Complete Remission/Response	0.03	NO	R1	Primary Tumor	01	4			NO	3	NO	YES	ZG	Apex|Middle|Base		Prostate		A	LIVING	2013	Overlapping / Multiple Zones	ed5fb1bc-ffb9-4946-89e0-73635d84f448	TCGA-ZG-A9NI-01A-11D-A41J-01	TCGA-ZG-A9NI-01A-11D-A41L-05		TCGA-ZG-A9NI-01A-11D-A41K-08	ed5fb1bc-ffb9-4946-89e0-73635d84f448	TCGA-ZG-A9NI-01	TCGA-ZG-A9NI-01	6341FCBF-06E0-43F2-80AE-FDDB1C7D120F	TCGA-ZG-A9NI-01A-11D-A41J-01	ed5fb1bc-ffb9-4946-89e0-73635d84f448	TCGA-ZG-A9NI-01	TCGA-ZG-A9NI-01			ed5fb1bc-ffb9-4946-89e0-73635d84f448
